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Scope 
 
Over the past decades our understanding of plant biology has been ever increasing thanks to elaborate 
development of genetics approaches. Classical genetics approaches have been, and still are very 
powerful tools to attribute a phenotype to a gene or group of genes. Different strategies allow us to 
further inquire gene function once it has been linked to a certain phenotype, such as over expression 
analysis and fluorescent labeling. Directed mutagenesis (i.e. amino acid substitutions) enables an 
even higher degree of characterization, as it allows to dissect protein function at the level of its 
primary sequence. Yet one of genetics inherit characteristics, alteration of the genome, can be a 
disadvantage in certain occasions. Essential genes can pose a problem as mutations are often lethal, 
while redundancy might imply that higher order mutants have to be generated, which are difficult to 
obtain and work with. In addition, highly dynamic processes, such as hormonal signaling and 
endomembrane traffic are difficult to approach dynamically at the protein level, as alterations in the 
genome imply a steady state. A possible solution might be provided by application of small molecules 
which alter protein function. Called chemical biology, application of small molecules to induce a 
particular phenotype can have important advantages over classical genetics approaches. In particular 
it’s conditional nature, certainly when small molecule binding is reversible, allow to probe essential 
gene function directly at the protein level. In addition, conditionality of small molecule application 
can serve as an on-off switch for processes such as hormone signaling and endomembrane traffic. 
Chemical biology is not restricted to altered protein function in presence of the small molecule of 
interest, but can also include the study on other mode of actions, such as binding to lipids. Chemical 
genetics therefore refers to the study of linking the phenotype induced by a small molecule to a protein 
or protein family, and thus gene function.  
This PhD thesis is geared towards an exploration of chemical genetics approaches in plant biology, 
with a special focus on small molecules which perturb endomembrane traffic and brassinosteroid 
signaling. Our starting point is a collection of small molecules which have been selected for their 
potential to affect endomembrane traffic. Screening of these small molecules for a variety of readouts 
is set to identify a select group which will be subject to further in depth characterization and target 
identification. We primarily aim to select those small molecules which affect clathrin-mediated 
endocytosis and brassinosteroid signaling, and to emphasize on biochemical target identification and 
validation of one hit molecule, as such approaches are best suited to identify the interactome of the 
small molecule. The interactome is the defined set of proteins which interacts with the small molecule 
of interest, and which are responsible for the overall phenotype induced by the small molecule. We 
will emphasize on interactors which are linked to endomembrane trafficking, and more specifically 
clathrin-mediated endocytosis, and attempt to characterize their contribution to the trafficking 
phenotype induced by the small molecule.  
In addition, we will attempt to predict target proteins of a small molecule hit by computational means, 
as this method of target identification is hardly explored in plant chemical genetics.although more of 
a side project, it concerns a proof of concept study where proteins identified as possible hits are set 
to be characterized in terms of biological function and as target proteins of the small molecule of 
interest. 
Furthermore, we discuss the advantages and disadvantages of chemical biology and biochemical 
target identification, and reflect on the future direction of plant chemical biology. 
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Summary 
This work explores chemical biology approaches in plant biology, with an emphasis on small 
molecules which affect clathrin-mediated endocytosis (CME) and brassinosteroid signaling. It first 
provides an introduction on small molecules which have contributed to a better understanding of 
brassinosteroid signaling and endomembrane traffic. The latter set of small molecules is restricted to 
small molecules identified through screening. Different target identification strategies are introduced, 
encompassing classical approaches such as resistance screens, and approaches which are less 
common in plant chemical biology, such as affinity purification. In the next chapter we introduce a 
screen for small molecule effectors of CME and brassinosteroid signaling which led to the selection 
of two promising hit molecules. The first hit, namely Endosidin 9 (ES9), was further characterized 
and different analogs were selected and characterized for structure activity relation analysis in order 
to identify chemical groups of ES9 which might tolerate modification for affinity purification. 
Characterization revealed ES9 mainly acts as an chemical uncoupler of proton gradients, with 
important implications on energy metabolism, pH homeostasis and dynamic processes in the cell, 
including CME. This mode of action also appeared to be conserved in other systems and is 
reminiscent of a known chemical uncoupler, but mimics also the known CME inhibitor Tyrphostin 
A23. The latter observation is new for the plant field, and implications are discussed. An analogue of 
ES9 was identified which retained the ability to inhibit CME, yet lacked characteristics of an 
uncoupler. These findings were the result of a further characterization of ES9 in different systems, 
revealing an additional mode of action aside the uncoupler effect. The analog ES9-17 proved to be 
more specific compared to ES9, and was found to bind to clathrin heavy chain as a result of affinity 
purification. We therefore present, what is to our knowledge the only specific small molecule 
inhibitor of clathrin-mediated trafficking, including CME, in Arabidopsis. 
A second small molecule hit from the screen was used in a target identification approach which was 
based on computational prediction of target proteins in plants with a human protein as a template. 
The human protein binds a drug, Rosiglitazone, which harbors the same chemical groups as our small 
molecule hit. We identified a plant specific trans-membrane protein family, for which we attempt to 
prove their binding to the small molecule hit through mutant analysis. In addition, we began to 
characterize the protein family, as it is a protein family of unknown function. Finally we discuss our 
findings in a more general perspective, highlighting important findings for the plant chemical biology 
field, and suggest a preferred target identification approach for small molecule modulators of 
endomembrane traffic. 
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Samenvatting 
Deze studie omvat een exploratie van chemische biologie in planten, met een speciale focus op kleine 
moleculen die een invloed hebben op de brassinosteroïde signalisatie en clathrine gemedieerde 
endocytose. Dergelijke kleine moleculen creëren de mogelijkheid om de onderlinge relatie te 
onderzoeken tussen brassinosteroïde signalisatie en endomembraan trafiek in Arabidopsis. 
De introductie schets een overzicht van de huidige stand van zaken in onderzoek naar 
brassinosteroïden en endomembraan trafiek, waarbij kleine moleculen als werktuig dienen om 
relevante moleculaire processen op een specifieke en dynamische manier te verstoren. In het kader 
van endomembraan trafiek vergelijken we dierlijke systemen met planten systemen, maar beperken 
we ons wel tot enkel kleine moleculen die geïdentificeerd werden door middel van screenings. 
Vervolgens geven we een plant gericht overzicht van klassieke en relatief nieuwe methoden om de 
eiwitten te identificeren die de relevante kleine moleculen binden, en bespreken we strategieën die al 
gebruikt worden in dierlijke systemen, maar die veelbelovend kunnen zijn voor planten. 
In het volgende hoofdstuk beschrijven we een screen van kleine moleculen met het doel om 
zogenaamde ‘hit’ moleculen te identificeren die zowel clathrine gemedieerde endocytose inhiberen 
als brassinosteroïde signalisatie activeren in Arabidopsis. Als gevolg identificeren we twee ‘hit’ 
moleculen die in de volgende hoofdstukken verder gekarakteriseerd worden, en waarvoor we de 
eiwitten trachten te achterhalen waarop de kleine moleculen binden. 
In hoofdstuk 3 tonen we aan dat een van de ‘hit’ moleculen, Endosisdin 9 (ES9), protonophore 
karakteristieken vertoont, wat wil zeggen dat ES9 protonen over een membraan kan transporteren 
door middel van zijn chemische eigenschappen. Dit heeft gevolgen voor verschillende processen in 
de cel, waaronder ATP productie, pH homeostase, endomembraan dynamiek en clathrine 
gemedieerde endocytose. Hetzelfde principe is van toepassing voor Tyrphostin A23 (TyrA23), een 
molecule die specifiek clathrine gemedieerde endocytose inhibeert, en  daarvoor veelvuldig gebruikt 
wordt in de planten biologie. De bevinding dat TyrA23 zich gedraagt zoals een protonophoor, en 
daardoor endocytose blokkeert, plaats vraagtekens bij het gebruik van TyrA23 om endocytose op een 
specifieke manier te inhiberen. 
Hoofdstuk 4 is een verder gevolg van de karakterisatie van ES9, gezien bepaalde bevindingen 
aantoonden dat ES9 nog andere effecten kan induceren, naast die van een protonophoor. We gaan 
specifiek op zoek naar analoge moleculen aan ES9 die nog altijd in staat zijn om clathrine 
gemedieerde endocytose te inhiberen, maar geen, of sterk verminderde eigenschappen vertonen van 
een protonophoor. We isoleren ES9-17 als een veelbelovend analoog, en tonen aan dat ES9-17 nog 
altijd clathrine gemedieerde endocytose blokkeert, maar geen ATP depletie meer induceert, of 
dynamische endomembraan processen affecteert. Affiniteit purificatie, en daaropvolgende 
biochemische validatie identificeert ES9-17 als een inhibitor van clathrine gemedieerde endocytose 
door het binden op clathrin heavy chain (CHC). Het is daardoor, voor zover wij weten, de meest 
specifieke inhibitor van clathrine gemedieerde endocytose in Arabidopsis, op dit moment. 
In hoofdstuk 5 proberen we te achterhalen op welke eiwitten de tweede ‘hit’ molecule, 39, bindt. We 
doen dit via een computationele predictie die gebaseerd is op gegevens uit dierlijke systemen voor 
een molecule met een zelfde chemische groep als 39. We identificeren 4 potentiële bindingspartners 
die allemaal tot dezelfde plant specifieke familie behoren. Hun functie is echter niet gekend, behalve 
dat ze trans-membraan eiwitten zijn. Naast de validatie als mogelijke bindingspartners van 39, 
initiëren we daarom de characterisatie van die eiwit familie. 
Tot slot nemen we een stap terug en bespreken we een aantal algemene inzichten die van toepassing 
zijn wanneer met kleine moleculen gewerkt wordt, en die in het verloop van deze thesis aan bod 
komen. 
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Abstract 
 
The current striving to understand gene function in plant biology increasingly requires more dynamic 
and conditional approaches opposed to classic genetic strategies. In addition, gene redundancy and 
lethality can substantially complicate research. These issues might be solved by applying small 
molecules to a biological system to induce a phenotype of interest. Application of small molecules 
often implies a conditional interference with protein function as small molecule treatment can be 
reversible, and is time and dose dependent. Therefore small molecules offer considerable 
opportunities to perturb systems in a dynamic and conditional manner, opposed to classical genetics. 
Now understood as the study of small molecules and their effect on biological systems with 
subsequent target identification, chemical genetics is a fast developing field with a strong history in 
pharmaceutical research and drug discovery. In plant biology however, chemical genetics is still 
largely in the starter blocks, with most studies relying on forward genetics and phenotypic analysis 
for target identification, while studies including direct target identification are limited.  
In this chapter we first provide an overview on small molecules used in brassinosteroid research and 
the insights they provided, followed by small molecule effectors of endomembrane traffic identified 
through screening of small molecule libraries in different systems. Finally we provide an overview 
of recent chemical genetics advances in plant biology with a focus on target identification, as 
identification of small molecule targets becomes increasingly important. Furthermore, we discuss 
different strategies for direct target identification and the possibilities and challenges for plant 
biology. 
1.1. Brassinosteroids and their chemical toolbox* 
 
1.1.1 A short introduction to brassinosteroid biosynthesis and signaling  
Brassinosteroids (BRs) are plant steroid hormones that play an essential role in plant growth and 
development and their biosynthesis, signaling, and transcriptional responses are well studied and 
understood processes in plant biology1-3. BRs are the result of several enzymatic conversions of 
campesterol, a precursor derived from isoprenoid-based sterol biosynthesis1.Several biosynthetic 
routes have been described, including the early and late C-22 oxidation to form campestanol. The 
early C-22 branch appears to be the most prominent of the two in Arabidopsis1. Similarly, 
campestanol is further derivatized through two biosynthetic routes, the late and early C-6 oxidation, 
to form brassinolide (BL) or castasterone (CS). In Arabidopsis, as for many other plant species, the 
late C-6 oxidation route is the most important1. Biosynthesis of BRs occurs in the smooth 
endoplasmatic reticulum (ER), from which it is transported to the plasma membrane. Little is known 
yet about trafficking of BRs throughout the endomembrane system, but possibly involves 
MEMBRANE STEROL BINDING PROTEIN1 (MSBP1), as it has been described to bind BL with 
high affinity1,4.  
The signaling cascade initiates once BRs are perceived by the plasma membrane-localized leucine-
rich repeat (LRR) receptor kinase BRASSINOSTEROID INSENSITIVE1 (BRI1). Perception of BRs 
trigger the binding of BRI1 to BRI1-ASSOCIATED KINASE1 (BAK1), which in turn is required to 
activate the kinase domain of BRI1 through trans-phosphorylation events. Dissociation of BRI1 
KINASE INHIBITOR1 (BKI1) from BRI1, an inhibitor of BRI1 kinase activity in absence of BRs, 
is triggered by the trans-phosphorylation events upon BRI1-BAK1 binding, and renders the kinase 
domain fully active. Subsequently, active BRI1 phosphorylates BRASSINOSTEROID SIGNALING 
KINASE1 (BSK1) and CONSTITUTIVE DIFFERENTIAL GROWTH1 (CDG1), which in turn bind 
and phosphorylate BRI1-SUPPRESSOR1 (BSU1). The latter is a phosphatase that will inactivate 
BRASSINOSTEROID INSENSITIVE2 (BIN2), a kinase which is responsible for negative regulation 
of two key transcriptional regulators, BRASSINAZOLE RESISTANT1 (BZR1) and BZR2/BRI1-
EMS-SUPPRESSOR1 (BES1) (Figure 1). In absence of BR signaling, BIN2 phosphorylates 
BZR1/2, which enables 14-3-3 proteins to retain both transcriptional regulators in the cytosol. When 
BIN2 is inactivated upon BRs signaling, PROTEIN PHOSPHATASE 2A (PP2A) dephosphorylates 
BZR1/2, which allows them to migrate in the nucleus and exert their function. 
 
*Adapted from: Dejonghe, W., Mishev, K. & Russinova, E. The brassinosteroid chemical toolbox. Curr Opin Plant 
Biol 22C, 48–55 (2014). D. W. and R. E. wrote the manuscript. M. K. and D. W. designed and made figures. All 
authors reviewed the manuscript. 
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Figure 1. Small-molecule effectors of brassinosteroid signaling. 
In the absence of brassinosteroid (BR) hormones, the leucine-rich repeat (LRR) receptor kinase 
BRASSINOSTEROID INSENSITIVE1 (BRI1) is associated with the BRI1 KINASE INHIBITOR1 
(BKI1). Most of the BRI1 molecules undergo continuous cycling between the plasma membrane 
(PM) and endosomal compartments, and only a small fraction is sorted for vacuolar degradation to 
ensure the protein turnover. BR sensing is initiated at the PM. The BR hormone binds to the 
extracellular domain of BRI1 and induces BKI1 phosphorylation through activation of the 
intracellular BRI1 kinase domain. The phosphorylated BKI1 dissociates from the PM, allowing the 
interaction of BRI1 with the BRI1-ASSOCIATED RECEPTOR KINASE1 (BAK1). After a number 
of autophosphorylations and transphosphorylations, the BRI1-BR-BAK1 complex becomes fully 
activated and triggers the downstream BR SIGNALING KINASE1 (BSK1) through BRI1 kinase-
mediated phosphorylation. In turn, BSK1 activates the BRI1 SUPPRESSOR1 (BSU1). BSU1 
dephosphorylates BRASSINOSTEROID INSENSITIVE2 (BIN2), a serine/threonine GSK3/shaggy-
like kinase that acts as a negative regulator in the BR signaling pathway through repression of the 
transcription factors BRASSINAZOLE RESISTANT1 (BZR1) and BZR2/BRI1 EMS 
SUPPRESSOR1 (BES1). The dephosphorylated form of BIN2 is destined for degradation. 
Alternatively, effective inhibition of BIN2 can be achieved by exogenous application of bikinin and 
related derivatives. In the absence of BIN2 activity, the BZR1/2 transcription factors are 
dephosphorylated by a protein phosphatase 2A (PP2A) and translocate to the nucleus to trigger the 
expression of BR-responsive genes. Application of chemical modifiers of endomembrane trafficking 
can efficiently block BRI1 at the level of PM or in the endosomes, thus modulating the receptor 
availability for its ligand and the BR signaling outputs, respectively. 
 
1.1.2 Small molecules affecting BR biosynthesis 
Specific inhibitors of BRs biosynthesis offer a powerful tool to manipulate BR levels in different 
plant tissues and have been crucial for identifying novel components involved in BR signal 
transduction pathway5. All known inhibitors of BR biosynthesis (Figure 2) share an azole moiety 
that is thought to bind the iron-containing heme prosthetic group of P450 cytochrome enzymes. The 
best known examples with a specific impact on BR biosynthesis are brassinazole (brz)6 and brz20017. 
Both small molecules are similar to uniconazole, a known gibberellin biosynthesis inhibitor that also 
affects BR biosynthesis8 and result from uniconazole derivatization to obtain specific BR biosynthesis 
inhibitors. A similar strategy has been adopted with another BR biosynthesis inhibitor propiconazole9, 
which was used to develop a more potent inhibitor, namely brz22010. Brz, brz2001, and brz220 target 
DWARF4 (DWF4), a P450 monooxygenase hydroxylating the C-22 position during BR 
biosynthesis11,12 (Figure 2). Brz2001, recently used in a quartz-crystal microbalance-based T7 phage 
display target identification strategy, confirmed DWF4 as its target, mapping the binding site as a 
potential disordered region of the enzyme13. 
 Several other BR biosynthesis inhibitors have been found. Voriconazole inhibits the BR-
dependent sterol biosynthesis at the level of the P450 cytochrome CYP51 (Figure 2) resulting in 
accumulation of the sterol biosynthesis intermediate obtusifoliol14. In addition, voriconazole appears 
to be specific to BR biosynthesis, because gibberellin application did not rescue the voriconazole 
caused growth phenotypes. A group of BR biosynthesis inhibitors, designated the YCZ series, was 
developed from a ketoconazole scaffold15 (Figure 2). The rationale to use a ketoconazole scaffold is 
based on (i) its similarity with the most potent BR biosynthesis inhibitor, brz220; (ii) its known ability 
to inhibit P450 enzymes; and (iii) analogs would retain the phenoxy moiety found in ketoconazole 
with different substitutions. From this series, the most active inhibitor was used as a scaffold to 
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generate analogs with different substitutions on either the phenoxy moiety or the aro- matic ring 
attached at the C2 position from the 1,3- dioxolane moiety16 (Figure 2). An additional structure-
activity relation analysis resulted in YCZ-18, a BR biosynthesis inhibitor more potent than brz22017. 
Further developments of the YCZ series include analysis of the absolute stereochemistry of YCZ-
2013 on activity18 and synthesis of a fluorescently labeled YCZ analog19. The latter small molecule 
might play an important role in visualization of BR biosynthetic processes. 
 
Figure 2. Chemical manipulation of brassinosteroid biosynthesis. 
The chemical structure of brassinolide (BL), the most potent natural brassinosteroid is presented. The 
BL biosynthesis is accomplished by a number of cytochrome P450 enzymes that are involved in 
highly branched and parallel pathways (enzymes that catalyze key reactions are boxed in orange). 
Most of the chemical tools that interfere with BL biosynthesis deal with the P450 monooxygenase 
DWARF4 (DWF4) (implicated in the hydroxylation at the C22 position of the molecule) and share a 
common triazole moiety (highlighted in red). Brassinazole (Brz) and its derivative Brz2001 have been 
developed from the uniconazole scaffold (green dashed rectangle). In turn, the propiconazole scaffold 
(yellow dashed rectangle) has been used to create Brz220. Modifications on the ketoconazole scaffold 
(purple dashed rectangle) have led to the discovery of the YCZ series of DWF4 inhibitors that differ 
in substitutions on either the phenoxy moiety (R1 substitutions) or the aromatic ring attached at C2 
position from the 1,3-dioxolane moiety (R2 substitutions). The only small molecule that targets an 
enzyme other than DWF4 is voriconazole. The inhibitor has been shown to be specific for P450 
cytochrome CYP51, an enzyme catalyzing a step from the sterol biosynthetic pathway that provides 
precursors for the BL synthesis. 
 
1.1.3. Small molecules affecting BR signaling 
To date, 69 naturally occurring BRs are known, including 5 conjugated forms, with BL and CS being 
the most abundant and active20,21. This natural variation depicts a common 5α-cholestane structure 
and some essential requirements for highly active BRs, such as an α-hydroxyl group at the C2 position 
and vicinal hydroxyl groups at positions C22 and C23, both in R orientation21 (Figure 2). 
 The recent crystallographic structure reports on the extracellular part of BRI1 in the presence 
of BL allow an improved rationalization of the chemical requirements for proper ligand binding and 
signaling activation. The extracellular domain forms an atypical superhelical structure comprised of 
25 LRRs with an insertion domain in between LRR 21 and 22 that is partially unstructured in the 
absence of BL. As BL binds BRI1 in between the insertion domain and the LRR domain (Figure 3), 
part of the insertion domain becomes structured, whereas the side chain of BL is accommodated by 
a hydrophobic pocket22,23. The hydroxyl groups at position C2 and C3 and the B-ring are exposed to 
solvent for a considerable degree and seemingly not implicated in polar interactions. This position of 
the B-ring might also explain the reported tolerated modification on the 6-oxo position of CS24,25. 
However, structural data of the extracellular domains of BRI1 with either BAK1 or the SOMATIC 
EMBRYOGENSIS RECEPTOR KINASE1 (SERK1), another BRI1 co-receptor and a close homolog 
of BAK1, in the presence of BL provided evidence for the requirement of the hydroxyl groups at 
position C2 and C3 as well as the solvent-exposed A and B rings of the BRI1-bound BL in recognizing 
and binding the N-terminal part of either BAK1 or SERK1 (Figure 3). Besides the BL-mediated 
interactions, BRI1 makes direct contact with the co-receptors through its last two LRRs and the C-
terminal cap domain26,27. 
 Development of new BR analogs with different activity can provide further information on 
the molecular interactions involved in BR recognition and function. Alternatively, bioactive analogs 
can be used as cheap BR substitutes for massive applications in agriculture. Several structure-activity 
relation studies have allowed a better understanding of the chemical and structural degrees of freedom 
in terms of BR signaling activation (Figure 3). By means of the bean second internode bioassay, two 
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BR analogs with a 5α-hydroxy-6-oxo moiety and lacking hydroxylations on the side chain, but with 
either hydroxylations on both C2 and C3 or only C3 positions were found biologically active28. A set 
of monohydroxylated analogs on C2 and C3 with a carboxyl group as side chain illustrate the 
importance of the side chain for efficient BR binding29. Assessment of the possibility to exchange 
ring A for an aromatic ring revealed that, compared to 28-homotasterone, one analog bearing an 
aromatic ring and hydroxy groups on the C3, C22, and C23 positions, but lacking the 6-oxo moiety, 
was only 30% less active, indicating for the first time that aromatic rings are tolerated for BR 
activity30. To replace hydroxyl groups, fluorination of the A ring has been applied. The 
electronegativity of fluor is similar to that of oxygen and can replace an -OH group. Although fluor 
can act as a hydrogen bond acceptor, it cannot act as a donor. Hence, the analog with fluor on both 
the C2 and C3 positions had a biological activity similar to that of 28-homocastasterone, hinting 
toward a role for the natural occurring hydroxyl groups at positions C2 and C3 as hydrogen bond 
acceptors31. This hypothesis was supported by the structural data from the BRI1-BL-BAK1 complex 
at low pH26. 
 Thanks to these structural insights, a BR antagonist has been developed for the first time. As 
the C2 and C3 hydroxyl groups of BL are involved in H-bond formation with BAK1, the search for 
antagonists was directed to derivatization of the hydroxyl groups at position C2, C3, C22, and C23. 
Only the BL analogs derivatized on either the C2 and C3 or C22 and C23 positions, creating a 2,3-
acetonide and a 22,23-acetonide, showed an antagonistic activity32. The antagonistic activity of the 
analog derivatized on the C2 and C3 positions can be explained easily with the structural data 
available, but explanation for the C22 and C23-derivatized antagonist might be less straightforward, 
because both hydroxyl groups are quite distant from BAK1 and buried in the hydrophobic pocket22,23. 
 An important tool for BR signaling research is the Alexa Fluor 647-CS (AFCS), an active 
fluorescent CS analog25. Besides being the first reported active fluorescent BR, AFCS also allowed 
the visualization of the endomembrane trafficking of the green fluorescent protein (GFP)-tagged 
BRI1 in the presence of its ligand and by means of pharmacological and genetic tools revealed that 
the major pool of active BRI1 resides in the plasma membrane25. Previous reports indicated that BRI1 
was endocytosed and present on endosomal structures independent of ligand binding33,34, yet the 
implication for signaling were unclear34,35. To understand by which endocytic mechanism BRI1-GFP 
enters the plant cell, AFCS was used to show that BRI1 endocytosis depends on clathrin and 
ADAPTOR PROTEIN COMPLEX-2 (AP-2)36. In addition, AFCS was used as a tool to show that 
BRI1 is a cargo of the TPLATE adaptor complex, which is required for endocytosis37. Thus, thanks 
to AFCS, light was shed on the BRI1 endomembrane trafficking mechanisms and their implications 
for signaling, highlighting the importance of functional fluorescent hormone analogs for 
understanding contextual cellular environments and hormone signaling processes. Other plant 
hormones have been labeled for visualization purposes as well, namely gibberellin38, jasmonic acid39, 
and strigolactones40,41. 
 Further downstream, the small molecule bikinin has been identified as an inhibitor of a GSK3-
like kinase subset, including BIN242. A recent study aimed at increasing affinity for BIN2 and its 
homologs involved in BR signaling by screening for bikinin analogs with higher activity42. An iodo 
analog of bikinin has been identified with increased potency and its methylated derivatives have been 
found to be more active than nonmethylated forms. The reason is the rapid hydrolysis upon uptake, 
making the methyl group a vehicle for enhanced uptake into the cell and, therefore, increased activity. 
In addition, a novel inactivation mechanism of applied small molecules was detected through 
conjugation with malate42. Bikinin proved to be indispensable for BR research as numerous studies 
made use of bikinin to reveal BIN2 as a major hub for BR-related crosstalk and to highlight the role 
of plant GSK3-like kinases in stomatal development43-45, xylem cell differentiation46 and lateral root 
formation47. 
 
Figure 3. Brassinosteroid analogs as tools to study hormonal recognition. 
(a) As revealed by the crystal structure of the BRI1 ectodomain in complex with brassinolide (BL) 
(PDB code: 3RJ0), the hormonal molecule (stick model; carbons in grey, oxygens in red) binds to a 
hydrophobic surface formed by amino acid residues (lines representation) from the LRR domain 
(cartoon model, in yellow) and the island domain (cartoon model, in blue) of BRI1. Besides the 
hydrophobic interactions with the BL side chain, a direct hydrogen bond (grey dashed line) between 
the hydroxyl group at C23 position in the steroid and a nitrogen from the main chain of a serine 
residue (S647) from the island domain is also established (the water-mediated hydrogen bonds are 
omitted). No polar interactions have been found for the B-ring lactone of BL. In the absence of a co-
receptor the hydroxyl groups at C2 and C3 remain solvent exposed. (b) In the BRI1-BL- SOMATIC 
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EMBRIOGENSIS RECEPTOR KINASE (SERK1) complex (PDB code: 4LSX), the N-terminal cap 
of SERK1 (cartoon representation, in green) interacts with both the LRR and the island domain of 
BRI1 as well as with the hormone through hydrogen bond formation between a histidine residue 
(H62) and the hydroxyl groups at C2 and C3 in the BL molecule (grey dashed lines). (c) Recently 
created BR analogs, such as sterols with 5α-hydroxy-6-oxo moiety lacking the C22 and C23 OH 
groups with preserved bioactivity (1) and nonactive derivatives with a carboxyl group (2), have been 
used to explore the role of the alkyl chain for BR binding to the hydrophobic pocket in BRI1. In turn, 
active derivatives with an aromatic ring (3), difluorinated analogues with preserved activity (4), and 
2,3-acetonides acting as BR antagonists (5) can be used to analyze the involvement of the A ring from 
the sterol in SERK recruitment and BR receptor complex activation. Crystal structures were 
visualized using PyMOL molecular viewer (http://www.pymol.org/). 
  
1.2. Small molecules for dissecting endomembrane trafficking: a cross‐systems 
view** 
 
1.2.1. Endomembrane trafficking routes in yeasts, plants and mammals: a comparative view 
The eukaryotic endomembrane system is composed of membrane-delimited organelles, small 
vesicular compartments that shuttle between those organelles and a spectrum of transiently 
associated, peripheral membrane components from the cytosol that support, regulate and define 
endomembrane trafficking48, in a highly dynamic and interconnected manner involving alternating 
steps of membrane deformation, budding, fission, tethering and fusion. It serves multiple cellular 
processes essential for survival, including uptake of plasma membrane (PM) cargo and extracellular 
content, secretion, degradation of cellular content, protein folding and sequestration of ion pools 
through compartmentalization. Proteins that are co-translationally translocated into the ER are 
subsequently sorted for trafficking through the Golgi apparatus and the trans-Golgi network (TGN). 
Anterograde transport from the ER is mediated by COPII-coated vesicles which fuse with pre-Golgi 
intermediates to release their cargo, while Golgi-to-ER protein recycling requires COPI vesicle 
formation. Unlike mammals, the plant endomembrane system lacks an ER-Golgi intermediate 
compartment49. After reaching the TGN, secretory proteins are packaged into secretory vesicles and 
targeted to the PM50. So far, the secretory route from the TGN to the PM in plants is poorly 
understood. The TGN compartment also produces clathrin-coated vesicles directed to the lytic 
compartment (the lysosome in mammalian cells or the vacuole in plants and yeasts). The latter route 
involves late endosomes (LEs) in mammals, also called prevacuolar compartments/multivesicular 
bodies (PVCs/MVBs) in plant cells. Unlike mammals, the post-TGN trafficking to the lytic vacuole 
in plants appears to occur independently of clathrin51. Trafficking routes bypassing the 
LE/PVC/MVB compartment have also been reported in yeasts, mammals and plants52,53. 
The endocytic pathway begins with invagination of the PM and formation of clathrin-coated vesicles 
through membrane fission. Similar to mammalian and yeast cells, clathrin-mediated endocytosis 
(CME) appears to be an essential trafficking route in plants, indicating the conservation throughout 
evolution54. Besides CME, growing evidence supports the importance of clathrin-independent 
endocytosis in mammals, yeasts and plants55-57. Most of the cargo internalized by endocytosis 
undergoes recycling back to the PM. In contrast to mammals, the mechanisms of PM protein recycling 
in plants are still obscure. A small fraction of the endocytosed cargo is targeted for degradation to the 
lysosome by passing through early endosomes (EEs), which will gradually maturate into LEs58. 
Recently, the maturation-based sorting model known from mammalian systems has been considered 
**Adapted from: Mishev, K., Dejonghe, W. & Russinova, E. Small molecules for dissecting endomembrane 
trafficking: a cross-systems view. Chem Biol 20, 475–486 (2013). M. K., D. W. and R. E. wrote the manuscript. D. 
W. and M. K. designed and made figures. All authors reviewed the manuscript. 
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in plants in which MVBs/LEs are most likely formed through gradual transformation of parts of the 
TGN51. 
An additional route to the lysosome and vacuole is provided by autophagy. This process involves the 
enclosure of cellular contents such as long-lived proteins and organelles by a double membrane 
structure to form vesicles, called autophagosomes, which will eventually fuse with the lysosome or 
vacuole in order to degrade their content. Autophagy is an essential process for recycling cellular 
contents in yeasts, plants and mammals56,59. The identification of autophagy-related (ATG) genes in 
Saccharomyces cerevisiae and subsequently in other organisms revealed that the molecular 
machinery responsible for autophagy seems to be well conserved, although plants appear to have a 
much more diverse array of ATG genes to their disposal56.  
Although the fundamental mechanism of intracellular vesicle trafficking appears to be conserved in 
eukaryotes, there are several notable differences. In contrast to mammalian cells, the TGN in plants 
is morphologically and functionally distinguished from the trans Golgi cisternae60. A number of 
experimental evidences revealed that, the plant TGN possesses features of EEs and is involved in 
both endocytic and secretory pathways. The TGN in plants can be subdivided into several domains, 
including domains where secretory vesicles are released to the PM, into domains releasing clathrin-
coated vesicles for recycling to the PM and into domains, which mature into MVBs61. Another 
specific feature of the yeast and plant endomembrane systems is the vacuole, which in the plant cell 
occupies up to 90 % of the total cell volume61. Two types of functionally distinct vacuoles coexist in 
the plant cell, namely protein storage vacuoles (PSVs) and lytic vacuoles which are analogous to 
lysosomes in mammalian cells62. The PSVs can be distinguished by the presence of reserve proteins 
used mainly during seed germination and by their neutral pH in contrast to lytic vacuoles. However, 
the two types of plant vacuoles can fuse and give rise to a large central vacuole63. 
 
1.2.2. In search for small-molecule modifiers of endomembrane trafficking 
Small molecules offer major advantages over classical genetics approaches, given the essential and 
highly dynamic nature of the endomembrane system. Important advantages include the ability to 
target in a reversible manner essential gene products, but equally important is the scenario where the 
small molecule targets an entire gene family through perturbation of a common feature of the 
corresponding proteins, thus addressing redundancy among genes64,65. Recent advances in systems 
biology, bioinformatics and modern cell imaging opened novel opportunities for identifying small 
molecules that can be used as tools to dissect endomembrane trafficking pathways. Here, we outline 
the progress in current chemical genetics related to intracellular vesicle trafficking, with an emphasis 
on the use of small molecules in plants, mammals and yeasts identified through high-throughput 
screens (Figure 4). The central routes and hubs of the endomembrane trafficking network in 
eukaryotic cells will be discussed for their sensitivity to the compounds (Figure 5, Table 1), which 
is determined by the extent of conservation of the protein targets. The latter is also reflected in the 
use of different small molecules across systems (Figure 6). 
 
 
 
Figure 4 Forward and reverse chemical genetic screens across yeasts, plants and mammals 
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Forward chemical genetics is represented by cell-based and phenotypic-based screens. Reverse 
chemical genetics is represented by functionality-based, in silico-based and phenotypic-based 
screens. Only the relevant systems are shown for each screen. 
 
Small bioactive molecules have long been used in medicine and agriculture66,67. Recently, large-scale 
systematic screens have boosted the search for novel chemical regulators for mammalian drug 
discovery, and this strategy is being rapidly adopted in plants64,68. Two types of chemical genetics 
screens (forward and reverse) have been employed to dissect the endomembrane trafficking in 
eukaryotes (Figure 4). 
 
Forward chemical genetics uses growth phenotype- or cell-based screens for inhibition or activation 
of a particular cellular process, followed by molecular target identification. Growth phenotype-based 
forward chemical genetics screens for endomembrane trafficking modulators have been carried out 
in plants where a high-throughput screen based on the germination and growth of tobacco pollen was 
used to interrogate more than 46,000 compounds35,69. Other growth phenotypes related to 
endomembrane systems, such as gravitropic responses or cell elongation during hypocotyl growth, 
were also used in chemical genetics screens70,71. 
The cell-based screens often employ the use of fluorescent marker proteins as readouts for activity or 
inhibition of trafficking pathways. Examples from the mammalian systems are the high-throughput 
screen for inhibitors of exocytosis by using BSC1 fibroblast cells infected with GFP-fused vesicular 
stomatitis virus (VSVGts-GFP)72, the screen for inhibitors of endocytosis based on transferrin (Tf) 
receptor-mediated iron uptake in HeLa cells measured by the quenching of calcein fluorescence73 and 
the screen for inhibitors of Golgi-mediated trafficking based on the expression of the YFP-tagged 
Golgi-residing protein p5874. Several screens based on autophagosome markers coupled with either 
GFP or luciferase have assessed the ability of small molecules to affect autophagy75-78. Flow-
cytometry has also been used to quantify fluorescent protein-based sensors for autophagic and 
endolysosomal activities in a screen for autophagy modulators79. In plants, PM proteins or other 
endomembrane compartment markers tagged with fluorescent proteins have been used as markers to 
identify compounds affecting endocytosis, recycling or vacuolar morphogenesis35,69-71. 
Cell-based screens for endomembrane trafficking modulators can also employ other readouts such as 
cell viability, enzymatic reactions or secretion. For example, cytotoxicity measurements using 
destabilized firefly luciferase80 or radioactive-labeled amino acids81 were used in screens for 
inhibitors of retrograde trafficking of toxins (shiga, cholera and ricin) in mammalian cells. Small-
molecule enhancers and inhibitors of autophagy were identified in a screen for their ability to affect 
the clearance of the autophagy substrate A53T -synuclein in mammalian cells82,83. In yeasts, high-
throughput immunoassays for detection of mis-secreted carboxypeptidase Y (CPY) have been 
performed to screen for bioactive compounds which interfere with the sorting of lytic enzymes to the 
vacuolar lumen84. 
Reverse chemical genetics searches for compounds that inhibit or activate in vitro proteins known to 
be involved in a defined process followed by further characterization of the phenotypic effects at 
cellular and/or organism level (Figure 4). In comparison to forward chemical genetics, this approach 
has the significant advantage that the targeted protein is known. However, the existence of additional 
protein targets leading to pleiotropic phenotypes upon chemical treatment in vivo cannot be excluded. 
The reverse chemical genetics strategy has been successful when searching for chemical modulators 
of protein trafficking components involved in early steps of CME, such as Dynasore and Pitstops85,86. 
Because of the available large collections of deletion mutants, the yeast S. cerevisiae has become a 
powerful tool for small molecule discovery by using synthetic lethality87. Synthetic lethality screens 
were used to identify inhibitors of exocytosis88 and the trafficking between the TGN and the 
endosomes89. Whole-genome yeast deletion collections have also been screened for responses to 
chemical libraries in diverse environmental conditions, where genes involved in endomembrane 
trafficking and vacuolar degradation were found essential for resistance to multiple compounds90. 
Alternative in silico screening approaches have enabled the search for novel exocytosis inhibitors in 
mammals. An example includes an in silico screen designed to specifically probe the interaction 
between the ARF1 GTPase and its guanine exchange factor (GEF) ARNO based on known crystal 
structures of their complex91. Drug sensitivity databases have also been exploited to find novel 
inhibitors of ARF1 GTPase activation based on functional correlation with compounds with already 
known properties92. 
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Figure 5 Schematic representation of major trafficking routes and their small molecule 
effectors in different systems 
Shown are a mammalian/yeast cell (left) and plant cell (right). Only endomembrane compartments 
relevant for this review are shown. Discussed small molecules are indicated close to the compartment 
or route they affect. Dark blue: nucleus/ER; light blue: Golgi; yellow: EE (mammalian/yeast) or TGN 
(plants). Yellow to green route: exocytic or recycling pathway with recycling endosomes; green to 
yellow route: endocytic pathway with endocytic vesicles maturating into EEs. Yellow to red 
(lysosome/vacuole) route: LE and/or MVB maturation from EE into lysosome/vacuole. Dark blue to 
red route: Golgi/TGN-independent trafficking from ER to vacuole. Grey (cytosol) to red route: 
autophagy. Note the absence of an autophagic route in the plant cell since rapamycin has not been 
shown to affect autophagy in plant cells yet. 
 
1.2.3. Chemical effectors of exocytosis/secretion/anterograde trafficking 
In the early 2000s only very few small molecule modulators of the secretory pathways were known. 
The best example of such an inhibitor of secretion in eukaryotic cells is the fungal macrocyclic lactone 
Brefeldin A (BFA), which has been instrumental for studying the function of the Golgi93. Structural 
insights into the mechanism of BFA action in mammalian cells have revealed that this compound 
impedes the interaction between different members of the ARF GTPase family and their associated 
large GEFs and thus, causes a diversity of effects including tubulation of EEs, redistribution and 
fusion of the TGN with EEs, and fusion of the ER with the Golgi94,95. In contrast to mammalian and 
yeast systems, plants, for example Arabidopsis, have only large ARF-GEFs, of which some are 
resistant to BFA96. In plants, BFA has been described as an inhibitor of either secretory or endocytic 
pathways depending on where in the cell, the BFA-sensitive ARF-GEFs are residing97. Chemical 
genetics has been used to search for small molecules with more specific effects on exocytosis than 
BFA in mammalian systems (Figure 5, Table 1). Two compounds structurally different from BFA, 
Exo1 and Exo2, were found to inhibit the traffic from the ER to the Golgi. Although the direct targets 
of Exo1 and Exo2 are not known, their mode of action differs from that of BFA72,98. Treatment with 
either Exo1 or Exo2 induces reversible redistribution of Golgi material back to the ER without any 
concomitant effects on endocytic pathways. In contrast to BFA, Exo1 does not directly inhibit ARF-
GEFs and has less effect on the organization of the TGN72. The effect of Exo2 on the Golgi and the 
TGN is similar to that of BFA except that it does not induce tubulation and merging of the TGN and 
endosomal compartments98,99. Therefore, it was proposed that Exo2 is more selective than BFA, 
possibly inhibiting the function of only the cis-Golgi residing ARF-GEF, GBF1. A modified version 
of Exo2, LG186 was further developed in order to increase selectivity towards GBF1100. Another 
chemical modifier of GBF1 activity, AG1478, was also found to preferentially target the cis-Golgi in 
human cell lines74.  
In contrast to mammalian cells, Exo2 was not active in plant cells101. Screening a number of Exo2 
derivatives revealed LG8 as an active analog in Arabidopsis root cells that causes severe changes in 
the morphology of the ER and the Golgi, but not the post-Golgi compartments. Unlike BFA, the 
intracellular targets of LG8 in plants still remain elusive101.  
A high-throughput screen for small molecules that inhibit the toxin retrograde transport has identified 
a novel inhibitor of protein secretion called Golgicide A (GCA)80,102. GCA exhibits BFA-and LG186-
like effects by specifically targeting GBF1100,102. Other recently identified exocytosis inhibitors, such 
as AMF-26 and LM11 have been designed to specifically impair the interaction between the ARF1 
GTPase and its GEFs in mammals. Although the chemical structure of AMF-26 differs from that of 
BFA, this compound induces disruption of the cis- and trans-Golgi, targeting the activation of ARF1 
GTPase92. To date, BFA is known to inhibit only large, but not small and medium-sized ARF-GEFs96. 
Conversely, LM11 targets the interaction between ARF1 and ARNO, a BFA-insensitive human ARF-
GEF. This compound has been shown to induce changes in the Golgi similar to those provoked by 
BFA, however, it leads to the formation of large endosomal structures differing from the phenotype 
observed after BFA treatment91. 
The mechanisms of regulation of the anterograde transport from the Golgi to the PM have been 
approached with the help of Secramine103. In mammalian cells, this compound has been shown to 
perturb the protein export from the Golgi by inhibiting the activation of Cdc42, revealing the essential 
role of this Rho GTPase for vesicle trafficking. In particular, Secramine targets the association of 
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Cdc42 with its guanine dissociation inhibitor RhoGDI1 and prevents binding of this Rho GTPase to 
the Golgi membranes. 
 
1.2.4. Chemical effectors of endocytosis/retrograde trafficking 
One way to interfere with endocytosis in mammals and plants is the use of Tyrphostin A23 
(TyrA23)98,104, a low molecular weight compound, which has originally been identified in a chemical 
screen for inhibitors of protein tyrosine kinases105. It has been found that TyrA23, but not its inactive 
analogue Tyrphostin A51 (TyrA51), perturbs the interaction between the AP-2 adaptor complex and 
consensus tyrosine-containing motifs in the cytosolic domain of PM cargoes, leading to block of 
cargo sorting in clathrin-coated vesicles106. TyrA23 inhibits both endocytosis and vesiculation at the 
TGN in plants97. Although the function of the plant AP-2 complex is most likely conserved in plants, 
the target of TyrA23 has not yet been defined. Nevertheless, the use of this compound has been 
instrumental in studies related to CME in plants25,36,107-120. 
CME in mammals has been successfully approached by means of reverse chemical genetics (Figure 
5, Table 1), which has been facilitated by the considerable knowledge about the CME machinery in 
this system. Dynasore has been identified as a non-competitive and reversible inhibitor of the GTPase 
activity of dynamin, a protein essential for vesicle formation in CME and caveolae-mediated 
trafficking85,121. Dynasore arrests the progression of vesicle coat assembly and the subsequent 
uncoating. Most of the plant genomes encode dynamin-related proteins, some of which might 
function in CME122. A recent study on the intracellular trafficking of the fungal protein elicitor 
receptor, LeEix2, demonstrated the use of Dynasore for blocking endocytosis in plant cells123, yet it 
remains till date the only study in plants employing Dynasore. In addition, as Dynasore exhibits 
undesirable side-effects, recent efforts where geared towards improving on the Dynasore scaffold. 
This led to the generation of the Dyngo series, a group of Dynasore analogues with Dyngo 4a as most 
potent member in terms of specificity and dynamin inhibition124. Supplementing Dynasore and 
Dyngo series of dynamin inhibitors are the indole-based Dynole series125,126. Based on a 
bisindolylmaleimide scaffold, two generations of focused libraries resulted in Dynole 2-24, the most 
potent inhibitor of dynamin mediated endocytosis to date126. 
Two structurally different compounds, Pitstop 1 and Pitstop 2, have also been used to elucidate the 
mechanisms of clathrin-coated pit formation in mammals86. Pitstops have been found to compete with 
clathrin box-containing accessory proteins for a common binding site on the terminal domain of the 
clathrin heavy chain. Interference with the function of this domain does not affect clathrin 
recruitment, but Pitstops severely perturb clathrin-coated pit dynamics, due to the inability of clathrin 
to bind regulatory proteins required for progression in vesicle maturation. Similar to Dynasore, 
Pitstops induce the accumulation of endocytic intermediates at the PM representing different stages 
of this trafficking route. Pitstop 2 was shown to be effective in blocking the internalization of PM 
cargo markers like the Tf receptor and the epidermal growth factor in mammalian cells through 
selective impairment of CME86. The Pitstop family has been growing over the recent years, including 
active and inactive analogues of Pitstop 2127,128, amidst the discussion about specificity of Pitstops 
towards inhibition of clathrin mediated endocytosis129-131. 
Several compounds identified through forward chemical genetics have been found to target 
endosomal compartments from the endocytic pathway downstream of the PM. A group of 
sulfonamides (with a representative member, the compound 16D10) was identified in the Exo 
screen72 and shown to affect trafficking from the Golgi to the PM132. Although the protein target of 
this group is unknown, it is likely that sulfonamides exert their action indirectly by suppressing the 
V-ATPase function, or directly as proton ionophores132. Chemical screens for inhibitors of 
endocytosis of toxins (shiga, cholera and ricin) in mammalian cells facilitated the identification of 
compounds specifically affecting the retrograde toxin trafficking at the level of recycling endosomes 
and the Golgi (compound 75 and 134)80, or the EEs and TGN (Retro-1 and Retro-2) level81.  
Receptor-mediated endocytosis in mammals has been tackled with the use of Ferristatin, which is a 
selective inhibitor of Tf-mediated iron uptake73,133. Interestingly, Ferristatin has led to the discovery 
of a novel endocytic route for the PM-localized Tf receptor by inducing its enhanced internalization 
in a clathrin-independent manner126. In plants, the limonoid Endosidin 1 (ES1) has been found to 
induce selective intracellular accumulation of some, but not all, PM cargoes35. ES1 specifically 
affects the trafficking of PM proteins at the level of TGN/EEs through stabilization of actin 
filaments134. Another Endosidin compound , named ES5, has been implicated in the inhibition of PM 
protein recycling in both plant and mammalian cells69, whereas the small molecule TENin171 was 
recently reported to inhibit endocytosis and affect trafficking between TGN and PVC/MVB 
compartments135. 
 
1.2.5. Chemical effectors of vacuolar trafficking and autophagy 
Studies of vacuolar transport and biogenesis have been approached, for the first time, by forward 
chemical screens in yeast because of the conserved trafficking machinery between yeasts and plants136 
(Figure 5, Table 1). Three compounds called Sortin1, Sortin2 and Sortin3 induced secretion of the 
vacuolar protein carboxypeptidase Y in yeast and affected the morphology of Arabidopsis or yeast 
vacuoles136. Although the targets of Sortins are not identified, evidence has been provided that Sortin1 
targets the crosstalk between vacuolar biogenesis and transport137, whereas Sortin2 and Sortin3 affect 
vacuolar trafficking, possibly by inhibition of the endosomal trafficking138,139. Another small 
molecule linked to vacuolar trafficking is gravacin, which strongly inhibits gravitropism in 
Arabidopsis and blocks the trafficking of tonoplast markers to the vacuolar membrane by a yet 
unknown mechanism71. 
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Larger chemical genetic screens in plants have revealed several more small molecules affecting PM 
cargo trafficking to the vacuole or vacuolar morphogenesis the targets of which remain to be 
identified69. For example, apart from perturbing the recycling pathway, ES5 has been proven to 
severely enhance the vacuolar accumulation of PM proteins69. Another compound derived from the 
same screen, namely C834, has been shown to selectively reduce the levels of PM residing proteins 
paralleled by an increase in their vacuolar targeting140. Remarkably, C834 has also been instrumental 
in revealing the diversity of pathways for trafficking of newly synthesized tonoplast intrinsic proteins 
to the vacuole140. 
A compound derived from the Exo screen72, named Vacuolin-1, has been shown to induce the 
formation of large swollen vacuoles in different mammalian cell types through fusions of endosomes 
and lysosomes141,142. 
In mammals and yeast, extensive research has gone into identifying small molecule effectors of 
autophagy. One of the best examples of small molecules affecting autophagy is rapamycin, the well-
known inhibitor of the phosphatidylinositol kinase Target Of Rapamycin (TOR)143,144. Screens for 
chemical modifiers of rapamycin identified several small-molecule inhibitors/enhancers of 
rapamycin (SMIR/SMER) with an effect on autophagy in yeast and mammalian systems83. Despite 
previous reports145,146, plants are sensitive to rapamycin, which uncovered a role of TOR in glucose 
metabolism147.However, in contrast to mammals and yeasts, no direct link between rapamycin and 
autophagy has yet been shown in plants. 
 
1.2.6. Special considerations when analyzing drug-induced endomembrane trafficking 
phenotypes 
Growing evidence suggests that, when targets of endomembrane effectors are not known, the 
interpretation of the observed phenotypes should account for possible effects of the compounds on 
the cytoskeleton dynamics. The endosomal maturation in mammalian cells is dependent on the 
microtubule network148 as disruption of microtubules leads to dispersal of LEs and lysosomes 
throughout the cytoplasm58. In turn, formation and motility of EEs and concurrent sorting of 
internalized proteins for either recycling or lysosomal degradation are largely dependent on the actin 
dynamics92,149. Similarly, stabilizing actin in plant cells by using chemicals interferes with 
endocytosis and vesicle transport150. Examples exist where the observed endomembrane trafficking 
phenotype in the presence of a bioactive compound is not due to disturbance of the function of an 
endomembrane protein but rather is a result of a modulation of the cytoskeleton organization. This is 
illustrated by the endocytic inhibitor ES1, also called prieurianin35,134. Recent findings suggest that 
ES1 acts primarily as an actin stabilizer by an unknown mechanism without affecting the 
microtubules, thus possibly inhibiting intracellular vesicle movement. The effect of ES1 on actin 
dynamics has been observed in both plants and mammals, pointing to conservation of its molecular 
target in eukaryotes134. Another example concerns the use of Secramine which affects the cellular 
functions of the Rho GTPase Cdc42 and in this way impairs the Golgi-to-PM vesicle trafficking, but 
also inhibits actin polymerization103. Taken together, these examples corroborate the need the 
chemical screening hits to be routinely tested for their possible impact on the cytoskeleton 
components. Such studies are already greatly facilitated by the recent advances in light microscopy-
based approaches. 
Another consideration in studying endomembrane trafficking through chemical biology is the need 
to discriminate between primary compound-specific effects and general changes in the cellular 
homeostasis. Essentially all steps from the intracellular vesicle transport are ATP- or GTP-dependent, 
hence any energy depletion induced by the compound hit would lead to a global disruption of the 
endomembrane system. Notably, cytotoxicity assays, such as those dealing with ATP content 
determination, could reveal the borderline dose and time of exposure, beyond which the compound 
hit induces unspecific responses. 
 
Figure 6 Distribution of discussed small molecules with activity in mammalian, yeast and plant 
systems. 
Small molecules are distributed according to overall activity, thus not specific to endomembrane 
compartments. 
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Table 1 Small molecule effectors of endomembrane trafficking identified through large-scale 
chemical genetic screens 
Name Structure 
Affected 
endomembrane 
compartment 
Known 
target 
Screen References 
Chemical effectors of exocytosis/secretion/anterograde trafficking 
Exo1 
 
ER to Golgi 
trafficking 
 
Fluorescence-
based imaging 
screen of 
VSV-Gts 
trafficking 
Feng et al., 
2003 
Exo2 
 
ER to Golgi 
trafficking, Golgi, 
TGN 
Arf-GEF 
GBF1 
Fluorescence-
based imaging 
screen of 
VSV-Gts 
trafficking 
Spooner et 
al., 2008 
LG186 
 
Golgi 
Arf-GEF 
GBF1 
 
Boal et al., 
2010 
AG1478 
 
Cis-Golgi  
P58-YFP 
based screen 
in H4 human 
glioblastoma 
cells 
Pan et al., 
2008 
LG8 
 
ER, Golgi  
Exo2 analog 
screen for 
activity in A. 
thaliana 
Sorieul et 
al., 2011 
Golgicide A 
 
Golgi 
Arf-GEF 
GBF1 
Luciferase-
based toxin 
susceptibility 
screen 
Saenz et al., 
2009 
AMF-26 
 
Cis- and trans-Golgi  
COMPARE-
guided in 
silico 
screening 
Ohashi et 
al., 2012 
LM11 
 
Golgi, endosomal 
structures 
Arf1-
GDP/ARN
O complex 
In silico 
structure-
based screen 
Viaud et al., 
2007 
Secramine 
B 
 
Golgi to PM 
trafficking 
Rho GTPase 
Cdc42 
Fluorescence-
based imaging 
screen of 
VSV-Gts 
trafficking 
Pelish et al., 
2006 
Chemical effectors of endocytosis/retrograde trafficking 
Tyrphostin 
A23 
 
Endocytosis 
Interfering 
between 
tyrosine 
motifs and 
AP2 
complex 
Screen for 
tyrosine 
kinases 
Yaish et al., 
1988 
Dynasore 
 
Endocytosis Dynamin 
Dynamin 
GTPase-
activity 
inhibitor 
screen 
Macia et al., 
2006 
Pitstop 1 
 
Endocytosis 
Clathrin 
terminal 
domain 
(TD) 
ELISA-based 
screen for 
inhibition of 
amphiphysin 
and clathrin 
TD 
association 
Von Kleist 
et al., 2011 
Pitstop 2 
 
Endocytosis 
Clathrin 
terminal 
domain 
(TD) 
ELISA-based 
screen for 
inhibition of 
amphiphysin 
and clathrin 
TD 
association 
Von Kleist 
et al., 2011 
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16D10 
 
Endosomes, 
lysosomes 
Likely 
inhibition of 
V-ATPases 
or as proton 
ionophore 
Fluorescence-
based imaging 
screen of 
VSV-Gts 
trafficking 
Nieland et 
al., 2004 
Comp. 75 
 
Early retrograde 
transport 
 
Luciferase-
based toxin 
susceptibility 
screen 
Saenz et al., 
2007 
Comp. 134 
 
Recycling endosomes 
to Golgi, retrograde 
transport 
 
Luciferase-
based toxin 
susceptibility 
screen 
Saenz et al., 
2007 
Retro-1 
 
EE to TGN retrograde 
trafficking 
 
Screen for 
inhibitors of 
ricin toxicity 
Stechmann 
et al., 2010 
Retro-2 
 
EE to TGN retrograde 
trafficking 
 
Screen for 
inhibitors of 
ricin toxicity 
Stechmann 
et al., 2010 
Ferristatin 
 
Increased transferrin 
receptor 
internalization and 
degradation 
 
Fluorescence-
based screen 
for calcein 
quenching 
Brown et al., 
2004 
ES1 
 
Endosomes  
Screen for 
pollen tube 
growth and 
germination 
inhibitors 
Robert et al., 
2008 
ES5 
 
Endosomes, recycling  
Screen for 
pollen tube 
growth and 
germination 
inhibitors 
Drakakaki et 
al., 2011 
Chemical effectors of vacuolar trafficking and autophagy 
Sortin 1 
 
Vacuolar traffic and 
morphology 
 
Screen for 
mis-targeting 
of 
carboxypeptid
ase Y 
Zouhar et 
al., 2004 
Sortin 2 
 
Vacuolar traffic and 
morphology 
 
Screen for 
mis-targeting 
of 
carboxypeptid
ase Y 
Zouhar et 
al., 2004 
Sortin 3 
 
Vacuolar traffic and 
morphology 
 
Screen for 
mis-targeting 
of 
carboxypeptid
ase Y 
Zouhar et 
al., 2004 
Gravacin 
 
ER to vacuole 
trafficking 
PGP19 
Screen for 
gravitropic 
response 
Surpin et al., 
2005 
C834 
 
Vacuolar trafficking  
Screen for 
pollen tube 
growth and 
germination 
inhibitors 
Rivera-
Serrano et 
al., 2012 
Vacuolin-
1 
 
Induction of vacuole 
formation, inhibition 
of exocytic PM-
lysosome fusion 
 
Fluorescence-
based imaging 
screen of 
VSV-Gts 
trafficking 
Cerny et al., 
2004 
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SMER 10 
 
Enhancer of 
autophagy 
 
Cytotoxicity 
screen in yeast 
and autophagy 
substrate 
clearance in 
mammals 
Sarkar et al., 
2007 
SMER 18 
 
Enhancer of 
autophagy 
 
Cytotoxicity 
screen in yeast 
and autophagy 
substrate 
clearance in 
mammals 
Sarkar et al., 
2007 
SMER 28 
 
Enhancer of 
autophagy 
 
Cytotoxicity 
screen in yeast 
and autophagy 
substrate 
clearance in 
mammals 
Sarkar et al., 
2007 
 
  
1.3. Target Identification Strategies in Plant Chemical Biology*** 
 
A proven way to study how something works is to perturb the process of interest in a well-defined 
and controlled way. In biology, this is often accomplished by introducing alterations in the genome 
of an organism, such as mutations or ectopic expression. A major disadvantage of working at the gene 
level, is that the resulting organism will live in a steady state with the induced genetic change. 
Additionally, perturbation of essential gene functions will lead to lethality, unless conditional, and 
perturbation of a gene member of a large gene family might have no effect due to redundancy. In 
order to address gene redundancy and lethality problems, together with the possibility to perturb a 
system in a more dynamic manner, chemical biology approaches can be adopted. In chemical biology, 
typically small molecules are applied to a biological system, altering the process of interest by binding 
target molecules. A key feature of chemical biology is its conditional nature. Small molecules can be 
applied for any desired time and concentration, and in most cases can be washed out of the system of 
choice, making them an ideal tool to study dynamic processes for a certain period of time. Crucially, 
small molecules will not alter an organism over generations and are not restricted to bind only proteins, 
but can modulate a biological system by binding lipids or nucleic acids151. Finally, using different 
approaches, the target of small molecules needs to be identified in order to get a better understanding 
of the affected process. 
Chemical genetics strategies in plant biology lag behind the animal field, in which drug development 
provided a plethora of different target identification strategies. In plant biology, most target 
identification strategies consist of a phenotypical approach or forward genetics strategy based on 
small molecule resistance screens. A few examples exist of strategies such as affinity purification that 
were successfully applied152. 
An important aspect of chemical biology is linking the induced phenotype to one or more targets 
(Figure 7). Usually, only the relevant target, or target with the highest affinity for the small molecule 
is identified and validated, although so-called ‘off-targets’ might contribute substantially to the 
overall phenotype. Therefore, it becomes increasingly important to understand and generate the small 
molecule interactome, in order to explain the observed phenotypes153. This becomes especially 
important for small molecules with a commercial application in healthcare or agriculture. 
Several reviews have addressed chemical genetics approaches and aspects in plant biology, and the 
challenges and opportunities that lay ahead64,65,154,155. Other recent reviews include a comprehensive 
overview of target identification strategies in mostly animal systems151, and a thorough overview of 
small molecules with known targets and mode of action in plant biology152. Given that plant 
***Adapted from: Dejonghe, W. & Russinova, E. Target identification strategies in plant chemical biology. Front 
Plant Sci 5, 352 (2014). D. W. and R. E. wrote the manuscript. D. W. designed and made the figures. All authors 
reviewed the manuscript. 
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biological research is using limited target identification strategies, this review will briefly discuss 
current target identification approaches, and will mostly focus on emerging new strategies, which 
have not found a broad application in plant biology yet (Table 2). Where applicable, examples from 
plant biology will be given, and benefits and shortcomings will be discussed. 
 
 
Figure 7. Schematic representation of target identification strategies. 
Target identification strategies are represented in function of their ability to identify only one target 
or several targets (interactome), and the potential to identify non-specific interactors (e.g. proteins 
which will confer resistance or induce the appropriate readout without actually binding specifically 
the small molecule). 
 
1.3.1. Commonly used target identification strategies in plant chemical biology 
 
1.3.1.1. Forward genetic screen for compound resistance 
Forward genetic screen for compound resistance is a commonly used target identification strategy in 
plant chemical biology where a mutant population is grown in the presence of small molecules and 
screened for resistance. Selected resistant individuals are subsequently characterized in terms of their 
mutations. A major disadvantage is the inherent selection against targets with an essential gene 
product, provided that the induced mutation induces a knock-out or renders the protein inactive. 
Essential gene targets might still be selected in case the mutation allows proper protein function, but 
prevents the small molecule from binding. Additionally, gene redundancy can prevent identification 
of the target, and certain mutations might render plant resistance to compound treatment, without 
affecting the true target. A small molecule called ‘non-auxin-like lateral root inducer’ or naxillin 
illustrates the latter scenario. Identified from a screen for small molecules able to enhance lateral root 
development, naxillin was found to affect lateral root development more specifically than auxin. The 
only identified resistant mutant from an ethylmethane sulfonate (EMS)-mutagenized Arabidopsis 
population, naxillin resistant 1 (nar1), proved to be affected in the INDOLE-3-BUTYRIC ACID 
RESPONSE 3 (IBR3) gene, which is involved in the conversion of idole-3-butyric acid (IBA) to 
indole-3-acetic acid (IAA). The identification of nar1 helped to reveal that naxillin acts upstream of 
auxin signaling by positively affecting the IBA to IAA conversion at specific sites in the root, thereby 
inducing lateral root development, but failed to identify the true target of naxillin156. Major 
advantages of the forward genetic screen approach are the straightforward experimental setup and the 
availability of high-throughput next-generation sequencing techniques, which allow relatively quick 
target identification once the resistant individuals are identified. 
Whether or not mutants are more sensitive to the compound depends on the nature of the mutation. 
Resistant mutants might occur from mutations affecting small molecule binding, or from the absence 
of the target protein, although the latter is not applicable to proteins with essential function. 
Alternatively, less, or no protein might mean a higher sensitivity of the mutant, as less small molecule 
is required to exert the same phenotypical effect. This dosage response is in line with resistance to 
the small molecule upon over expression of the target protein. 
 
Examples of such approach are the identification of targets for pyrabactin, gravacin and DAS734. 
The synthetic seed germination inhibitor pyrabactin was shown to act as a specific agonist of abscisic 
acid (ABA). Specific because transcriptional responses for seed growth in presence of ABA 
compared to pyrabactin were highly correlated, while this was not the case in seedlings157. Pyrabactin 
allowed to identify the PYR/PYLs (for “pyrabactin resistance” and “PYR-like”), members of the 
ligand binding cyclase subfamily of the START protein superfamily, through a forward genetics 
screen for compound resistance since pyrabactin targets the conserved ABA binding domain 157,158. 
This protein family was independently identified as RCAR (for “regulatory component of ABA 
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receptor”)159. The PYR/PYL/RCARs were shown to be ABA receptors157, which after perception 
bind to type 2C protein phosphatases, thereby inactivating them. The role as ABA receptor for the 
PYR/PYL/RCAR protein family was later confirmed by crystallographic data158. 
Gravacin was identified as an inhibitor of the gravitropic response in Arabidopsis seedlings71. A 
population of 220,000 EMS-mutagenized F2 seeds were screened for a gravitropic response when 
grown on gravacin, identifying through a map-based cloning approach an E to K substitution in the 
gene coding for P-GLYCOPROTEIN 19 (PGP19)160. Several different mutant alleles for PGP19 
showed resistance to gravacin, confirming the identified mutation as the cause of gravacin resistance. 
Furthermore, the authors could show that gravacin binding to PGP19-containing microsomes in 
pgp19 mutants was severely reduced compared to wild type controls160. 
A phenyltriazole acetic acid compound, DAS734, was identified as a potent bleaching agent of 
developing leaves. Addition of adenine could alleviate the effects, hinting toward a target in the purine 
biosynthesis pathway161. A screen for DAS734 resistance of 480,000 EMS-mutagenized Arabidopsis 
ecotype Col-0 seedlings resulted in several resistant lines, some of which had the same mutation. 
Map-based cloning identified glutamine phosphoribosylamidotransferase 2 (GPRAT2) as the gene 
containing all mutations161. Expression of AtGPRAT2 in E. coli allowed to purify the protein, and to 
evaluate its activity in the presence of DAS734. The small molecule was able to potently inhibit 
GPRAT2 activity in a slow, but reversible manner. In addition, expression of the mutant GPRAT2 
gene in E. coli, identified in the forward genetics screen, showed an increase in the inhibitory 
concentration (IC50) of more than 500 times, indicating a strong resistance to DAS734, and 
confirming GPRAT2 as its target161. 
 
1.3.1.2. Phenotyping approach 
Opposed to a forward genetics approach, the phenotyping approach usually starts from a screen of 
small molecules against an appropriate readout for the biological process of interest, followed by 
further tests which narrow down the possible target proteins. Biochemical validation is used to 
confirm the hypothesized target protein. The requirement for proper readouts, which is applicable for 
known signaling pathways and enzymes involved in primary and secondary metabolism, is a potential 
drawback. Processes of highly organized, rapid and dynamic nature, such as endomembrane 
trafficking, or unknown processes will be much harder to approach with such strategy. As one 
searches specifically within a process of interest, this approach usually will yield only one target, or 
target family, but cannot provide an overall picture of small molecule interactors. The latter implies 
however that target identification can be fairly straightforward because the search is directed. Some 
recent examples are the identification of targets for bikinin, kynurenine imprimatins and Jarin-1. 
The small molecule bikinin was identified in a screen for molecules able to induce phenotypes similar 
to those caused by the application of the most active BR, BL, in young Arabidopsis seedlings42. The 
target of bikinin was identified through comparative phenotypical analysis of different BR-related 
mutants grown on bikinin. As bikinin was able to rescue a gain-of-function bin2-1 mutant to wild 
type, it was hypothesized that the GSK3-like kinase BIN2 is the direct target. This hypothesis was 
confirmed by in vitro binding studies. In addition, the list of bikinin targets was expanded to other 
BIN2 homologs and it was suggested that a competition with ATP is the mode of compound action. 
The selective aminotransferase inhibitor affecting local auxin biosynthesis, L-Kynurenine (kyn), was 
identified in a screen for suppressors of the constitutive ethylene response162. Although kyn did not 
rescue the constitutive ethylene response phenotypes of the eto1-2 and ctr1-1 mutants and wild type 
plants treated with the synthetic ethylene precursor 1-aminocyclopropane-1-carboxylic acid, it did 
rescue the shortened root phenotype at submicromolar concentrations. Kyn was shown to inhibit 
ETHYLENE INSENSITIVE 3 (EIN3) accumulation in Arabidopsis roots, which led to a reduction 
of local auxin responses. Since active ethylene signaling increased the reduction of local auxin 
responses in presence of kyn, it was concluded that kyn represses ethylene-mediated auxin 
responses162. Further unraveling of auxin responses led to the hypothesis that kyn might inhibit 
TRYPTOPHANE AMINOTRANSFERASE OF ARABIDOPSIS1 (TAA1). Enzymatic activity tests 
of kyn on purified TAA1 confirmed it as a competitive and potent inhibitor, thereby inhibiting the 
conversion of tryptophan to indole-3-pyruvic acid. Computational modeling confirmed kyn as a 
competitive inhibitor of TAA1, outcompeting tryptophan. In addition, when tryptophan was applied 
in excess, it reversed the inhibitory effects of Kyn162. 
The third example comes from a screen for small molecules affecting disease resistance in plants, 
which identified five small molecules belonging to two different structural groups, named 
imprimatins163. The authors showed an increase of salicylic acid (SA) in treated plants, but unlike 
control plants, after pathogen infection imprimatins did not accumulate the inactive form of SA, SA-
2-O--D-glucoside (SAG), which usually increases in parallel with an increase in SA. An enzymatic 
test on UGT74F1 and UGT76B1, two enzymes that convert SA to its inactive form SAG, confirmed 
imprimatins as inhibitors of these enzymes. The authors concluded that the increased Pst-avrRpm1-
induced cell death after imprimatins treatment is due to an inhibition of SA to SAG conversion. 
The last and most recent example concerns Jarin-1, a small molecule inhibitor of jasmonate responses 
identified through a screen for suppression of LIPOXYGENASE2 (LOX2) expression in presence of 
jasmonic acid (JA) methyl ester (JAMe)164. Its binding to the biosynthetic enzyme JASMONATE 
RESISTANT1 (JAR1), which conjugates JA to isoleucine to form the active JA-Ile conjugate, was 
shown through narrowing down on possible candidate target proteins by evaluating different JA 
induced cellular responses, and eventually enzymatic assays with purified JAR1. Jarin-1 was 
subsequently shown to inhibit JAR1-mediated synthesis of JA-Ile in planta164. 
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1.3.1.3. In silico-based target identification strategies 
Not only forward, but also reverse and in silico design strategies have been successfully used. The 
starting point is a protein of interest, or a small molecule scaffold. Screening of additional small 
molecules aims at finding a specific interactor for the protein of interest, or at improving binding 
characteristics for an existing small molecule. A validation step in vivo confirms the findings of the 
reverse or in silico strategy. 
A first example concerns a study of more than a decade ago in search of novel inhibitors of imidazole 
glycerol phosphate dehydratase (IGPD), an attractive herbicide target165. Based on previously 
identified IGPD triazole inhibitors166, a pharmacophore model was developed to search available 3D-
databases165. A pharmacophore model contains spatial information on functional groups essential for 
small molecule action. The model was used to search commercial databases of about 370,000 small 
molecules in total. From the approximately 1,200 hits, small molecules, which were too high in 
molecular weight or too expensive, were excluded. From the resulting 140 hits, a group of bispyrroles 
proved to be interesting from a chemistry perspective and was chosen to perform a substructure search 
on about 600,000 small molecules. Finally a group of monopyrrole aldehydes was selected as a new 
class of IGPD inhibitors with activity in the low micromolar range. As this group does not fit the 
original pharmacophore model perfectly, it might be possible this new group acts through a different 
mechanism as the original triazole inhibitors165. 
A second example illustrates a screen for inhibitors of monogalactosyldiacylglycerol (MGDG) 
synthesis in Arabidopsis, which made use of E. coli lipid vesicles containing recombinant MGD1 and 
a small molecule library of a little less than 24,000 entries. After initial screening, a new set of small 
molecules was put together based on chemical similarities with the hits from the first screen, which 
led to a selection of 2 small molecules: galvestine-1 and 2, two competitive inhibitors relative to 
diacylglycerol (DAG) of MGDG synthases MGD1, 2 and 3167. 
 
1.3.2. Emerging target identification strategies in plant chemical biology 
 
1.3.2.1. Activity-based protein profiling (ABPP) 
The activity-based protein profiling (ABPP) target identification strategy relies on small molecules 
with a so-called ‘warhead’, which react with residues in the active site of enzymes in an irreversible 
manner168. The small molecules are attached via a linker to a functionality such as biotin for affinity 
purification, or to a fluorophore for visualization. Since the small molecules react with their respective 
target proteins to form a covalent bond, no additional cross-linking is required for further affinity 
purification. However, not every small molecule is capable of reacting with its target protein, 
therefore ABPP is only applicable for such small molecules. Equally, not every protein will react with 
a small molecule to form a covalent bond, and thus ABPP results in a substantially less complex 
proteome, which facilitates a more straightforward analysis. Importantly, ABPP enables to assign 
activity to a certain protein, not only within the entire proteome, but also within a certain family of 
proteins, thereby creating sub-classes based on activity. Recent examples of the use of ABPP are 
illustrated by studying the mode of action of the bicyclic hydantoin and several serine hydrolases 
(SHs) inhibitors in Arabidopsis. 
Different putative SH inhibitors were employed in a competitive ABPP approach to evaluate the 
effect in Arabidopsis169. Competitive ABPP assesses the ability of small molecules to compete with 
ABPP probes. A reduced labeling by the probe in presence of the small molecule indicates binding 
of the small molecule to the protein(s) under investigation. A rhodamine-tagged fluorophosphonate 
(FP) and a trifunctional nitrophenol phosphonate (TriNP) tagged with both rhodamine and biotin were 
used as ABPP probes. The main finding of the study was a differential sensitivity of different 
Arabidopsis SHs to the SH inhibitors tested169. An additional study on SHs reports the development 
of a paraoxon-like para-nitrophenol phosphonate activity-based probe predominantly labeling 
carboxylesterase12 in Arabidopsis170. 
The bicyclic hydantoin sparked the attention when it was found as a side product from synthesis 
efforts for syringolins171. To identify a molecular target from Arabidopsis cell cultures, the bicyclic 
hydantoin was labeled with biotin and rhodamine, and both versions were used to either detect or pull 
down the protein target. An affinity purification coupled with a mass spectrometry (MS) was used to 
identify the glyceraldehyde 3-phosphate dehydrogenase GAPC1 and GAPC2 as targets of the bicyclic 
hydantoin. Both GAPC1 and GAPC2 were heterologously expressed in E. coli, and shown to bind 
the rhodamine-tagged bicyclic hydantoin in an activity dependent manner171. 
 
1.3.2.2. Yeast 3-hybrid 
The yeast 3-hybrid (Y3H) approach relies on the principles of the yeast 2-hybrid (Y2H) technology, 
but employs a modified small molecule of interest to allow interaction between the DNA-binding 
domain and the transcriptional activator (Figure 8). When initially described172, Y3H was based on 
the Y2H system using the LexA DNA-binding domain and the trans-activation domain from the 
bacterial protein B42173. The so called ‘hook’ consisted of the LexA DNA-binding domain fused to 
the hormone-binding domain of the rat glucocorticoid receptor. The latter binds to dexamethasone, 
which is part of the hybrid small molecule comprising dexamethasone and FK506, or the ‘bait’. 
Finally, the ‘fish’ consisted of human FKBP12 (for 12-kDa FK506-binding protein) fused to the 
transcriptional activator B42. FK506 is an immunosuppressant drug in the mammalian field, and the 
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small molecule interactor of FKBP12. For screening purposes, FKBP12 represents any cDNA library 
of choice, whereas FK506 represents the small molecule of interest. 
To date, Y3H in plant chemical biology was used in an attempt to identify targets for small molecules 
with implications in plant defense responses174. The Y3H system used to this end was based on the 
LexA DNA-binding domain fused to dihydrofolate reductase (DHFR), which binds with high affinity 
to methotrexate (Mtx), and was used previously with success175. The hybrid ligand was composed of 
Mtx fused via a polyethylene glycol (PEG) linker to several small molecules, namely JA, ABA, 
compound 8 (cpd 8), cucurbic acid (CA), cucurbic acid methylester (CAMe) and 2,6 
dihydroxybenzoic acid (6OH-SA). The ‘fish’ was a collection of cDNA libraries from wounded or 
pathogen infected leaves and inflorescence from Arabidopsis, fused to the GAL4 transcriptional 
activator174. Although no targets were identified for Mtx-ABA and Mtx-JA, and no interaction could 
be shown when the known ABA and JA receptors were expressed as ‘fish’, potential target proteins 
were identified for the other small molecules. This study validates Y3H as a target identification 
strategy for plant chemical biology. 
The Y3H technique has a few notable advantages as it allows to screen for small molecule-protein 
interactions in vivo; to correct for low abundant proteins, and to easily identify the target protein(s) 
or even interacting protein domains. In addition, it allows for the identification of essential gene 
products, and should make it straightforward to identify an entire protein family as the target of a 
small molecule. However, although Y3H is an in vivo method, the ability of the protein to bind the 
small molecule of interest is assessed out of its biological context and one protein at a time, and 
therefore is less suited if small molecules require more than one protein to bind or the proper 
biological context. Moreover, proteins not able to translocate to the yeast nucleus such as trans-
membrane or membrane associated proteins cannot be screened, and the fact that the small molecules 
need to be modified, and the occurrence of multi-drug resistance in yeast can pose a problem. Variants 
of the Y3H system have been described151, but have not found an implementation in plant chemical 
biology yet. 
An improved version of Y3H screening is based on covalent labeling of SNAP-tag fusion proteins176. 
The SNAP-tag is based on the human O6-alkylguanine-DNA alkyltransferase which will covalently 
attach the alkyl group of its substrate to one of its cysteine residues. As its substrate specificity is not 
so high, it can also accept O6-benzylguanine (BG) as a substrate177. The Y3H is modified in such a 
way that the DNA-binding domain LexA is fused to a SNAP-tag, and the small molecule of interest 
is derivatized with BG176. The improved Y3H approach includes first, the use of a triple mutant for 
broad-spectrum drug-transporters. Second, false-positives are eliminated by a negative selection 
using 5-fluoroorotic acid in the absence of the modified small molecule, and later colonies are grown 
both in the presence and absence of the modified compound to score for specific interactions. 
Additionally, growth of colonies in the presence of the ‘bait’ and an excess of free, unmodified small 
molecule could potentially pinpoint colonies expressing a specific target, as the free small molecule 
will out-compete the ‘bait’, thereby preventing further growth or reporter expression172. The SNAP-
tag can also be combined with a GST-tag and thus, the GST-SNAP-tagged fusion protein can readily 
be used in affinity purification approaches with the same modified small molecules176. 
Concerning synthesis of the modified small molecule for Y3H, a recent study evaluated the length 
and nature of the linker178. An important conclusion using a triazole-containing linker opposed to a 
PEG linker was the lower background growth of yeast in the presence of a negative control, and thus 
a decreased amount of possible false-positives. 
 
1.3.2.3. Affinity-based technologies 
A much less explored target identification strategy in plant chemical biology is affinity purification. 
Typically, a derivatized small molecule is generated consisting of a selectivity function, which is the 
small molecule of interest, bound via a linker moiety to a tag such as biotin, which allows target 
isolation from a complex mixture. Incubation of an appropriate lysate with the modified compound, 
immobilizing it on a solid support, and subsequent washing of unbound proteins enables isolation of 
target proteins for liquid chromatography and MS analysis (Figure 8). As such, the general principle 
of this approach is shared with ABPP. 
Crucial for derivatization is structure activity relation (SAR) analysis. SAR analysis involves testing 
a collection of analogs of the original small molecule to assess which functional groups and moieties 
are essential for its activity. SAR analysis is not only important for derivatization, but can also provide 
crucial information about the mode of action of small molecules. A good illustration of the latter is 
sirtinol, identified as an inhibitor of sirtuin deacetylases in yeast and human cells179. Sirtinol in 
Arabidopsis was characterized as an enhancer of auxin signaling, and was found to bind and inhibit 
SIRTINOL RESISTANT 1 (SIR1), a negative regulator of auxin signaling upstream of the Aux/IAA 
genes. SIR1 and other SIR genes encode proteins involved in molybdopterin biosynthesis, and the 
incorporation of molybdenum to form molybdenum cofactor (moco), an essential cofactor in for 
example aldehyde oxidases. The target was identified through a sirtinol resistance screen on 60,000 
EMS-mutagenized Arabidopsis seeds180. A later study however, showed that sirtinol is enzymatically 
or non-enzymatically hydrolyzed into 2-hydroxy-1- naphthaldehyde (HNA). HNA is subsequently 
converted by a moco-containing aldehyde oxidase into 2-hydroxy-1- naphtoic acid (HNC). The latter 
is an active auxin analog, hence explaining the sirtinol induced phenotypes181. 
An important advantage of affinity purification is the ability to probe for target proteins of any 
molecular process of interest, hence any small molecule can be potentially used, and does not require 
activity toward the target in contrast to ABPP. It provides the possibility to uncover the small 
molecule interactome, thus not only the main target, but also ‘off-targets’, which might contribute to 
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the observed phenotype. The latter implies that specific readouts should be available to distinguish 
the target of interest from off-targets in the validation procedure. Additionally, affinity purification 
yields data on potential targets as well as biochemical proof of binding, provided proper controls are 
included. 
A variant of affinity purification consists of the incorporation of a cross-linking moiety, which results 
into the formation of a tri-functional probe. These so called ‘capture compounds’ consist of a 
selectivity function which is the small molecule of interest, a reactivity function, which is the cross-
linking moiety, and a sorting function (e.g. Biotin)182-184. The cross-linking moiety usually is activated 
by UV-light, thereby forming covalent bonds with proteins in close proximity. As the small molecule-
target interaction is secured by a covalent bond, washing can be stringent, removing unspecific 
binders, and, hence, incorporating a cross-linking moiety might solve problems with weak 
interactions and low abundant or less accessible protein targets. Crucial for both affinity purification 
and procedures involving cross-linking moieties are proper controls, to distinguish ‘true‘ targets from 
non-specific interactors. Preferably an inactive analog of the small molecule modified in the same 
way is used, but it should be noted that inactivity in vivo does not necessarily mean it will not bind 
the target protein in a lysate, as inactivity might be due to altered uptake. In addition, the ‘interactome’ 
used for the solid phase (e.g. streptavidin coated beads), or the linker with biotin alone might serve 
as an essential background list. Equally, multiple repeats with different probes can distinguish targets 
from background signals in a statistical manner. Competition experiments with unmodified 
compounds may reveal specific binders from non-specific binders, and serve as an essential control. 
However, in order to detect a competition with the unmodified small molecule, quantification of 
eluted proteins is required. To this end, stable isotope labeling with amino acids in cell culture 
(SILAC)185,186 can be used or other forms of differential labeling of peptides or proteins187,188. In short, 
two samples are prepared and differentially labeled (e.g. heavy and light) according to the SILAC 
protocol. Both samples are differentially treated: one with the probe only, the other with the probe 
and free small molecule in competition. If the concentration of the free small molecule is high enough, 
and it has a higher affinity toward the target than the modified small molecule, specific targets should 
not be retained after pull-down. Subsequent combination of both samples in a 1:1 ratio and MS 
analysis results in a distinguishable peptide pair originating from the different samples as they only 
differ by their isotopic mass-difference. Non-specific binders should be represented by peptides of 
equal intensity for both samples, opposed to peptides representing specific binders, as those peptides 
should be much lower in intensity due to the imposed competition with the free small molecule186. 
Additional issues might arise if the target protein is low abundant, or when of hydrophobic nature. 
One of the first examples of compound photo-affinity labeling in plant research concerns the 
modification of atrazine with a photo-reactive azido group. The subsequent azido-atrazine was 
radioactively labeled to allow detection of covalently bound polypeptides on a polyacrylamide gel189. 
Although atrazine is a well-characterized inhibitor of photosystem II reactions, and azido-atrazine 
was shown by the authors to act in a very similar way, target identification stops at the level of 
radioactively labeled polypeptides of 32-34 kDa on a polyacrylamide gel, be it from purified 
chloroplast thylakoids. 
A second example is given by efforts to identify the molecular target of the small molecule 
responsible for nyctinastic leaf movement of Albizzia saman190. The tri-functional probe consisted of 
the small molecule of interest, a jasmonate glucoside, benzophenone as the reactivity function and 
biotin as the selectivity function. Additionally, an inactive enantiomeric analog was modified in the 
same way, serving as a control190. Both probes were activated at 365nm, and SDS-PAGE analysis 
revealed a differential band, which disappeared using the unmodified small molecule as competitor. 
Until now to our knowledge no examples exist in plant research of an affinity purification approach 
without covalent binding to the target protein. 
A third example concerns the biotin-labelled photoaffinity castasterone (BPCS)24. This report shows 
the ability of castasterone, one of most active BRs aside BL1, to bind the receptor BRI1. The binding 
site is mapped to an island domain in between LRR21 and LRR22 of the extracellular domain of 
BRI1. This observation was later confirmed by structural data of BRI1 in complex with BL22;23. 
 
In order to circumvent the bio-availability problems that are likely to arise with biotin tags or 
fluorophores attached to the small molecule, a two-step labeling of small molecules was optimized 
in Arabidopsis using so called mini-tags, based on azide and alkyn functional groups191. The well-
known cystein-protease inhibitor E64 was used to study and establish the two-step labeling technique. 
Because E64 is a covalent inhibitor of its targets, the two-step labeling consists of a first modification 
of E64 with a mini-tag, minimizing interference of the tag on E64 activity and bioavailability. After 
incubation of the sample with modified E64, a second step attaches biotin modified with the 
appropriate mini-tag in a click-chemistry reaction, allowing subsequent purification and detection of 
the target protein191. One of the main advantages is the ability to label in vivo, which, in the explained 
setup is not possible for small molecules that do not bind covalently to their target protein. This 
problem can be solved by introducing a photo-activatable group together with a mini-tag, which 
allows cross-linking in vivo, with subsequent preparation of the lysate and attaching biotin for affinity 
purification. 
Although in situ proteome profiling with a small molecule modified for photo-cross-linking has the 
advantage of identifying target proteins in the proper biological context, care should be taken with 
possible effects of UV irradiation on the proteome. Certainly if exposure remains for several minutes, 
damage might be induced, which eventually might compromise the final protein target list. 
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In order to perform in situ proteome profiling, the small molecule of choice should be modified with 
a photo-cross-linking group, together with a group which allows additional bioorthogonal 
modification, usually done with a clickable group. In this way, after cross-linking in live cells, a group 
for affinity purification or visualization can be added afterward. The latter option allows the usage of 
a technique called fluorescence difference in two-dimensional gel electrophoresis (FITGE). This 
method uses two samples, one labeled with the active small molecule, the other with an inactive form 
or other control, and labels both samples with a different fluorophore. This differential labeling allows 
detecting both samples together on a 2D SDS-PAGE gel. Spots that are labeled by both fluorophores 
are probably because of unspecific binding events, whereas spots only labeled with the fluorophore 
attached to the active small molecule are potential hits that can be identified by subsequent MS 
approaches192. Differences between lysates and live cells as starting material were reported, where 
live cells might likely provide more reliable target identification and can be even a requirement to 
detect the main target. 
 
1.3.2.4. Phage display 
The phage display strategy relies on whole, fragmented cDNA or random peptide sequences being 
translationally fused to the phage coat protein, so that the peptides are displayed on the outside. An 
immobilized small molecule can retain those peptides binding to the small molecule. A subsequent 
bacterial infection allows to identify selected peptides. A recent example in plants used a quartz-
crystal microbalance (QCM) biosensor in combination with T7 phage display and the receptor-ligand 
contacts (RELIC) bioinformatics server to identify binding sites of brassinazole (Brz2001) on the 
cytochrome P450 DWF413. Brz2001 is an improved version of brassinazole, a BR biosynthesis 
inhibitor acting at the level of DWF4, which catalyzes the rate limiting hydroxylation of the C22 
position in the BR biosynthesis1,6,7.The QCM measures voltage-induced crystal vibrations on a gold 
electrode, which will decrease as the overall mass on the gold electrode increases. A modified version 
of Brz2001 was used, which forms a monolayer on the gold electrode. The QCM-measured vibrations 
will decrease as peptides bind the immobilized small molecule. A random 15-mer peptide library was 
incubated with the Brz2001-covered gold electrode, which resulted in the identification of 34 peptides. 
Subsequent use of the RELIC bioinformatics platform193 identified within the 34 selected peptides a 
subset of amino acids potentially involved in small molecule binding which map to a potential 
disordered loop of DWF413. 
Given the possibility to modify the small molecule of interest, and the ability to coat the gold 
electrode, this technique allows for a quick assessment of possible target proteins. It allows for a 
coverage of the proteome without the possibility of missing out on low abundant proteins due to the 
easy amplification of the signal by bacterial infection. It is less suited for those interactions requiring 
post-translational modifications, very hydrophobic peptides, and protein-small molecule interactions, 
for which several amino acid residues involved in binding are scattered across the protein primary 
sequence. When the small molecule only binds if the appropriate amino acid residues are forming a 
binding pocket after protein folding, phage display with a random small peptide library will likely 
not work. Phage display with entire proteins might solve the problem, but will select against any 
hydrophobic protein, besides the possibility that the protein might not fold properly. 
 
 
Figure 8. General principle of emerging and novel target identification strategies in plant 
chemical biology 
A. Strategies relying on the affinity of the small molecule to isolate the target protein from a complex 
mixture such as a lysate or cellular environment. B. The yeast-3-hybrid approach employs the 
activation of a transcriptional response by bringing together a DNA binding domain and 
transcriptional activator via a fusion of the small molecule of interest and a known small molecule 
with high affinity for a known protein target. The latter is fused to the DNA binding domain. The 
small molecule probes a cDNA library fused to the transcriptional activator. C. Strategies relying on 
increased protein stability employ small molecules to stabilize the increased dynamics, instability and 
degradation upon treatments such as denaturants or proteases, preventing or slowing down target 
protein degradation. Grey spheres: non-target proteins; blue spheres: target protein; orange cartoon: 
small molecule of interest; Lex A: Lex A DNA binding domain; Mtx: methotrexate; DHFR: 
dihydrofolate redutase, target protein of Mtx; GAL4: GAL4 transcriptional activator. 
 
1.3.3. Label-free compound based technologies 
An obvious drawback of affinity purification is the requirement for ‘taggable’ positions on the small 
molecule of interest. In addition, the small molecule should still be active with at least part of the 
intended modification (e.g. the linker), as the modification might hinder proper binding of the small 
molecule to its targets. Efficient isolation of the target is also dependent on the affinity of the small 
molecule, as low affinity interactions might be lost during washing. Therefore, rather gentle washing 
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conditions should be used, which have the disadvantage of generating extensive lists of possible target 
proteins. In an effort to solve these problems, approaches which do not require labeled small 
molecules are being developed. 
 
1.3.3.1. Chemical denaturation shift 
One way of testing ligand interactions is by measuring protein stability, which is dependent on a 
number of factors, including temperature, denaturants and ligand binding. An increase of protein 
stability, and thus denaturing conditions, to higher temperatures is indicative of ligand binding. 
Classically, this is measured by fluorescence or differential scanning calorimetry194,195. However, as 
estimations on binding affinities require prior knowledge on enthalpy and heat capacity of protein 
denaturation and ligand binding, such an approach is not suited for high throughput screening, 
because binding thermodynamics are yet unknown for small molecules in a library. Additionally, the 
rank order given to small molecule interactors based on the induced shift in protein denaturation 
temperature (Tm) is not necessarily the same at the physiological temperature and the measured Tm. 
An alternative approach was proposed based on a chemical denaturation shift196, where instead of 
measuring Tm, the increase in concentration of a denaturant is measured required to denature the 
protein in the presence of its ligand. Although the study is an optimization and proof of concept of 
the chemical denaturation shift approach, it illustrates the usability to provide proof of ligand binding, 
and is additionally suited for high throughput screening setups in a reverse chemical genetics strategy. 
 
1.3.3.2. Target identification by chromatographic co-elution (TICC) 
Another example of a label free approach is the TICC technology197. The idea is to look for a shift in 
the retention time of the small molecule of interest in a complex protein mixture compared to the 
small molecule alone during non-denaturing high performance liquid chromatography. The shift in 
retention time would be indicative of binding to a particular protein target, which can be identified 
by further deconvolving the fraction in which the small molecule elutes by additional complementing 
and orthogonal fractionations. Key to the success of this approach is the ability to separate free from 
protein-bound ligand197. 
 
1.3.3.3. Drug affinity-responsive target stability (DARTS) 
The DARTS approach takes advantage of the stabilization of a protein target upon small molecule 
binding, thereby rendering the protein less susceptible to proteolytic digestion198,199. This idea also 
formed the basis for the chemical denaturation shift approach200. DARTS can be used to confirm a 
certain small molecule-protein interaction by specifically evaluating proteolytic digestion via western 
blotting, but equally can be used to evaluate possible new small molecule-protein interactions by 
looking at entire lysates. Although the latter situation might result in visibly stabilized targets when 
high abundant, low abundant target proteins might not be readily visible on gel199. 
Both DARTS and TICC share some important advantages. First they are label free, require no 
derivatization and use the original small molecule. This is not only important in terms of small 
molecule tolerance toward modification, but also saves time, as SAR analysis can be limited. A 
second important advantage is their independency of any protein nature, mode of action or model 
system. Both techniques solely rely on affinity of the small molecule for its target protein. The latter 
also dictates an inherent weakness: interactions of lower affinity might be missed. Both techniques 
have their specific weaknesses too. While membrane proteins remain challenging for TICC, DARTS 
is not applicable to any protein, as some proteins are more resistant to digestion and might be missed. 
In addition, the small molecule might interact in such a way that digestion of the protein is not, or 
hardly affected. 
Table 2. Overview of the target identification strategies 
Target identification 
strategy 
Examplesa Modified 
small 
molecule 
References 
Established strategies 
Forward genetics screen for 
small molecule resistance 
Pyrabactin, gravacin, 
DAS734 
No Park et al. (2009), Rojas-Pierce et al. 
(2007), Walsh et al. (2007) 
Phenotyping approach Bikinin, kynurenine, 
imprimatins, Jarin-1 
No De Rybel et al. (2009), He et al. (2011), 
Noutoshi et al. (2012) Meesters et al. 
(2014) 
In silico and reverse target 
identification 
IGPD inhibitors, 
galvestine 1 and 
galvestine 2 
No Schweitzer et al. (2002), Botté,et al. 
(2011). 
Emerging strategies    
Activity-based protein 
profiling 
Bicyclic hydantoin, serine 
hydrolases 
Yes Kaschani et al. (2012a, 2012b) 
    
Yeast-3-Hybrid Jasmonic acid, abscisic 
acid, compound 8, 
cucurbic acid, cucurbic 
acid methylester, 2,6 
dihydroxybenzoic acid 
Yes Cottier et al. (2011). 
Affinity purification with cross 
linking moiety 
Atrazine, a jasmonate 
glucosate 
Yes Pfister et al. (1981), Nakamura et al. 
(2008), (Kinoshita et al., 2005) 
Phage display Brz2001 Yes Takakusagi et al. (2013) 
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Promising strategies    
Affinity purification None yet Yes Ziegler et al. (2013) 
Chemical denaturation shift None yet No Schön et al. (2013) 
Target identification by 
chromatographic co-elution 
None yet No Chan et al. (2012) 
Drug affinity responsive target 
stability 
None yet No Lomenick et al. (2009) 
aThe examples correspond with those given in the text. 
 
1.4. Future perspectives 
 
To date BR research has benefited from four different classes of small molecules, namely brz-based 
molecules, the ketoconazole scaffold-containing molecules, BR analogs, and bikinin-based 
molecules. Brz and bikinin have both been used extensively. Brz resistance screens have recently led 
to the discovery of several components involved or related to BR signaling200-203 and bikinin revealed 
crosstalk between BR signaling and other developmental pathways43-47. Although the major 
components of BR signaling and biosynthesis are known, small molecules can still play an important 
role. The recent characterization of YCZ-18 as an inhibitor of BR biosynthesis is a good illustration 
of the potential of new small molecules, as it targets CYP90D1 (Figure 2), a different biosynthetic 
enzyme as DWRF4204. It therefore offers the opportunity to inhibit BR biosynthesis in an alternative 
way, which potentially offers the ability to assess the role of different BR biosynthetic intermediates 
on cell growth and development. Small molecules can also offer opportunities to dissect different 
molecular functions within the same protein. For example, the recent insights gained on the kinase 
domains of BRI1205 and BAK1206 could provide a reverse chemical genetics platform for the 
development of small molecules targeting specific domains of the kinase. This would allow altering 
interactions and output of the kinase in a dynamic and reversible manner. As illustrated before207, the 
development of specific agonists, or antagonists, both chemically and at the target protein level, could 
constitute a small molecule toolbox which allows specific targeting of BR signaling components. 
This in turn would allow a better understanding of crosstalk between different BR signaling 
components and a plethora of other developmental, growth or stress responses. In addition, affinity 
purification with tagged small molecules could improve our understanding on binding partners of 
components involved in BR signaling and biosynthesis. Finally, because little is understood about the 
molecular mechanisms involved in delivering BR upon biosynthesis to the site of BRI1 perception at 
the PM, small molecules might serve to disrupt or visualize molecular components involved. 
BR signaling in relation to endomembrane traffic has benefited from a pharmacological approach as 
well25,36,37. A collection of small molecules that can provide valuable new hit molecules to decipher 
the endomembrane regulation of BR signaling, transport or turnover has been obtained from a large-
scale screen for inhibitors of pollen germination and growth69. A number of chemicals have been 
identified in a secondary screen for small molecules capable of affecting endomembrane trafficking 
of BRI1-GFP, which when explored might provide valuable leads for BR research. Taken together, 
the above examples of chemical biology approaches illustrate the potential of small molecule tools 
for BR research in the future. 
Not only the studies of the relation between BR signaling and endomembrane traffic, but also studies 
of endomembrane traffic in general will benefit from the small molecule screen for inhibitors of 
pollen germination and growth69 This is exemplified by two recent reports on the characterization of 
ES7208 and ES8209. ES7 was characterized as an inhibitor of callose deposition during cell plate 
maturation, and has since been used in localization studies of different RAB GTPases involved in cell 
plate formation210, while ES8 was shown to affect early secretory pathways mediated by GNOM and 
GNOM-LIKE1, with effects on polar distribution of the auxin efflux carrier PIN-FORMED1 (PIN1). 
Although ES8 and the other examples of endomembrane affectors described in this introduction will 
likely provide important insights on endomembrane traffic in the future, target identification and 
knowledge on off-target proteins contributing to the overall phenotype are lacking for most of them, 
yet is an important step in developing the hit molecule as a research tool, and by extension as 
agrochemical or drug. Depending on which aspect of plant biology the small molecule of choice is 
affecting, and what the intended use will be, knowledge on the interactome of the small molecule is 
essential. Since the induced phenotype is only the sum of multiple affected targets, a deconvolution 
of the phenotype toward the individual contributions of the affected targets is of paramount 
importance. To this end, current commonly used target identification strategies in plant biology fall 
short. Therefore, an evolution toward more biochemical and alternative strategies is required. 
Surprisingly, one of the most successful target identification strategies in animal research is much 
less used in plant research: affinity purification. Although the technique has important shortcomings 
such as the need for small molecule modification and the preference for abundant soluble protein 
targets, it is one of the few strategies capable of revealing the small molecule interactome. Several 
variants exist of the basic affinity-based pull-down principle to accommodate for shortcomings of the 
technique, and their implementation in fundamental plant biology research as well as in a more 
commercial research environment should spur our understanding of dynamic cellular mechanisms. 
In addition, development of affinity purification based approaches in combination with other well-
established techniques might provide additional dimensions to the interactome resulting from classic 
affinity-based setups. One such example is Chem-seq, in which a combination of affinity purification 
and chromatin immunoprecipitation (ChIP) technology can provide new insights in the role of small 
molecules at a genome-wide level211. 
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Other approaches more established in other systems than plants, besides the ones mentioned in this 
introduction, might find their way into plant biology as well. A possible example could be multi-copy 
suppression profiling, where the central idea relies on increased tolerance toward the small molecule 
if the target protein is present in higher copy numbers158. Similarly to EMS-screens, overexpression 
line collections such as activation-tag collections could be screened for more tolerance toward small 
molecules. Problems with gene redundancy and lethality would be overcome, and identification of 
the potential target should be simple. Equally, one overexpression line could be used to screen an 
entire collection of small molecules for more tolerance. In addition, adaptation of the Cellular 
Thermal Shift Assay (CETSA)212 for target identification purposes might be the onset towards a 
relatively easy strategy to identify possible target proteins without the need of small molecule 
modification. The technique relies on increased stability of the target protein in presence of the small 
molecule at higher temperatures, according to a similar principle as DARTS and the chemical 
denaturation shift. The major difference with the latter two is that CETSA works at the cell and even 
tissue level210. In addition, a recent report illustrates the compatibility of CETSA with a proteome-
wide assessment of small molecule binding to target proteins213, which opens the possibility to assess 
small molecule binding to target proteins for the entire proteome, without modification, and at the 
cell or tissue level. Computational approaches are likely to find their way into plant chemical biology 
as well, and will mature into essential tools for target and off-target predictions for any new small 
molecule tool in plant chemical biology, given the surge of new algorithms in mammalian drug 
discovery214,215. A major limitation for plant chemical biology, and holding back the breakthrough of 
computational approaches, is the availability of large scale data-bases and repositories for small 
molecule data in plant biology. 
Finally, the choice for a particular target identification strategy greatly depends on the aim of the 
study and available resources, yet considering several complementary approaches to prove protein 
target binding will only make the study stronger. Although initial efforts to setup an affinity 
purification target identification approach are greater compared to for example resistance screens, 
affinity purification has important advances over the well-established target identification strategies 
in plant biology. Therefore, plant biology can only benefit from adapting affinity-based target 
identification approaches in future chemical biology projects. 
 
This thesis aims at adopting new and less common target identification strategies as part of the 
characterization of small molecule affectors of BR signaling and endomembrane traffic. As such we 
hope to develop new chemical tools for cell biology , which can probe endomembrane traffic in a 
specific way, and provide new insights into the complex relation between BR signaling and 
endomembrane traffic. The small molecules will be derived from the previously mentioned screen 
for inhibitors of pollen germination and growth69, and further screened to identify hit molecules 
targeting BR signaling and specific aspects of endomembrane traffic. 
 
1.5. Acknowledgments 
 
We would like to thank Martine De Cock and Annick Bleys for help in preparing the manuscripts.  
  
65 
 
1.6. References 
 
1. Vriet, C., Russinova, E. & Reuzeau, C. From squalene to brassinolide: the steroid metabolic 
and signaling pathways across the plant kingdom. Mol Plant 6, 1738–1757 (2013). 
2. Zhu, J.-Y., Sae-Seaw, J. & Wang, Z.-Y. Brassinosteroid signalling. Development 140, 1615–
1620 (2013). 
3. Wang, W., Bai, M.-Y. & Wang, Z.-Y. The brassinosteroid signaling network-a paradigm of 
signal integration. Curr Opin Plant Biol 21, 147–153 (2014). 
4. Yang, X.-H., Xu, Z.-H. & Xue, H.-W. Arabidopsis membrane steroid binding protein 1 is 
involved in inhibition of cell elongation. Plant Cell 17, 116–131 (2005). 
5. Wang, Z.-Y. et al. Nuclear-localized BZR1 mediates brassinosteroid-induced growth and 
feedback suppression of brassinosteroid biosynthesis. Dev Cell 2, 505–513 (2002). 
6. Asami, T. et al. Characterization of brassinazole, a triazole-type brassinosteroid biosynthesis 
inhibitor. Plant Physiol 123, 93–100 (2000). 
7. Sekimata, K. et al. A specific brassinosteroid biosynthesis inhibitor, Brz2001: evaluation of 
its effects on Arabidopsis, cress, tobacco, and rice. Planta 213, 716–721 (2001). 
8. Rademacher, W. Growth retardants: Effects on Gibberellin Biosynthesis and Other Metabolic 
Pathways. Annu. Rev. Plant Physiol. Plant Mol. Biol. 51, 501–531 (2000). 
9. Hartwig, T. et al. Propiconazole is a specific and accessible brassinosteroid (BR) biosynthesis 
inhibitor for Arabidopsis and maize. PLoS ONE 7, e36625 (2012). 
10. Sekimata, K. et al. A specific and potent inhibitor of brassinosteroid biosynthesis possessing 
a dioxolane ring. J. Agric. Food Chem. 50, 3486–3490 (2002). 
11. Asami, T. et al. Selective interaction of triazole derivatives with DWF4, a cytochrome P450 
monooxygenase of the brassinosteroid biosynthetic pathway, correlates with brassinosteroid 
deficiency in planta. J Biol Chem 276, 25687–25691 (2001). 
12. Sekimata, K. et al. Brz220 interacts with DWF4, a cytochrome P450 monooxygenase in 
brassinosteroid biosynthesis, and exerts biological activity. Biosci Biotechnol Biochem 72, 7–
12 (2008). 
13. Takakusagi, Y. et al. Mapping a disordered portion of the Brz2001-binding site on a plant 
monooxygenase, DWARF4, using a quartz-crystal microbalance biosensor-based T7 phage 
display. Assay Drug Dev Technol 11, 206–215 (2013). 
14. Rozhon, W. et al. Genetic variation in plant CYP51s confers resistance against voriconazole, 
a novel inhibitor of brassinosteroid-dependent sterol biosynthesis. PLoS ONE 8, e53650 
(2013). 
15. Oh, K., Yamada, K., Asami, T. & Yoshizawa, Y. Synthesis of novel brassinosteroid 
biosynthesis inhibitors based on the ketoconazole scaffold. Bioorg. Med. Chem. Lett. 22, 
1625–1628 (2012). 
16. Yamada, K., Yoshizawa, Y. & Oh, K. Synthesis of 2RS,4RS-1-[2-phenyl-4-[2-(2-
trifluromethoxy-phenoxy)-ethyl]-1,3-dioxolan-2-yl-methyl]-1H-1,2,4-triazole derivatives as 
potent inhibitors of brassinosteroid biosynthesis. Molecules 17, 4460–4473 (2012). 
17. Yamada, K., Yajima, O., Yoshizawa, Y. & Oh, K. Synthesis and biological evaluation of 
novel azole derivatives as selective potent inhibitors of brassinosteroid biosynthesis. Bioorg. 
Med. Chem. 21, 2451–2461 (2013). 
18. Oh, K., Yamada, K. & Yoshizawa, Y. Asymmetric synthesis and effect of absolute 
stereochemistry of YCZ-2013, a brassinosteroid biosynthesis inhibitor. Bioorg. Med. Chem. 
Lett. 23, 6915–6919 (2013). 
19. Hoshi, T., Matsumoto, T., Yamada, K., Yoshizawa, Y. & Oh, K. Synthesis of New 
Brassinosteroid Biosynthesis Inhibitor with Coumarin Moiety as a Fluorescent Probe. Int J 
Chem Eng Appl. 5:379-383 (2014). 
20. Piotrowska, A. & Bajguz, A. Conjugates of abscisic acid, brassinosteroids, ethylene, 
gibberellins, and jasmonates. Phytochemistry 72, 2097–2112 (2011). 
21. Bajguz, A. Brassinosteroids — occurence and chemical structures in plants. In 
Brassinosteroids: A Class of Plant Hormone. Springer 1–27 (2011). 
22. Hothorn, M. et al. Structural basis of steroid hormone perception by the receptor kinase BRI1. 
Nature 474, 467–471 (2011). 
23. She, J. et al. Structural insight into brassinosteroid perception by BRI1. Nature 474, 472–476 
(2011). 
24. Kinoshita, T. et al. Binding of brassinosteroids to the extracellular domain of plant receptor 
kinase BRI1. Nature 433, 167–171 (2005). 
25. Irani, N. G. et al. Fluorescent castasterone reveals BRI1 signaling from the plasma membrane. 
Nat Chem Biol 8, 583–589 (2012). 
26. Sun, Y. et al. Structure reveals that BAK1 as a co-receptor recognizes the BRI1-bound 
brassinolide. Cell Res 23, 1326–1329 (2013). 
27. Santiago, J., Henzler, C. & Hothorn, M. Molecular mechanism for plant steroid receptor 
activation by somatic embryogenesis co-receptor kinases. Science 341, 889–892 (2013). 
28. Rosado-Abón, A., de Dios-Bravo, G., Rodríguez-Sotres, R. & Iglesias-Arteaga, M. A. 
Synthesis and plant growth promoting activity of polyhydroxylated ketones bearing the 5α-
hydroxy-6-oxo moiety and cholestane side chain. Steroids 77, 461–466 (2012). 
29. Kvasnica, M. et al. Biological activities of new monohydroxylated brassinosteroid analogues 
with a carboxylic group in the side chain. Steroids 85, 58–64 (2014). 
67 
 
30. Acebedo, S. L., Alonso, F., Ramírez, J. A. & Galagovsky, L. R. Synthesis of aromatic 
stigmastanes: application to the synthesis of aromatic analogs of brassinosteroids. 
Tetrahedron 68, 3685–3691 (2012). 
31. Acebedo, S. L., Alonso, F., Galagovsky, L. R. & Ramírez, J. A. Synthesis and biological 
activity of ring-A difluorinated brassinosteroids. Steroids 76, 1016–1020 (2011). 
32. Muto, T. & Todoroki, Y. Brassinolide-2,3-acetonide: a brassinolide-induced rice lamina joint 
inclination antagonist. Bioorg. Med. Chem. 21, 4413–4419 (2013). 
33. Russinova, E. et al. Heterodimerization and endocytosis of Arabidopsis brassinosteroid 
receptors BRI1 and AtSERK3 (BAK1). Plant Cell 16, 3216–3229 (2004). 
34. Geldner, N., Hyman, D. L., Wang, X., Schumacher, K. & Chory, J. Endosomal signaling of 
plant steroid receptor kinase BRI1. Genes Dev 21, 1598–1602 (2007). 
35. Robert, S. et al. Endosidin1 defines a compartment involved in endocytosis of the 
brassinosteroid receptor BRI1 and the auxin transporters PIN2 and AUX1. Proc Natl Acad 
Sci USA 105, 8464–8469 (2008). 
36. Di Rubbo, S. et al. The clathrin adaptor complex AP-2 mediates endocytosis of brassinosteroid 
insensitive1 in Arabidopsis. Plant Cell 25, 2986–2997 (2013). 
37. Gadeyne, A. et al. The TPLATE adaptor complex drives clathrin-mediated endocytosis in 
plants. Cell 156, 691–704 (2014). 
38. Shani, E. et al. Gibberellins accumulate in the elongating endodermal cells of Arabidopsis 
root. Proc Natl Acad Sci USA 110, 4834–4839 (2013). 
39. Gao, Y. H., Yu, Y., Hu, X. G., Cao, Y. J. & Wu, J. Z. Imaging of jasmonic acid binding sites 
in tissue. Anal. Biochem. 440, 205–211 (2013). 
40. Rasmussen, A. et al. A fluorescent alternative to the synthetic strigolactone GR24. Mol Plant 
6, 100–112 (2013). 
41. Prandi, C. et al. Strigolactone analogs as molecular probes in chasing the (SLs) receptor/s: 
design and synthesis of fluorescent labeled molecules. Mol Plant 6, 113–127 (2013). 
42. De Rybel, B. et al. Chemical inhibition of a subset of Arabidopsis thaliana GSK3-like kinases 
activates brassinosteroid signaling. Chem Biol 16, 594–604 (2009). 
42. Rozhon, W. et al. Bikinin-like inhibitors targeting GSK3/Shaggy-like kinases: 
characterisation of novel compounds and elucidation of their catabolism in planta. BMC Plant 
Biol 14, 172 (2014). 
43. Kim, T.-W., Michniewicz, M., Bergmann, D. C. & Wang, Z.-Y. Brassinosteroid regulates 
stomatal development by GSK3-mediated inhibition of a MAPK pathway. Nature 482, 419–
422 (2012). 
44. Gudesblat, G. E. et al. SPEECHLESS integrates brassinosteroid and stomata signalling 
pathways. Nat Cell Biol 14, 548–554 (2012). 
45. Khan, M. et al. Brassinosteroid-regulated GSK3/Shaggy-like Kinases Phosphorylate 
Mitogen-activated Protein (MAP) Kinase Kinases, Which Control Stomata Development in 
Arabidopsis thaliana. J Biol Chem 288, 7519-7527. (2013). 
46. Kondo, Y. et al. Plant GSK3 proteins regulate xylem cell differentiation downstream of TDIF–
TDR signalling. Nat Commun 5, 3504 (2014). 
47. Cho, H. et al. A secreted peptide acts on BIN2-mediated phosphorylation of ARFs to 
potentiate auxin response during lateral root development. Nat Cell Biol 16, 66–76 (2014). 
48. Foresti, O. & Denecke, J. Intermediate organelles of the plant secretory pathway: identity and 
function. Traffic 9, 1599–1612 (2008). 
49. Robinson, D. G., Herranz, M.-C., Bubeck, J., Pepperkok, R. & Ritzenthaler, C. Membrane 
Dynamics in the Early Secretory Pathway. Critical Reviews in Plant Sciences 26, 199–225 
(2007). 
50. Vázquez-Martínez, R. et al. Revisiting the regulated secretory pathway: from frogs to human. 
Gen. Comp. Endocrinol. 175, 1–9 (2012). 
51. Scheuring, D. et al. Multivesicular bodies mature from the trans-Golgi network/early endosome 
in Arabidopsis. Plant Cell 23, 3463–3481 (2011). 
52. Dell’Angelica, E. C. AP-3-dependent trafficking and disease: the first decade. Curr Opin Cell 
Biol 21, 552–559 (2009). 
53. Feraru, E. et al. The AP-3 β adaptin mediates the biogenesis and function of lytic vacuoles in 
Arabidopsis. Plant Cell 22, 2812–2824 (2010). 
54. Chen, X., Irani, N. G. & Friml, J. Clathrin-mediated endocytosis: the gateway into plant cells. 
Curr Opin Plant Biol 14, 674–682 (2011). 
55. Howes, M. T., Mayor, S. & Parton, R. G. Molecules, mechanisms, and cellular roles of clathrin-
independent endocytosis. Curr Opin Cell Biol 22, 519–527 (2010). 
56. Li, F. & Vierstra, R. D. Autophagy: a multifaceted intracellular system for bulk and selective 
recycling. Trends Plant Sci 17, 526–537 (2012). 
57. Prosser, D. C., Drivas, T. G., Maldonado-Báez, L. & Wendland, B. Existence of a novel 
clathrin-independent endocytic pathway in yeast that depends on Rho1 and formin. J Cell Biol 
195, 657–671 (2011). 
58. Huotari, J. & Helenius, A. Endosome maturation. EMBO J 30, 3481–3500 (2011). 
59. Yang, Z. & Klionsky, D. J. Eaten alive: a history of macroautophagy. Nat Cell Biol 12, 814–
822 (2010). 
69 
 
60. Viotti, C. et al. Endocytic and secretory traffic in Arabidopsis merge in the trans-Golgi 
network/early endosome, an independent and highly dynamic organelle. Plant Cell 22, 1344–
1357 (2010). 
61. Surpin, M. & Raikhel, N. Traffic jams affect plant development and signal transduction. Nat 
Rev Mol Cell Biol 5, 100–109 (2004). 
62. Zouhar, J. & Rojo, E. Plant vacuoles: where did they come from and where are they heading? 
Curr Opin Plant Biol 12, 677–684 (2009). 
63. Frigerio, L., Hinz, G. & Robinson, D. G. Multiple vacuoles in plant cells: rule or exception? 
Traffic 9, 1564–1570 (2008). 
64. Hicks, G. R. & Raikhel, N. V. Small Molecules Present Large Opportunities in Plant Biology. 
Annu Rev Plant Biol 63, 261-282 (2012). 
65. Tóth, R. & van der Hoorn, R. A. L. Emerging principles in plant chemical genetics. Trends 
Plant Sci 15, 81–88 (2010). 
66. Cong, F., Cheung, A. K. & Huang, S.-M. A. Chemical Genetics-Based Target Identification in 
Drug Discovery. Annu. Rev. Pharmacol. Toxicol. 52, 57-78 (2011). 
67. Delaney, J., Clarke, E., Hughes, D. & Rice, M. Modern agrochemical research: a missed 
opportunity for drug discovery? Drug Discov Today 11, 839–845 (2006). 
68. Knight, Z. A. & Shokat, K. M. Chemical genetics: where genetics and pharmacology meet. Cell 
128, 425–430 (2007). 
69. Drakakaki, G. et al. Clusters of bioactive compounds target dynamic endomembrane networks 
in vivo. Proc Natl Acad Sci USA 108, 17850–17855 (2011). 
70. Codreanu, M.-C., Audenaert, D., Nguyen, L., Beeckman, T. & Russinova, E. Small-molecule 
dissection of brassinosteroid signaling. Methods Mol Biol 876, 95–106 (2012). 
71. Surpin, M. et al. The power of chemical genomics to study the link between endomembrane 
system components and the gravitropic response. Proc Natl Acad Sci USA 102, 4902–4907 
(2005). 
72. Feng, Y. et al. Exo1: a new chemical inhibitor of the exocytic pathway. Proc Natl Acad Sci USA 
100, 6469–6474 (2003). 
73. Brown, J. X., Buckett, P. D. & Wessling-Resnick, M. Identification of small molecule inhibitors 
that distinguish between non-transferrin bound iron uptake and transferrin-mediated iron 
transport. Chem Biol 11, 407–416 (2004). 
74. Pan, H. et al. A novel small molecule regulator of guanine nucleotide exchange activity of the 
ADP-ribosylation factor and golgi membrane trafficking. J Biol Chem 283, 31087–31096 
(2008). 
75. Balgi, A. D. et al. Screen for chemical modulators of autophagy reveals novel therapeutic 
inhibitors of mTORC1 signaling. PLoS ONE 4, e7124 (2009). 
76. Farkas, T., Høyer-Hansen, M. & Jäättelä, M. Identification of novel autophagy regulators by a 
luciferase-based assay for the kinetics of autophagic flux. Autophagy 5, 1018–1025 (2009). 
77. Farkas, T., Daugaard, M. & Jäättelä, M. Identification of small molecule inhibitors of 
phosphatidylinositol 3-kinase and autophagy. J Biol Chem 286, 38904–38912 (2011). 
78. Zhang, L. et al. Small molecule regulators of autophagy identified by an image-based high-
throughput screen. Proc Natl Acad Sci USA 104, 19023–19028 (2007). 
79. Hundeshagen, P., Hamacher-Brady, A., Eils, R. & Brady, N. R. Concurrent detection of 
autolysosome formation and lysosomal degradation by flow cytometry in a high-content screen 
for inducers of autophagy. BMC Biol. 9, 38 (2011). 
80. Sáenz, J. B., Doggett, T. A. & Haslam, D. B. Identification and characterization of small 
molecules that inhibit intracellular toxin transport. Infect. Immun. 75, 4552–4561 (2007). 
81. Stechmann, B. et al. Inhibition of retrograde transport protects mice from lethal ricin challenge. 
Cell 141, 231–242 (2010). 
82. Huang, J. et al. Finding new components of the target of rapamycin (TOR) signaling network 
through chemical genetics and proteome chips. Proc Natl Acad Sci USA 101, 16594–16599 
(2004). 
83. Sarkar, S. et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease 
models. Nat Chem Biol 3, 331–338 (2007). 
84. Zouhar, J., Hicks, G. R. & Raikhel, N. V. Sorting inhibitors (Sortins): Chemical compounds to 
study vacuolar sorting in Arabidopsis. Proc Natl Acad Sci USA 101, 9497–9501 (2004). 
85. Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10, 839–850 (2006). 
86. Kleist, von, L. et al. Role of the clathrin terminal domain in regulating coated pit dynamics 
revealed by small molecule inhibition. Cell 146, 471–484 (2011). 
87. Roemer, T., Davies, J., Giaever, G. & Nislow, C. Bugs, drugs and chemical genomics. Nat 
Chem Biol 8, 46–56 (2012). 
88. Zhang, L. et al. A high-throughput screen for chemical inhibitors of exocytic transport in yeast. 
Chembiochem 11, 1291–1301 (2010). 
89. Duncan, M. C., Ho, D. G., Huang, J., Jung, M. E. & Payne, G. S. Composite synthetic lethal 
identification of membrane traffic inhibitors. Proc Natl Acad Sci USA 104, 6235–6240 (2007). 
90. Hillenmeyer, M. E. et al. The chemical genomic portrait of yeast: uncovering a phenotype for 
all genes. Science 320, 362–365 (2008). 
91. Viaud, J. et al. Structure-based discovery of an inhibitor of Arf activation by Sec7 domains 
through targeting of protein-protein complexes. Proc Natl Acad Sci USA 104, 10370–10375 
(2007). 
71 
 
92. Ohashi, Y. et al. AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation 
factor 1 (Arf1) with potential for cancer therapy. J Biol Chem 287, 3885–3897 (2012). 
93. Lippincott-Schwartz, J. et al. Brefeldin A's effects on endosomes, lysosomes, and the TGN 
suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67, 
601–616 (1991). 
94. Dinter, A. & Berger, E. G. Golgi-disturbing agents. Histochem. Cell Biol. 109, 571–590 (1998). 
95. Renault, L., Guibert, B. & Cherfils, J. Structural snapshots of the mechanism and inhibition of 
a guanine nucleotide exchange factor. Nature 426, 525–530 (2003). 
96. Anders, N. & Jürgens, G. Large ARF guanine nucleotide exchange factors in membrane 
trafficking. Cell. Mol. Life Sci. 65, 3433–3445 (2008). 
97. Robinson, D. G., Jiang, L. & Schumacher, K. The endosomal system of plants: charting new 
and familiar territories. Plant Physiol 147, 1482–1492 (2008). 
98. Feng, Y. et al. Retrograde transport of cholera toxin from the plasma membrane to the 
endoplasmic reticulum requires the trans-Golgi network but not the Golgi apparatus in Exo2-
treated cells. EMBO Rep 5, 596–601 (2004). 
99. Spooner, R. A. et al. The secretion inhibitor Exo2 perturbs trafficking of Shiga toxin between 
endosomes and the trans-Golgi network. Biochem J 414, 471–484 (2008). 
100. Boal, F. et al. LG186: An inhibitor of GBF1 function that causes Golgi disassembly in human 
and canine cells. Traffic 11, 1537–1551 (2010). 
101. Sorieul, M. et al. An Exo2 derivative affects ER and Golgi morphology and vacuolar sorting in 
a tissue-specific manner in arabidopsis. Traffic 12, 1552–1562 (2011). 
102. Sáenz, J. B. et al. Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. 
Nat Chem Biol 5, 157–165 (2009). 
103. Pelish, H. E. et al. Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation 
in vitro. Nat Chem Biol 2, 39–46 (2006). 
104. Irani, N. G. & Russinova, E. Receptor endocytosis and signaling in plants. Curr Opin Plant Biol 
12, 653–659 (2009). 
105. Yaish, P., Gazit, A., Gilon, C. & Levitzki, A. Blocking of EGF-dependent cell proliferation by 
EGF receptor kinase inhibitors. Science 242, 933–935 (1988). 
106. Banbury, D. N., Oakley, J. D., Sessions, R. B. & Banting, G. Tyrphostin A23 inhibits 
internalization of the transferrin receptor by perturbing the interaction between tyrosine motifs 
and the medium chain subunit of the AP-2 adaptor complex. J Biol Chem 278, 12022–12028 
(2003). 
107. Ortiz-Zapater, E., Soriano-Ortega, E., Marcote, M. J., Ortiz-Masiá, D. & Aniento, F. Trafficking 
of the human transferrin receptor in plant cells: effects of tyrphostin A23 and brefeldin A. Plant 
J 48, 757–770 (2006). 
108. Dhonukshe, P. et al. Clathrin-Mediated Constitutive Endocytosis of PIN Auxin Efflux Carriers 
in Arabidopsis. Curr Biol 17, 520–527 (2007). 
109. Konopka, C. A., Backues, S. K. & Bednarek, S. Y. Dynamics of Arabidopsis dynamin-related 
protein 1C and a clathrin light chain at the plasma membrane. Plant Cell 20, 1363–1380 (2008). 
110. Lam, S. K. et al. BFA-induced compartments from the Golgi apparatus and trans-Golgi 
network/early endosome are distinct in plant cells. Plant J 60, 865–881 (2009). 
111. Robert, S. et al. ABP1 mediates auxin inhibition of clathrin-dependent endocytosis in 
Arabidopsis. Cell 143, 111–121 (2010). 
112. Boutté, Y. et al. Endocytosis restricts Arabidopsis KNOLLE syntaxin to the cell division plane 
during late cytokinesis. EMBO J 29, 546–558 (2010). 
113. Fujimoto, M. et al. Arabidopsis dynamin-related proteins DRP2B and DRP1A participate 
together in clathrin-coated vesicle formation during endocytosis. Proc Natl Acad Sci USA 107, 
6094–6099 (2010). 
114. Santuari, L. et al. Positional information by differential endocytosis splits auxin response to 
drive Arabidopsis root meristem growth. Curr Biol 21, 1918–1923 (2011). 
115. Li, R. et al. A Membrane Microdomain-Associated Protein, Arabidopsis Flot1, Is Involved in a 
Clathrin-Independent Endocytic Pathway and Is Required for Seedling Development. Plant Cell 
24 2105-2122 (2012). 
116. Luu, D.-T., Martinière, A., Sorieul, M., Runions, J. & Maurel, C. Fluorescence recovery after 
photobleaching reveals high cycling dynamics of plasma membrane aquaporins in Arabidopsis 
roots under salt stress. Plant J 69, 894–905 (2011). 
117. Beck, M., Zhou, J., Faulkner, C., MacLean, D. & Robatzek, S. Spatio-temporal cellular 
dynamics of the Arabidopsis flagellin receptor reveal activation status-dependent endosomal 
sorting. Plant Cell 24, 4205–4219 (2012). 
118. Kim, S. Y. et al. Adaptor protein complex 2-mediated endocytosis is crucial for male 
reproductive organ development in Arabidopsis. Plant Cell 25, 2970–2985 (2013). 
119. Smith, J. M., Salamango, D. J., Leslie, M. E., Collins, C. A. & Heese, A. Sensitivity to Flg22 is 
modulated by ligand-induced degradation and de novo synthesis of the endogenous flagellin-
receptor FLAGELLIN-SENSING2. Plant Physiol 164, 440–454 (2014). 
120. Carluccio, A. V., Zicca, S. & Stavolone, L. Hitching a ride on vesicles: cauliflower mosaic virus 
movement protein trafficking in the endomembrane system. Plant Physiol 164, 1261–1270 
(2014). 
73 
 
121. Kirchhausen, T., Macia, E. & Pelish, H. E. Use of dynasore, the small molecule inhibitor of 
dynamin, in the regulation of endocytosis. Meth. Enzymol. 438, 77–93 (2008). 
122. Fujimoto, M. & Ueda, T. Conserved and plant-unique mechanisms regulating plant post-Golgi 
traffic. Front Plant Sci 3, 197 (2012). 
123. Sharfman, M. et al. Endosomal signaling of the tomato leucine-rich repeat receptor-like protein 
LeEix2. Plant J 68, 413–423 (2011). 
124. McCluskey, A. et al. Building a better dynasore: the dyngo compounds potently inhibit dynamin 
and endocytosis. Traffic 14, 1272–1289 (2013). 
125. Hill, T. A. et al. Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and 
functional activity of a family of indoles. J. Med. Chem. 52, 3762–3773 (2009). 
126. Gordon, C. P. et al. Development of Second-Generation Indole-Based Dynamin GTPase 
Inhibitors. J. Med. Chem. 56, 46–59 (2013). 
127. Stahlschmidt, W., Robertson, M. J., Robinson, P. J., McCluskey, A. & Haucke, V. Clathrin 
terminal domain-ligand interactions regulate sorting of mannose 6-phosphate receptors 
mediated by AP-1 and GGA adaptors. J Biol Chem 289, 4906–4918 (2014). 
128. Robertson, M. J. et al. Synthesis of the Pitstop family of clathrin inhibitors. Nature Protoc 9, 
1592–1606 (2014). 
129. Dutta, D., Williamson, C. D., Cole, N. B. & Donaldson, J. G. Pitstop 2 is a potent inhibitor of 
clathrin-independent endocytosis. PLoS ONE 7, e45799 (2012). 
130. Lemmon, S. K. & Traub, L. M. Getting in touch with the clathrin terminal domain. Traffic 13, 
511–519 (2012). 
131. Willox, A. K., Sahraoui, Y. M. E. & Royle, S. J. Non-specificity of Pitstop 2 in clathrin-
mediated endocytosis. Biol Open 3, 326–331 (2014). 
132. Nieland, T. J. F. et al. Chemical genetic screening identifies sulfonamides that raise organellar 
pH and interfere with membrane traffic. Traffic 5, 478–492 (2004). 
133. Horonchik, L. & Wessling-Resnick, M. The small-molecule iron transport inhibitor 
ferristatin/NSC306711 promotes degradation of the transferrin receptor. Chem Biol 15, 647–
653 (2008). 
134. Tóth, R. et al. Prieurianin/endosidin 1 is an actin-stabilizing small molecule identified from a 
chemical genetic screen for circadian clock effectors in Arabidopsis thaliana. Plant J 71, 338–
352 (2012). 
135. Paudyal, R. et al. Trafficking modulator TENin1 inhibits endocytosis, causes endomembrane 
protein accumulation at the pre-vacuolar compartment and impairs gravitropic response in 
Arabidopsis thaliana. Biochem J 460, 177–185 (2014). 
136. Zouhar, J., Hicks, G. R. & Raikhel, N. V. Sorting inhibitors (Sortins): Chemical compounds to 
study vacuolar sorting in Arabidopsis. Proc Natl Acad Sci USA 101, 9497–9501 (2004). 
137. Rosado, A. et al. Sortin1-hypersensitive mutants link vacuolar-trafficking defects and flavonoid 
metabolism in Arabidopsis vegetative tissues. Chem Biol 18, 187–197 (2011). 
138. Chanda, A. et al. A key role for vesicles in fungal secondary metabolism. Proc Natl Acad Sci 
USA 106, 19533–19538 (2009). 
139. Norambuena, L., Zouhar, J., Hicks, G. R. & Raikhel, N. V. Identification of cellular pathways 
affected by Sortin2, a synthetic compound that affects protein targeting to the vacuole in 
Saccharomyces cerevisiae. BMC Chem Biol 8, 1 (2008). 
140. Rivera-Serrano, E. E., Rodriguez-Welsh, M. F., Hicks, G. R. & Rojas-Pierce, M. A small 
molecule inhibitor partitions two distinct pathways for trafficking of tonoplast intrinsic proteins 
in Arabidopsis. PLoS ONE 7, e44735 (2012). 
141. Cerny, J. et al. The small chemical vacuolin-1 inhibits Ca(2+)-dependent lysosomal exocytosis 
but not cell resealing. EMBO Rep 5, 883–888 (2004). 
142. Shaik, G. M., Dráberová, L., Heneberg, P. & Dráber, P. Vacuolin-1-modulated exocytosis and 
cell resealing in mast cells. Cell Signal 21, 1337–1345 (2009). 
143. Blommaart, E. F., Luiken, J. J., Blommaart, P. J., van Woerkom, G. M. & Meijer, A. J. 
Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. 
J Biol Chem 270, 2320–2326 (1995). 
144. Noda, T. & Ohsumi, Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in 
yeast. J Biol Chem 273, 3963–3966 (1998). 
145. Mahfouz, M. M., Kim, S., Delauney, A. J. & Verma, D. P. S. Arabidopsis TARGET OF 
RAPAMYCIN interacts with RAPTOR, which regulates the activity of S6 kinase in response 
to osmotic stress signals. Plant Cell 18, 477–490 (2006). 
146. Menand, B. et al. Expression and disruption of the Arabidopsis TOR (target of rapamycin) gene. 
Proc Natl Acad Sci USA 99, 6422–6427 (2002). 
147. Xiong, Y. & Sheen, J. Rapamycin and glucose-target of rapamycin (TOR) protein signaling in 
plants. J Biol Chem 287, 2836–2842 (2012). 
148. Hehnly, H. & Stamnes, M. Regulating cytoskeleton-based vesicle motility. FEBS Lett. 581, 
2112–2118 (2007). 
149. Boulant, S., Kural, C., Zeeh, J.-C., Ubelmann, F. & Kirchhausen, T. Actin dynamics counteract 
membrane tension during clathrin-mediated endocytosis. Nat Cell Biol 13, 1124–1131 (2011). 
150. Dhonukshe, P. et al. Auxin transport inhibitors impair vesicle motility and actin cytoskeleton 
dynamics in diverse eukaryotes. Proc Natl Acad Sci USA 105, 4489–4494 (2008). 
75 
 
151. Ziegler, S., Pries, V., Hedberg, C. & Waldmann, H. Target identification for small bioactive 
molecules: finding the needle in the haystack. Angew Chem Int Ed Engl 52, 2744–2792 
(2013). 
152. Tresch, S. Strategies and future trends to identify the mode of action of phytotoxic compounds. 
Plant Sci. 212, 60–71 (2013). 
153. Lounkine, E. et al. Large-scale prediction and testing of drug activity on side-effect targets. 
Nature 486, 361–367 (2012). 
154. Kumari, S. & van der Hoorn, R. A. L. A structural biology perspective on bioactive small 
molecules and their plant targets. Curr Opin Plant Biol 14, 480–488 (2011). 
155. Xuan, W., Murphy, E., Beeckman, T., Audenaert, D. & De Smet, I. Synthetic molecules: 
helping to unravel plant signal transduction. J Chem Biol 6, 43–50 (2013). 
156. de Rybel, B. et al. A role for the root cap in root branching revealed by the non-auxin probe 
naxillin. Nat Chem Biol 8, 798–805 (2012). 
157. Park, S.-Y. et al. Abscisic acid inhibits type 2C protein phosphatases via the PYR/PYL family 
of START proteins. Science 324, 1068–1071 (2009). 
158. Santiago, J. et al. The abscisic acid receptor PYR1 in complex with abscisic acid. Nature 462, 
665–668 (2009). 
159. Ma, Y. et al. Regulators of PP2C phosphatase activity function as abscisic acid sensors. 
Science 324, 1064–1068 (2009). 
160. Rojas-Pierce, M. et al. Arabidopsis P-glycoprotein19 participates in the inhibition of 
gravitropism by gravacin. Chem Biol 14, 1366–1376 (2007). 
161. Walsh, T. A. et al. Chemical genetic identification of glutamine phosphoribosylpyrophosphate 
amidotransferase as the target for a novel bleaching herbicide in Arabidopsis. Plant Physiol 
144, 1292–1304 (2007). 
162. He, W. et al. A small-molecule screen identifies L-kynurenine as a competitive inhibitor of 
TAA1/TAR activity in ethylene-directed auxin biosynthesis and root growth in Arabidopsis. 
Plant Cell 23, 3944–3960 (2011). 
163. Noutoshi, Y. et al. Novel plant immune-priming compounds identified via high-throughput 
chemical screening target salicylic acid glucosyltransferases in Arabidopsis. Plant Cell 24, 
3795–3804 (2012). 
164. Meesters, C. et al. A chemical inhibitor of jasmonate signaling targets JAR1 in Arabidopsis 
thaliana. Nat Chem Biol 10, 830–836 (2014). 
165. Schweitzer, B. A. et al. Discovery of imidazole glycerol phosphate dehydratase inhibitors 
through 3-D database searching. Bioorg. Med. Chem. Lett. 12, 1743–1746 (2002). 
166. Mori, I. et al. A Novel Class of Herbicides (Specific Inhibitors of Imidazoleglycerol Phosphate 
Dehydratase). Plant Physiol 107, 719–723 (1995). 
167. Botté, C. Y. et al. Chemical inhibitors of monogalactosyldiacylglycerol synthases in 
Arabidopsis thaliana. Nat Chem Biol 7, 834–842 (2011). 
168. van der Hoorn, R. A. L. et al. Mining the Active Proteome of Arabidopsis thaliana. Front 
Plant Sci 2, 89 (2011). 
169. Kaschani, F. et al. Selective inhibition of plant serine hydrolases by agrochemicals revealed 
by competitive ABPP. Bioorg. Med. Chem. 20, 597–600 (2012). 
170. Nickel, S., Kaschani, F., Colby, T., van der Hoorn, R. A. L. & Kaiser, M. A para-nitrophenol 
phosphonate probe labels distinct serine hydrolases of Arabidopsis. Bioorg. Med. Chem. 20, 
601–606 (2012). 
171. Kaschani, F. et al. Identification of a selective, activity-based probe for glyceraldehyde 3-
phosphate dehydrogenases. Angew Chem Int Ed Engl 51, 5230–5233 (2012). 
172. Licitra, E. J. & Liu, J. O. A three-hybrid system for detecting small ligand-protein receptor 
interactions. Proc Natl Acad Sci USA 93, 12817–12821 (1996). 
173. Gyuris, J., Golemis, E., Chertkov, H. & Brent, R. Cdi1, a human G1 and S phase protein 
phosphatase that associates with Cdk2. Cell 75, 791–803 (1993). 
174. Cottier, S. et al. The yeast three-hybrid system as an experimental platform to identify proteins 
interacting with small signaling molecules in plant cells: potential and limitations. Front Plant 
Sci 2, 101 (2011). 
175. Becker, F. et al. A three-hybrid approach to scanning the proteome for targets of small 
molecule kinase inhibitors. Chem Biol 11, 211–223 (2004). 
176. Chidley, C., Haruki, H., Pedersen, M. G., Muller, E. & Johnsson, K. A yeast-based screen 
reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis. Nat Chem Biol 7, 375–383 
(2011). 
177. Keppler, A. et al. A general method for the covalent labeling of fusion proteins with small 
molecules in vivo. Nat Biotechnol 21, 86–89 (2003). 
178. Tran, F., Odell, A. V., Ward, G. E. & Westwood, N. J. A modular approach to triazole-
containing chemical inducers of dimerisation for yeast three-hybrid screening. Molecules 18, 
11639–11657 (2013). 
179. Grozinger, C. M., Chao, E. D., Blackwell, H. E., Moazed, D. & Schreiber, S. L. Identification 
of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases 
by phenotypic screening. J Biol Chem 276, 38837–38843 (2001). 
180. Zhao, Y., Dai, X., Blackwell, H. E., Schreiber, S. L. & Chory, J. SIR1, an upstream component 
in auxin signaling identified by chemical genetics. Science 301, 1107–1110 (2003). 
77 
 
181. Dai, X., Hayashi, K.-I., Nozaki, H., Cheng, Y. & Zhao, Y. Genetic and chemical analyses of 
the action mechanisms of sirtinol in Arabidopsis. Proc Natl Acad Sci USA 102, 3129–3134 
(2005). 
182. Köster, H. et al. Capture compound mass spectrometry: a technology for the investigation of 
small molecule protein interactions. Assay Drug Dev Technol 5, 381–390 (2007). 
183. Fischer, J. J. et al. Capture compound mass spectrometry sheds light on the molecular 
mechanisms of liver toxicity of two Parkinson drugs. Toxicol. Sci. 113, 243–253 (2010). 
184. Fischer, J. J. et al. Improvement of capture compound mass spectrometry technology (CCMS) 
for the profiling of human kinases by combination with 2D LC-MS/MS. J. Biomed. 
Biotechnol. 2011, 850589 (2011). 
185. Ong, S.-E. et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple 
and accurate approach to expression proteomics. Mol Cell Proteomics 1, 376–386 (2002). 
186. Ong, S.-E. et al. Identifying the proteins to which small-molecule probes and drugs bind in 
cells. Proc Natl Acad Sci USA 106, 4617–4622 (2009). 
187. Collier, T. S. & Muddiman, D. C. Analytical strategies for the global quantification of intact 
proteins. Amino Acids 43, 1109–1117 (2012). 
188. Gant-Branum, R. L., Kerr, T. J. & McLean, J. A. Labeling strategies in mass spectrometry-
based protein quantitation. Analyst 134, 1525–1530 (2009). 
189. Pfister, K., Steinback, K. E., Gardner, G. & Arntzen, C. J. Photoaffinity labeling of an 
herbicide receptor protein in chloroplast membranes. Proc Natl Acad Sci USA 78, 981–985 
(1981). 
190. Nakamura, Y., Miyatake, R. & Ueda, M. Enantiodifferential approach for the detection of the 
target membrane protein of the jasmonate glycoside that controls the leaf movement of 
Albizzia saman. Angew Chem Int Ed Engl 47, 7289–7292 (2008). 
191. Kaschani, F. et al. Minitags for small molecules: detecting targets of reactive small molecules 
in living plant tissues using 'click chemistry'. Plant J 57, 373–385 (2009). 
192. Park, J., Oh, S. & Park, S. B. Discovery and target identification of an antiproliferative agent 
in live cells using fluorescence difference in two-dimensional gel electrophoresis. Angew 
Chem Int Ed Engl 51, 5447–5451 (2012). 
193. Mandava, S., Makowski, L., Devarapalli, S., Uzubell, J. & Rodi, D. J. RELIC--a 
bioinformatics server for combinatorial peptide analysis and identification of protein-ligand 
interaction sites. Proteomics 4, 1439–1460 (2004). 
194. Straume, M. & Freire, E. 2-Dimensional Differential Scanning Calorimetry - Simultaneous 
Resolution of Intrinsic Protein Structural Energetics and Ligand-Binding Interactions by 
Global Linkage Analysis. Anal. Biochem. 203, 259–268 (1992). 
195. Lo, M. C. et al. Evaluation of fluorescence-based thermal shift assays for hit identification in 
drug discovery. Anal. Biochem. 332, 153–159 (2004). 
196. Schön, A., Brown, R. K., Hutchins, B. M. & Freire, E. Ligand binding analysis and screening 
by chemical denaturation shift. Anal. Biochem. 443, 52–57 (2013). 
197. Chan, J. N. Y. et al. Target identification by chromatographic co-elution: monitoring of drug-
protein interactions without immobilization or chemical derivatization. Mol Cell Proteomics 
11, M111.016642 (2012). 
198. Lomenick, B. et al. Target identification using drug affinity responsive target stability 
(DARTS). Proc Natl Acad Sci USA 106, 21984–21989 (2009). 
199. Lomenick, B., Olsen, R. W. & Huang, J. Identification of direct protein targets of small 
molecules. ACS Chem. Biol. 6, 34–46 (2011). 
200. Komatsu, T. et al. The chloroplast protein BPG2 functions in brassinosteroid-mediated post-
transcriptional accumulation of chloroplast rRNA. Plant J 61, 409–422 (2010). 
201. Yoshizawa, E. et al. BPG3 is a novel chloroplast protein that involves the greening of leaves 
and related to brassinosteroid signaling. Biosci Biotechnol Biochem 78, 420–429 (2014). 
202. Bekh-Ochir, D. et al. A novel mitochondrial DnaJ/Hsp40 family protein BIL2 promotes plant 
growth and resistance against environmental stress in brassinosteroid signaling. Planta 237, 
1509–1525 (2013). 
203. Kim, B. et al. The arabidopsis gulliver2/phyB mutant exhibits reduced sensitivity to 
brassinazole. J. Plant Biol. 57, 20–27 (2014). 
204. Oh, K. et al. YCZ-18 Is a New Brassinosteroid Biosynthesis Inhibitor. PLoS ONE 10, 
e0120812 (2015). 
205. Bojar, D. et al. Crystal structures of the phosphorylated BRI1 kinase domain and implications 
for brassinosteroid signal initiation. Plant J 78, 31–43 (2014). 
206. Yan, L. et al. Structural basis for the impact of phosphorylation on the activation of plant 
receptor-like kinase BAK1. Cell Res 22, 1304–1308 (2012). 
207. Mosquna, A. et al. Potent and selective activation of abscisic acid receptors in vivo by 
mutational stabilization of their agonist-bound conformation. Proc Natl Acad Sci USA 108, 
20838–20843 (2011). 
208. Park, E. et al. Endosidin 7 Specifically Arrests Late Cytokinesis and Inhibits Callose 
Biosynthesis, Revealing Distinct Trafficking Events during Cell Plate Maturation. Plant 
Physiol 165, 1019–1034 (2014). 
209. Doyle, S. M. et al. An early secretory pathway mediated by GNOM-LIKE 1 and GNOM is 
essential for basal polarity establishment in Arabidopsis thaliana. Proceedings of the National 
Academy of Sciences 112, E806–15 (2015). 
79 
 
210. Davis, D. J. et al. The RAB GTPase RABA1e localizes to the cell plate and shows distinct 
subcellular behavior from RABA2a under Endosidin 7 treatment. Plant Signal Behav 10, 
e984520 (2015). 
211. Anders, L. et al. Genome-wide localization of small molecules. Nat Biotechnol 32, 92–96 
(2014). 
212. Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the 
cellular thermal shift assay. Science 341, 84–87 (2013). 
213. Savitski, M. M. et al. Proteomics. Tracking cancer drugs in living cells by thermal profiling 
of the proteome. Science 346, 1255784 (2014). 
214. Lounkine, E. et al. Large-scale prediction and testing of drug activity on side-effect targets. 
Nature 486, 361–367 (2012). 
215. Cereto-Massagué, A. et al. Tools for in silico target fishing. Methods 71, 98–103 (2015). 
  
   
81 
 
 
 
 
 
 
 
 
Chapter II: Small molecule screen for effectors of clathrin-
mediated endocytosis and brassinosteroid signaling 
  
 Small molecule screen for effectors of clathrin-mediated endocytosis and brassinosteroid 
signaling 
 
Wim Dejonghe1,2, Evelien Mylle1,2 Simone Di Rubbo1,2, Anna-Maria Szatmári1,2 and Eugenia 
Russinova1,2 
 
1Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium 
2Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Author contributions: W.D. did the growth and BES1 de-phosphorylation assays, and was involved 
in confocal screening of marker lines. W.D. wrote the manuscript and made the figures.  
83 
 
Abstract 
 
The use of small molecules to probe hormone signaling or endomembrane trafficking in plants have 
proven to be successful. Such small molecules have given us unique insights into brassinosteroid 
biosynthesis and signaling (brassinazole and bikinin) and clathrin-mediated endocytosis (tyrphostin 
A23), but also the interplay between both processes. An illustration of the latter concerns the 
increased signaling output of the brassinosteroid leucine-rich repeat receptor kinase 
BRASSINOSTEROID INSENSITIVE1 at the plasma membrane upon inhibition of clathrin mediated 
endocytosis, both by pharmacological and genetic means. Therefore an increase of the available 
chemical tools which affect brassinosteroid signaling and endomembrane traffic might provide new 
insights as to how these highly dynamic processes are linked and influence each other. We therefore 
screened a subset of small molecules originating from a screen for inhibitors of pollen germination 
and growth in search of small molecules which will potentially inhibit clathrin-mediated endocytosis 
and enhance brassinosteroid signaling. Identified hits will be considered for further characterization 
and target identification. 
  
Introduction 
 
Small molecules have been instrumental in providing a better understanding of brassinosteroid (BR) 
signaling1. Examples include bikinin2 and brassinazole (brz)3, and both have gained a prominent role 
in BR research. For example, brz and derivatives are frequently used to inhibit BR biosynthesis, while 
the original brz has contributed in the discovery of BRASSINAZOLE RESISTANT1 (BZR1)4, a 
transcriptional regulator of BR signaling from the same family as BRI1 EMS-SUPPRESSOR1 
(BES1)5. Especially the latter is used frequently to assess BR signaling, as de-phosphorylation of 
BES1 can be measured by western blot, and indicates the active state of BES15. Phosphorylation of 
BES1 or BZR1, which is mediated by the kinase domain of BRASSINOSTEROID 
INSENSITIVE26,7, and retains BZR1/BES1 in the cytosol through binding of 14-3-3 proteins8, 
indicates the inactive state of both transcriptional regulators. 
BR signaling can also be influenced through endomembrane traffic, similar as seen for receptor 
kinases in mammalian systems9. Two scenarios are commonly recognized, where either signaling is 
attenuated through receptor uptake in the cell, often through clathrin-mediated endocytosis (CME), 
or requires uptake, as receptor and other accessory proteins meet in endosomes and initiate signaling. 
Small molecules are appropriate tools to dissect this relation, and plant endomembrane research can 
dispose of several small molecule effectors of endomembrane traffic, as identified through screening 
of small molecule libraries10. Yet only one is frequently used as an inhibitor CME in plants: tyrphostin 
A23 (TyrA23). Identified in mammalian systems as an inhibitor of ADAPTOR PROTEIN-2 (AP-2) 
mediated cargo recruitment11, TyrA23 interferes through binding of tyrosine-containing recognition 
motifs on AP-2, thereby preventing binding of cargo12. The mode of action of TyrA23 has been shown 
to be true in plants as well13, though biochemical proof of binding is lacking in plants. TyrA23 has 
since been used in numerous studies to inhibit CME in plants, including the uptake inhibition of the 
plasma membrane (PM) localized leucine-rich repeat receptor kinase BRASSINOSTEROID 
INSENSITIVE1 (BRI1)14. Previous studies showed that BRI1 is present on the PM and endosomes, 
and its uptake appears to be independent of ligand binding15,16, yet the implications for signaling were 
less clear. The use of TyrA23 to inhibit BRI1 internalization increased the signaling output as more 
BRI1 is retained on the PM, a finding which was confirmed genetically14. The uptake inhibition of 
BRI1 caused by either TyrA23 or by the expression of a dominant negative clathrin construct 
supported CME of BRI1, a hypothesis which was later confirmed17. Together, the above findings 
demonstrated that BRI1 mainly signals from the PM, while, supposedly and in analogy with 
mammalian systems the CME of BRI1 attenuates signaling. 
Although in recent years several new insights emerged related to molecular components of CME, 
including the report on TPLATE complex18 and characterization of AP-2 subunits17,19,20, less is 
known about cargo recruitment and possible implications for downstream signaling. Therefore we set 
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out to identify and characterize small molecule inhibitors of CME, which at the same time enhance 
BR signaling as measured through BES1 phosphorylation status. As such we seek small molecules 
which mimic the phenotype induced by TyrA23, yet aim at identifying other molecular components 
which are crucial for CME and BR signaling. 
Small molecules are ideal tools for this purpose, as they allow for a conditional and reversible 
perturbation of a system, which in nature is very dynamic and often only occurs through triggers from 
the environment. Classical genetics strategies to dissect a relation between BR signaling and 
endomembrane traffic are less suited, as problems might arise with essential or redundant gene 
products21. In addition, they impose a steady state, which even in case of inducibility of transgenes 
can be a problem, as the intended condition might be established after too long period to dissect rapid 
changes in signaling and traffic. 
 
Results and Discussion 
 
We have previously shown that CME inhibition by either using drugs or genetic tools enhanced BR 
signaling14. To further dissect the interaction between BR signaling and endocytosis we set to identify 
small molecules that affect both CME and BR signaling in Arabidopsis. We relied on a previously 
described large chemical screen for inhibitors of tobacco pollen germination and polar growth22,23. 
Pollen germination and tube growth rely on multiple processes, among which vesicle trafficking and 
endocytosis, therefore any inhibitor is a potential effector of endomembrane transport22,23. The screen 
identified 360 compounds that affected pollen germination and growth, a success rate of about 0.7%. 
Out of those 360 small molecules, 123 altered the localization of different plasma membrane proteins 
including BRI1 and PIN FORMED2 (PIN2)22. Based on availability, 51 small molecules of the 123 
were considered for the screen, as altered localization of plasma membrane proteins might indicate 
defects in CME (Table 1). Several readouts were used in order to characterize and identify the best 
candidates and the small molecules were grouped according to different induced phenotypes related 
to the relevant readouts (Table 2). 
 
Compound Screen for CME inhibitors 
The amphiphilic styryl dye FM4-64 is commonly used as an endocytic tracer in plant biology24,25, 
and inhibition of FM4-64 uptake into the cell is an indication of defective CME. Therefore, 51 small 
molecules were screened for their ability to inhibit FM4-64 uptake in Arabidopsis root epidermal 
cells at a concentration of 50 µM. Four different phenotypes of FM4-64 uptake were observed. The 
first group of small molecules (FM01), allowed uptake of FM4-64, although uptake could be reduced 
compared to the mock treatment. Important was the visibility of FM4-64 positive endosomal 
structures in the cytosol, indication of uptake and functional CME (Figure 1a). The second group, 
FM02 appeared to inhibit FM4-64 uptake to a large extent, as FM4-64 positive endosomal structures 
were not visible in the cytosol, though often FM4-64 positive structures could be distinguished which 
localized on the PM, and were never seen separate from the PM (Figure 1a, inset). Thus, unlike small 
molecules belonging to the FM01 group, small molecules from the FM02 group did not show the 
typical FM4-64 positive foci in the cytosol. The small molecules of the FM03 group allowed PM 
labeling of FM4-64 but inhibited its uptake completely, and lacked the FM4-64 labeled structures 
seen in the FM02 group (Figure 1a). FM03 therefore encompasses these small molecules which only 
induce a clean PM labeling by FM4-64. Two small molecules (group FM04) induced cytoplasmic 
labeling of FM4-64, most likely due to cytotoxicity effects at this concentration (Figure 1a). Overall 
the majority of small molecules severely affected FM4-64 uptake, and belonged either to the FM02 
or FM03 groups (Figure 3a).  
As all 51 small molecules were previously selected and described as effectors of plasma membrane 
protein localization22, we validated those observations by evaluating their effect on BRI1-GFP26 
localization in Arabidopsis root epidermal cells at a concentration of 50 µM. Again small molecules 
were divided in several groups, according to the observed phenotypes. The first group (BRI01), 
encompasses these small molecules that seem to increase the size of BRI1-GFP positive foci in the 
cytosol (Figure 1b) and reduced their number, possibly due to clustering. The second group (BRI02) 
includes small molecules which seem to reduce the number of BRI1-GFP positive foci, without 
affecting size of foci in an obvious manner (Figure 1b). Compounds in groups BRI03 and BRI04 
altered the BRI1-GFP localization in a more profound way. Small molecules from the BRI03 group 
shifted the GFP signal towards the cytosol, though foci might still be visible (Figure 1b). For small 
molecules PMRA2C05 and PMRA1B07 cytosolic localization corresponds to what appears to be 
auto-fluorescence, as the cytosolic GFP signal overlaps with signal in the RFP channel, while no RFP 
or red dye was present. Small molecules from the BRI04 group shifted the GFP signal towards the 
vacuolar lumen, yet foci are still present. Finally small molecules from the BRI05 group induced a 
strong reduction in overall GFP signal intensity (Figure 1c), without necessarily affecting the BRI1-
GFP localization. Globally the overall contribution of the BRI05 group stands out (Figure 3b), and 
might indicate that a considerable amount of small molecules display widespread effects throughout 
the cell, and possibly toxicity, at a concentration of 50 µM. 
Cytoskeletal interactions with different aspects of endomembrane traffic are of paramount importance 
for proper mechanical and physiological functioning of the endomembrane system27. Therefore the 
MAP4-GFP28 marker was chosen as a primary readout for screening to assess small molecule effects 
on the microtubule cytoskeleton. Eventually small molecule hits will also need to be evaluated for 
their effect on the actin cytoskeleton. Here, we define three different groups. The first group 
(MAP01), did not affect MAP4-GFP localization (Figure 1d). The second group (MAP02), included 
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small molecules which induced a distinct punctate localization of MAP4-GFP, while the typical 
bundles were in most cases completely absent (Figure 1d). In addition, in almost all cases MAP4-
GFP localized to a diffuse cytoplasmic signal as well. Finally MAP03 encompasses small molecules 
which induced a diffuse cytoplasmic labeling of MAP4-GFP, yet in contrast to the MAP02 group, 
few or no punctate structures were visible (Figure 1d). Both MAP02 and MAP03 groups indicate a 
heavily affected microtubule cytoskeleton, and together encompass about 75% of screened small 
molecules (Figure 3c), which is a similar distribution seen for inhibition of FM4-64 uptake. 
 
 
 
Figure 1. Compound screen for CME inhibitors. 
(a) Different patterns of the FM4-64 uptake in presence of small molecules. (b) Localization of BRI1-
GFP upon small molecule treatment, and (c) loss of GFP fluorescence. (d) Localization of MAP4-
GFP in presence of small molecules. Mock treatment (Ø), no effect of FM4-64 uptake (FM01), 
complete block of FM4-64 uptake apart from foci at the plasma membrane (FM02), complete uptake 
inhibition (FM03) and cytosolic signal of FM4-64 (FM04). BRASSINOSTEROID INSENSITIVE1 
(BRI1). Slightly bigger BRI1 labelled foci (BRI01), less BRI1 labelled foci (BRI02), apparent 
cytosolic signal (BRI03) and increased vacuolar signal (BRI04). Loss of overall fluorescence 
(BRI05). MICROTUBULE ASSOCIATED PROTEIN4 (MAP4). No effect on MAP4 localization 
(MAP01), appearance of dotted MAP4 localization in presence of small molecule (MAP02) and 
complete cytosolic signal (MAP03). Arabidopsis root epidermal cells of 5 day old seedlings were 
used in all experiments. Scale bar: 5 µm. 
 
BR signaling in response to small molecules 
To assess the effects of selected 51 small molecules on BR signaling, we evaluated the 
phosphorylation status of the BR transcriptional regulator BES15 after chemical application. In 
absence of BRs, we expect to see a phosphorylated form on western blot, as this transcription factor 
is phosphorylated by BIN2 and retained in the cytosol29. Upon BR application we expect to detect a 
de-phosphorylated form of BES1 by using western blot, since inactivation of BIN2 and de-
phosphorylation of BES1 causes its migration into the nucleus and is required for activation of 
transcription29. We evaluated the phosphorylation status of BES1 by means of western blot analysis5, 
as shown before. Small molecules were applied at a concentration of 50 µM for 1 hour to Arabidopsis 
PSB-D cell suspension cultures transformed with a BES1-TAP construct for easy detection. Three 
different phenotypes were observed (Figure 2a). The first group of compounds (assigned as BES01) 
had very little or no effect on the phosphorylation status of BES1 compared to the mock treatment. 
An example of this phenotype is the treatment with 50 µM of compound PMRA1B09 (Figure 2a). 
The second group of small molecules (BES02) induced partial de-phosphorylation of BES1, 
exemplified by treatment with 50 µM of compound PMRA1B06, while the third group (BES03) 
caused a complete shift towards the de-phosphorylated form of BES1, exemplified by treatment with 
50 µM of compound PMRA1D02 and PMRA1F11 (Figure 2a). Both phenotypes indicate a 
presumably increased activation of BR signaling, with the latter one being the most efficient. In 
conclusion, small molecules distributed to the three groups in comparable numbers, with the largest 
group being small molecules which dephosphorylated BES1 completely (Figure 3d). 
 
Small molecule screen on light-grown and dark-grown seedlings  
In order to assess the effect of the small molecules on overall seedling growth, seedlings were grown 
on small molecule containing medium for 7 days either in light or in dark. Seedlings grown in the 
light were categorized in four different groups. The first group, Light Grown01 (LiGr01) includes 
these small molecules which inhibit germination (Figure 2b). Second, LiGr02 encompasses seedlings 
which compare in growth to the mock treated seedlings (Figure 2b). The third group, LiGr03, 
concerns small molecules which induce a reduction in seedling growth. This can range from severe 
growth reduction, exemplified by seedlings with very small cotyledons and hardly any root, to 
seedlings showing only slight reduction in root growth and cotyledon size (Figure 2b). Finally, 
LiGr04 represents small molecules which seem to affect root growth specifically. In this group, 
seedlings appear to have cotyledons comparable in size to mock treated seedlings, yet root growth is 
severely affected (Figure 2b).  
Dark-grown seedlings were divided in 6 different groups. A first group, Dark Grown01 (DaGr01), 
failed to germinate under test conditions (Figure 2c). A second group, DaGr02, induced a phenotype 
very similar to mock treated dark grown seedlings (Figure 2c). Thirdly, DaGr03 represents seedlings 
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which showed varying degrees of growth inhibition (Figure 2c). Phenotypes ranged from little effect 
on seedling growth to severe growth inhibition, with only few seedlings germinating. Next, DaGr04 
represents seedlings which grew agravitropically, while growth was not severely affected (Figure 
2c). Often root growth is more affected than hypocotyl growth. The latter observation is also true for 
the group DaGr05. This group seemed to have a normal gravitropic response, while root growth was 
severely affected. In most cases only a small stub of what is supposedly the root is visible (Figure 
2c). Finally the group DaGr06 represents seedlings which showed what resembled photomorphogenic 
responses. The apical hook and closed cotyledons seen for mock treatment was not present and 
replaced by upwards facing open cotyledons, while seedlings still developed an elongated hypocotyl 
(Figure 2c). As expected, phenotypes induced by small molecule are not always belonging clearly to 
the groups described above. For example, small molecules PMRA2C05 and PMRA2B11 induced at 
25 µM a phenotype which appears to be a mixture between an agravitropic response (DaGr04) and 
hardly any root growth (DaGr05) (Figure 2d). Additionally, small molecule PMRP3B05 induced at 
50 µM a phenotype unlike all described groups. Seedlings in most cases developed what appeared to 
be a normal root, yet the hypocotyl was severely stunted (Figure 2e). In summary, light-grown 
seedlings displayed in more than half of the cases reduced growth (LiGr03) (Figure 3e). A similar 
trend was seen for dark grown seedlings, where growth inhibition (DaGr03) and seedlings without 
root (DaGr05) were among the most seen phenotypes. In contrast, only 2 small molecules induced a 
clear agravitropic response without severely affecting either hypocotyl or root growth, or both 
(Figure 3f). 
In addition, we compared dark grown seedlings on small molecules to seedlings on brz3. In presence 
of brz in the dark, which is an inhibitor of the BR biosynthetic enzyme DWARF4 (DWF4)30, 
seedlings develop a de-etiolated phenotype with short hypocotyl and open cotyledons (Figure 2c), 
which can be rescued by either application of BRs or by overexpressing BR signaling components. 
Seedlings grown on small molecules, which phenocopy the effect of brz, as an indication of inactive 
BR signaling or biosynthesis were not favorable in our screen. However, none of the small molecules 
tested, induced a brz-like phenotype. Later, the brz phenotype was used eventually for a different 
purpose, where small molecules activating BR signaling could be applied in an attempt to rescue the 
brz phenotype. 
Not all small molecules were screened at the same concentration of 50 µM. The main reason, as 
sometimes became apparent for short time incubation with the small molecule for cell biological 
purposes, was acute toxicity. As a substantial amount of small molecules would otherwise inhibit 
germination, small molecules were often tested at lower concentrations for longer incubations, as 
indicated (Table 2).  
  
Figure 2. Compound screen for BR signaling activation and overall growth effects.  
(a) BES1 phosphorylation as measured in PSB-D cell cultures expressing BES1-TAP, incubated for 
1 hour with 50 µM small molecules. (b) Different observed phenotypes for 5 day old seedlings grown 
in the light for 7 days in presence of small molecules and (c) in the dark. (d,e) examples of specific 
phenotypes induced by small molecules PMRA2C05 and PMRP3B05. Phosphorylated form of BES1 
(BES1-p), dephosphorylated form of BES1 (BES1), Mock treatment (Ø), brassinolide (BL), bikinin 
(BK), brassinazole (brz). Small molecules inhibiting germination in the light (LiGr01), hardly 
affecting seedling growth in the light (LiGr02) and affecting overall seedling growth (LiGr03) or root 
growth specifically in the light (LiGr04). DaGr01 indicates no germination, DaGr02 a mock-like 
phenotype, DaGr03 various degrees of growth inhibition, DaGr04 an agravitropic response, DaGr05 
seedlings which lack a root, and DaGr06 a phenotype which resembles a light response. All small 
molecule treatments at 50µM, unless indicated differently. BRI1 EMS-SUPPRESSOR1 (BES1) 
 
Comparative summary of screening results and selection of hit molecules 
When the different phenotypic groups of compounds were compared amongst screening readouts, a 
few interesting trends appeared. For example, when BES1 phosphorylation status was evaluated in 
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function of BRI1-GFP and FM4-64 localizations the predominant distribution of small molecules 
which retained the phosphorylated state of BES1 (BES01) was in the groups inhibiting FM4-64 
uptake (FM02 and FM03), while these small molecules mostly caused an increase in size of BRI1-
labelled foci (BRI01) or accumulation of BRI1-GFP in the vacuole (BRI04) (Figure 4a). Another 
possibility for the increased fluorescence in the vacuole is an increase in vacuolar pH31. When BES1 
was de-phosphorylated, ether partially (BES02) or completely (BES03) a relative high number of 
small molecules decreased the overall fluorescence of BRI1-GFP (BR05), while inhibited the FM4-
64 uptake (FM02 and FM03). We can speculate that these small molecules might impose cytotoxicity 
at a concentration of 50 µM. Small molecules which hardly affected microtubule organization 
(MAP01) almost all allowed FM4-64 uptake (FM01) (Figure 4b). Similarly, small molecules 
affecting MAP4-GFP, thus from both MAP02 and MAP03 groups, almost in all cases inhibited FM4-
64 uptake (FM02 or FM03) (Figure 4b). 
Overall, the groups of main interest were the small molecules which inhibited FM4-64 uptake (both 
the FM02 and FM03 groups) and de-phosphorylate BES1 (BES02 and BES03). However, since this 
included 33 small molecules, we decided to primarily focus on small molecules belonging to groups 
FM03 and BES03, thus reducing the number of possible hits to 10 small molecules. The group which 
completely de-phosphorylated BES1 (BES03) was selected as it presented the strongest phenotype in 
terms of BES1 de-phosphorylation, while group FM03 contained compounds that clearly inhibited 
the of FM4-64 uptake without causing an accumulation of FM4-64 in foci as observed for the 
compounds in group FM02. From this subpopulation of small molecules we explored the possibility 
if certain small molecules could rescue brz treated seedlings through re-activation of BR signaling. 
We selected a group of 6 small molecules which completely de-phosphorylated BES1, and grew 
seedlings in the dark for 7 days in presence of brz and respective small molecules. Only 2 (PMRA2 
A05 and PMRA2 B02) were able to partially rescue the dark grown phenotype of wild type seedlings 
grown on 1 µM brz (Figure 4c,d). As BR signaling is largely inactivated upon brz treatment, both 
small molecules are potentially able to re-activate BR signaling. To test this hypothesis PMRA2 A05 
and PMRA2 B02 were tested on a semi-dominant mutant of BIN2, bin2-16. However, both PMRA2 
A05 and PMRA2 B02 were unable to partially rescue the dark grown bin2-1 phenotype (Figure 4c,d), 
thus are either increasing hypocotyl length in presence of brz through a mechanism independent from 
BR signaling, or are rescuing through signaling activation upstream of BIN2. 
In conclusion, 51 small molecules were screened for different readouts related to endomembrane 
traffic and BR signaling, in order to identify small molecule hits which could reveal new mechanisms 
and proteins involved in cross-talk between BR signaling and endomembrane traffic. We identified a 
group of small molecules which inhibit endocytosis and activate BR signaling. Of this group, two 
small molecules were selected based on their potency for further characterization and target 
identification, which will be discussed in following chapters. 
 
 
 
Figure 3. Distribution of the observed phenotypes of different readouts. 
(a) Phenotypic group distribution for FM4-64 uptake, (b) BRI1-GFP localization, (c) MAP4-GFP 
localization (d) BES1 phosphorylation , (e) light grown seedlings and (f) dark grown seedlings. No 
effect of FM4-64 uptake (FM01), complete block of FM4-64 uptake apart from foci at the plasma 
membrane (FM02), complete uptake inhibition (FM03) and cytosolic signal of FM4-64 (FM04). 
Slightly bigger BRI1 labelled foci (BRI01), less BRI1 labelled foci (BRI02), apparent cytosolic signal 
(BRI03) and increased vacuolar signal (BRI04). Loss of overall fluorescence (BRI05). No effect on 
MAP4 localization (MAP01), appearance of dotted MAP4 localization in presence of small molecule 
(MAP02) and complete cytosolic signal (MAP03).Small molecules which are not changing BES1 
phosphorylation status are represented by BES01, inducing partial de-phosphorylation BES02, and 
complete de-phosphorylation BES03. Small molecules inhibiting germination in the light (LiGr01), 
hardly affecting seedling growth in the light (LiGr02) and affecting overal seedling growth (LiGr03) 
or root growth specifically in the light (LiGr04). DaGr01 indicates no germination, DaGr02 a mock-
like phenotype, DaGr03 various degrees of growth inhibition, DaGr04 an agravitropic response, 
DaGr05 seedlings which lack a root, and DaGr06 a phenotype which resembles a light response. 
BRI1 EMS-SUPPRESSOR1 (BES1), number of small molecules not tested (n/a), 
BRASSINOSTEROID INSENSITIVE1 (BRI1), MICROTUBULE ASSOCIATED PROTEIN 4 
(MAP4). 
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Figure 4. Distribution across different phenotypic groups and initial characterization of small 
molecules.  
(a) Distribution of small molecules across different readouts, depicted as BES1 phosphorylation 
status in function of FM4-64 uptake and BRI1-GFP localization. (b) Distribution of small molecules 
depicted as MAP4-GFP localization in function of FM4-64 uptake phenotypes. (c) Two selected 
small molecules able to de-phosphorylate BES1 partially rescue the brz dark grown phenotype, but 
not the bin2-1 dark grown phenotype. (d) Quantification of (c). Small molecules which are not 
changing BES1 phosphorylation status are represented by BES01, inducing partial de-
phosphorylation BES02, and complete de-phosphorylation BES03. No effect of FM4-64 uptake 
(FM01), complete block of FM4-64 uptake apart from foci at the plasma membrane (FM02), 
complete uptake inhibition (FM03) and cytosolic signal of FM4-64 (FM04). Slightly bigger BRI1 
labelled foci (BRI01), less BRI1 labelled foci (BRI02), apparent cytosolic signal (BRI03) and 
increased vacuolar signal (BRI04). Loss of overall fluorescence (BRI05). No effect on MAP4 
localization (MAP01), appearance of dotted MAP4 localization in presence of small molecule 
(MAP02) and complete cytosolic signal (MAP03). BRI1 EMS-SUPPRESSOR1 (BES1), 
Brassinazole (Brz), BRASSINOSTEROID INSENSITIVE1 (BRI1), MICROTUBULE 
ASSOCIATED PROTEIN4 (MAP4), BRASSINOSTEROID INSENSITIVE2 (BIN2). 
 
Table 1. Overview of chemical structures, names and source for small molecules used in this 
study. 
Structure 
I.D./ 
Ordering 
I.D. 
Plate I.D. Supplier g/mole Nr. 
 
5474792 
/ 
5474792 
PMRA1 B09 Chembridge 312.4 1 
 
LAT035E07 
/ 
S 12156 
PMRA2 B04 
LATCA-
Maybridge 
179 2 
 
LAT045F06 
/ 
S 11468 
PMRA2 C06 
LATCA-
Maybridge 
167 3 
 
ST026563 PMRA2 C09 
Myria-
TimTec 
281.23 4 
 
5274192 
/ 
5274192 
PMRA1 A04 Chembridge 272.3 5 
 
6118237 
/ 
6118237 
PMRA1 D10 Chembridge 397.3 6 
 
LAT029G06 
/ 
DP 00892 
PMRA2 A06 
LATCA-
Maybridge 
392 7 
 
LAT045B08 
/ 
S 14817 
PMRA2 C04 
LATCA-
Maybridge 
205 8 
95 
 
 
ST014024 PMRA2 C07 
Myria-
TimTec 
323.38 9 
 
ST026114 PMRA2 C10 
Myria-
TimTec
  
347.20 10 
 
ST034275 PMRA2 D02 
Myria-
TimTec
  
295.61 11 
 
5670720 
/ 
5670720 
PMRA1 C04 Chembridge 301.8 12 
 
6938485 
/ 
6938485 
PMRA1 E11 Chembridge 241.1 13 
 
LAT045C05 
/ 
S 04777 
PMRA2 C05 
LATCA-
Maybridge 
271 14 
 
5809280 
/ 
5809280 
PMRA1 C10 Chembridge 256.7 15 
 
LAT035C06 
/ 
S 10775 
PMRA2 A11 
LATCA-
Maybridge 
234 16 
 
5521757 
/ 
5521757 
PMRA1 B06 Chembridge 310.3 17 
 
5565929 
/ 
5565929 
PMRA1 C02 Chembridge 377.8 18 
 
5718008 
/ 
5718008 
PMRA1 C09 Chembridge 263.4 19 
 6444878 
/ 
6444878 
PMRA1 E05 Chembridge 275.7 20 
 
6972268 
/ 
6972268 
PMRA1 E09 Chembridge 258.3 21 
 
LAT009E04 
/ 
5528794 
PMRA1 H06 
LATCA-
Chembridge 
441 22 
 
LAT036G07 
/ 
SEW 04168 
PMRA2 B07 
LATCA-
Maybridge 
343 23 
 
ST014025 PMRA2 C08 
Myria-
TimTec
  
343.80 24 
 
6288782 
/ 
6288782 
PMRA1 E02 Chembridge 302.2 25 
 
LAT037D08 
/ 
SPB 04446 
PMRA2 B09 
LATCA-
Maybridge 
371 26 
 
7684211 
/ 
7684211 
PMRA1 F10 Chembridge 236.3 27 
 
7801871 
/ 
7801871 
PMRA1 G05 Chembridge 261.7 28 
 
LAT041E04 
/ 
HAN 00069 
PMRP3 B05 
LATCA-
Maybridge 
473 29 
 
LAT013C05 
/ 
5721666 
PMRA1 H10 
LATCA-
Chembridge 
273 30 
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7699278 
/ 
7699278 
PMRA1 F11 Chembridge 322.8 31 
 
LAT034H07 
/ 
S 01528 
PMRA2 A07 
LATCA-
Maybridge 
313 32 
 
LAT035A07 
/ 
S 11753 
PMRA2 A09 
LATCA-
Maybridge 
179 33 
 
LAT035D03 
/ 
S 06736 
PMRA2 B02 
LATCA-
Maybridge 
229 34 
 
LAT035H11 
/ 
S 14672 
PMRA2 B06 
LATCA-
Maybridge 
201 35 
 
LAT036H11 
/ 
S 02113 
PMRA2 B08 
LATCA-
Maybridge 
229.27 36 
 
5308158 
/ 
5308158 
PMRA1 A07 Chembridge 330.3 37 
 
5478801 
/ 
5478801 
PMRA1 B07 Chembridge 276.7 38 
 
5581956 
/ 
5581956 
PMRA1 B11 Chembridge 342.4 39 
 
5885031 
/ 
5885031 
PMRA1 D02 Chembridge 306.4 40 
 
5943276 
/ 
5943276 
PMRA1 D11 Chembridge 258.2 41 
 7598798 
/ 
7598798 
PMRA1 F07 Chembridge 363.2 42 
 
LAT013B05 
/ 
5721479 
PMRA1 H08 
LATCA-
Chembridge 
300 43 
 
LAT029E10 
/ 
GK 01394 
PMRA2 A05 
LATCA-
Maybridge 
396 44 
 
LAT035D05 
/ 
S 09759 
PMRA2 B03 
LATCA-
Maybridge 
236 45 
 
LAT038C03 
/ 
XAX 00025 
PMRA2 B11 
LATCA-
Maybridge 
258 46 
 
5262578 
/ 
5262578 
PMRA1 A06 Chembridge 311.8 47 
 
6441066 
/ 
6441066 
PMRA1 D06 Chembridge 450.3 48 
 
LAT035A05 
/ 
S 09528 
PMRA2 A08 
LATCA-
Maybridge 
334 49 
 
5538434 
/ 
5538434 
PMRA1 D09 Chembridge 406.3 50 
 
6846814 
/ 
6846814 
PMRA1 E08 Chembridge 366.3 51 
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Table 2. Overview of different phenotypes observed for tested readouts. 
Plate ID 
BES1-P 
phosphoryla
tion 
Effect on 
BRI-GFP 
Effect on 
MAP4 
FM4-64 
uptake 
Light-grown 
phenotype at 
(µM) 
Dark-grown 
phenotype at 
(µM) 
PMRA1 B09 BES01 BRI05 MAP03 FM01 LiGr02 (50) DaGr05 (50) 
PMRA2 B04 BES01 BRI01 MAP02 FM02 LiGr03 (50) DaGr03 (50) 
PMRA2 C06 BES01 BRI01 MAP02 FM02 LiGr03 (50) DaGr05 (50) 
PMRA2 C09 BES01 BRI01 MAP03 FM02 LiGr02 (25) DaGr03 (25) 
PMRA1 A04 BES01 BRI04 MAP03 FM03 LiGr03 (50) DaGr05 (50) 
PMRA1 D10 BES01 BRI04 MAP02 FM03 LiGr03 (50) DaGr05 (50) 
PMRA2 A06 BES01 BRI04 MAP03 FM03 LiGr04 (50) DaGr03 (50) 
PMRA2 C04 BES01 BRI01 MAP02 FM03 LiGr03 (50) DaGr06 (50) 
PMRA2 C07 BES01 BRI04 MAP03 FM03 LiGr02 (50) DaGr02 (50) 
PMRA2 C10 BES01 BRI03 MAP03 FM03 LiGr01 (50) DaGr05. (25) 
PMRA2 D02 BES01 BRI01 MAP03 FM03 LiGr02 (25) DaGr02 (50) 
PMRA1 C04 BES01 BRI02 MAP03 FM01 LiGr02 (50) DaGr06 (50) 
PMRA1 E11 BES01 BRI03 N/A N/A LiGr01 (50) DaGr01 (50) 
PMRA2 C05 BES02 BRI03 MAP03 FM04 LiGr03 (50) DaGr05 (25) 
PMRA1 C10 BES02 BRI01 MAP01 FM01 LiGr03 (50) DaGr02 (50) 
PMRA2 A11 BES02 BRI01 MAP03 FM02 LiGr03 (50) DaGr03 (50) 
PMRA1 B06 BES02 BRI05 MAP03 FM03 LiGr02 (50) DaGr02 (50) 
PMRA1 C02 BES02 BRI05 MAP03 FM03 LiGr01 (50) DaGr03 (50) 
PMRA1 C09 BES02 BRI05 MAP02 FM03 LiGr03 (50) DaGr03 (50) 
PMRA1 E05 BES02 BRI05 MAP02 FM03 LiGr01 (50) DaGr06 (25) 
PMRA1 E09 BES02 BRI01 MAP02 FM03 LiGr04 (50) DaGr05 (50) 
PMRA1 H06 BES02 BRI02 MAP03 FM03 LiGr03 (50) DaGr05 (50) 
PMRA2 B07 BES02 BRI05 MAP03 FM03. LiGr01 (25) DaGr01 (12.5) 
PMRA2 C08 BES02 BRI04 MAP03 FM03 LiGr02 (50) DaGr03. (50) 
PMRA1 E02 BES02 BRI02 MAP01 FM01 LiGr03 (50) DaGr05 (50) 
PMRA2 B09 BES02 BRI05 MAP01 FM01 LiGr03 (50) DaGr01 (50) 
PMRA1 F10 BES02 BRI02 N/A N/A LiGr03 (50) DaGr03 (50) 
PMRA1 G05 BES02 BRI01 N/A N/A LiGr02 (50) DaGr02 (50) 
PMRP3 B05 BES02 BRI01 N/A N/A LiGr03 (50) DaGr03 (50) 
PMRA1 H10 BES03 BRI05 MAP02 FM04 LiGr02 (12,5) DaGr06 (50) 
PMRA1 F11 BES03 BRI02 MAP02 FM02 LiGr03 (50) DaGr03 (50) 
PMRA2 A07 BES03 BRI02 MAP02 FM02 LiGr04 (50) DaGr03 (50) 
PMRA2 A09 BES03 BRI01 MAP03 FM02 LiGr01 (50) DaGr01 (50) 
PMRA2 B02 BES03 BRI02 MAP03 FM02 LiGr03 (50) DaGr03 (50) 
PMRA2 B06 BES03 BRI01 MAP03 FM02 LiGr03 (50) DaGr04 (50) 
PMRA2 B08 BES03 BRI02 MAP03 FM02 LiGr03 (50) DaGr06 (25) 
PMRA1 A07 BES03 BRI05 MAP02 FM03. LiGr03 (50) DaGr05 (50) 
PMRA1 B07 BES03 BRI03 MAP03 FM03 LiGr01 (50) DaGr05 (25) 
PMRA1 B11 BES03 BRI05 MAP03 FM03 LiGr03 (50) DaGr05 (50) 
PMRA1 D02 BES03 BRI05 MAP03 FM03 LiGr03 (50) DaGr01 (50) 
PMRA1 D11 BES03 BRI02 MAP03 FM03 LiGr04 (50) DaGr04 (50) 
PMRA1 F07 BES03 BRI04 MAP03 FM03 LiGr03 (12,5) DaGr05 (12.5) 
PMRA1 H08 BES03 BRI03 MAP02 FM03. LiGr03 (50) DaGr03 (50) 
PMRA2 A05 BES03 BRI02 MAP01 FM03 LiGr02 (50) DaGr02 (50) 
PMRA2 B03 BES03 BRI02 MAP02 FM03 LiGr04 (50) DaGr03 (25) 
PMRA2 B11 BES03 BRI05 MAP02 FM03 LiGr03 (50) DaGr05 (25) 
PMRA1 A06 BES03 BRI02 MAP01 FM01 LiGr03 (50) DaGr03 (50) 
PMRA1 D06 BES03 BRI01 MAP01 FM01 LiGr04 (50) DaGr05 (50) 
PMRA2 A08 BES03 BRI01 MAP01 FM01 LiGr03 (50) DaGr04 (50) 
PMRA1 D09 N/A N/A MAP01 FM01 LiGr03 (50) N/A 
PMRA1 E08 N/A N/A MAP02 FM03 LiGr01 (50) N/A 
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Materials and methods 
Plant material and growth conditions 
For screening of light and dark grown seedlings, wild type Arabidopsis thaliana ecotype Col-0 or 
bin2-16 seedlings were stratified for 2 days at 4°C, on half strength Murashige and Skoog (½ MS) 
plates with 1% (w/v) sucrose supplemented with small molecules or dimethyl sulfoxyde (DMSO) as 
a mock treatment. Subsequently plates were incubated for 3-4 hours in the light (and remained there 
in case of light grown seedlings), before transfer to dark  for an additional 7 days at 22°C, and grown 
vertically. For imaging purposes, BRI1-GFP26 or MAP4-GFP28 Arabidopsis thaliana ecotype Col-0 
seedlings were stratified for 2 days at 4°C, and grown on vertical ½ MS plates with 1% (w/v) sucrose 
for an additional 5 days at 22°C in a light/dark cycle of 16hrs/8hrs respectively, prior to imaging. 
 
Chemical treatments and imaging 
Small molecules for screening were acquired through Chembridge (http://www.chembridge.com/), 
brassinazole through TCI Europe, brassinolide through Fuji Chemical Industries and Bikinin through 
Sigma-Aldrich. All small molecules were dissolved in DMSO (Sigma-Aldrich). Imaging of seedlings 
was performed with an Olympus FV10 ASW confocal microscope. For MAP4-GFP and FM4-64 
screening, MAP4-GFP seedlings were incubated with the respective small molecules for 30 min in ½ 
MS, followed by a pulse with 2 µM N-(3-Triethylammoniumpropyl)-4-(6-(4-(Diethylamino) Phenyl) 
Hexatrienyl) Pyridinium Dibromide (FM4-64, Life technologies) for another 30 min. BRI1-GFP 
seedlings were incubated with small molecules for 60 min in ½ MS, followed by imaging. 
 
BES1 dephosphorylation assay 
PSB-D cell cultures expressing BES1-TAP were generated and maintained as described before17,32. 
Cell cultures were treated with small molecules (50 µM), brassinolide (BL, 1 µM) and Bikinin (BK, 
30 µM) for 1 hour while shaking at 130 rpm and harvested and homogenized in liquid nitrogen. 
Protein extraction was performed with a 20mM Tris-HCl buffer containing 150 mM NaCl, 1% 
Sodium Dodecyl Sulfate (SDS), 100 mM Dithiothreitol (DTT) and 1 cOmplete ultra tablet per 10 ml 
of EDTA free protease inhibitor cocktail (Roche). Protein concentration was determined with the 
Quick start Bradford 1x Dye reagent (Bio-Rad). Samples (30 µg) were run on a 10% SDS-PAGE gel 
and transferred to polyvinyl difluoride (PVDF) membrane from iBlot Gel Transfer Stack (Novex, 
Life Technologies) using the iBlot device (Life technologies). Membranes were blocked for 1 hour 
in Tris buffered Saline with 0.1 % Tween 20 (TBS-T, Sigma-Aldrich) and 3% Difco Skim milk 
(Becton, Dickinson and Company). Detection of BES1-TAP occurred with a 1/5000 dilution in TBS-
T 3% skim milk of Horseradish peroxidase (HRP) conjugated Peroxidase Anti-Peroxidase (PAP) 
Soluble Complex antibody produced in rabbit (P1291, Sigma) for 1 hour. Membrane was developed 
with application of Western Lightning® Plus–ECL, Enhanced Chemiluminescence Substrate 
(Perkin-Helmer) and Amersham Hyperfilm ECL (GE Healthcare). 
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Abstract 
Because of its highly dynamic nature and importance, classical genetic strategies for studying 
clathrin-mediated endocytosis (CME) are faced with limitations, especially in plants, where 
knockouts of CME components are either lethal or absent due to gene redundancy. Hence, specific 
chemical inhibitors are more suitable for probing CME. Here, we report the identification and 
characterization of the small molecule Endosidin9 (ES9). ES9 interfered with receptor-mediated 
endocytosis in Arabidopsis and with synaptic vesicle recycling in Drosophila similarly to loss-of-
function CME mutants. Though ES9 functioned as a mitochondria uncoupler, the ES9-induced 
inhibition of CME in Arabidopsis was primary due to its uncoupling activity at the plasma membrane 
causing cytoplasmic acidification but not to the reduction in the cellular ATP content. Similar 
properties were observed for the known tyrosine kinase inhibitor Tyrphostin A23 (TyrA23) routinely 
used to block CME in plants thus, raising questions about its use as a selective inhibitor in cell biology 
studies. 
  
Introduction 
Clathrin-mediated endocytosis (CME) is a major pathway for the uptake of extracellular and plasma 
membrane material in all eukaryotic cells1-3. CME is of vital importance for the cell to quickly 
respond to environmental changes and its purposes are manifold including pathogen entry, synaptic 
vesicle turn-over, uptake of membrane bound receptors either constitutively or following stimuli, 
which in turn influences signaling outputs1. In plants mechanistic understanding of CME is not as 
advanced as compared to the yeast or mammalian field, even though in recent years important insights 
have been achieved. For example, part of the core machinery is conserved between plants, yeast and 
mammals4, yet differences exist as illustrated by the recent report on the TPLATE adaptor complex4-
6. Similarly to mammals and yeast, CME in plants has major effects on a plethora of physiological 
responses7-10, including hormone signaling, polarity establishment, plant defense responses, transport 
of nutrients and cell wall materials. 
The essential and dynamic nature of CME makes it difficult to dissect with classical genetic tools, as 
each mutant, if viable, represents a steady state. In order to circumvent those limitations and interfere 
with CME in a conditional manner, the use of small molecule effectors offers important advantages11. 
A well-known example of an endocytic inhibitor frequently used in the plant field is tyrphostinA23 
(TyrA23). TyA23 is a tyrosine-like small molecule originally developed as a substrate-competitive 
inhibitor of mammalian tyrosine kinases12. TyrA23 also interferes with the interaction between the 
tyrosine-based internalization motifs of different cargos and the medium subunit of the clathrin-
associated adaptor complex AP-2, and it inhibited CME in vitro and in a yeast two-hybrid growth 
inhibition assay13,14. The inhibitory effect of TyrA23 on CME was later confirmed in plants15, and 
has since been used in numerous studies8-10,16-31, although its mode of action in plants has not been 
clarified as yet. In contrast to plant systems, where TyrA23 is almost exclusively used to specifically 
inhibit CME, mammalian and yeast systems can rely on a larger collection of small molecule tools, 
including dynasore32 and Pitstops33, though both display off-target effects and efforts are on-going to 
further improve on their scaffolds in order to develop novel, specific inhibitors of CME34-36. Although 
dynasore has been used in plants37, reports for the activity of other compounds in plant cells are still 
lacking. 
Here, we described the identification and characterization of a small molecule inhibitor, Endosidin9 
(ES9), of CME in Arabidopsis and Drosophila and revealed that this molecule is a mitochondrial 
uncoupler. Furthermore, we showed that the known specific CME inhibitor in plant cells TyrA23 is 
also a mitochondrial uncoupler, a major activity of this popular small molecule that has been 
overlooked in previous studies. We demonstrate that the mitochondrial uncouplers such as ES9, 
TyrA23 and known protonophores inhibited CME in Arabidopsis by primary inducing acidification 
of the cytosol, indicating a possible general inhibitory mechanism through dissipating plasma 
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membrane potentials rather than through ATP depletion. ATP depletion alone was found not to impair 
CME to the same extent. 
 
Results 
 
ES9 blocks clathrin-mediated endocytosis in different systems 
To identify chemical inhibitors of CME in plants we analyzed a set of 123 small molecules previously 
identified as inhibitors of both pollen germination and growth38. We screened for their ability to 
inhibit the uptake of the lipophilic styryl dye FM4-64, a well-known and commonly used tracer of 
CME in plants39. We identified ES9, a small molecule which activity allowed binding of FM4-64 to 
the plasma membrane but effectively inhibited its internalization when co-applied at a concentration 
of 10 M for 30 min (Fig. 1a,b). To rule out that the effect of ES9 was limited to FM4-64, we tested 
the uptake of the fluorescent castasterone AFCS, previously shown to be internalized via CME8,9. In 
absence of ES9, AFCS (20 µM, 30 min, 20 min chase) stained the vacuole as previously shown8. 
However, in presence of ES9, AFCS was not internalized, indicating an effective uptake inhibition 
(Supplemental Fig. 1a). 
To test whether the inhibitory effect of ES9 was specific to CME in plants, we assessed if ES9 
interfered with synaptic vesicle endocytosis in Drosophila neurons and with the uptake of transferrin 
in HeLa cells. When tested on boutons of the neuromuscular junction (NMJ) in third instar larvae of 
Drosophila stimulated with KCl in the presence of FM 1-43, a dye analogous to FM 4-64, treatment 
with ES9 (10 µM, 30 min) induced the uptake of large FM1-43 positive membrane structures 
(Supplemental Fig. 1b,c). This phenotype is reminiscent of the acute loss of clathrin heavy chain 
(CHC)40, clathrin light chain (CLC)41 or dynamin42 functions. To strengthen this observation, CHC-
HA positive larvae were treated with ES9 either in a non-stimulated (NS) or stimulated situation, 
where endocytosis and exocytosis are enhanced40. Visualization of CHC revealed that ES9 activity 
(10 µM, 30 min) prevented the recruitment of CHC from the bouton center to the periphery in the 
induced situation (Fig. 1c), a phenotype also observed when dynamin function is impaired40,42. 
Additional graphical explanation on the Drosophila NMJ and synaptic boutons, applicable for the 
CHC and FM1-43 phenotypes, can be found in supplemental figure 1d. Finally we evaluated if ES9 
activity was able to inhibit the internalization of transferrin, a hallmark tracer of CME in mammalian 
systems1. In HeLa cells, ES9 inhibited the uptake of transferrin at 50 µM to a comparable extent as 
50 µM Dynasore (Fig. 1d). Altogether these data show that ES9 was able to inhibit CME in different 
model systems, although with different efficiencies. 
 Figure 1. ES9 inhibits CME in different systems 
(a) Chemical structure of ES9. (b) FM4-64 uptake (2 µM, 30 min) in Arabidopsis root cells for mock 
treatment (DMSO, Ø) and in presence of 10 µM ES9. (c) Boutons of the neuromuscular junction in 
third instar larvae of Drosophila positive for HA-tagged clathrin heavy chain (HA-CHC) for mock or 
10 µM ES9 30 min pretreatments, in both non-stimulated (NS) or 90 mM KCl stimulated conditions. 
(d) Boxplot representation of transferrin uptake in HeLa cells in presence of 50 μM Dynasore and 10 
or 50 μM ES9, relative to mock (DMSO). Center lines show the medians; box limits indicate the 25th 
and 75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range 
from the 25th and 75th percentiles, outliers are represented by dots. Box width relative to sample size. 
N = 35, 29 and 61 sample points respectively. Scale bars: 5 µm in (b), 2 μm in (c). 
 
ES9 affects energy metabolism through uncoupling of oxidative phosphorylation in 
mitochondria 
As CME is an energy dependent process1 and ATP depletion has been shown to either inhibit or 
severely reduce CME43,44, we assessed the capacity of ES9 to affect cellular ATP content. Cellular 
ATP was measured in dark-grown Arabidopsis PSB-D wild type cell cultures. Aside ES9 we included 
the known plant CME inhibitor TyrA23 and its inactive analog TyrA5115 as negative references, 
while several known inhibitors of ATP production such as Antimycin A (AA)45, Oligomycin46 and 
carbonyl cyanide m-chlorophenyl hydrazone (CCCP)47,48 were included as positive controls. ES9 (10 
M) induced a quick initial depletion of ATP to about 50% cellular ATP after 2 min of treatment. 
The ATP concentration further declined for the following 20 min, after which a base line of about 
10% remaining ATP was established compared to mock treatment (Fig. 2a). Interestingly, TyrA23, 
but not TyrA51, induced a reduction in the cellular ATP of about 75% within 2 min, which 
subsequently stabilized at about 10% residual ATP as compared to the mock control (Fig. 2a). The 
ATP depletion profile of ES9 and TyrA23 were similar to those of AA and CCCP but differed from 
Oligomycin (Fig. 2a), where the reduction in ATP content occurred more gradually. To rule out that 
ATP depletion was a result of an acute cytotoxic effects of the compounds, all small molecules were 
tested on PSB-D wild type cell cultures for fluorescein diacetate (FDA) hydrolysis49, a marker for 
cell viability. In all cases, FDA profiles increased similar to the control treatment (Supplemental Fig. 
111 
 
2a). These results suggest that ES9 and TyrA23 affected ATP production, which was not due to an 
acute loss in cell viability.  
Since PSB-D cell cultures are dark grown, mitochondria represent the main ATP producer for the 
cell. We therefore hypothesized that ES9 and TyrA23 could alter mitochondrial properties. In order 
to test this hypothesis, we isolated mitochondria from Arabidopsis leaves50 and performed a series of 
respiratory measurements ex cellulo. Mock treatment did not affect the mitochondrial electron 
transport chain (mETC) as high respiratory control ratios (RCRs) were maintained (Supplemental 
Fig. 2b-c). Addition of CCCP (1 μM) led to a characteristic rapid and transient increase in the 
respiratory rate as well as a clear uncoupling between oxidations and phosphorylations within the 
mETC as shown by the RCR drop even after addition of ADP (Supplemental Fig. 2b-c). ES9 (1 μM) 
and TyrA23 (5 μM) at even lower concentrations, but not TyrA51 (5 μM), had a similar effect as 
CCCP on respiratory properties (Supplemental Fig. 2b-c), suggesting that like CCCP, both TyrA23 
and ES9 are mitochondrial uncouplers in Arabidopsis cells. 
The dissipation of mitochondrial membrane potential in the presence of ES9 and TyrA23 was 
confirmed in vivo using MitoTracker Red CM-H2XRos staining of mitochondria in Arabidopsis root 
cells, which is reduced or prevented when electron transport is uncoupled or inhibited51. Therefore, 
MitoTracker Red CM-H2XRos was subsequently used to visualize disruptions of mitochondrial 
membrane potential in the early differentiation zone of Arabidopsis roots, as individual mitochondria 
can be easily distinguished in these cells. The mitochondrial labeling was not affected after mock 
(DMSO) and TyrA51 treatments (50 µM, 30 min) (Fig. 2b), whereas in cells treated for the same 
time with CCCP (1 µM), ES9 (10 µM), AA (20 µM) or TyrA23 (50 µM) no mitochondria were 
detected, though non-mitochondrial labeling seemed to be increased (Fig. 2b).  
The ability of ES9 to deplete ATP was also evaluated in Drosophila. Comparable to Arabidopsis, 
ES9 depleted ATP in Drosophila S2 cell cultures similar to CCCP, TyrA23 and AA (Supplemental 
Fig. 2d). Surprisingly, TyrA51 was also able to deplete ATP in Drosophila cells to approximately 
50% of control conditions. Active mitochondria in Drosophila are labeled with tetramethylrhodamine 
ethyl ester (TMRE)52, which was greatly impaired in the presence of ES9 (10 μM, 30 min) and CCCP 
(10 μM, 30 min), confirming disruption of mitochondrial function (Fig. 2c, Supplemental Fig. 2e). 
 
  
Figure 2. ES9 acts as a protonophore in Arabidopsis and Drosophila 
(a) ATP depletion induced by 10 µM ES9 compared to 1 µM carbonyl cyanide m-chlorophenyl 
hydrazine (CCCP), 50 µM TyrphostinA23 (TyrA23), 50 µM TyrphostinA51 (TyrA51), 50 µM 
Antimycin A (AA) and 10 µM Oligomycin (Oligo), relative to mock treatment. (b) 250 nM 
MitoTracker Red CM-H2XRos labeling of mitochondria in Arabidopsis root cells in presence of 10 
µM ES9, 1 µM CCCP, 50 µM TyrA23, 50 µM TyrA51, 20 µM AA and the mock (DMSO, Ø) 
treatment for 30 min. (c) Tetramethylrhodamine ethyl ester (TMRE) labeling of mitochondria in 
D42mitoGFP positive Drosophila neuromuscular junctions for 10 µM ES9 (30min pretreatment), 10 
µM CCCP ( and mock (1% DMSO in HL-3 medium) treatment 15 minutes). Scale bar, 5 µm 
 
Cytosolic acidification but not ATP depletion rapidly inhibits CME in Arabidopsis 
In mammalian systems, AA and CCCP have been linked to inhibition of CME as metabolic 
inhibitors43,53,54. We therefore evaluated the effect of CCCP, AA and Oligomycin on endocytosis in 
Arabidopsis, given that the CME inhibitors ES9 and TyrA23 also depleted cellular ATP. CCCP (1 
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µM) induced a complete inhibition of FM4-64 uptake when both CCCP and FM4-64 were co-applied 
for 30 min (Fig. 3a, Supplemental Fig. 3a), a pattern very similar to that of ES9 and TyrA23. In 
contrast, the inhibition of FM4-64 uptake, as measured from the plasma membrane/cytosolic signal 
intensity ratio, appeared not significant when FM4-64 was co-applied with AA (20 M, 30 min) or 
added after pretreatment with Oligomycin (50 M, 30 min) and imaged after an additional 30 min 
(Fig. 3a, Supplemental Fig. 3a). The pre-incubation with Oligomycin served to reach similar levels 
of ATP in the cell compared to AA and ES9, based on the ATP depletion results obtained from PSB-
D cell cultures (Fig. 2a). The results for AA and Oligomycin indicated that depletion of ATP alone 
is not enough to completely block FM4-64 uptake. Moreover, we also tested whether CCCP caused 
phenotypes similar to ES9 in Drosophila because they both affected TMRE labeling of mitochondria 
and caused ATP depletion. CCCP treatment (10 μM, 15 min) did significantly reduce the uptake of 
FM1-43 but failed to form the large FM1-43 labeled inclusions seen when the boutons were incubated 
in ES9 (Supplemental Fig. 3b,c). The latter observation implicates that the CHC- or dynamin-related 
phenotype of ES9 are not caused by the dissipation of proton gradients and ATP production in 
mitochondria, further indicating that ES9 also harbors effects on CME beyond ATP depletion. 
The differential phenotypes between AA and Oligomycin versus CCCP, TyrA23, and ES9, together 
with their function as mitochondrial uncouplers led to the hypothesis that, in contrast to AA and 
Oligomycin, CCCP, TyrA23, and ES9 could uncouple proton gradients throughout the entire cell, 
and therefore act as general protonophores in Arabidopsis. This might result in a substantial flow of 
protons from either the vacuole or the apoplast to the cytosol. To visualize this, Arabidopsis seedlings 
were treated with the respective small molecules and Lyso Tracker Red DND 99, a dye that labels 
acidic compartments in the cell55. Seedlings were first pre-incubated with Lyso Tracker Red DND 99 
for 30 min, in order to label acidic compartments. Subsequent mock treatment of 30 min did not alter 
staining (Fig. 3b, Supplemental Fig. 3d), nor a treatment with 50 µM TyrA51 or 20 µM AA (Fig. 
3b). However, addition of CCCP (1 µM), ES9 (10 µM) or TyrA23 (50 µM) for 30 min relocated Lyso 
Tracker Red DND 99 to the cytosol, and increased its signal dramatically, especially for the latter 
two (Fig. 3b). The relocation of Lyso Tracker Red DND 99 suggests a change in proton concentration 
throughout the cell, possibly as a result of proton gradient dissipation over the tonoplast and plasma 
membrane. To test this, we measured the pH in the vacuole and the cytosol in root cells in the presence 
of small molecules. The cytosol acidified significantly in presence of 10 µM ES9, 50 µM TyrA23 
and 1 µM CCCP (Fig. 3c), with ES9 having the strongest effect. The vacuolar pH was most hardly 
affected by 50 µM TyrA23 and 1 µM CCCP (Fig. 3d), which were comparable to 50 µM TyrA51 
(Supplemental Fig. 3e) in terms of alkalinisation. Only TyrA23 induced a significant change. ES9 
(10 µM) induced a stronger and more significant alkalinisation (Figure 3d), comparable to 50 µM 
AA (Supplemental Fig. 3e). Yet ES9 and AA treatment failed to induce an alkalinisation similar to 
1 µM Concanamycin A (Conc. A) treatment, or as compared to the vacuolar pH in the vha-a2 vha-
a3 mutant background56. Both latter conditions are affected in the vacuolar H+-proton pumps, and 
thus have impaired H+-pumping over the tonoplast. These data suggest that the main uncoupling 
activity occurred at the plasma membrane, which might indicate that the main influx of protons into 
the cytosol occurred over the PM.  
 
 
Figure 3. Cytosolic acidification, and subsequent ATP depletion completely inhibit CME 
(a) FM4-64 uptake (2 µM, 30 min) in Arabidopsis root cells in presence of mock (DMSO, Ø), 50 µM 
Antimycin A (AA), 1 µM carbonyl cyanide m-chlorophenyl hydrazine CCCP and 50 µM Oligomycin 
(Oligo). Only in the case of Oligomycin cells were pretreated with the compound for 30 min before 
FM4-64 application. (b) Lyso Tracker Red DND 99 labeling (30 min) followed by an additional 30 
min in presence of vehicle, ES9, AA, CCCP, TyrA23 and TyrA51. (c) Box plot representation of 
cytosolic pH measurements for 10 µM ES9, 50 µM TyrA23, and 1 µM CCCP. **P<0.01 and 
***P<0.001 with a Kruskal-Wallis ANOVA on Ranks. N = 59, 60, 54 and 61 respectively. Individual 
data points are represented. (d) Vacuolar pH measurement for mock treatment (DMSO, Ø), 10 µM 
ES9, 50 µM TyrA23, and 1 µM CCCP. *P<0.05 and ***P<0.001 with a Kruskal-Wallis ANOVA on 
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Ranks. N = 32 for all measurements. (e) Comparison of 30 min FM4-64 uptake at pH 5,5 or 7, after 
15 min pre-treatment with DMSO (Ø), 1 µM CCCP, 50 µM TyrA23 and 10 µM ES9. (f) 
Quantification of plasma membrane/cytosolic FM4-64 signal intensity for the different conditions in 
(e). Error bars: standard error of the mean. *P< 0,05 and ***P<0.001 with a Student’s t-test for at 
least 3 biological repeats. Box plot center lines show the medians; box limits indicate the 25th and 
75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from 
the 25th and 75th percentiles, outliers are represented by dots. Scale bar, 5µm. 
 
If a large part of the observed acidification would be caused by influx of apoplastic protons, changing 
the pH of the apoplast by incubating seedlings in more alkaline conditions would prevent this. 
Therefore, the FM4-64 uptake was evaluated when seedlings were incubated with small molecules in 
more alkaline medium (pH 7). An elevated pH of the incubation medium appeared to have little effect 
on the FM4-64 internalization, as no obvious differences were observed when the FM4-64 uptake (30 
and 150 min) was carried out at either pH 5.5 or pH 7 (Supplemental Fig. 3f). However, co-
application of CCCP (1 µM, 15 min pretreatment) with FM4-64 (30 min) at pH 7 allowed FM4-64 
in the cell, indicating CCCP lost the ability to inhibit effectively FM4-64 uptake (Figure 3e,f). 
Similarly, application of TyrA23 (50 µM, 15 min pretreatment) at pH 7 reduced the signal intensity 
of FM4-64 dramatically, yet FM4-64 appeared not inhibited. ES9 treatment (10 M, 15 min 
pretreatment) at pH 7 remained sufficient to inhibit FM4-64 uptake entirely, indicating ES9 might 
possibly inhibit FM4-64 through an additional mechanism (Figure 3e,f). Altogether these data 
suggest that the primary (very fast) block of CME by ES9, TyrA23 and CCCP is not due to energy 
depletion, but most likely to cytosolic acidification and possibly dissipation of plasma membrane 
potential. 
 
E S9 activity causes an arrest in dynamic behavior of CME machinery at the plasma membrane 
The apparent inhibition of FM4-64 and AFCS internalization by ES9 activity implies nonfunctional 
CME machinery. To test this, the behavior of TPLATE Muniscin Like fused to GFP (TML-GFP), a 
component of the TPLATE adaptor protein complex of CME5, was evaluated in presence of the 
different small molecules. The previously reported TML-GFP life time at the plasma membrane of 
about 20 sec5 was observed for mock-treated (DMSO) seedlings and seedlings treated with 50µM 
TyrA51 (Fig. 4a,b). However, for seedlings treated with 10 µM ES9, 1 µM CCCP or 50 µM TyrA23, 
TML-GFP-labeled foci at the plasma membrane lost their dynamic behavior and appeared stationary, 
often with a life-time of several minutes (Fig. 4a,b). The loss of dynamic behavior was established 
quickly, as images were acquired 3-5 min after start of treatments. AA treatment increased the life-
time of the TML-labeled foci, but did not block their dynamics (Fig. 4a,b), correlating with the 
observed uptake of FM4-64 in presence of AA. The ES9 induced phenotype, which appeared to be 
representative for CCCP and TyrA23 treatment, was also observed for other components of CME 
machinery in Arabidopsis. The dynamic behavior of TPL-GFP57 the AP2 complex, represented by 
AP2A1-GFP9, AP2M-GFP29 and AP2S-GFP31, and the clathrin cage represented by CLC1-GFP, 
CLC2-GFP, CLC3-GFP and CHC1-GFP appeared to be inhibited similar to TML-GFP 
(Supplemental Fig. 4a). ES9 also affected the phospholipid components involved in CME, such as 
phosphatidylinositol 4,5-biphosphate (PI(4,5)P2)
58, which was detected with the 2xPHPLC (P24Y) 
marker59. Upon ES9 application (10 M, 30 min), P24Y localized largely to the cytosol, opposed to 
a predominant plasma membrane localization in control conditions (Supplemental Fig. 4d), which 
possibly reflected the overall decrease of PI(4,5)P2 levels after the compound treatment 
(Supplemental Fig. 4e). In contrast, other phospholipid species were hardly affected in overall 
concentration (Supplemental Fig. 4e), and PI4P maintained its plasma membrane localization, as 
exemplified by the 2xPHFAPP1 (P21Y)59 marker (Supplemental Fig. 4d). These results indicate that 
most of the essential components for CME are affected in their life-time at the plasma membrane, 
thereby affecting proper unfolding of endocytic events. 
 
Protonophores affect multiple aspects of endomembrane trafficking 
In addition to the arrest in dynamic behavior seen at the plasma membrane we also observed impaired 
dynamics at the level of endomembrane compartments such as the Golgi and the Trans Golgi Network 
(TGN)/Early Endosome (EE). When seedlings expressing the Golgi (ST-mRFP60) or the TGN/EE 
(Vha-a1-mRFP61) markers were treated with AA (20 µM) or TyrA51 (50 µM), a similar dynamic 
behavior compared to the control was observed for both the Golgi and TGN/EE, although Golgi 
appeared to move slower compared to mock in presence of AA (Fig. 4c). However, application of 
ES9 (10 µM), CCCP (10 µM) or TyrA23 (50 µM), inhibited movement throughout the cell almost 
completely (Fig. 4c). Again the loss in dynamic behavior was established quickly, as images were 
acquired 3-5 min after start of treatment, similar as for the measurements of endocytic life-times at 
the plasma membrane. The arrest in TGN/EE movement might explain a different observation, 
whereby application of ES9, CCCP or TyrA23 together with Brefeldin A (BFA), a fungal lactone 
interfering with ARF-GEF mediated vesicle traffic62,63, prevented the formation of the BFA body 
(Supplemental Fig. 4b), whilst this was not observed for mock (DMSO) treatment or TyrA51 
application. The formation of the BFA body might therefore require active vesicle movement in order 
to facilitate the clustering of TGN/EE. 
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Figure 4. Protonophores inhibit CME dynamics in the plasma membrane and vesicle movement 
in the cytosol 
(a) Kymographs representing a set of pixels (horizontal axis) over a period of time (vertical axis, 5 
min), illustrating life times of endocytic spots labeled by TML-GFP for the control treatment (DMSO, 
Ø), 10 µM ES9, 20 µM Antimycin A (AA), 1 µM carbonyl cyanide m-chlorophenyl hydrazine 
(CCCP), 50 µM TyrphostinA23 (TyrA23) and 50 µM TyrphostinA51 (TyrA51). (b) Boxplot 
representation of measured endocytic spot life times. Center lines show the medians; box limits 
indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the 
interquartile range from the 25th and 75th percentiles, outliers are represented by dots. N = 1646, 
171, 423, 218, 121 and 868 sample points (c) Golgi (ST-mRFP) and Trans Golgi Network (TGN, 
Vha-a1-mRFP) in presence of the control treatment, 10 µM ES9, 20 µM AA, 1 µM CCCP, 50 µM 
TyrA23 and 50 µM TyrA51 (time of treatment?). Images are composed of 6 differentially colored 
images with a 10 sec interval. Movement is illustrated by different colors, while static compartments 
appear white due to overlay of different colored frames. Scale bar, 5 µm. 
 
Interestingly, ES9 also affected the localization of CLC in the TGN/EE. Upon treatment with ES9 
(10 µM, 30 min), CLC2, but not CLC1 and CLC3, dislodged from the TGN/EE, a phenotype which 
was also observed upon 1 µM CCCP treatment (Supplemental Fig. 4c). This suggests a pH 
sensitivity of CLC2 association with the TGN/EE, which might reflect a different mode of action for 
CLC2-association with the TGN/EE compared to CLC1 and CLC3. 
To better characterize the effects of protonophores on endomembrane trafficking, the impact of ES9 
and CCCP was evaluated at the ultrastructural level using transmission electron microscopy of high-
pressure frozen and freeze-substituted Arabidopsis root cells. While the plasma membrane and 
mitochondria were unaffected (Supplementary Fig. 5), both ES9 and CCCP induced morphological 
alterations of both the Golgi apparatus and the TGN/EE, moreover multivesicular bodies (MVBs) 
were not present anymore (Fig. 5). Similar effects were previously reported for CCCP treatment of 
BHK cells64. Treatment with ES9 (5 M or 10 M, 30 min) caused the Golgi cisternae to swell, and 
the TGN/EE sometimes formed circle-like structures. The latter observation well explains the 
confocal microscopy data, where the TGN/EE marker VHA-a1 labeled circle-like structures in the 
presence of ES9 (Supplemental Fig. 6a, arrowheads). Both compounds also induced the 
accumulation of large inclusions inside the vacuole, which often contained portions of the cytosol, 
and are probably of autophagic nature. These inclusions were also observed when the line expressing 
the tonoplast marker SYP22-YFP65 was treated with ES9 (Supplemental Fig. 6b, arrowheads). 
Surprisingly, in the meristematic cells of the root tip, but not in the elongation zone, 10 M ES9 
treatment induced the formation of Golgi-ER hybrid compartments (Fig. 5h), which were not seen 
for the CCCP treatment. The presence of Golgi-ER hybrids has been previously reported66 and is 
indicative of a non-functional COPI trafficking. The observation that ES9 induced Golgi-ER hybrid 
compartments, while CCCP did not, might indicate that ES9 targets additional processes, independent 
from its capability to uncouple proton gradients. 
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Figure 5. Protonophores causes morphological alterations in the endomembranes 
(a) The Golgi apparatus (G) and the trans-Golgi network (T), (b) vacuoles (V), (c) multivesicular 
bodies (M) and (d) the endoplasmic reticulum (ER) display a normal morphology upon 30 min 
exposure to DMSO in meristematic root cells of five-day-old Arabidopsis seedlings. Upon 30 min 
exposure to 5 M ES9, (e) the Golgi apparatus (G) displays an aberrant morphology with swollen 
stacks, the trans-Golgi network is often not recognizable or displays highly aberrant morphology 
(black arrowheads), and multivesicular bodies are absent. (f) Vacuoles accumulate autophagic bodies 
due to an impaired post-Golgi trafficking which prevents the delivery of proteolytic enzymes to the 
vacuolar lumen. Upon 30 min exposure to 10 M ES9, (g) the Golgi apparatus (G) is even more 
affected, and (h) sometimes ER-Golgi hybrid compartments form in meristematic cells (white 
arrowhead). (i) CCCP causes morphological alteration to the Golgi and the trans-Golgi network, often 
by bending the stacks to form cup-shaped structures (G). (j) CCCP also induces the accumulation of 
autophagic bodies in the vacuole (V), however (k) it does not induce the formation of ER-Golgi 
hybrids, but it locally causes the swelling of the ER cisternae. (l) Quantification of the effects of 
DMSO (D), ES9 (E) and CCCP (C). One-hundred Golgi and one-hundred vacuoles were analyzed 
for each treatment Black, dark grey and light grey colors refer to altered, partly altered and normal 
compartments respectively. Scale bars, 200 nm. 
Discussion 
 
ES9 and TyrA23 are mitochondrial uncouplers 
In this study we have identified and characterized the mode of action of a small molecule ES9, which 
activity inhibited CME in Arabidopsis and synaptic vesicle recycling in Drosophila. ES9 affected 
energy metabolism in both Arabidopsis and Drosophila cells and reduced the cellular ATP production 
by acting as a mitochondrial uncoupler, similar to known protonophores such as CCCP. Surprisingly 
TyrA23, a known and widely used inhibitor of CME in plants67-69 , similarly showed activity of 
mitochondrial proton gradient uncoupling. Both ES9 and TyrA23 had a comparable effect as CCCP 
on the stimulation of mitochondrial respiration and a clear uncoupling activity of oxidations and 
phosphorylations. Likewise, treatments with ES9 or TyrA23 depolarized the mitochondria 
membranes in vivo in Arabidopsis and Drosophila. The similarity of phenotypes exhibited by ES9, 
TyrA23 and CCCP suggest that those compounds share a common mechanism of action as 
mitochondrial uncouplers, which is different from AA or Oligomycin. Indeed, while AA and 
Oligomycin are known specific inhibitors of ATP production45,46, CCCP and Carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone (FCCP), a small molecule uncoupler similar to CCCP, are known 
non-specific inhibitors of ATP production as they depolarize the plasma membrane47,48,70-74. 
Interestingly, an increase in medium pH has been shown to reduce the protonophore action of FCCP 
over the plasma membrane74, an observation which could be linked with the inability of CCCP to 
inhibit FM4-64 uptake in neutral pH, probably as a consequence of the lack in protonophoric activity 
at neutral pH. In support of the cell-wide complications of CCCP, opposed to a specific mode of 
action for the mitochondrial electron transport chain complex III inhibitor AA75,76, is the failure of 
AA to induce similar cell-wide disruptions as induced by CCCP, ES9 and TyrA23, such as an 
immediate complete inhibition of FM4-64 uptake, general inhibition of dynamic events and cytosolic 
acidification. As ES9 and TyrA23 mimicked CCCP action in almost all aspects tested, it is reasonable 
to assume that ES9 and TyrA23 act through a mechanism similar as CCCP. This is supported by the 
chemical characteristics of each compound. Like CCCP, both ES9 and TyrA23 are weak acids 
(sulfonamide and phenol, respectively) that can dissociate into a proton and a stabilised, lipophilic 
anionic compound at physiological pH, thus fitting the classical biochemical description of 
uncouplers. Although TyrA23 is quite hydrophilic compared to known potent uncouplers, upon closer 
inspection, its anionic form can be further stabilised by an intramolecular hydrogen bond, a known 
chemical feature in uncouplers that further increases anion lipophilicity, and thus, membrane 
permeability77. An overview of the structural and electronic features of CCCP, ES9 and TyrA23 and 
several related known uncouplers is provided as supplemenatery information (Supplemental Figure 
7). 
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ATP depletion alone does not efficiently block CME in Arabidopsis root cells and Drosophila 
neuromuscular junctions 
Because CME is an energy-dependent process and certain levels of ATP are required for the receptor-
mediated endocytosis44, ES9 and TyrA23 might efficiently block CME through ATP depletion. 
However Oligomycin and AA both reduced cellular ATP in Arabidopsis cell culture cells but did not 
efficiently block endocytosis in root cells, although a longer pretreatment with the compounds 
reduced the uptake of the endocytic tracer FM4-64. It was previously shown that a reduction in ATP 
content to a level < 5% with AA is sufficient to prevent endocytosis of epidermal growth factor and 
the translocation of β-adrenergic receptors43. It is possible that the length of treatments with the 
metabolic inhibitors in root cells used in our study did not efficiently reduce ATP levels to 
concentrations low enough to block endocytosis. However, in yeast cells CME was not inhibited by 
depletion of ATP to 1-3 % of the normal level, whereas vacuolar transport was78, suggesting that 
different eukaryotic systems might have different ATP requirements for CME. However, the 
inhibitory effect of ES9 and TyrA23 on CME was instant suggesting that the endocytosis block 
induced by those compounds is not due to ATP depletion. This conclusion is consistent with the 
observations in Drosophila. Here, the mitochondrial uncoupler, CCCP, did not cause obvious defects 
in FM1-43 dye uptake. In contrast, ES9 also dissipates the mitochondrial membrane potential and 
results in lower ATP levels, but in contrast to CCCP, this compound caused mislocalization of CHC-
HA and resulted in FM 1-43 dye uptake defects. This supports an additional mode of action for ES9, 
as defects in mitochondrial functions and reduction in ATP have no clear implications in synaptic 
vesicle recycling except under intense stimulation of neurons to mobilize reserve pool vesicles79,80.  
 
ES9 and TyrA23 inhibit CME through cytosol acidification and possibly dissipation of proton 
gradients at the plasma membrane 
In mammalian systems, acidification of the cytosol with weak acids strongly reduced CME of 
transferrin and epidermal growth factor but had a little effect on the uptake of some toxins and fluid 
phase endocytosis81,82. Mitochondrial uncouplers of oxidative phosphorylation are also weak acids 
which, due to their ability to cross the membranes in both their protonated and unprotonated form, 
should be much more effective in perturbing cytosolic pH than those weak acids that cross a 
membrane mainly in their protonated form. Indeed several reports show that uncouplers like CCCP 
and others have activity at other membranes that lead to cell acidification and cytotoxicity74,83. 
Related to endomembrane trafficking, protonophore uncouplers were most commonly used to disturb 
the proton gradients and increase the pH of the endocytic vesicles and lysosomes in mammalian 
cells74,84. The cytoplasmic and vacuolar pH measurements in Arabidopsis are in agreement with the 
mammalian literature, and suggest that the main proton flow into the cytoplasm is established over 
the PM. It can be expected that protonophores would induce more drastic effects in Arabidopsis 
compared to mammalian systems, as the pH of the growth medium differs in more than one pH unit.  
Furthermore, the large inclusions seen in the vacuole, which are likely of autophagic nature, are in 
agreement with reports where protonophores are used to induce autophagy and mitophagy85,86, though 
recent reports suggest caution when using protonophores to induce autophagy related processes, as 
the induction is likely not specific, owing to the general effect on cellular proton gradients by 
protonophores87. In contrast, the described effects of the protonophore uncouplers on CME are not 
consistent for all experimental systems and difficult to interpret. Whereas CCCP blocks the uptake of 
iron from transferrin, mediated by CME in reticulocytes82, in yeast cells CCCP did not block the 
internalization of FITC-dextran into the endosomal compartments78. One possible explanation 
concerning the different effects of protonophore uncouplers on CME might be related to the different 
cellular environment in differential systems. Our observations that the pH of the incubation media 
influenced the effect of the uncouplers on CME favor this.  
Acidification of the cytosol in mammalian cells interferes with budding of clathrin-coated vesicles 
from the plasma membrane as well as from the TGN81,88,89. Interestingly an altered structure of 
clathrin lattices on the inside of the plasma membrane was observed, and it was proposed that some 
acidification is required for the clathrin lattice curvature to occur88. Although we were not able to 
evaluate clathrin lattice structure upon acidification of the cytoplasm in plants, one could expect that 
acidification would affect a similar deformation of clathrin coated pits and vesicles as in mammalian 
systems, which in turn could explain the impaired dynamics of CME foci at the plasma membrane, 
as seen for CCCP, ES9 and TyrA23. More importantly, our results indicate that, similar to mammalian 
systems, acidification of the cytosol in Arabidopsis inhibits CME. Apart from the small molecules 
described here, other well-known small molecules such as auxin and salicylic acid (SA) can also 
induce cytosolic acidification90,91, and inhibit CME21,92. It would therefore be of interest to establish 
if auxin and SA induce a similar effect on CME dynamics compared to ES9, TyrA23 and CCCP, and 
if the cytoplasmic acidification is the underlying mechanism by which auxin and SA mediate 
inhibition of CME. Moreover, a possible physiological role for cytosolic acidification and subsequent 
inhibition of endocytosis in Arabidopsis might involve the inhibition of endocytosis in general upon 
hyperosmotic stress, as shown in Dictyostelium cells93. 
The impaired dynamics at the plasma membrane and by extension other endomembrane 
compartments such as the Golgi and TGN/EE, could be explained by a heavily affected cytoskeleton. 
Indeed, early reports suggest an effect of protonophores on the microtubule cytoskeleton through a 
change in pH and the inability of accessory proteins to associate94. Similarly, CHC was also 
mislocalized at synaptic boutons in Drosophila when treated with ES9. The ultrastructural analysis 
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in plant cells did not reveal accumulation of clathrin-coated pits in the plasma membrane or in fact 
any membrane alterations, consistent with the mislocalization of CHC. 
Plant cells treated with either ES9 or CCCP also displayed aberrant Golgi morphology. Similarly, it 
was previously shown that the protonophore CCCP inhibits secretion in Baby Hamster Kidney 
fibroblasts (BHK) cells by interfering with Golgi function and causing dilation of the Golgi cisternae 
and accumulation of large vacuoles in the Golgi region64,95. Interestingly, the ATP depletion over 
time induced by CCCP95 was similar to what we reported. However, ES9 treatment also led to a 
Golgi-ER fusion which was not detected in CCCP-treated cells. This presence of Golgi-ER hybrid 
compartment has been previously reported66 and is indicative of a non-functional COPI trafficking. 
The observation that ES9 induces a Golgi-ER hybrid compartment, while CCCP did not, might 
indicate that ES9 targets additional processes, independent from its capability to uncouple proton 
gradients. In addition to affecting the Golgi and TGN/EE morphology, treatments with protonophores 
(ES9, TyrA23 and CCCP) strongly affected the motility of these compartments. This can explain why 
pretreatment with TyrA23, ES9 and CCCP prevented the formation of BFA bodies, visualized with 
the TGN/EE markers Vha-a1 (our data) or SCAMP196,97. TyrA23 also affected cytokinesis98, a 
process dependent on the Golgi-based secretion, suggesting that TyrA23 similar to ES9 and CCCP 
might also act at the level of Golgi apparatus. 
Finally, the absence of MVBs can be explained by the impairment of TGN/EE function, on which 
MVB formation depends99. This event is probably a consequence of Golgi- and TGN/EE-mediated 
vacuolar trafficking impairment, since proteolitic enzymes would not be delivered into the vacuolar 
lumen, leading to an accumulation of undegraded autophagic bodies. This effect, as well as the 
morphological alteration of both Golgi and TGN/EE, has also been reported by using the well-known 
V-ATPase inhibitor concanamycin A (ConcA)61,100. 
 
The use of TyrA23 in plants 
As most of the TyrA23 use in plants is related to studies on CME, and given our report on the 
protonophoric characteristics of TyrA23, data obtained with this inhibitor should be carefully revised. 
Although our results suggest that TyrA23-mediated inhibition of CME in plants primarily occurs 
through acidification of the cytosol and possibly dissipation of the proton gradient over the plasma 
membrane , inhibition of CME through interference with cargo recognition cannot be excluded. 
Interference of cargo recognition does not affect all cargos to the same extent as shown for epidermal 
growth factor receptor and transferrin receptor recognition by a dominant negative form of AP-2 
medium subunits101. While application of TyrA23 strongly reduced, but not abolished transferrin 
uptake, and no other effect on endomembrane traffic could be concluded14, one could speculate that 
the complete inhibition of FM4-64 by TyrA23 application in Arabidopsis is most likely the result of 
the protonophore nature of TyrA23, similar as what we report for CCCP and ES9, which is much 
stronger at the plasma membrane compared to other systems given the relative low pH of the 
surrounding medium. 
Small molecule hits which affect mitochondrial functions are of increasing concern in the mammalian 
drug discovery field, as considerable numbers of small molecule hits appear to affect mitochondrial 
functions, and thus induce undesirable side effects102-105. In this respect TyrA23 does not seem to be 
an exception, yet questions its further use as a specific inhibitor of CME in plants. In addition, our 
results illustrate the necessity to fully characterize small molecules which are adopted from the 
mammalian field. Though TyrA23 still might affect cargo recruitment by AP-2, essential biochemical 
proof is lacking in plants, as subtle differences in amino acid composition and tertiary or quaternary 
structure of AP-2 might compromise TyrA23 binding in plants. However, the protonophore activity 
of TyrA23 overrides any specificity at the level of CME, as cytosolic acidification and possibly the 
loss of membrane potential will impair CME severely. Unless a TyrA23 analogue is developed, which 
is unable to dissipate proton gradients, yet maintains the ability to interfere with cargo recruitment, 
the use of TyrA23 in plant biology to inhibit specifically cargo recruitment to AP-2 should be 
carefully evaluated. 
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Material and methods 
 
Plant material and growth conditions 
Arabidopsis thaliana (accession Columbia-0 [Col-0]) seedlings and other lines were  stratified for 2 
days at 4°C, and grown vertically on agar plates containing ½ strength Murashige and Skoog (½MS) 
medium supplemented with 1% (w/v) sucrose for 5 days at 22°C in a light/dark cycle of 16 h/ 8 h 
respectively, prior to use. Arabidopsis seedlings were used as control or for labeling of mitochondria 
and acidic compartments. Following marker lines were used: TML-GFP5, TPLATE-GFP (TPL-
GFP)57, CLC1-GFP, CLC2-GFP, CLC3-GFP, CHC1-GFP, AP2A1-GFP9, AP2M-GFP29, AP2S-
GFP31, ST-mRFP60, Vha-a1-mRFP61, SYP22-YFP65. 
Generation of GFP-tagged CHC1 
Entry clone generated before23 was used together with pDONRRP4-1R_RPS5A, pDONRRP2R-
P3_GFPstop and pK7m34GW in multisite Gateway reactions (Life technologies) to yield C-terminal 
tagged CHC1 
Chemical treatments, chemical labeling and imaging in Arabidopsis 
TyrphostinA23, tyrphostinA51, oligomycin, antimycin A, carbonyl cyanide 3-
chlorophenylhydrazone, brefeldin A, and fluorescein diacetate were acquired through Sigma-Aldrich. 
All were dissolved in DMSO (Sigma-Aldrich) except for Oligomycin (ethanol). ES9 was acquired 
through Chembridge (http://www.chembridge.com/). Visualization of endocytosis was achieved with 
2μM N-(3-Triethylammoniumpropyl)-4-(6-(4-(Diethylamino) Phenyl) Hexatrienyl) Pyridinium 
Dibromide (FM4-64, Life technologies) application. For staining of mitochondria, seedlings were 
first treated for 30 min in ¼ MS (a 1:1 dilution of ½ MS with water) with the respective small 
molecules. Subsequently, seedlings are transferred to liquid ¼ MS with 250 nM MitoTracker Red 
CM-H2XRos (Molecular Probes®, Life Technologies) and the respective small molecules for an 
additional 30 min. Similarly, acidic compartments were labeled with Lyso Tracker Red DND 99 
(Molecular Probes®, Life Technologies) by treating seedlings with 250 nM Lyso Tracker Red DND 
99 in liquid ¼ MS for 30 min. Small molecule treatment was started by adding small molecule at 
respective concentrations to seedlings in the Lyso Tracker Red DND 99 containing solution for 
another 30 min. Imaging of seedlings was performed with an Olympus FV10 ASW confocal laser 
scanning microscope using a 60x water immersion lens (NA 1.2) and 3x digital zoom. Endocytic foci 
Life-time measurements were determined using a Perkin Elmer Ultra View Vox Spinning disc 
confocal imaging system running on the Volocity software package mounted on aNikon Eclipse Ti 
inverted microscope using a Plan Apo Lambda 100x oil (NA 1.45) corrected lens and third generation 
perfect focus system (PFSIII) for Z-drift compensation. Time series were acquired at 2 time points 
per second intervals, for 5 minutes. Excitation was done using a solid state 488nm DPSS laser 
(50mW) and images were acquired using a Hamamatsu ImagEM C9100-13 512x512 BI (16umx16um 
pixel size) EmCCD camera. Images were processed using the imageJ (Fiji) software packages. For 
Kymographs, background was substracted with a rolling ball radius of 50 pixels, and a walking 
average (2) was performed. Kymographs were generated with a line thickness of 3. For quantification 
of the plasma membrane/cytosol signal intensity ratio, images were converted in ImageJ to 8-bit, and 
regions of interest (ROIs) were selected based on the plasma membrane or cytosol localization. 
Histograms listing all intensity values per ROI were generated, and the averages of the 100 most 
intense pixels were used for calculations. 
ATP measurements 
Wild type PSB-D Arabidopsis cell cultures were used and maintained as described before106. Cell 
culture of 3 days old was diluted 100 times and mixed thoroughly prior to distribution of 95 μl in 96-
well plates. Subsequently, 5 μl of a 1/50 dilution of small molecule stock solution (1000x) in MS 
medium with Minimal Organics (MSMO) medium was added to cells (final dilution of 1000x) using 
a Tecan Freedom EVO® robot. ATP levels were detected by addition of 80 μl of ATPlite 1step 
Luminescence Assay System (Perkin Elmer) after incubation of cells in presence of small molecule 
for indicated time. Fluorescence was detected using a Perkin Elmer EnVision 2104 multilabel reader 
with the Wallac Envision manager software package. ATP-lite luminescence was detected with the 
ultra-sensitive luminescence techonology. Fluorescein diacetate (FDA) stock solution (2% FDA in 
acetone [w/v]) was diluted 100x in target medium and 5 μl was added to 95 μl cell culture. 
Fluorescence was detected with an excitation at 485nm (bandwidth 14nm), and emission at 535nm 
(bandwidth 25nm). Same procedure applies for Drosophila Schneider 2 (S2) cell suspension cultures, 
which were maintained in Sf-900 II SFM (Serum free medium , Gibco) at 25 °C without CO2, and 
distributed in 96-well plates for analysis (95 μl, 25000 cells). 
Isolation of mitochondria and measurement of respiratory control ratios. 
Mitochondria from Arabidopsis leaves were isolated as previously described50 following method A. 
Respiratory measurements were overall performed according to previous report50, with a clark-type 
oxygen electrode (Hansatech) at 25°C and recorded with a sekonic SS-250F recorder. Dioxygen 
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concentration in air-saturated water was established at 240μM and a final volume of only 0.5mL was 
used in the cuvett. A mix of Malate/Glutamate (0.1M/1M) was chosen as substrate for the mETC and 
was injected to a final dilution of 1/100. Mitochondrial respiration was further stimulated by injection 
of ADP (10mM) to a final dilution of 1/100. TyrA23, TyrA51 and CCCP were solubilized with 
DMSO. Controls with injection of 5μL DMSO alone at the beginning, the middle and at the end of 
the measurements were performed. Experiments from independent extractions were performed 4-6 
times with identical results. Traces shown are actual traces obtained with the recorder, scanned and 
digitalized. 
pH measurements 
For cytosolic pH measurements, 4 days old UB10:pH-GFP plants107,108 were transferred to 2ml of 
liquid 1/2MS (pH5.5, 2.15g/l MS salts, 0.5g/l MES) for 30 min with the indicated drugs or mock 
(DMSO). Imaging was done with a Zeiss 700 confocal, Plan-Apochromat 20x/0.8 M27 objective. 
pH-GFP was excited by 405 and 488nm diode lasers and the emission was collected separately 
between 500-555nm. The images were evaluated in Fiji (ImageJ) by measuring intensities of both 
channels in 6 circulars ROIs per root meristematic zone. Vacuolar pH measurements were performed 
as described before56 for a 2hr incubation with the indicated small molecules. 
Transmission electron microscopy 
Arabidopsis root tips from 5-day-old seedlings were submerged in 200 mM sucrose, 10 mM trehalose, 
and 10 mM Tris buffer, pH 6.6109, transferred into planchettes (Leica Microsystems; 3.0x0.5mm, Al, 
type A and B), and frozen in a high-pressure freezer HPM100 (Leica Microsystems). Freeze 
substitution was performed in a Leica EM AFS2 unit (Leica Microsystems) in dry acetone 
supplemented with 0.4% uranyl acetate at −85°C for 16 h, followed by 5 h warm-up to −50°C. After 
washing with 100% ethanol for 60 min, samples were infiltrated and embedded in Lowicryl HM20 
resin at −50°C (intermediate steps of 30%, 50%, 70% HM20 in ethanol, 1 h each). The resin was 
polymerized with ultraviolet (UV) light for 3 days in the freeze substitution unit. Ultrathin sections 
were cut on a Leica UC7 (Leica Microsystems) and post-stained with aqueous uranyl acetate/lead 
citrate. Sections were examined in a JEM 1230 (Jeol) or in a Phillips CM100 transmission electron 
microscopes, both operating at 80 kV. Micrographs were recorded with a MSC 600CW (Gatan) 
digital camera or by scanning negatives (MACO EM films TYP S, 6.5x9 cm, ES 206) with an Epson 
Perfection V750 Pro system. 
Drosophila genetics  
Fly stocks were maintained on standard maize meal and molasses medium and were obtained from 
the Bloomington Drosophila Stock Center or from42.  
FM1-43 dye uptake assay and visualization of HA-CHC in Drosophila 
FM1-43 labeling was performed as described110. Third instar larvae were dissected in HL-3 and prior 
to a stimulation protocol animals were incubated for 30 minutes in HL-3 supplemented with and 
without 10µM ES9 or for 10 minutes in HL-3 supplemented with 10µM CCCP  or mock (1% DMSO). 
Next, neurons were stimulated for 5 min in HL-3 with 90 mM KCl and 1.5 mM CaCl2 in the presence 
of FM 1-43 (4 µM) (Life Technologies) with or without small molecule. After labeling, the 
preparation was washed several times with HL-3 supplemented with or without small molecule. 
Images were captured using a confocal microscope (A1R, Nikon) with a 60x NA 1.0 water dipping 
lens. The boutonic FM1-43 intensity was quantified using ImageJ and was corrected for background 
labeling in the muscle. 
Immunohistochemistry was performed to visualize HA-CHC as described42. Larvae were treated in 
a similar fashion as for the FM1-43 dye uptake assay without the presence of FM1-43. Next, the 
treated animals were fixed and stained with a mouse anti-HA antibody (Covance) at 1:500. Alexa 
555-conjugated secondary antibodies (Life Technologies) were used at 1:1000. Super resolution 
structural illumination microscopy images were acquired on a microscope (Elyra S.1; Carl Zeiss) 
using a 63×, NA 1.4 oil lens and three rotations at room temperature. Next, acquired images were 
processed and stored using the ZEN 2011 software (Carl Zeiss). 
TMRE labeling 
Tetramethylrhodamine ethyl ester (TMRE) was used to label the mitochondrial membrane potential 
as described111. D42mitoGFP/+ third instar larvae were dissected in HL-3 and incubated  for 30 
minutes in HL-3 supplemented with and without 10µM ES9. Subsequently, larvae were treated for 
15 minutes with HL-3 medium supplemented with 50 mM TMRE (Abcam) and the appropriate small 
molecule at room temperature. For CCCP treatment, larvae wer incubated for 15 minutes in HL-3 
supplemented with 50 mM TMRE and 10 µM CCCP  or mock (1% DMSO). Next, fillets were washed 
with HL-3 with the appropriate small molecule and images were captured using a confocal 
microscope (A1R, Nikon) with a 60x NA 1.0 water dipping lens. The TMRE labeling intensity was 
quantified using ImageJ. First, 32-bit image of the mitoGFP channel was thresholded to select the 
mitochondria of the neuromuscular junction. Subsequently, the TMRE labeling intensity was 
measured in that region. 
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Supplemental information 
 
 
Supplemental Figure 1. ES9 inhibits CME in Arabidopsis and Drosophila 
(a) Uptake of AFCS (magenta, 20 µM, 30 min pulse, 20 min chase) for mock (Ø, DMSO) or 10 µM 
ES9 (30 min) in VAMP727-GFP (green) positive Arabidopsis root cells. (b) FM1-43 labeling of 
neuromuscular junction boutons in third instar larvae of Drosophila, in the control situation (CS) and 
in presence of 10 µM ES9 for 30 min. Note the large FM1-43 labeled structures (arrowhead). (c) 
Signal quantification of (b). (d) Schematic representation of the neuromuscular junction in 
Drosophila, and the synaptic boutons. Image: http://biochemistry2.ucsf.edu/labs/davis/projects/. 
Scale bar, 5 µm in (a), 2 µm in (b).  
 
 
 Supplemental Figure 2. ES9 and TyrA23 affect mitochondrial functions, similar to CCCP 
(a) Fluorescindiacetate (FDA)-based fluorescent measurement PSB-D wild type cell cultures for 1 
µM carbonyl cyanide m-chlorophenyl hydrazine (CCCP), 50 µM TyrphostinA23 (TyrA23), 50 µM 
TyrphostinA51 (TyrA51), 10 µM ES9, 10 µM Oligomycin and 50 µM Antimycin A (AA). 
Representation of Murashige and Skoog with Minimal Organics (MSMO) medium serves to show 
the need for active and viable cells to induce fluorescence. (b-c) Measurement of mitochondrial 
electron transport chain (mETC) characteristics, where respiratory control ratios (RCRs) are not 
affected when treated with mock (DMSO) and 5 µM TyrA51. In presence of 1 µM ES9, 1 µM CCCP 
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or 5 µM TyrA23, clear uncoupling between oxidations and phosphorylations occurs as shown by a 
RCR drop, even after addition of ADP. (d) Measurement of ATP in Drosophila S2 cell cultures for 
10 µM CCCP, 10 µM ES9, 50 µM AA, 50 µM TyrA23 and 50 µM TyrA51. Relative to mock. (e) 
Relative intensity of mitochondrial tetramethylrhodamine ethyl ester (TMRE) labeling in 
D42mitoGFP positive Drosophila neuronal cells for ES9 and CCCP treatments. 
 
 
Supplemental Fig. 3. Inhibition of FM4-64 uptake is dependent on extracellular pH in presence 
of protonophores in Arabidopsis 
(a) Quantification of plasma membrane derived FM4-64 signal over cytosolic signal, relative to 
control conditions. 30 min treatment for 20 µM Antimycin A (AA) and 1µM CCCP. Oligomycin 
(Oligo) treatment (50 µM, 30min) prior to 30 min FM4-64 labeling in continuing presence of 
Oligomycin. (b) FM1-43 labeling of neuromuscular junction boutons in third instar larvae of 
Drosophila, in the control situation (Ø, 30 min) and in presence of 10 µM CCCP for 30 min. Note the 
absence of large FM1-43 labeled structures (compare with Supplemental Fig. 1). (c) Signal 
quantification of (b). (d) Lyso Tracker Red DND 99 labeling (30 min) of Arabidopsis seedlings is 
not altered after the addition of DMSO (Ø) and incubation in presence of Lyso Tracker Red DND 99 
for another 30 min. (e) Vacuolar pH measurement for mock treatment and 50 µM TyrA51, 50 µM 
AA 1 µM Concanamycin A (ConcA) and the vha-a2 vha-a3 double mutant. n = 32, 32, 24, 24 sample 
points. **P < 0.01 and ***P<0.001 for a Kruskal-Wallis One Way ANOVAon Ranks and pairwise 
comparison according to Dunn’s method. (f) Comparison of FM4-64 uptake at pH 5,5 or 7, after 30 
min or 150 min mock treatment (Ø, DMSO). Box plot center lines show the medians; box limits 
indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the 
interquartile range from the 25th and 75th percentiles, outliers are represented by dots. Box width 
relative to sample size. **P<0.01 with a two-tailed Student’s t-test for at least 3 biological repeats in 
(a) and (c). Scale bar: 5µm 
 
 Supplemental Figure 4. Several aspects of endomembrane traffic are affected in presence of 
protonophores 
(a) Box plot representation of foci life time at the plasma membrane in presence of 10 µM ES9 for 
Green fluorescent Protein (GFP) tagged TPLATE Muniscin Like (TML), TPLATE (TPL), Clathrin 
light chain (CLC), clathrin heavy chain (CHC), and the adaptor complex 2 (AP2), represented by its 
alpha subunit (AP2A1), mu subunit (AP2M) and sigma subunit (AP2S). Center lines show the 
medians; box limits indicate the 25th and 75th percentiles as determined by R software; whiskers 
extend 1.5 times the interquartile range from the 25th and 75th percentiles, outliers are represented 
by dots. n = 171, 204, 125, 142, 243, 60, 150 and176 sample points (b) Brefeldin A (BFA, 50 µM, 
30 min) is prevented in presence of 1 µM CCCP, 10 µM ES9 and 50 µM TyrphostinA23 (TyrA23). 
The Vha-a1-GFP is used to mark the Trans-Golgi network in the BFA body, while FM4-64 (2 µM) 
indicated the inhibition of CME. (c) CLC1/2/3 treated with mock (Ø,?), ES9 and CCCP. Note that 
CLC2 dislodges from the trans Golgi network and becomes almost entirely cytosolic, which is not 
the case for CLC1 and CLC3. (d) Sensors for phosphatidylinositol 4-phosphate (PI4P, P21Y) and 
phosphatidylinositol 4,5-biphosphate (PI(4,5)P2, P24Y) in presence of mock treatment and 10 µM 
ES9. (e) Biochemical quantification of overall phospholipid concentrations for mock treatment and 
10 µM ES9 for 30 min. Scale bar, 5µm. 
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Supplemental Figure 5. The plasma membrane appears not affected by ES9 and CCCP 
The plasma membrane (PM) and mitochondria (MI) of DMSO-treated samples (a-b), ES9-treated (10 
µM, 30 min) samples (c-d), or CCCP-treated (1 µM, 30 min) samples (e-f) are morphologically 
normal. CW, cell wall. Scale bars, 200 nm. 
 
 
 
Supplemental Figure 6. ES9 affects vacuolar and TGN morphology 
(a) Treatment with 10 µM ES9 induced doughnut-like Vha-a1-GFP (green) labeled compartments 
(arrowheads). (b) Treatment with 10 µM ES9 seemed to induce the formation of spherical membrane 
structures in the vacuole (arrowheads), probably of tonoplastic origin, as they are labeled by SYP22-
YFP (green). FM4-64: magenta. Scale bar: 5 µm. 
 
 
Supplemental Figure 7. Chemical features of protonophores 
(a). Four known potent chemical classes of protonophore uncouplers of oxidative phosphorylation 
giving lipohilic anions either through electronic conjugation (charge delocalised resonance 
stabilisation) or through intramolecular hydrogen bond stabilisation. (b). structures of chemicals 
found to be protonophore uncouplers in this study (ES9 and TyrA23) and the structural features of 
their anions. (c). structure of Tyrphostin A51 which evidently gives a higly stabilised but much less 
lipophilic anion than the related TyrA23 compound. 
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Abstract 
 
Clathrin-mediated endocytosis (CME) is an essential and highly dynamic process which ensures 
proper responses to environmental cues and correct function of the plasma membrane within the 
eukaryotic cell. Classical genetic strategies have been important tools for our understanding of CME, 
yet certain aspects such as its dynamic and essential nature are difficult to approach. Small molecules 
targeting CME can provide a solution, as they impose only temporal changes which can be easily 
adjusted. Despite their promise, few specific small molecule effectors of CME in plants are known. 
Mammalian systems can dispose of a larger collection, yet successful translations and 
implementations to the plant field are scarce. Here, we report on the identification and 
characterization of a small molecule inhibitor of CME in Arabidopsis, ES9-17. Affinity-based target 
identification revealed clathrin heavy chain as a potential target of ES9-17. Cellular thermal shift and 
drug affinity responsive target stability assays further validated the ES9-17 mode of action. Hence, 
this study provides a bioactive molecule that can be used to specifically probe CME in Arabidopsis. 
  
Introduction 
Chemical inhibitors of endocytosis are an attractive alternative to the current methods for disrupting 
protein function, but despite extensive structural and biochemical knowledge about clathrin-mediated 
endocytosis (CME) in eukaryotic cells1-4, development of chemical tools to interfere with this process 
is still at an relative early stage. Although small molecule inhibitors of CME such as Dynasore and 
Pitstop25,6 have been described and exploited in mammalian systems, current debates on their off-
target effects and lack of specificity7,8 are spurring on further development of Dynasore or Pitstop2 
derivatives with higher specificity9-11. Dynasore is described as an inhibitor of dynamin, a molecular 
component involved in formation and scission of the clathrin-coated vesicle6. Since Dynasore appears 
to have side-effects such as serum protein binding and association with detergents, a new series of 
Dynasore-based small molecules, named Dyngo10 were tested. Compared to Dynasore the Dyngo 
series are more potent and specific, with some analogs able to distinguish different oligomerization 
states of dynamin10. An additional group of dynamin inhibitors have been described, called the 
Dynoles11, including different indoles of which one possess higher potency towards dynamin 
inhibition compared to Dynasore. Similarly, the Pitstop small molecules were reported as specific 
inhibitors of clathrin heavy chain (CHC)5. Both Pitstop1 and Pitstop2 are developed to specifically 
target the CHC N-terminal domain, yet only Pitstop2 is used in subsequent studies, as Pitstop1 has 
reduced efficacy compared to Pitstop25. Also in case of Pitstop2, side-effects are reported7,8, 
including inhibition of non-clathrin mediated endocytosis. However, a follow-up study on the original 
report of Pitstops challenges the reports on off-target action by Pitstop2, and reports a further 
improved version of Pitstop2, Pitstop2-100, together with inactive analogs (Pitnots)9. Clearly, the 
development of specific inhibitors is a very active field of research in mammalian systems, however 
none of the small molecules mentioned above have found broad application in plant biology yet. One 
study on the tomato receptor-like protein LeEix2 used Dynasore to successfully reduce uptake of 
LeEix2-GFP expressed transiently in tobacco12, yet remains till date the sole plant study using 
Dynasore. 
Typically, plant biology takes advantage of TyrphostinA23 (TyrA23), a small molecule inhibitor of 
CME. Originally derived from tyrosine kinase inhibitors targeted against the kinase domain of 
epidermal growth factor (EGF)13, TyrA23 was found to inhibit endocytosis of the transferrin receptor 
through interference with cargo recognition by tyrosine containing recognition sequences of the 
adaptor complex-2 (AP-2) medium subunit14,15, a finding which was successfully translated to 
plants16. Despite its broad use in the plant field, few studies in mammalian systems use TyrA23 as a 
specific inhibitor of CME. However, TyrA23 has recently been described as a protonophore in 
Arabidopsis, shuttling protons chemically across membranes and along proton gradients, thereby 
enabling a complete inhibition of endocytosis (Chapter 3, this thesis). Since the use of TyrA23 as a 
specific inhibitor of CME in plants is questionable, and as Dynasore and Pitstop25,6 have not found 
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wide application, the plant field would benefit from a novel and specific small molecule inhibitors of 
CME. As such, the development of novel inhibitors to use in conjunction with existing inhibitors will 
assist in the molecular and functional dissection of the endocytic pathway, resulting in an increased 
understanding of many physiological processes that rely on this pathway.  
Here, we describe the identification and characterization of a specific inhibitor of CME in 
Arabidopsis, ES9-17. Validation of potential targets, found through affinity purification, with 
Cellular Thermal Shift Assay (CETSA)17 and Drug Affinity Responsive Target Stability (DARTS)18 
identified clathrin heavy chain (CHC) as a potential target of ES9-17. In addition, genetic evidence 
supported this hypothesis. We therefore present a more specific small molecule inhibitor of CME in 
Arabidopsis. 
 
Results 
 
Identification of ES9-17.  
We previously described the small molecule ES9 as a nonspecific inhibitor of CME in Arabidopsis 
due to its protonophore activity (Chapter 3, this thesis). Interestingly, ES9 was able to block the 
synaptic vesicle recycling in Drosophila, generating phenotypes reminiscent to a loss-of-function in 
either CHC, clathrin light chain (CLC) or dynamin19-21 and this effect was independent of its chemical 
uncoupling ability (Chapter 3, this thesis). Thus, we hypothesized that ES9 might have protein targets 
related to CME in plants and in flies, but its strong protonophore activity masked them. In order to 
identify ES9 analogs that blocked CME but lost their protonophore activity we conducted a structure 
activity relation (SAR) analysis using the inhibition of the FM4-64 uptake assay (Chapter 3, this 
thesis) as a readout for compound activity. 
Several commercial available and newly synthesized analogs were used for SAR analysis. First, 
removal of the bromine on the thiophene moiety (ES9-2, Figure 1a) enabled complete inhibition of 
FM4-64, yet at a higher concentration compared to ES9 (Figure 1b). The retained activity of ES9-2 
in respect to FM4-64 uptake inhibition indicated that the bromine was not essential for ES9 activity. 
A similar analog, ES9-8, which has the bromothiophene moiety substituted for a bromobenzene 
moiety (Figure 1a), also retained the ability to completely inhibit FM4-64 uptake, though, similarly 
to ES9-2, at higher concentrations compared to ES9 (Figure 1b). Next, analogs representing parts of 
the original ES9 structure were also tested for activity. Both the 5-bromo-N-methyl thiophene-2-
sulfonamide moiety (ES9-3, Figure 1a) and the 4-nitroaniline moiety (ES9-7, Figure 1a) proved to 
be inactive in terms of FM4-64 uptake inhibition (Figure 1b). We also evaluated the sulfonamide 
and nitro moiety for activity. Methylation of the sulfonamide resulted in ES9-6 (Figure 1a), and 
rendered the analog completely inactive in terms of FM4-64 uptake inhibition (Figure 1b). 
Substitution of the nitrobenzene group with a phenol (ES9-15, Figure 1a) or pyridine group (ES9-
16, Figure 1a) resulted in much less potent analogs, as FM4-64 uptake was reduced, but not inhibited 
(Figure 1b). However, ES9-17, which had the nitrobenzene substituted with a benzene moiety 
(Figure 1a) retained the ability to inhibit FM4-64 uptake, even at 10 µM (Figure 1b) thus, providing 
a minimal active structure for ES9. 
 
Figure 1. Structure activity relation analysis of ES9.  
(a) Chemical structures of selected ES9 analogues. (b) FM4-64 uptake inhibition assay in Arabidopsis 
seedlings as a readout for activity of ES9 and its analogues (30 min treatment with small molecules 
and FM4-64). Scale bar, 5μm 
 
Key analogs ES9-6, ES9-8 and ES9-17, which retained the ability to inhibit FM4-64 uptake, were 
compared to ES9 in terms of ATP depletion in order to assess to what extent the difference in chemical 
structure would affect the ability to uncouple proton gradients in the mitochondria. As expected, 
application of 50 µM ES9-6 did not affect ATP levels whereas, 50 µM ES9-8 depleted it to a similar 
extent as ES9 (Figure 2a). Interestingly, 10 µM ES9-17 treatment did not affect the ATP levels. All 
small molecules increased fluorescein diacetate (FDA) fluorescence over time, indicating 
metabolically active cells (Supplemental Figure 1a). To confirm the inability to uncouple proton 
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gradients in the mitochondria in vivo, mitochondrial function in presence of 10 µM ES9-17 was tested 
by applying MitoTracker Red CM-H2XRos22 to wild type Arabidopsis root cells. As expected based 
on the ATP depletion results, ES9-17 was unable to abolish mitochondrial staining (Figure 2b), in 
contrast to ES9, which prevents mitochondrial labeling by MitoTracker Red CM-H2XRos (Chapter 
3, this thesis). Altogether our SAR analysis identified the small molecule ES9-17 as a potent inhibitor 
of FM4-64 uptake in Arabidopsis root cells without affecting ATP levels. 
 
Figure 2. Protonophore characteristics of selected ES9 analogues.  
(a) ATP depletion analysis in PSB-D wild type cell cultures. (b) MitoTracker Red CM-H2xRos 
labeling of respiring mitochondria in Arabidopsis Col-0 roots in presence of mock (Ø, DMSO) or 
ES9-17 (10 μM). Seedlings were first treated for 30 min with small molecule or mock, followed by 
30 min 250 nM MitoTracker Red CM-H2xRos staining in presence appropriate treatments. (c) 
Tetramethylrhodamine ethyl ester (TMRE) labeling of mitochondria in D42mitoGFP positive 
Drosophila neuronal cells for 10 µM ES9-17 and mock treatment. Cells are incubated in the dark for 
30 min with ES9-17 or mock, followed by 15 min of TMRE labeling. (d) FM1-43 labeling (30 min) 
of neuromuscular junction boutons in third instar larvae of Drosophila, in the control situation (Ø, 
DMSO) and in presence of 10 µM ES9-17. Scale bars, 5 μM (b) and 20 μM (c,d). 
 
ES9-17 inhibited CME in Arabidopsis 
Independent of its chemical uncoupling ability, parent molecule ES9 was able to block the synaptic 
vesicle recycling in Drosophila through possibly affecting either CHC, CLC or dynamin functions 
(Chapter 3, this thesis). Therefore, we tested if ES9-17 would have the same effect when applied to 
Drosophila neuronal cells. First, active mitochondria were visualized in vivo with 
tetramethylrhodamine ethyl ester (TMRE)23 to confirm the preservation of mitochondrial function in 
presence of ES9-17, as seen in Arabidopsis. Indeed, labeling of mitochondria was hardly affected in 
presence of 10 µM ES9-17, and resembled the control situation (Figure 2c). Second, when applied 
on boutons of the neuromuscular junction in third instar larvae, 10 µM ES9-17 failed to induce the 
formation of large FM1-43 labeled membrane structures (Figure 2d) as seen in presence of ES9 
(Chapter 3, this thesis). To strengthen the FM1-43-based observation, HA-CHC positive larvae were 
treated with 10 µM ES9-17 and stimulated with KCl19. As expected, no difference could be seen 
when compared to the control treatment (Supplemental Figure 1b). However, at much higher 
concentrations (100 µM) ES9-17 partially inhibited FM1-43 uptake, and induced occasional FM1-43 
labeled inclusions (Supplemental Figure 1c-d). However, at 100 µM ES9-17 affected mitochondrial 
TMRE labeling substantially (Supplemental Figure 1e-f). Together these results indicate that the 
activity in ES9-17 in Drosophila required much higher concentrations of compound than in the plant 
cells. 
We next explored how ES9-17 affected endomembrane trafficking in Arabidopsis root epidermal 
cell. Application of ES9-17 (10μM, 30 min) did not visibly affect the cytoskeleton (Supplemental 
Figure 2a-b) or caused aberrant localization of any of the endomembrane markers tested. The 
vacuolar compartment appeared the same as compared to the mock treatment (Supplemental Figure 
2c). Electron microscopy strengthens these observations, as no differences were observed for 
different endomembrane compartments when compared to mock treatment (Supplemental Figure 
2d). The vacuole lacked the large inclusions as previously seen for ES9 (Chapter 3, this thesis), while 
multi vesicular bodies, the trans-Golgi network/early endosome (TGN/EE) and Golgi compartments 
appeared normal, without swelling.  
In contrast to the parent molecule ES9 (Chapter 3, this thesis), ES9-17 did not inhibit or affect the 
formation of Brefeldin A (BFA) bodies. The TGN/EE marker, VhA-a1-GFP24 accumulated into the 
BFA bodies in presence of 10 µM ES9-17 and 50 µM BFA (Figure 3a), while FM4-64 uptake was 
inhibited, and as a consequence unable to label the BFA body. To further strengthen this observation 
with plasma membrane-localized cargo, we treated PIN2-GFP-expressing seedlings for 60 min with 
mock or 10 µM ES9-17, both in presence of 50 µM cycloheximide (CHX) to inhibit protein synthesis. 
The subsequent 30 min pulse of FM4-64 and 50 µM BFA indicated that aside FM4-64, PIN2-GFP 
failed to label BFA bodies, though smaller PIN2 labeled agglomerations were visible (Figure 3b). 
Therefore, we concluded that ES9-17 inhibited endocytosis of PIN2, and its subsequent delivery to 
the BFA body. The remaining agglomerations were presumably labeled by PIN2 which was present 
in the cell prior to the endocytic block.  
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Figure 3. ES9-17 is an inhibitor of CME in Arabidopsis. 
(a) Brefeldin A (BFA) compartments were formed in presence of ES9-17. Seedlings were pre-treated 
with ES9-17 (10 µM) for 15 min followed by a FM4-64 (2 µM) and 50µM BFA treatment for 30 
min. (b) ES9-17 inhibited the recruitment of the plasma membrane-localized PIN2 to the BFA body. 
Samples were pretreated with 50 µM cyclohexemide (CHX) and either mock (Ø, DMSO) or ES9-17 
(10 µM), followed by FM4-64 (2µM) and BFA (50 µM) for an additional 30 min. Scale bars, 5 μm. 
 
As the main activity of ES9-17 appeared to be associated with the plasma membrane we sought to 
characterize the dynamic behavior of known components of CME in Arabidopsis. The two adaptor 
complexes involved in plant CME, TPLATE and AP-23 were represented by TML-GFP25 and AP2S-
GFP26 respectively. In addition, CHC1-GFP and CLC1-GFP were used and represented clathrin 
(Figure 4a). We measured the life-time of foci labeled by the different markers as an indication of 
correct CME unfolding. In control conditions, all marker lines showed average life-times around 25 
seconds, as previously reported for members of the TPLATE complex25. We distinguished different 
populations in presence of 10 µM ES9-17, some with life-times similar to mock (DMSO), others with 
life-times well over 3 minutes, which resulted in median values between 2-3 times the life-times 
measured in control conditions (Figure 4b). In conclusion, the ES9-17 activity was correlated with 
CME inhibition, while the dynamics and the morphology of the endomembrane compartments 
appeared unaffected by the compound. 
 
Figure 4. ES9-17 increased the life-time of the endocytic foci in the plasma membrane.  
(a) Kymographs representing a set of pixels (horizontal axis) over a period of time (vertical axis, 5 
min), illustrating life times of endocytic spots labeled by Green fluorescent Protein (GFP) tagged 
TPLATE Muniscin Like (TML), the Adaptor complex-2 (AP-2), represented by its sigma subunit 
(AP2S), clathrin heavy chain1 (CHC1) and clathrin light chain1 (CLC1) for the control treatment (Ø, 
DMSO) and ES9-17 (10 µM) (b) Boxplot representation of measured endocytic spot life times. 
Center lines show the medians; box limits indicate the 25th and 75th percentiles as determined by R 
software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, outliers 
are represented by dots. n = 1646, 1086, 711, 130, 383, 650, 249, 134 sample points. 
 
Brassinosteroid signaling is enhanced in the presence of ES9-17 
Inhibition of CME will have a plethora of effects on molecular processes implicated at the plasma 
membrane, among which receptor-mediated signaling4. In previous studies we have shown that the 
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genetic inhibition of CME enhanced the BRASSINOSTEROID INSENSITIVE1 (BRI1) receptor-
mediated signaling from the plasma membrane27,28. As a readout for BR signaling activation we used 
the phosphorylation state of the transcriptional regulator BRI1 EMS-SUPPRESSOR1 (BES1)29. In 
the presence of BRs BES130 was dephosphorylated, an indication of active signaling. To evaluate if 
the pharmacological inhibition of CME by ES9-17 affected BR signaling in a similar way we assessed 
the phosphorylation status of BES1 in PSB-D wild type cell cultures in the presence of the small 
molecule (Figure 5a). Previously TyrA23 was also used to inhibit CME and to dephosphorylate 
BES127. However, because our previous findings revealed a protonophore activity for TyrA23 
(Chapter 3, this thesis) we also assessed the phosphorylation status of BES1 in the presence of the 
known protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP)31,32 and the mitochondrial 
inhibitor Antimycin A (AA)33. As expected we observed an almost complete dephosphorylation for 
the positive control, brassinolide (BL, 0,1µM, 60 min). Treatments with 10 µM ES9, 10 µM CCCP 
and 50 µM TyrA23 also caused an almost complete dephosphorylation of BES1 (Figure 5a). The 
relative population of dephosphorylated BES1 in mock treatment was about half that of 
phosphorylated BES1, similar as seen for 50 µM ES9-6 and 50 µM TyrA51, the inactive analog of 
TyrA23. Both ES9-17 (10 µM) and Antimycin A (AA, 50 µM) induced intermediate levels of BES1 
dephosphorylation, approximate 1:1 ratio between the phosphorylated and dephosphorylated forms 
of BES1. Increasing concentrations of ES9-17 indicated a more pronounced BES1 dephosphorylation 
(Figure 5b). Our results indicated that although the complete shift towards the dephosphorylated 
form of BES1 might be a consequence of the protonophore characteristics of ES9 and TyrA23, 
pharmacological inhibition of CME with ES9-17 also enhanced BR signaling, confirming earlier 
findings27. 
Another straightforward way of assessing active BR signaling is by evaluating BRI1 KINASE 
INHIBITOR 1 (BKI1) localization at the plasma membrane, as BKI1 dissociates from the plasma 
membrane into the cytosol upon BR signaling34,35. We therefore treated BKI1-mCitrine35 seedlings 
with 10µM ES9-17 and compared to mock (DMSO). Treatment of 30 min ES9-17 dissociated BKI1-
mCitrine significantly from the plasma membrane (Figure 5c,d) compared to mock, strengthening 
our BES1 observations that inhibition of CME via ES9-17 enhances BR signaling. 
 Figure 5. Brassinosteroid signaling was enhanced in the presence of ES9-17. 
(a) BES1 phosphorylation was measured in PSB-D cell cultures expressing BES1-TAP, incubated 
for 1 hour with 0,1 µM brassinolide (BL), 10 µM ES9, 50 µM ES9-6, 10 µM ES9-17, 10 µM CCCP, 
50 µM tyrphostinA23 (TyrA23), 50 µM tyrphostinA51 (TyrA51) and 50 µM antimycin A (AA). 
Quantification of band intensity is shown below. (b) BES1 phosphorylation as explained in (a), but 
with different concentrations of ES9-17. Quantification of band intensity shown below. (c) BKI1-
mCitrine dissociates from the plasma membrane in presence of 10 μM ES9-17 for 30 minutes 
compared to the mock (Ø , DMSO) situation. (d) Quantitation of plasma membrane localized BKI1-
mCitrine as the plasma membrane/cytosol signal intensity ratio. * = p value < 0.01 for a two sided T-
Test assuming unequal variances. Scale bar = 5 μm 
 
CHC is a likely target of ES9-17 
The SAR analysis of ES9 revealed that the bromine substitution was not essential for its activity, as 
the ES9-2 analog, which lacked this bromine, was still able to inhibit the uptake of FM4-64. Hence 
this position could serve as a site for derivatisation of both ES9 and ES9-17 with a linker biotin moiety 
to facilitate affinity purification of potential target proteins. Substitution of the bromothiophene 
moiety with a bromobenzene moiety resulted in ES9-8 (Figure 1a), which was a better analog to 
initiate derivatisation compared to ES9-2 due to improved reactivity. We first synthesized the active 
analog ES9-9, followed by biotin addition, resulting in ES9-10 (Figure 6a). Whereas the ES9-9 
analog was active in terms of FM4-64 uptake inhibition, ES9-10 was inactive (Figure 6b), 
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presumably because the addition of biotin prevented the uptake of the probe in living cells. A similar 
strategy was used to generate the ES9-17-linker-biotin construct (ES9-18), including the substitution 
of the bromothiofene for the bromobenzene moiety. Although ES9-18 was not tested for bioactivity, 
it was presumed to be impenetrable to cell membranes as it contained a biotin moiety. A linker-biotin 
probe ES9-13, without small molecule attached, was included as a negative control in the pull-down 
experiments (Figure 6a). Lysate used for affinity purification was prepared from PSB-D wild type 
cell cultures, and proteins bound to ES9-10, ES9-18 and ES9-13 were analyzed using mass 
spectrometry. In total three biological repeats were run, each of which was represented by three 
technical repeats, for the ES9-10 affinity purification and its respective ES9-13 control. Peptides of 
several hundreds of proteins were identified (Supplemental Table 1). Different proteins involved in 
endomembrane traffic were found, some of which were among the best candidate target proteins 
(Table 1). Several subunits of the coatomer complex were prevalent, while both CHC alleles were 
present. However, as the coatomer complexes are mostly implicated in ER-Golgi traffic36, the best 
candidate target with clear implications in CME was CHC. The ES9-18 affinity purification and ES9-
13 control resulted in less purified proteins (Supplemental Table 2). Three biological repeats yielded 
a similar set of proteins implicated in endomembrane traffic, yet the efficiency of purification 
appeared to be less compared to the ES9-10 purification, as overall quantity seemed reduced, and 
some proteins were not identified with the ES9-18 analog (Table 1). 
 
Figure 6. ES9 and ES9-17 linker-biotin derivatisation. 
(a) Chemical structures for ES9 modified with linker, fictionalized ES9 with linker-biotin, 
fictionalized ES9-17 with linker-biotin and a linker-biotin control probe. (b) FM4-64 uptake for 
modified ES9 compared to mock (Ø, DMSO) treated seedlings. Co-application of small molecules 
and FM4-64 (2 μM) for 30 min. 
 
accession description ES9-10 ES9-13 ES9-18 ES9-13 
AT4G34450 coatomer gamma-2 subunit, putative 5 0 1 0 
AT3G11130 Clathrin, heavy chain 4 0 0 1 
AT2G21390 Coatomer, alpha subunit 3 0 2 2 
AT1G30630 Coatomer epsilon subunit 3 3 3 3 
AT1G31730 Adaptin family protein 2 0 0 0 
AT1G52360 Coatomer, beta' subunit 2 1 0 2 
AT1G62020 Coatomer, alpha subunit 2 1 2 2 
AT4G11380 Adaptin family protein 2 2 3 3 
AT3G08530 Clathrin, heavy chain 2 3 2 1 
AT4G31480 Coatomer, beta subunit 2 0 0 0 
AT1G48760 delta-adaptin 1 1 2 2 
AT5G22770 alpha-adaptin 1 0 0 0 
AT1G23900 gamma-adaptin 1 1 1 0 0 
Table 1. Potential target proteins identified through affinity purification with implications in 
endomembrane traffic 
Numbers indicate the times a respective protein was identified out of 9 (ES9-10 and its respective 
ES9-13 control) or 3 (ES9-18 and its respective ES9-13 control) repeats. 
 
ES9-17 binds to CHC 
First, we used Cellular Thermal Shift Assay (CETSA) to validate the binding of ES9 and ES9-17 to 
the putative target CHC. CETSA is based on the thermal stabilization or destabilization of 
endogenous target proteins in presence of the small molecule interactor17, which is quantified after 
samples are processed by classical western blotting. Alternatively, western blot based quantitation 
can be circumvented by monitoring thermal denaturation with mass spectrometry37. as samples As 
control proteins we used γCOPI, identified in the affinity purification analysis, the β subunit of ATP 
synthase (AtpB), and tubulin as negative controls. CHC and γCOPI behaved like potential target 
proteins in presence of both ES9 and ES9-17, as the thermal denaturation in the presence of the small 
molecule was shifted to lower temperatures, with the most pronounced effect for CHC 
(Supplemental Figure 3a). Thermal denaturation curves for tubulin and AtpB appeared very similar 
to the mock treated lysate (Supplemental Figure 3a). Isothermal denaturation curves at 40°C 
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indicated that ES9-17 had the highest affinity to bind CHC with an IC50 of approximately 10 µM, 
whereas ES9 had an IC50 of about 100 µM (Supplemental Figure 3b). In addition, removal of 
detergent from the extraction buffer resulted in slightly changed thermal denaturation curves, which 
is presumably the result of increased overall stability of the protein (Supplemental Figure 3c). These 
results indicate that ES9-17 binds CHC more efficiently compared to ES9. Given the described 
protonophore characteristics of ES9 (Chapter 3, this thesis) we focused further on ES9-17 in absence 
of detergent, as the latter appeared to influence the potential binding of ES9-17 to CHC. Interestingly, 
ES9-17 lost the ability to destabilize γCOPI in absence of detergent, similar to AtpB (Figure 7a), 
while it retained the ability to destabilize CHC (Figure 7a). 
 
 
Figure 7. CHC is destabilized by ES9-17 as measured with CETSA. 
(a) Thermal denaturation for endogenous CHC, AtpB and γCOPI respectively in lysate extracted 
without detergent and detected with respective antibodies. Average values of CHC from four, AtpB 
from five, and γCOPI from three biological repeats. (b) Thermal denaturation of CHC1-GFP and 
CHC2-GFP expressed in PSB-D cell cultures, extracted without detergent and detected with anti GFP 
antibody. Three biological repeats for CHC1-GFP and CHC2-GFP are presented. All compound 
treatments were done with 100 μM ES9-17. Error bars indicate standard error of the mean. 
 
As the above results did not distinguish the two CHC isoforms in Arabidopsis, CHC1 and CHC2 in 
terms of ES9-17 binding, we re-evaluated the thermal stability for each protein using Arabidopsis cell 
cultures expressing C-terminal GFP-fusions of either CHC1 or CHC2. The difference in thermal 
stability in presence of ES9-17 detected with anti-GFP antibody was largely the same for CHC1-GFP 
compared to detection with endogenous antibody, although thermal denaturation started at slightly 
lower temperature (compare Figure 7a and Figure 7b). The shift to lower temperature might be the 
result from the GFP tag, indicating a decreased overall stability of CHC1. Thermal denaturation of 
the GFP-tagged CHC2 in presence of ES9-17 was similar to mock-treated lysate (Figure 7b). The 
latter observation could indicate that ES9-17 preferentially binds to CHC1. Interestingly, CHC1-GFP 
expressed in Arabidopsis seedlings was considerable more affected by ES9-17 compared to CHC1-
GFP expressed in PSB-D cell cultures (Supplemental Figure 3d). Unfortunately, CHC2-GFP 
expression was too low in Arabidopsis seedlings, to quantify in a reliable way. 
To strengthen the results obtained with CETSA, DARTS18 was employed on the same set of proteins. 
DARTS assesses the potential of a small molecule to protect target proteins from protease digestion, 
which is subsequently visualized by standard western blot. As such DARTS relies on the same 
principle as CETSA, yet destabilization is unlikely for DARTS. We expected a stabilization of CHC 
in presence of ES9-17 upon different dilutions of protease mix (Pronase), as small molecule 
interactors protect their protein targets from digestion. We observed an overall stabilization of CHC 
in presence of ES9-17 for different dilutions of Pronase, visible as fewer degradation products 
compared to the corresponding mock treated sample, a pattern which was even apparent in the 
undigested control (Figure 8a). Stabilization of full-length CHC became visible in the sample with a 
1/2500 dilution of Pronase (Figure 8a, arrowhead), which represented a more than 2-fold 
stabilization compared to the corresponding control sample upon quantification of the full-length 
CHC band (Figure 8b). Stabilization and overall degradation of CHC appeared to be unaffected by 
detergent, as similar results were obtained for samples with and without NP-40 (Figure 8a). 
Quantification of full-length protein bands for other proteins, namely γCOPI and tubulin in samples 
without detergent, showed no such stabilization (Figure 8b). As CETSA revealed a differential effect 
of ES9-17 on CHC1 and CHC2, both GFP-tagged proteins were evaluated with DARTS in PSB-D 
cell cultures. A first observation was the overall higher sensitivity to Pronase of CHC1-GFP and 
CHC2-GFP from Pronase, as higher dilutions had to be used to detect both proteins (Figure 8c). A 
second observation was the consistent overall protection of CHC1-GFP from Pronase in presence of 
ES9-17, on average a 2-fold stabilization compared to the mock control, while CHC2-GFP displayed 
very little stabilization except for the 1/10000 Pronase dilution, which, similar to CHC1-GFP had an 
approximate 2-fold stabilization (Figure 8d). Quantification of AtpB in the CHC1-GFP and CHC2-
GFP samples indicated that all ES9-17 treated samples contained similar amounts of AtpB compared 
to mock treatment (Figure 8d), suggesting AtpB was unaffected by ES9-17, which is in agreement 
with the CETSA data. 
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Figure 8. ES9-17 stabilized CHC upon protease digestion. 
(a) Western blot for CHC detected with endogenous anti CHC antibody in presence or absence of 
ES9-17 and in presence or absence of detergent (NP-40) Samples were treated with different dilutions 
of Pronase, with an undigested sample as control. Note the full-length CHC band for the 1/2500 
dilution (arrowhead). (b) Quantification of signal derived from full-length protein for CHC from the 
Western blot in (a), and γCOPI (anti Sec21p antibody) and tubulin on the same blot. (c) 
Representative blot for CHC1-GFP and CHC2-GFP in presence of mock (Ø) and ES9-17 for 
undigested samples and samples treated with different dilutions of Pronase. (d) Quantification of 
western blots as shown in (c). Four biological repeats are presented for each experiment.. Error bars 
indicate standard error of the mean 
 
chc1 and chc2 mutants are more sensitive to ES9-17 
To further validate the interaction of ES9-17 with CHC we assessed root growth and FM4-64 uptake 
for several mutants of CHC1 and CHC238 in presence of ES9-17. Primary root growth for Arabidopsis 
thaliana Col-0 seedlings (5 days old) was inhibited at concentrations higher than 10 μM, with an EC50 
of approximately 6 µM (Supplemental Figure 4a). Seedlings of chc1-1, and chc2-2 mutant lines 
displayed a significant increased sensitivity at the EC50 compared to Col-0 seedlings (Figure. 9a), 
while chc2-1 was more resistant. The increased sensitivity is ES9-17 specific, as all three mutants 
were slightly, but significantly more resistant compared to Col-0 when grown on 0.5 µM cyanide m-
chlorophenyl hydrazone (CCCP) (Figure 9b). To assess if the sensitivity on ES9-17 was translated 
to CME inhibition, we measured FM4-64 uptake in chc1-1, chc2-1 and chc2-2 seedlings at 6 µM 
ES9-17, and compared to wild type seedlings (Supplemental Figure 4b,c). FM4-64 uptake as 
represented by the ratio of the PM/cytosol FM4-64 signal intensity was less in the chc1-1 background 
compared to Col-0 in presence of ES9-17, while in chc2-2 there was a greater reduction in uptake 
(Supplemental Figure 9b,c). Little difference could be detected in the chc2-1 background compared 
to the wild type. In addition, treatment with ES9-17 induced an agravitropic response in all 
backgrounds, though was more pronounced in the chc1-1, chc2-1 and chc2-2 mutants (Figure 9c). 
This observation is consistent with the agravitropic response of chc linked to defective auxin 
redistribution and transport38. Together with the CETSA and DARTS findings we concluded that 
ES9-17 binds both CHCs in Arabidopsis, however binding to CHC1 was more efficient. 
 
 
Figure 9 Arabidopsis chc mutants were more sensitive to ES9-17. 
(a) Boxplot representation of relative root growth over 48 hours on 6 µM ES9-17. (b) Boxplot 
representation of relative root growth over 48 hours on 0.5 µM carbonyl cyanide m-chlorophenyl 
hydrazone (CCCP). (c) Box plot representation of agravitropic response as seen for seedling grown 
on 6 µM ES9-17 and mock. Box plots: Center lines show the medians; box limits indicate the 25th 
and 75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range 
from the 25th and 75th percentiles, outliers are represented by dots. n = 40 sample points. **P<0.01 
***P<0.001 for a Kruskal-Wallis One Way ANOVA on Ranks 
 
ES9-17 possibly binds the N-terminal domain of CHC 
The observation that ES9-17 might preferentially bind CHC1, as indicated by our CETSA and 
DARTS results, provided the opportunity to map the possible binding site of ES9-17 in CHC1 protein. 
Alignment of the Arabidopsis CHC1 and CHC2 amino acid sequences showed little difference in 
amino acid contents, with only a few amino acid substitutions resulting in a change of amino acid 
properties (Supplemental Figure 5). This, in principle, would allow to swap certain domains of the 
CHC1 sequence containing possible binding sites and enough differential amino acid contents with 
the same domains of CHC2. Assessment of ES9-17 binding through CETSA and DARTS of these 
CHC1 chimeras would allow to assess which domain swap is responsible for the loss of CHC1 
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sensitivity towards ES9-17, and therefore the identification of the binding site of ES9-17 through 
docking on that particular CHC1 domain. 
 
 
Figure 10. Arabidopsis CHC putatively folds as human CHC. 
(a) Overlay of I-TASSER39 predictions for CHC1 and CHC1 with the N-terminal domain of human 
CHC in complex with Pitstop2 (PDB accession 4G55)5. Different views on the overlay are shown. 
(b) I-TASSER prediction of CHC1, showing the N-terminal domain, ankle region and large part of 
the leg region in different orientations. Red colored areas indicate predicted binding sites. All renders 
are made with the PyMol application40. Pitstop2 is not visualized. 
 
Plant CHC has not been crystallized yet, therefore we relied on the I-TASSER39 predictions for CHC1 
and CHC2. The prediction which resembled best the known overall structure of human CHC was 
selected for both CHC1 and CHC2. Subsequently we overlaid the predictions with the crystal 
structure of the N-terminal domain of CHC in complex with Pitstop2 (PDB ID: 4G55)5. This resulted 
in a considerable overlap between all 3 structures, indicating conservation between the human and 
Arabidopsis CHC structure (Figure 10a). Submission of CHC sequences to protein BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi#alnHdr_4758012) and alignment (Supplemental Figure 5) 
indicated a high sequence similarity between CHC1 and CHC2 in Arabidopsis (98%), while 
comparison with human CHC indicated only about 55% sequence similarity (Supplemental Figure 
6). Therefore any predictions based on dockings are only indications, which will have to be validated 
experimentally. Prediction of possible ligand binding sites by I-TASSER, based on known 
interactions with CHC in other systems (Supplemental Figure 5), resulted in 3 possible regions for 
ligand binding on CHC in Arabidopsis, of which 2 were located in the N-terminal domain, and one 
in the leg region of CHC (Figure 10b, Supplemental Figure 5). Based on these predictions we 
initiated blind and local docking of ES9-17 and ES9 on the N-terminal domain of human CHC 
(4G55)5. Specifics about the docking procedures are provided in material and methods. Two sites 
were identified as potential binding pockets of ES9-17 and ES9. The first, which was identified by 
blind docking, was located in the center of the N-terminal β-barrel (Figure 11a). However the 
bromine of ES9-17 and ES9, which was used as a site for derivatisation, appeared to be orientated 
towards the blades of the β-barrel, while both small molecules appeared to be buried in the center of 
the β-barrel (Figure 11a, arrow). Based on the prediction it seems unlikely that this particular 
orientation would allow derivatisation with a linker-biotin moiety for successful affinity purification. 
The second putative binding pocket is that of Pitstop25 (Figure 11b). It concerns a local docking, 
based on the published binding characteristics of Pitstop25. Here the orientation of the bromine is 
outwards, which would perfectly allow derivatisation with a linker-biotin moiety. However, ES9 
adopted a slightly different orientation compared to ES9-17. Currently efforts are ongoing to 
experimentally determine the possible binding site by swapping domains of CHC1 with the same 
domain of CHC2. We took into consideration the N-terminal region, the putative binding site in the 
leg region, and the C-terminal part, which is expected to be a control. If we identify a possible binding 
region of ES9-17 and ES9, more detailed docking might provide insights into the nature of binding 
to CHC. 
 
 
 
165 
 
Figure 11 ES9-17 likely binds the Pitstop2 bindings pocket 
(a) Blind docking of ES9 and ES9-17 on human CHC in complex with Pitstop2 (PDB accession 
45GG)5. Both small molecules dock in the central cavity of the β-barrel, but are quite buried. (b) 
Local docking of ES9-17 (central image) and ES9 (right image) or both (left image) on human CHC 
in complex with Pitstop2 (PDB accession 4G55)5 in the bindings pocket of Pitstop2. Pitstop2 is not 
shown. 
 
 
Discussion 
Here, we presented the identification and characterization of a specific small molecule inhibitor of 
CME in Arabidopsis, named ES9-17, which mediated inhibition through binding of clathrin. ES9-17, 
unlike its parent molecule ES9 (Chapter 3, this thesis), had no effect on ATP depletion and 
mitochondrial function in Arabidopsis at concentrations for which it inhibited FM4-64 uptake. As 
such ES9-17 lacked the potency to affect general metabolism, a complication which is now generally 
recognized as a possible side-effect for lead molecules in drug discovery, and a phenotype which is 
increasingly screened for in small molecule libraries41-44. Further characterization highlighted the 
possible species specificity of ES9-17, as it was much less active in Drosophila compared to ES9 
(Chapter 3, this thesis), although we cannot exclude that ES9-17 might have been less accessible to 
Drosophila cells. This was corroborated as we observed residual activity related to FM1-43 uptake 
for much higher concentrations, yet these conditions affected mitochondrial functions.  
In Arabidopsis the ES9-17 effect appeared to be mainly related to CME as it did not affect the motility 
and morphology of TGN/EE or Golgi. In addition, both the actin and microtubule cytoskeleton 
appeared normal, indicating that CME inhibition is likely not due to acute loss of cytoskeleton 
functionality, as has been reported in yeast, though is of lesser importance for CME in mammalian 
systems45. Moreover, ES9-17 allowed the formation of the BFA body, yet inhibited the accumulation 
of plasma membrane-derived content into the BFA body. This is unlike its parental molecule ES9 or 
TyrA23 and CCCP, where the TGN/EE marker Vha-a1-GFP failed to accumulate into BFA bodies, 
indicating that BFA body formation was prevented because of impaired motility of TGN/EE and 
Golgi compartments (Chapter 3, this thesis). The formation of the BFA body as visualized by the 
Vha-a1-GFP24 marker in presence of ES9-17 therefore indicated that vesicle and compartment 
dynamics were not affected. This opens as such new opportunities to evaluate the influence of 
pharmacological CME interference on other endomembrane compartments, and the implications for 
CME cargo. 
The previously reported general freeze in CME components dynamics in the plasma membrane 
caused by ES9, Tyr23 and CCCP, (Chapter 3, this thesis), was not observed for ES9-17 application. 
Several CME markers showed an overall increase (2-3 fold) in the life-time in the plasma membrane 
as compared with the control. This observation is in agreement with life-times measured for endocytic 
machinery in presence of Pitstop25 where the increase in life-time might reflect non-functional and 
eventually abortive clathrin coated pits, as the life-time of a molecular component at the plasma 
membrane depends on the presence and nature of interactors. The least difference was observed 
between the control and ES9-17 treated CHC1-GFP labeled samples. Here, a possible explanation 
might be the apparent reduced stability of CHC1-GFP in presence of ES9-17, as measured with 
CETSA, which might reflect on the overall stability of the clathrin cage in vivo. It would therefore be 
of interest to purify CHC interactors in presence of ES9-17, and compare with control samples, in 
order to assess if ES9-17 would interfere with any CHC interactor required for proper unfolding of 
CME. 
The purification of ES9 and ES9-17 interactors by affinity purification with different biotinylated 
ES9 derivatives revealed a remarkable difference between ES9 and ES9-17. As ES9-17 lacked the 
nitro-group compared with ES9, it became more hydrophobic in nature, which had possibly 
implications for affinity purification. As ES9-17 became more hydrophobic, interaction with beads 
might be an explanation as to why it failed to purify CHC. This particular problem is not encountered 
by ES9, as the nitro-group, which is more hydrophilic, possibly directs the probe away from the beads, 
thereby facilitating effective purification. The same difference between ES9 and ES9-17 might have 
implications for CHC binding, as a recent report indicates that even close analogs might bind the 
same bindings pocket in completely different orientations46. 
For the validation of the putative targets we employed two relatively new, but promising approaches, 
CETSA17 and DARTS18, previously not used in plant systems. Both have been used in numerous 
studies, reconfirming known small molecule interactions as well as establishing new ones. DARTS 
has been used in studies including target identification of disulfiram47, the identification of the ATP 
synthase β subunit as target of α-ketoglutarate in C. elegans48, and has even been used to identify 
target proteins of grape seed extract49. DARTS is used to identify small molecules which stabilize 
their protein target by protection from protease digestion. CETSA, on the other hand, can work in 
both ways, as it can reveal compound binding by stabilization or destabilization of its target protein37. 
Destabilization might indicate binding of protein interfaces, thereby destabilizing protein complexes, 
which as a consequence disassemble quicker at higher temperatures opposed to control conditions. 
This type of interactions could be missed by DARTS, as the nature of small molecule binding not 
necessarily offers enough protection from proteases. CETSA is a relative new approach, yet has 
already been used in a proteome profiling for interactors of the kinase inhibitor staurosporine, 
identifying over 50 potential targets37. CHC was analyzed as a potential target protein for ES9 and 
ES9-17, along with control proteins such as γCOPI, AtpB and Tubulin. CETSA revealed a 
destabilization of CHC and γCOPI in presence of ES9-17 and ES9. Removal of detergent from the 
extraction buffer, indicated that ES9-17 binds CHC, as is was the only potential target which remained 
responsive to ES9-17 treatment. Interestingly, the ES9 induced destabilization of γCOPI corresponds 
167 
 
with the ER-Golgi hybrid compartment observed upon ES9 treatment in Arabidopsis (Chapter 3, this 
thesis). Similarly, the absence of a hybrid ER-Golgi compartment upon ES9-17 corresponds with the 
inability of ES9-17 to destabilize γCOPI. 
An even higher degree of ES9-17 specificity towards CHC was revealed when CHC1-GFP and 
CHC2-GFP were analyzed with CETSA and DARTS. Mainly CHC1-GFP remained responsive to 
ES9-17, indicating a preferential binding of ES9-17 to CHC1. However, these findings as such are 
insufficient to conclude that CHC2 is not a target of ES9-17. Indeed, analysis of previously reported 
mutant lines of CHC38 indicated that chc1 and chc2 mutant lines were sensitive in terms of root 
growth, whith chc2-2 the most sensitive. In case ES9-17 would only bind CHC1, one could expect 
chc1 mutants to be resistant to ES9-17, while chc2 mutants would be more sensitive as only CHC1 
is functionally available. Though chc1-1 was not resistant, the sensitivity on ES9-17 was less 
pronounced compared to Col-0 and chc2-2. As such it fits with the hypothesis that ES9-17 binds 
preferably CHC1. In addition, the sensitivity appears to be ES9-17 specific, as root growth of chc 
mutants on CCCP was less affected compared to Col-0. A further extension to other, unrelated small 
molecules will strengthen the specificity of ES9-17 towards CHC. Notably the effect on root growth 
compared to Col-0 is not very strong, which might indicate that ES9-17 mediates root growth 
inhibition through additional target proteins, and as such could be expected, since predictions indicate 
small molecules have on average 6 targets50,51. As we could not observe major endomembrane 
disruptions apart from CME, additional protein targets are likely not linked to endomembrane traffic. 
FM4-64 uptake quantification in mutant lines resulted in a similar pattern in terms of sensitivity, 
though the apparent resistance of chc1-1 was more pronounced, confirming our hypothesis of the 
preferential binding of ES9-17 to CHC1. The chc2-1 line was found to behave different as expected 
for all readouts, which might be due to the intronic nature of the insertion38. An additional effect of 
endocytic inhibition by ES9-17 was revealed by the agravitropic response of seedlings grown on ES9-
17 without stimulating gravitropic responses. Since presumably proteins implicated in sensing 
gravity, such as PINs52, are not taken up and redistributed properly, the plant loses the ability to 
correctly sense and response to the gravity vector52. Again the lack of difference between mutant lines 
in terms of gravitropic response indicate that both CHC1 and CHC2 are affected by ES9-17 binding. 
It is the efficiency if binding, and thus the efficiency of endocytic inhibition, which appeared to be 
different, as shown by FM4-64 uptake and the biochemical validation. 
The mechanism by which ES9-17 inhibits CHC function is still very much speculative, however, 
based on I-TASSER39 predictions and preliminary docking exercises few possible scenarios can be 
distinguished. A first possibility is the binding of ES9-17 to the N-terminal domain of CHC, which 
is involved in recruitment and binding of several accessory proteins required for proper unfolding of 
CME1,5. As such ES9-17 could possibly interfere with proper recruitment, and as a consequence stall 
further formation and maturation of the clathrin coated pit. Eventually uncoating mechanisms, which 
are mostly situated at the C-terminus1, would disassemble the premature coat. This could be reflected 
in overall increased life-times of CHC at the PM, a phenotype which is indeed observed upon ES9-
17 application. However, none of the differential amino acids between CHC1 and CHC2 correspond 
to amino acids predicted to be involved in binding pockets (Supplemental Figure 5). A second 
possibility is the binding of ES9-17 in the region which possibly binds CLC. The implications for 
CLC binding could be two-fold. On the one hand ES9-17 might prevent CLC binding, yet this is not 
in favor of the cell biological evidence, as CLCs still localize to the PM. On the other hand CLC 
might still bind, yet is obstructed by ES9-17 in exerting its function, which might result in abortive 
coated pit formation. The site of CLC binding likely corresponds to the predicted bindings site in the 
leg region, and contains two differential amino acids between CHC1 and CHC2 (T in CHC1, A in 
CHC2 on position 1148, and Q in CHC1, H in CHC2 at position 1150) which might account for the 
difference in binding efficiency of ES9-17 to CHC1 and CHC2. Interestingly, when aligned to human 
CHC, these two amino acids are not preserved (Supplemental Figure 6). In contrast, most of the 
amino acids predicted to be involved in a binding pocket at the N-terminal domain are conserved. It 
remains to be seen if ES9-17 is active in human systems in terms of CME inhibition to be able to 
pinpoint possible binding sites based on activity and conservation of residues between Arabidopsis 
and human systems. Since no structural data of CHC in plants is available, all this remains very much 
speculation.  
In conclusion we present a small molecule inhibitor of CHC, ES9-17, with strong inhibitory effect on 
CME. As ES9-17 is more specific than any known small molecule effector of CME in Arabidopsis, 
it opens new possibilities to assess CHC function in endomembrane traffic and the implications for 
developmental, growth and defense responses. Aside a thorough analysis of CHC1 and CHC2 
function in CME, ES9-17 might also facilitate a further characterization of CHC function along other 
endomembrane trafficking routes53, something which is less explored in plants compared to their role 
in CME. In addition, it would be highly interesting to see if ES9-17 would have any effect on the 
recently reported clathrin independent endocytosis in Arabidopsis54. As such it would be the onset of 
a thorough analysis of possible non-specific effects of ES9-17 on endomembrane traffic, which is 
part of the further development of ES9-17 in a highly specific inhibitor of CHC function. Finally, in 
depth characterization of protein structural requirements for ES9-17 binding, together with mapping 
of the ES9-17 binding pocket on the CHC protein structure together with crystallization of CHC in 
presence of ES9-17 would facilitate an in-depth understanding of the molecular events unfolding 
upon formation of the clathrin cage in Arabidopsis.  
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Material and methods 
 
Plant material and growth conditions 
Arabidopsis thaliana (accession Columbia-0 [Col-0]) seedlings and other lines were stratified for 2 
days at 4°C, and grown vertically on agar plates containing ½ strength Murashige and Skoog (½MS) 
medium supplemented with 1% (w/v) sucrose for 5 days at 22°C in a light/dark cycle of 16 h/ 8 h 
respectively, prior to use. Arabidopsis seedlings were used as control or for labeling of mitochondria 
and acidic compartments. Following marker lines were used: TML-GFP25, CLC1-GFP, CHC1-GFP, 
AP2S-GFP26, Vha-a1-mRFP24, SYP22-YFP55, MAP4-GFP56, PIN2-GFP, BKI1-mCitrine35 and 
Fimbrin-GFP.  
Generation of GFP-tagged CHC2 and PSB-D cell culture transformation. 
Entry clone generated before59 was used together with pDONRRP4-1R_RPS5A, pDONRRP2R-
P3_GFPstop and pK7m34GW in multisite Gateway reactions (Life technologies) to yield C-terminal 
tagged CHC2. Both CHC1-GFP (Chapter 3, this thesis) and CHC2-GFP expression vectors were used 
to transform Agrobacterium tumefaciens C58. Subsequent transformation of PSB-D wild type cell 
cultures was performed as previously described60. 
Chemical treatments, chemical labeling and imaging in Arabidopsis 
ES9 and analogs were acquired through Chembridge (http://www.chembridge.com/) or synthesized 
as described below. .Brefeldin A and cycloheximide were acquired through Sigma-Aldrich. All were 
dissolved in DMSO (Sigma-Aldrich). Visualization of endocytosis was achieved with 2μM N-(3-
Triethylammoniumpropyl)-4-(6-(4-(Diethylamino) Phenyl) Hexatrienyl) Pyridinium Dibromide 
(FM4-64, Life technologies) application. For staining of mitochondria, seedlings were first treated 
for 30 min in ¼ MS (a 1:1 dilution of ½ MS with water) with the respective small molecules. 
Subsequently, seedlings are transferred to liquid ¼ MS with 250 nM MitoTracker Red CM-H2XRos 
(Molecular Probes®, Life Technologies) and the respective small molecules for an additional 30 min. 
Similarly, acidic compartments were labeled with Lyso Tracker Red DND 99 (Molecular Probes®, 
Life Technologies) by treating seedlings with 250 nM Lyso Tracker Red DND 99 in liquid ¼ MS for 
30 min. Small molecule treatment was started by adding small molecule at respective concentrations 
to seedlings in the Lyso Tracker Red DND 99 containing solution for another 30 min. Imaging of 
seedlings was performed with an Olympus FV10 ASW confocal laser scanning microscope using a 
60x water immersion lens (NA 1.2) and 3x digital zoom. Endocytic foci Life-time measurements 
were determined using a Perkin Elmer Ultra View Vox Spinning disc confocal imaging system 
running on the Volocity software package mounted on aNikon Eclipse Ti inverted microscope using 
a Plan Apo Lambda 100x oil (NA 1.45) corrected lens and third generation perfect focus system 
(PFSIII) for Z-drift compensation. Time series were acquired at 2 time points per second intervals, 
for 5 minutes. Excitation was done using a solid state 488nm DPSS laser (50mW) and images were 
acquired using a Hamamatsu ImagEM C9100-13 512x512 BI (16umx16um pixel size) EmCCD 
camera. Images were processed using the ImageJ (Fiji) software packages. 
For quantification of the plasma membrane/cytosol signal intensity ratio, images were converted in 
ImageJ to 8-bit, and regions of interest (ROIs) were selected based on the plasma membrane or 
cytosol localization. Histograms listing all intensity values per ROI were generated, and the averages 
of the 100 most intense pixels were used for calculations. 
ATP measurements 
Wild type PSB-D Arabidopsis cell cultures were used and maintained as described before60. Cell 
culture of 3 days old was diluted 100 times and mixed thoroughly prior to distribution of 95 μl in 96-
well plates. Subsequently, 5 μl of a 1/50 dilution of small molecule stock solution (1000x) in MS 
medium with Minimal Organics (MSMO) medium was added to cells (final dilution of 1000x) using 
a Tecan Freedom EVO® robot. ATP levels were detected by addition of 80 μl of ATPlite 1step 
Luminescence Assay System (Perkin Elmer) after incubation of cells in presence of small molecule 
for indicated time. Fluorescence was detected using a Perkin Elmer EnVision 2104 multilabel reader 
with the Wallac Envision manager software package. ATP-lite luminescence was detected with the 
ultra-sensitive luminescence techonology. Fluorescein diacetate (FDA) stock solution (2% FDA in 
acetone [w/v], Sigma) was diluted 100x in target medium and 5 μl was added to 95 μl cell culture. 
Fluorescence was detected with an excitation at 485nm (bandwidth 14nm), and emission at 535nm 
(bandwidth 25nm).  
BES1 dephosphorylation assay 
PSB-D wild type cell cultures were used and maintained as described before60. Cell cultures three 
days after sub-culturing were treated with 0,1 µM brassinolide (BL), 10 µM ES9, 50 µM ES9-6, 10 
µM ES9-17 (or other as indicated), 10 µM CCCP, 50 µM tyrphostinA23 (TyrA23), 50 µM 
tyrphostinA51 (TyrA51) and 50 µM antimycin A (AA) for 1 hour while shaking at 130 rpm and 
harvested and homogenized in liquid nitrogen. Protein extraction was performed with a 20mM Tris-
HCl buffer containing 150 mM NaCl, 1% Sodium Dodecyl Sulfate (SDS), 100 mM Dithiothreitol 
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(DTT) and 1 cOmplete ultra tablet per 10 ml of EDTA free protease inhibitor cocktail (Roche). 
Samples were run on precast NuPAGE Novex gels (Life Technologies) and transferred to polyvinyl 
difluoride (PVDF) membrane from iBlot Gel Transfer Stack (Novex, Life Technologies) using the 
iBlot device (Life technologies). Membranes were blocked for 1 hour in Tris buffered Saline with 0.1 
% Tween 20 (TBS-T, Sigma-Aldrich) and 5% Difco Skim milk (Becton, Dickinson and Company). 
Detection of BES1 occurred with a 1/2000 dilution in TBS-T 5% skim milk of anti-BES1, kindly 
provided by Yanhai Yin, and anti-rabbit IgG, Horseradish peroxidase (HRP)-linked (GE Healthcare, 
1:10000 in TBS-T with 5% skimmed milk) Membrane was developed with application of Western 
Lightning® Plus–ECL, Enhanced Chemiluminescence Substrate (Perkin-Helmer) and Amersham 
Hyperfilm ECL (GE Healthcare). 
Transmission electron microscopy 
Arabidopsis root tips from 5-day-old seedlings were submerged in 200 mM sucrose, 10 mM trehalose, 
and 10 mM Tris buffer, pH 6.661, transferred into planchettes (Leica Microsystems; 3.0x0.5mm, Al, 
type A and B), and frozen in a high-pressure freezer HPM100 (Leica Microsystems). Freeze 
substitution was performed in a Leica EM AFS2 unit (Leica Microsystems) in dry acetone 
supplemented with 0.4% uranyl acetate at −85°C for 16 h, followed by 5 h warm-up to −50°C. After 
washing with 100% ethanol for 60 min, samples were infiltrated and embedded in Lowicryl HM20 
resin at −50°C (intermediate steps of 30%, 50%, 70% HM20 in ethanol, 1 h each). The resin was 
polymerized with ultraviolet (UV) light for 3 days in the freeze substitution unit. Ultrathin sections 
were cut on a Leica UC7 (Leica Microsystems) and post-stained with aqueous uranyl acetate/lead 
citrate. Sections were examined in a JEM 1230 (Jeol) or in a Phillips CM100 transmission electron 
microscopes, both operating at 80 kV. Micrographs were recorded with a MSC 600CW (Gatan) 
digital camera or by scanning negatives (MACO EM films TYP S, 6.5x9 cm, ES 206) with an Epson 
Perfection V750 Pro system. 
Drosophila genetics  
Fly stocks were maintained on standard maize meal and molasses medium and were obtained from 
the Bloomington Drosophila Stock Center or from21.  
FM1-43 dye uptake assay and visualization of HA-CHC in Drosophila 
FM1-43 labeling was performed as described62. Third instar larvae were dissected in HL-3 and prior 
to a stimulation protocol animals were incubated for 30 minutes in HL-3 supplemented with and 
without ES9-17 (10 and 100 μM). Next, neurons were stimulated for 5 min in HL-3 with 90 mM KCl 
and 1.5 mM CaCl2 in the presence of FM 1-43 (4 µM) (Life Technologies) with or without small 
molecule. After labeling, the preparation was washed several times with HL-3 supplemented with or 
without small molecule. Images were captured using a confocal microscope (A1R, Nikon) with a 60x 
NA 1.0 water dipping lens. The boutonic FM1-43 intensity was quantified using ImageJ and was 
corrected for background labeling in the muscle. 
Immunohistochemistry was performed to visualize HA-CHC as described21. Larvae were treated in 
a similar fashion as for the FM1-43 dye uptake assay without the presence of FM1-43. Next, the 
treated animals were fixed and stained with a mouse anti-HA antibody (Covance) at 1:500. Alexa 
555-conjugated secondary antibodies (Life Technologies) were used at 1:1000. Super resolution 
structural illumination microscopy images were acquired on a microscope (Elyra S.1; Carl Zeiss) 
using a 63×, NA 1.4 oil lens and three rotations at room temperature. Next, acquired images were 
processed and stored using the ZEN 2011 software (Carl Zeiss). 
TMRE labeling 
Tetramethylrhodamine ethyl ester (TMRE) was used to label the mitochondrial membrane potential 
as described63. D42mitoGFP/+ third instar larvae were dissected in HL-3 and incubated for 30 
minutes in HL-3 supplemented with and without ES9-17 (10 µM and 100 μM. Subsequently, larvae 
were treated for 15 minutes with HL-3 medium supplemented with 50 mM  TMRE (Abcam) and the 
appropriate small molecule at room temperature. Next, fillets were washed with HL-3 with the 
appropriate small molecule and images were captured using a confocal microscope (A1R, Nikon) 
with a 60x NA 1.0 water dipping lens. The TMRE labeling intensity was quantified using ImageJ. 
First, 32-bit image of the mitoGFP channel was thresholded to select the mitochondria of the 
neuromuscular junction. Subsequently, the TMRE labeling intensity was measured in that region. 
Affinity purification with biotinylated small molecules 
Cell cultures (PSB-D wild type cells) were harvested by separating cells from medium, flash frozen 
in liquid nitrogen and grinded using a Retsch® MM400. Cell material was weighed and extraction 
buffer (50mM Tris-HCl pH 8, 150mM NaCl, 0.1% NP-40 [Sigma] with 1 tablet/10mL cOmplete 
ULTRA protease inhibitor cocktail, EDTA free [Roche] per 10 ml) was added in 2:1 ratio (200 µl 
extraction buffer for 100 mg material). Cell material was allowed to thaw on ice for 15 min with 
occasional mixing. Protein concentration was determined using the Bradford method (Quick start 
Bradford 1x Dye reagent [Bio-Rad]). Lysate was prepared for affinity purification by removing 
endogenous biotin. To this end, 50 μl of washed ( 3x with 500 μl extraction buffer, spun down at 
1500 rpm, 4°C) Steptavidin Sepharose High Performance beads (GE Healthcare, referred to as beads 
in the remainder of the protocol) were applied to 1 ml lysate and incubated at 4°C for 1hr on a rotary 
wheel. Meanwhile a second batch of beads was prepared in the same way as described above, but 
biotinylated small molecules (2 μl 50mM stock per 50 μl beads) were added with the last wash. The 
mixture was left at room temperature for 15 min, and transferred to 4°C until further use. Lysate 
incubated with beads for the removal of biotin was spun down (1500 rpm, 4°C), supernatant collected, 
and added to beads incubated with biotinylated small molecules, for which the supernatant was 
removed after centrifugation (1500 rpm, 4°C) prior to use. The subsequent mixture was incubated for 
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a minimum of 2 hrs, or overnight at 4°C on a rotary wheel. Next the mixture was spun down (1500 
rpm, 4°C), supernatant removed, and washed 3 times (50mM Tris-HCl pH 8, 150mM NaCl). After 
removal of supernatant from the last wash, appropriate amount of LDS sample buffer (4x LDS sample 
buffer supplemented with 10x sample reducing agent, Novex, Life Technologies) was added and 
samples were incubated for 10 min at 70°C and 350 rpm, followed by a 2 min centrifugation at 
maximum speed. The resulting supernatant was collected and run on 4-12% Bis-Tris protein gels with 
MES-buffer (NuPage Novex gels and buffer from Life technologies) for 7 min. Gels were stained 
with SYPRO Ruby protein gel stain (Molecular probes, Invitrogen) according to the rapid staining 
protocol. Stained gel regions were excised and cut in approximately 9 pieces before submission for 
LC-MS/MS analysis. 
LC−MS/MS Analysis 
Gel pieces containing the proteins of interest were cut out of the gel and transferred to Biopure® 
Eppendorf tubes (Eppendorf AG, Hamburg, Germany). Following two consecutive 15 min wash steps 
with water/acetonitrile (1/1, v/v) (both Baker HPLC analysed, Mallinckrodt Baker B.V., Deventer, 
The Netherlands), the gel pieces were dried to complete dryness in a centrifugal vacuum concentrator. 
They were subsequently re-hydrated in 10 µl of a 0.02 µg/µl of sequencing grade modified trypsin 
stock solution (Promega Corporation, Madison, WI, USA), 50 mM freshly prepared ammonium 
bicarbonate solution was added to complete submerge the gel pieces and the digestion proceeded 
overnight at 37°C. The digestion was stopped by acidification with TFA. 
Following centrifugation, the peptide mixture was removed from the gel pieces, transferred to a new 
Eppendorf tube and completely dried in a centrifugal vacuum concentrator. It was re-dissolved in 20 
μl of  0.1% TFA in water/acetonitrile (98/2, v/v) (loading solvent). 10 µl of the obtained peptide 
mixtures were introduced into an LC−MS/MS system through an Ultimate 3000 RSLC nano LC 
(Thermo Fisher Scientific, Bremen, Germany) in-line connected to a Q Exactive mass spectrometer 
(Thermo Fisher Scientific). The sample mixture was first loaded on a trapping column (made in-
house, 100 μm internal diameter (I.D.) × 20 mm, 5 μm beads C18 Reprosil-HD, Dr. Maisch, 
Ammerbuch-Entringen, Germany). After flushing from the trapping column, the sample was loaded 
on an analytical column (made in-house, 75 μm I.D. × 150 mm, 5 μm beads C18 Reprosil-HD, Dr. 
Maisch) packed in the needle (PicoFrit SELF/P PicoTip emitter, PF360-75-15-N-5, New Objective, 
Woburn, MA, USA). Peptides were loaded with loading solvent (0.1% TFA in water/ acetonitrile, 
2/98 (v/v) ) and separated with a linear gradient from 98% solvent A’ (0.1% formic acid in water) to 
40% solvent B′ (0.1% formic acid in water/acetonitrile, 20/80 (v/v)) in 30 min at a flow rate of 300 
nL/min. This is followed by a 5 min wash reaching 99% solvent B’. Two packing column and two 
analytical columns were configured in tandem LC mode, and switching between two flow paths – an 
analysis flow path and a regeneration flow path – allows column washing and re-equilibration off-
line; thus, while one column is re-equilibrated, the system injects a sample on the other column. 
The mass spectrometer was operated in data-dependent, positive ionization mode, automatically 
switching between MS and MS/MS acquisition for the 10 most abundant peaks in a given MS 
spectrum. 
The source voltage was 3.4 kV, and the capillary temperature was 275°C. One MS1 scan (m/z 
400−2000, AGC target 3 × 106  ions, maximum ion injection time 80 ms) acquired at a resolution of 
70000 (at 200 m/z) was followed by up to 10 tandem MS scans (resolution 17500 at 200 m/z) of the 
most intense ions fulfilling predefined selection criteria (AGC target 5 × 104  ions , maximum ion 
injection time 60 ms, isolation window 2 Da, fixed first mass 140 m/z, spectrum data type: centroid, 
underfill ratio 2%, intensity threshold 1.7xE4,  exclusion of unassigned, 1, 5-8, >8  charged 
precursors,  peptide match preferred, exclude isotopes on, dynamic exclusion time 20 s). The HCD 
collision energy was set to 25% Normalized Collision Energy and the polydimethylcyclosiloxane 
background ion at 445.120025 Da was used for internal calibration (lock mass). 
From the MS/MS data in each LC run, Mascot Generic Files (mgf) were created using the Mascot 
Distiller software (version 2.4.3.3, Matrix Science). These peak lists were then searched using the 
Mascot search engine with the Mascot Daemon interface (version 2.4, Matrix Science). Spectra were 
searched against the TAIR10 database. Variable modifications were set to pyro-glutamate formation 
of amino-terminal glutamine, acetylation of the protein N-terminus, methionine oxidation and 
propionaide formation of cysteines. Mass tolerance on precursor ions was set to ± 10 ppm (with 
Mascot’s C13 option set to 1), and on fragment ions to 20 mmu. The instrument setting was on ESI-
QUAD. The enzyme was set to trypsin/P, allowing for 1 missed cleavage, and cleavage was also 
allowed when lysine or arginine is followed by proline. Only peptides that were ranked first and 
scored above the threshold score, set at 99% confidence, were withheld.  
All data management was done by ms_lims , and data analysis was performed using R (http://www.R-
project.org) embedded in KNIME . The data were filtered by removing all peptides smaller than eight 
amino acids and only the proteins containing minimal two peptides in one of experiments were taken 
into account for data analysis. 
CETSA on lysate 
The protocol used is based to a large extent on the protocol published earlier17, with minor 
adjustments. Cell cultures (PSB-D wild type cell cultures or transformed with the appropriate 
constructs) were harvested by separating cells from medium, flash frozen in liquid nitrogen and 
grinded using a Retsch® MM400. Cell material was weighed and extraction buffer (50mM Tris-HCl 
pH 7.6, 150mM NaCl with 1 tablet/10mL cOmplete ULTRA protease inhibitor cocktail, EDTA free 
(Roche)) was added in 2:1 ratio (200 µl extraction buffer for 100 mg material). Cell material was 
allowed to thaw on ice for 15 min with occasional mixing. Next, samples were centrifuged for 30 min 
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at maximum speed at 4°C, and transferred to new recipients. Lysates were pooled per cell type, and 
protein concentration was determined using the Bradford method (Quick start Bradford 1x Dye 
reagent (Bio-Rad)). Pooled lysates were aliquoted according to the number of treatments, treated with 
small molecules or mock (DMSO, Sigma) at appropriate concentrations  and incubated for 30 min at 
room temperature on a rotary wheel. Next, treated lysates were aliquoted in 60 µl fractions in PCR 
tubes according to the different temperature treatments, and treated for 2 min at the respective 
temperature in a Bio-Rad thermal cycler. Samples were allowed to cool down, transferred to new 1.5 
ml eppendorf tubes and centrifuged at maximum speed for 30 min at 4°C. After centrifugation, 50 µl 
of the supernatant was taken and processed for standard western blot analysis. 
Detection of proteins was done according to standard western blot procedures. All antibodies were 
diluted in TBS-T with 5% skimmed milk. Anti CHC (kindly provided by Hwang, 1/3000 dilution), 
anti AtpB (1/4000, AS05085 Agrisera) and anti Sec21p (1/4000, AS08327 Agrisera) were detected 
with anti-rabbit IgG, HRP-linked (GE Healthcare, 1:10000) Anti-tubulin (1/15000, ) was detected 
with anti-mouse IgG, Horseradish peroxidase (HRP)-linked (GE Healthcare, 1:10000). GFP was 
detected with anti-GFP-HRP (1/4000, Miltenyi Biotec). Blots were developed with Western 
Lightning® Plus–ECL, Enhanced Chemiluminescence Substrate (Perkin-Helmer), and imaging with 
a Bio-Rad ChemiDoc XRS+ molecular imager. Intensity of bands was measured with the Bio-Rad 
Image Lab software package. 
DARTS 
The DARTS protocol was adopted as previously described18, with the exception of the different used 
Pronase dilutions. Preparation of lysates was done as described for CETSA. Lysates treated with ES9-
17 (100 μM) or mock (DMOS, Sigma) were incubated for 30 minutes on a rotary wheel at room 
temperature. After incubation lysate was split in equal aliquots for Pronase (Roche, 10 165 921 001) 
digestion. One aliquot was kept as a non-digested control. Pronase dilutions were prepared from a 
10mg/ml stock solution in dH2O. The 1/100 starting dilution of Pronase, which served to make all 
subsequent dilutions as indicated, was prepared by dissolving 12.5μl Pronase stock solution in 87.5 
μl 1x TNC buffer (500mM Tris-HCl, pH8, 500mM NaCl and 100mM CaCl2, 10X stock). All dilutions 
were prepared with 1x TNC buffer. Digestion (30 min) was started with 1 min intervals, and stopped 
by adding sample buffer at a 1x final concentration (4x LDS sample buffer with 10x sample reducing 
agent, Novex, Life Technologies) in the same sequence as the digestion was started. Western blotting, 
detection of proteins and quantification as described for CETSA. 
Docking of ES9-17 on CHC 
All waters and ligands of the protein crystal structures 2XZG (human clathrin terminal domain in 
complex with pitstop1) and 4G55 (idem with pitstop 2)5 were manually deleted from the pdb-text 
file. The emptied structures were subjected to a local minimization with the GROMOS96 (43B1 
parameter set)64 implementation within the Swiss-PdbViewer65, and polar hydrogens were added. 
Docking experiments were with AutoDock-Vina66, using AutoDockTools67 for pdbqt-format 
preparations of proteins and ligands. Comparison of the recognition site in respectively 2XZG and 
4G55 shows different orientations of the ligand-contacting residues Arg64, Gln89 and Phe91; these 
were set as flexible during the dockings. Grid-box settings for blind dockings (encompassing the 
whole protein) on 2XZG were: sizes x, y and z = 60 Å centered at x = 34.3, y = 1.9 and z = 5.6, and 
on 4G55 were: sizes x, y and z = 60 Å centered at x = 34.2, y = 1.9 and z = 5.6; with docking 
exhaustiveness set at 256. Grid-box settings for local dockings (encompassing the pitstop recognition 
site) on 2XZG were: sizes x = 20, y = 24 and z = 20 Å centered at x = 48.4, y = -9.8 and z = 23.3, and 
on 4G55 were: sizes x = 20, y = 22 and z = 20 Å centered at x = 50.0, y = -10.2 and z = 24.5; with 
docking exhaustiveness set at 64. Ligands were drawn in 3D with Avogadro68 and were minimized 
with the built-in MMFF94s force field69. Docking results (20 poses per docking) were visually 
inspected with PyMOL40. 
Chemical synthesis 
All reactions were, unless mentioned otherwise, performed under inert atmosphere in dried glassware 
with dried teflon stirbars. Thin Layer Chromatography was performed on silica (Macherey-Nagel, 
pre-coated TLC-plates SIL G-25 UV254, 0.25 mm). TLC plates were visualized by staining with a 5% 
phosphomolybdic acid-solution in ethanol. Flash chromatography was performed on silica (d=70-200 
m, ±30g silica/1g product). Solvents were used dry unless mentioned otherwise. Anhydric methanol 
and dimethylformamide were purchased and kept dry on molecular sieves. Solvents were of HPLC 
quality. 
Nuclear magnetic resonance spectra (NMR) were measured in deuterated acetone or deuterated 
chloroform. Proton (1H) and carbon-13 (13C) spectra were measured at 300MHz (13C: 75MHz) on a 
Bruker 300MHz Avance II or at 500MHz (13C: 125MHz) on a Bruker 500MHz Avance II or III. 
Chemical shift (δ) is reported in units ppm relative to residual acetone (1H: δ = 2.05 ppm; 13C = 29.8 
and 206.3 ppm) or residual chloroform (1H: δ = 7.26 ppm; 13C = 77.0 ppm). Multiplicites are reported 
as follows: s = singlet, d = doublet, t = triplet, q = quadruplet, q5 = quintuplet, m = multiplet, band = 
multiple overlapping signals, br = broad signal, AB = AB-system with clear roofing. Melting points 
were measured on an Electrothermal 1900. High Resolution Mass (HRMS) was measured with an 
Agilent Accurate-Mass Quadrupole Time-of-Flight mass spectrometer. 
Synthesis of ES9-10 
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4-nitroaniline (582 mg, 4.22 mmol, 1.08 equiv.) is dissolved in pyridine (8 ml). The mixture is cooled 
to 0°C and 4-bromobenzenesulfonyl chloride (1 g, 3.91 mmol, 1 equiv.) is added portionwise. The 
reaction is stirred at room temperature for 17 h. After concentration in vacuo, the residue is taken up 
in water and ethyl acetate (100 ml, 1:1 v/v). The organic phase is washed with hydrochloric acid (6 
× 30 ml, 6 M ), a saturated sodium bicarbonate solution (30 ml) and a saturated sodium chloride 
solution (30 ml). The organic phase is dried on sodium sulfate, filtered and concentrated in vacuo. 
The crude solid is recrystallized from 2-propanol to yield sulfonamide ES9-8 as yellow crystals (1.09 
g, 72 %).  
 
Formula: C12H9BrN2O4S; M: 357.21 g/mol; TLC (ethyl acetate:petroleum ether, 1:1 v/v): Rf = 0.7; 
1H-NMR (500MHz, (CD3)2CO): δ 8.20 – 8.13 (m, 2H), 7.89 – 7.82 (m, 2H), 7.82 – 7.76 (m, 2H), 
7.55 – 7.40 (m, 2H); 13C-NMR (125 MHz, (CD3)2CO): δ 144.6, 139.6, 133.5, 129.9, 128.7, 126.0, 
119.7; HRMS (m/z): [M-H+]- calcd. for C12H8BrN2O4S
-, 354.9394; found, 354.9407  
 
ES9-8 (1g, 2.8mmol, 1.0equiv.) is dissolved in dimethylformamide (20 ml) together with 
tetrakis(triphenylphosphine)palladium (226 mg, 0.2 mmol, 0.09 equiv.). The mixture is extensively 
purged with nitrogen gas during 30 min. Allyltributylstannane (1.09 ml, 3.5 mmol, 1.25 equiv.) is 
added and the mixture is purged for another 5 min. The reaction is heated to 90°C and after stirring 
for 3.5 h poured into ice water (100 ml). Ethyl acetate (100 ml) is added and the mixture is filtered 
over a pad of celite. The organic phase is separated and washed with water (30 ml), a saturated sodium 
bicarbonate solution (30 ml) and a saturated sodium chloride solution (30 ml). After drying on sodium 
sulfate, the organic phase is concentrated in vacuo. The residue is purified by flash chromatography 
(silica, ethyl acetate:petroleum ether, 3:7 v/v) to yield sulfonamide 1 as a viscous oil. The oil is 
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dissolved in methyl-tert-butylether and petroleum ether is added to give a pale yellow solid, which is 
recrystallised from carbondisulfide to yield sulfonamide 1 as a bright yellow crystalline solid (563 
mg, 1.76 mmol, 63 %).  
Formula: C15H14N2O4S; M: 318.35g/mol; TLC (ethyl acetate:petroleum ether, 1:1 v/v): Rf = 0.7; 
1H-
NMR (500MHz, (CD3)2CO): δ 8.20 – 8.11 (m, 2H), 7.91 – 7.82 (m, 2H), 7.51 – 7.44 (m, 2H), 7.44 – 
7.38 (m, 2 H), 5.93 (ddt, 1 H, J = 17.0, 10.1, 7.8 Hz), 5.08 (ddm(AB), 1H, J = 17.0,1.6Hz), 5.05 
(ddm(AB), 1H, J = 10.1,1.6Hz), 3.45 (d, 2H, J = 7.8 Hz, ); 13C-NMR (125 MHz, 
(CD3)2CO): δ 147.4, 145.0, 138.1, 137.1, 130.3, 128.2, 126.0, 119.2, 117.1, 40.3; 
HRMS (m/z): [M-H+]- calcd. For C15H13N2O4S
-, 317.0602; found, 317.0606  
 Sulfonamide 1 (100 mg, 314 μmol, 1.0 equiv.) and 1-mercaptoethanol (220 μl, 3.14 mmol, 10.0 
equiv.) is dissolved in methanol (2 ml) together with N,N’-azobisisobutyronitrile (4 mg, 24 μmol, 
0.08 equiv.) in a pressure tube. The mixture is heated to 95°C and stirred. The reaction is monitored 
with TLC and N,N’-azobisisobutyronitrile (4 mg) is added with 30 min intervals until complete 
conversion is observed. The crude mixture is concentrated in vacuo and the residue is purified by 
flash chromatography (silica, ethyl actetate:petroleum ether, 1:1 v/v) to yield ES9-9 as a yellow oil 
(68 mg, 59 %).  
Formula: C17H20N2O5S2; M: 368.48g/mol; TLC (ethylacetate:petroleum ether, 1:1 v/v): Rf = 0.2; 
1H-
NMR (300MHz, (CD3)2CO): δ 8.23 – 8.10 (m, 2H), 7.92 – 7.81 (m, 2H), 7.53 – 7.38 (band, 4H), 3.62 
(t, 2H, J = 6.8Hz), 2.79 (t, 2H, J = 7.5Hz), 2.61 (t, 2H, J = 6.8Hz), 2.54 (t, 2H, J = 7.5Hz), 1.88 (q, 2 
H, J = 7.5 Hz); 13C-NMR (125 MHz, CDCl3): δ 147.8, 143.5, 143.3, 136.5, 129.4, 127.3, 125.3, 118.2, 
60.3, 35.0, 34.4, 30.9, 30.5; HRMS (m/z): [M- H+]- calcd. for C17H19N2O5S2
-, 395.0741; found, 
395.0754 
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 Alcohol ES9-9 (53.2mg, 144μmol, 1.5equiv.) is dissolved in dimethylformamide (0.5 ml) together 
with biotin (23.5 mg, 96 μmol, 1.0 equiv.) and 4-dimethylaminopyridine (2 mg, 13 μmol, 0.09 equiv.). 
The mixture is then stirred until complete dissolution and cooled to 0°C. N,N’-
dicyclohexylcarbodiimide (23.8 mg, 145 μmol, 1.2 equiv.) is added and the mixture is stirred at the 
same temperature for another 5 min. After heating to room temperature, the reaction is stirred 
overnight. The mixture is concentrated in vacuo and purified by flash chromatography (silica, 
methanol:chloroform, 3:97 to 6:94 v/v) to yield ES9-10 as an amorphous yellow solid (63 mg, 74 %).  
Formula: C27H34N4O7S3; M: 622.78 g/mol; TLC (methanol:chloroform, 1:9 v/v): Rf = 0.35; 
1H-NMR 
(300 MHz, CDCl3): δ 10.88 (s(br), 1 H), 8.10 – 8.02 (m, 2H), 7.90 – 7.81 (m, 2H), 7.39 – 7.27 (band, 
4H), 5.90 (s(br), 1 H), 5.12 (s(br), 1H), 4.63 (dd(br), 1 H, J = 7.6, 5.5 Hz), 4.42 (ddd(br), 1H, J = 7.5, 
5.2, 1.1 Hz), 4.18 (t, 2 H, J = 6.4 Hz), 3.21 (ddd(br), 1H, J = 9.2, 5.6, 4.9 Hz), 2.97 (dd, 1H, J = 
13.0,4.9Hz), 2.75 (t, 2H, J = 6.6Hz), 2.74 (d, 1H, J = 12.2 Hz), 2.66 (t, 2H, J = 6.4 Hz), 2.49 (t, 2 H, 
J = 7.3 Hz), 2.19 (t, 2 H, J = 7.3 Hz), 2.02 – 1.34 (band, 8H+H2O); 13C-NMR (125 MHz, CDCl2): δ 
173.1, 163.8, 147.5, 144.1, 143.3, 136.8, 129.5, 127.4, 125.2, 118.1, 64.1, 62.3, 60.3, 55.7, 40.6, 34.1, 
33.6, 31.1, 30.5, 30.3, 28.4, 28.3, 24.8; HRMS (m/z): [M-H+]- calcd. For C27H33N4O7S3
-, 621.1517; 
found, 621.1512 
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Synthesis of ES9_6  
ES9 (100 mg, 275 μmol, 1.0 equiv.) is dissolved in dimethylformamide (700 μl). Potassium carbonate 
(76 mg, 550 μmol, 2.0 equiv.) is added and the mixture is stirred for 5 min. Methyl iodide (34 μl, 550 
μmol, 2.0 equiv.) is added and the reaction is heated to 80°C and stirred for 1 h. The reaction mixture 
is cooled down and diluted with ethyl acetate (20 ml) and the organic phase is washed with water (10 
ml) and a saturated sodium chloride-solution (7 ml). The organic phase is dried on sodium sulphate, 
filtered and concentrated in vacuo to yield a yellow solid which is recrystallized from 2-propanol to 
yield ES9-6 as a yellow crystalline solid (100 mg, 95 %).  
Formula: C11H9BrN2O4S2; M: 377.23 g/mol; TLC (ethyl acetate:petroleum ether, 3:7 v/v): Rf = 0.3; 
1H-NMR (500MHz, (CD3)2CO): δ 8.29 – 8.24 (m, 2H), 7.62 – 7.57 (m, 2H), 7.35 – 7.31 (band, 2H), 
3.38 (s, 3 H); 13C-NMR (125 MHz, (CD3)2CO): δ 147.7, 147.1, 138.0, 134.9, 132.5, 127.4, 125.1, 
121.0, 38.2; HRMS (m/z): [M+OAc-]- calcd. For C11H8BrN2O4S2
-, 434.9325; found, 434.9319 
Synthesis of ES9_17  
Aniline (193 μl, 2.13 mmol, 1.08 equiv.) is dissolved in pyridine (4 ml). The mixture is cooled to 0°C 
and 4-bromothiophenesulfonyl chloride (0.5 g, 1.95 mmol, 1.0 equiv.) is added portionwise. The 
reaction is stirred at room temperature for 17 h. After concentration in vacuo, the residue is taken up 
in water and ethyl acetate (50 ml, 1:1 v/v). The organic phase is washed with hydrochloric acid (6 × 
30 ml, 6 M), a saturated sodium bicarbonate solution (15 ml) and a saturated sodium chloride solution 
(15 ml). The organic phase is dried on sodium sulfate, filtered and concentrated in vacuo. The crude 
solid is purified by flash chromatography (silica, ethyl acetate:petroleum ether, 3:5 v/v) and 
recrystallized from 2-propanol to yield ES9-17 as yellow crystals (512 mg, 83 %).  
 
Formula: C10H8BrNO2S2; M: 318.20 g/mol; TLC (ethyl acetate:petroleum ether, 1:1 v/v): Rf = 0.6; 
1H-NMR (500 MHz, (CD3)2CO): δ 9.21 (s(br), 1 H), 7.36 – 7.30 (band, 3H), 7.30 – 7.25 (m, 2H), 
7.20 (d, 1H, J = 4.0 Hz), 7.19 – 7.14 (m, 1H); 13C-NMR (125 MHz, (CD3)2CO): δ 142.4, 138.1, 133.8, 
131.9, 130.2, 126.2, 122.3, 119.8; HRMS (m/z): [M-H+]- calcd. For C10H7BrNO2S2
-, 315.9107; found, 
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315.9116 
Synthesis of ES9-13  
 
1-hexene (0.5 g, 742 μl, 5.94 mmol, 1.0 equiv.) and 2-mercaptoethanol (414 μl, 59.4 mmol, 10.0 
equiv.) are dissolved in methanol (2 ml) together with N,N’-azobisisobutyronitrile (72 mg, 439 μmol, 
0.08 equiv.). The mixture is heated to 95°C and stirred for 1.5 h. After concentration in vacuo the 
residue is purified by flash chromatography (silica, ethyl acetate:petroleum ether, 2:3 v/v) to yield 
alcohol 2 quantitatively as a colourless oil.  
Formula: C8H18OS; M: 162.29 g/mol; TLC (ethyl acetate:petroleum ether, 1:1 v/v): Rf = 0.6; 
1H-
NMR (500 MHz, CDCl3): δ 3.71 (t, 2 H, J = 5.9 Hz), 2.73 (t, 2H, J = 5.9Hz), 2.52 (t, 2H, J = 7.4Hz), 
2.04 (s(br), 1H), 1.58 (q5, 2H, J = 7.4Hz), 1.38 (q5, 2H, J = 7.4Hz), 1.34 – 1.23 (band, 4H), 0.89 (t, 3 
H, J = 7.0 Hz), 13C-NMR (125 MHz, CDCl3): δ 60.3, 35.5, 31.8, 31.6, 29.9, 28.7, 22.7, 14.2 
 
Alcohol 2 (300 mg, 1.85 mmol, 1.0 equiv.) is dissolved in dimethylformamide (4 ml) together with 
biotin (452 mg, 1.85 mmol, 1.0 equiv.) and 4-dimethylaminopyridine (20 mg, 165 μmol, 0.09 equiv.). 
The mixture is then stirred until complete dissolution and cooled down to 0°C. A solution of N,N’-
dicyclohexylcarbodiimide (23.8 mg, 145 μmol, 1.2 equiv.) in dimethylformamide (2 ml) is added and 
the mixture is stirred at the same temperature for 1 h, after which it is heated to room temperature and 
stirred overnight. The mixture is concentrated in vacuo and purified with flash chromatography 
(silica, methanol:chloroform, 1:9 v/v) to yield ES9-13 as a white waxy solid (62.9 mg, 9 %).  
Formula: C18H32N2O3S2; M: 388.59 g/mol; TLC (methanol:dichloromethane, 1:8 v/v): Rf = 0.6; 
1H-
NMR (300MHz, CDCl3): δ 5.58 (s(br), 1H), 5.13 (s(br), 1 H), 4.51 (dd(br), 1H, J = 7.8, 4.9 Hz), 4.32 
(dd, 1H, J = 7.7, 4.6 Hz), 4.20 (t, 2H, J = 6.9 Hz), 3.16 (ddd(br), 1H, J = 8.5, 6.6, 5.0 Hz), 2.92 (dd, 
1H, J = 12.9,5.0 Hz), 2.78 – 2.69 (band, 3H), 2.55 (t, 2H, J = 7.3Hz), 2.35 (t, 2H, J = 7.3Hz), 1.76 – 
1.62 (band, 4H), 1.58 (q5, 2H, J = 7.5Hz), 1.51 – 1.22 (band, 8H+H2O), 0.89 (t, 3H, J = 6.7 Hz); 13C-
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NMR (125 MHz, CDCl3): δ 173.5, 163.4, 63.5, 62.1, 60.2, 55.5, 40.7, 33.9, 32.5, 31.6, 30.7, 29.8, 
28.7, 28.5, 28.4, 24.9, 22.7, 14.2; HRMS (m/z): [M+H+]+ calcd. for C18H33N2O3S2
+, 389.1927; found, 
389.1933  
Synthesis of ES9-15 
 
4-aminophenol (230 mg, 2.11 mmol, 1.08 equiv.) is dissolved in pyridine (4 ml). The mixture is 
cooled to 0°C and 4-bromobenzenesulfonyl chloride (500 mg, 1.95 mmol, 1 equiv.) is added 
portionwise. The reaction is stirred at room temperature for 17h. After concentration in vacuo, the 
residue is taken up in water and ethyl acetate (75 ml, 1:2 v/v). The organic phase is washed with 
hydrochloric acid (6 × 15 ml, 6 M ), a saturated sodium bicarbonate solution (15 ml) and a saturated 
sodium chloride solution (15 ml). The organic phase is dried on sodium sulfate, filtered and 
concentrated in vacuo to yield sulfonamide ES9-15 as a white solid (358.9 mg, 56 %). 
Formula: C11H9BrN2O2S; M: 313.17 g/mol; TLC (ethyl acetate:petroleum ether, 1:1 v/v): Rf = 0.4; 
1H-NMR (300MHz, (CD3)2CO): δ 8.63 (s(br), 1H), 8.34 (s, 1H), 7.73 – 7.69 (m, 2H), 7.63 – 7.59 (m, 
2H), 7.00 – 6.96 (m, 2H), 6.74 – 6.71 (m, 2H); 13C-NMR (125 MHz, (CD3)2CO): δ 156.5, 140.2, 
133.0, 129.9, 129.6, 127.6, 126.0, 116.5; HRMS (m/z): [M-H+]- calcd. for C11H8BrN2O2S
-, 325.9492; 
found, 325.9499 
Synthesis of ES9-16 
4-aminopyridine (199 mg, 2.11 mmol, 1.08 equiv.) is dissolved in pyridine (4 ml). The mixture is 
cooled to 0°C and 4-bromobenzenesulfonyl chloride (500 mg, 1.95 mmol, 1 equiv.) is added 
portionwise. The reaction is stirred at room temperature for 17 h during which a yellow precipitate is 
formed. After concentration in vacuo, the residue is taken up in ethyl acetate (10 ml). The organic 
phase is washed with sodium hydroxide (3 × 3 ml, 15%). The combined aquous phases are acidified 
with hydrochloric acid (6 M), until precipitation occurs. The solid is collected, washed with water 
and dried at 50°C under vacuum (). 
ES9-15 
ES9-16 
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Formula: C11H9BrN2O2S; M: 313.17 g/mol; 
1H-NMR (300MHz, (CD3)2SO): δ 12.63 (s(br), 1H), 7.99 
(d(br), 2H, J = 6.7 Hz), 7.74 – 7.67 (band, 2H), 6.90 (d(br), 2H, J = 7.0 Hz); 13C-NMR (125 MHz, 
(CD3)2SO): δ 131.7, 128.1, 124.8, 114.8; HRMS (m/z): [M+H+]+
 calcd. for C11H10BrN2O2S
+, 
312.9641; found, 312.9467 
  
Supplemental information. 
 
 
Supplemental Figure 1. Mitochondrial functions and FM1-43 uptake are affected at very high  
concentrations of ES9-17 in Drosophila  
(a) Relative fluorescein diacetate (FDA) fluorescence intensity for different small molecule 
treatments of PSB-D wild type cell cultures. Mock treatment (Ø, DMSO), 50 µM ES9-6, 50 µM ES9-
8 and 10 µM ES9-17. (b) Boutons of the neuromuscular junction in third instar larvae of Drosophila 
positive for clathrin heavy chain (CHC)-HA for mock or 10 µM ES9-17 in KCl stimulated conditions. 
(c) Tetramethylrhodamine ethyl ester (TMRE) labeling of mitochondria in D42mitoGFP positive 
Drosophila neuronal cells for 100 µM ES9-17 and mock treatment. Cells are incubated in the dark 
for 30 min with ES9-17 or mock, followed by 15 min of TMRE labeling. (d) FM1-43 labeling (30 
min) of neuromuscular junction boutons in third instar larvae of Drosophila, in the control situation 
(Ø) and in presence of 100 µM ES9-17. Scale bars: 2µm in (b), 5 µm in (c) and 20 µm in (e). 
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Supplemental Figure 2. ES9-17 had few notable effects on the cytoskeleton and other 
endomembrane compartments than the plasma membrane.  
(a) The actin cytoskeleton labeled by Fimbrin-GFP, (b) microtubules labeled by MAP4-GFP, and (c) 
vacuolar compartment labeled by SYP22,-GFP were not affected by the ES9-17 treatment. All 
seedlings were pre-treated for 15 min with ES9-17. Mock (DMSO) treatment, Ø (d) Transmission 
electron microscopy of high-pressure frozen and freeze-substituted Arabidopsis roots. Upon 30 min 
exposure to 10 μM ES9-17, (a) The Golgi apparatus (G), the trans-Golgi network (T), multivesicular 
bodies (M), and vacuoles were unaffected. (b) Control cells exposed to DMSO. Scale bars: 5 μm (a-
c) 200 nm (d) 
 
 Supplemental Figure 3. ES9-17 targets CHC  
(a) Representative thermal denaturation for tubulin, clathrin heavy chain (CHC), γCOPI, and the β 
subunit of ATP synthase (AtpB) respectively in lysate with detergent treated with mock (Ø) or with 
ES9 (500 μM) and ES9-17 (100 μM). (b) Representative isothermal denaturation at 40°C of CHC 
extracted with detergent in presence of different concentrations of ES9 and ES9-17 or (c) extracted 
without detergent. (d) Thermal denaturation for CHC1-GFP expressed in seedlings. 2 biological 
repeats (indicated by 1 or 2). 
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Supplemental Figure 4. chc1-1 and chc2-2 are more sensitive to ES9-17  
(a) Root growth upon transfer to ES9-17 containing medium of 5 days old seedlings as measured 
after 48 hours. Relative to mock (Ø) treatment. (b) Quantification of FM4-64 uptake for seedlings 
treated for 15 min after pre-treatment with 6 µM ES9-17 for 15 min. *P<0.5 **P<0.01 ***P<0.001 
for a two-sided Student’s t-test. N is at least 9 biological repeats. (c) Representative images for FM4-
64 uptake in (b). 
 
 Supplemental Figure 5. CHC1 and CHC2 are very similar in amino acid sequence.  
Amino acid sequence alignment of Arabidopsis CHC1 and CHC2 sequences. Alignment was 
performed with CLC workbench. Red residues indicate differences between CHC1 and CHC2. Green 
highlights the residues which are predicted to be part of a binding pocket, according to I-TASSER. 
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Supplemental Figure 6. Arabidopsis CHC1 and Human CHC amino acid sequence alignment 
Amino acid sequence alignment of Arabidopsis CHC1 and Human CHC sequences. Alignment was 
performed with CLC workbench. Different types of amino acids are color coded. Consensus sequence 
(Cons.) is depicted below the alignment. Pink highlight indicate the ATH CHC1 amino acids 
predicted to be part of a binding pocket, according to I-TASSER. 
  
 Supplemental table 1. List of identified proteins for the ES9-10 affinity purification 
Numbers indicate the times a protein is found out of 9 repeats (3 biological repeats, each consisting 
of 3 technical repeats). Proteins which were not found with the ES9-10 analog, yet were present with 
the ES9-13 analog, are removed. Similarly all proteins found only once with the ES9-10 analog, but 
present at least once with the ES9-13 analog were removed. 
ACCESSION DESCRIPTION ES9-10 ES9-13 
AT4G34450 coatomer gamma-2 subunit, putative / gamma-2 coat protein, putative / 
gamma-2 COP, putative 
5 0 
AT5G53480 ARM repeat superfamily protein 4 0 
AT3G11130 Clathrin, heavy chain 4 0 
AT5G40370 Glutaredoxin family protein 4 0 
AT2G27600 AAA-type ATPase family protein 3 0 
AT4G16760 acyl-CoA oxidase 1 3 0 
AT5G26210 alfin-like 4 3 0 
AT5G55670 RNA-binding (RRM/RBD/RNP motifs) family protein 3 0 
AT5G57870 MIF4G domain-containing protein / MA3 domain-containing protein 3 0 
AT2G23350 poly(A) binding protein 4 3 0 
AT3G12130 KH domain-containing protein / zinc finger (CCCH type) family protein 3 0 
AT1G56190 Phosphoglycerate kinase family protein 3 0 
AT2G21390 Coatomer, alpha subunit 3 0 
AT3G11830 TCP-1/cpn60 chaperonin family protein 3 0 
AT5G07440 glutamate dehydrogenase 2 3 0 
AT1G14810 semialdehyde dehydrogenase family protein 3 0 
AT1G02090 Proteasome component (PCI) domain protein 2 0 
AT1G04690 potassium channel beta subunit 1 2 0 
AT1G15710 prephenate dehydrogenase family protein 2 0 
AT1G35580 cytosolic invertase 1 2 0 
AT1G44835 YbaK/aminoacyl-tRNA synthetase-associated domain 2 0 
AT1G64790 ILITYHIA 2 0 
AT1G70660 MMS ZWEI homologue 2 2 0 
AT1G72730 DEA(D/H)-box RNA helicase family protein 2 0 
AT2G28760 UDP-XYL synthase 6 2 0 
AT2G33340 MOS4-associated  complex 3B 2 0 
AT2G47730 glutathione S-transferase phi 8 2 0 
AT3G03570 Protein of unknown function (DUF3550/UPF0682) 2 0 
AT3G51670 SEC14 cytosolic factor family protein / phosphoglyceride transfer family 
protein 
2 0 
AT3G51840 acyl-CoA oxidase 4 2 0 
AT3G51950 Zinc finger (CCCH-type) family protein / RNA recognition motif (RRM)-
containing protein 
2 0 
AT4G04020 fibrillin 2 0 
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AT4G11420 eukaryotic translation initiation factor 3A 2 0 
AT4G29480 Mitochondrial ATP synthase subunit G protein 2 0 
AT4G31480 Coatomer, beta subunit 2 0 
AT4G39230 NmrA-like negative transcriptional regulator family protein 2 0 
AT5G11880 Pyridoxal-dependent decarboxylase family protein 2 0 
AT5G12040 Nitrilase/cyanide hydratase and apolipoprotein N-acyltransferase family 
protein 
2 0 
AT5G19990 regulatory particle triple-A ATPase 6A 2 0 
AT5G58110 chaperone binding*ATPase activators 2 0 
AT1G10270 glutamine-rich protein 23 2 0 
AT1G31730 Adaptin family protein 2 0 
AT1G35620 PDI-like 5-2 2 0 
AT1G48030 mitochondrial lipoamide dehydrogenase 1 2 0 
AT1G48170 unknown protein. 2 0 
AT1G62740 stress-inducible protein, putative 2 0 
AT2G20860 lipoic acid synthase 1 2 0 
AT2G42500 protein phosphatase 2A-3 2 0 
AT3G07720 Galactose oxidase/kelch repeat superfamily protein 2 0 
AT4G20890 tubulin beta-9 chain 2 0 
AT5G19820 ARM repeat superfamily protein 2 0 
AT5G27640 translation initiation factor 3B1 2 0 
AT5G44780 unknown protein 2 0 
AT1G06220 Ribosomal protein S5/Elongation factor G/III/V family protein 2 0 
AT1G07890 ascorbate peroxidase 1 2 0 
AT1G08200 UDP-D-apiose/UDP-D-xylose synthase 2 2 0 
AT1G20950 Phosphofructokinase family protein 2 0 
AT1G43690 ubiquitin interaction motif-containing protein 2 0 
AT1G50200 Alanyl-tRNA synthetase 2 0 
AT1G62380 ACC oxidase 2 2 0 
AT2G16060 hemoglobin 1 2 0 
AT2G18040 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 2 0 
AT2G20420 ATP citrate lyase (ACL) family protein 2 0 
AT2G43360 Radical SAM superfamily protein 2 0 
AT2G47470 thioredoxin family protein 2 0 
AT3G09810 isocitrate dehydrogenase VI 2 0 
AT3G13460 evolutionarily conserved C-terminal region 2 2 0 
AT3G47520 malate dehydrogenase 2 0 
AT3G52880 monodehydroascorbate reductase 1 2 0 
AT4G16130 arabinose kinase 2 0 
AT4G30010 unknown protein 2 0 
AT5G20830 sucrose synthase 1 2 0 
AT5G26710 Glutamyl/glutaminyl-tRNA synthetase, class Ic 2 0 
AT5G52520 Class II aaRS and biotin synthetases superfamily protein 2 0 
AT5G66680 dolichyl-diphosphooligosaccharide-protein glycosyltransferase 48kDa 
subunit family protein 
2 0 
AT3G23990 heat shock protein 60 2 0 
AT5G49910 chloroplast heat shock protein 70-2 2 0 
AT1G01470 Late embryogenesis abundant protein 1 0 
AT1G01960 SEC7-like guanine nucleotide exchange family protein 1 0 
AT1G06060 LisH and RanBPM domains containing protein 1 0 
AT1G07170 PHF5-like protein 1 0 
AT1G11580 methylesterase PCR A 1 0 
AT1G12270 stress-inducible protein, putative 1 0 
AT1G13190 RNA-binding (RRM/RBD/RNP motifs) family protein 1 0 
AT1G15280 CASC3/Barentsz eIF4AIII binding 1 0 
AT1G24280 glucose-6-phosphate dehydrogenase 3 1 0 
AT1G29150 non-ATPase subunit 9 1 0 
AT1G29900 carbamoyl phosphate synthetase B 1 0 
AT1G31780 Protein coding 1 0 
AT1G32440 plastidial pyruvate kinase 3 1 0 
AT1G33120 Ribosomal protein L6 family 1 0 
AT1G36280 L-Aspartase-like family protein 1 0 
AT1G48760 delta-adaptin 1 0 
AT1G48900 Signal recognition particle, SRP54 subunit protein 1 0 
AT1G53310 phosphoenolpyruvate carboxylase 1 1 0 
AT1G53750 regulatory particle triple-A 1A 1 0 
AT1G59960 NAD(P)-linked oxidoreductase superfamily protein 1 0 
AT1G69740 Aldolase superfamily protein 1 0 
AT1G70520 cysteine-rich RLK (RECEPTOR-like protein kinase) 2 1 0 
AT1G72010 TCP family transcription factor 1 0 
AT1G76150 enoyl-CoA hydratase 2 1 0 
AT1G76810 eukaryotic translation initiation factor 2 (eIF-2) family protein 1 0 
AT1G77670 Pyridoxal phosphate (PLP)-dependent transferases superfamily protein 1 0 
AT1G80720 Mitochondrial glycoprotein family protein 1 0 
AT2G06530 SNF7 family protein 1 0 
AT2G14260.2 proline iminopeptidase 1 0 
AT2G15430 DNA-directed RNA polymerase family protein 1 0 
AT2G15620 nitrite reductase 1 1 0 
AT2G16485 nucleic acid binding*zinc ion binding*DNA binding 1 0 
AT2G17130 isocitrate dehydrogenase subunit 2 1 0 
AT2G17390 ankyrin repeat-containing 2B 1 0 
AT2G20190 CLIP-associated protein 1 0 
AT2G20690 lumazine-binding family protein 1 0 
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AT2G23890 HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase 1 0 
AT2G31240 Tetratricopeptide repeat (TPR)-like superfamily protein 1 0 
AT2G31810 ACT domain-containing small subunit of acetolactate synthase protein 1 0 
AT2G34970 Trimeric LpxA-like enzyme 1 0 
AT2G35690 acyl-CoA oxidase 5 1 0 
AT2G36160 Ribosomal protein S11 family protein 1 0 
AT2G37790 NAD(P)-linked oxidoreductase superfamily protein 1 0 
AT2G40765 unknown protein 1 0 
AT2G42120 DNA polymerase delta small subunit 1 0 
AT2G42810 protein phosphatase 5.2 1 0 
AT2G44350 Citrate synthase family protein 1 0 
AT2G45980 unknown protein 1 0 
AT3G02360 6-phosphogluconate dehydrogenase family protein 1 0 
AT3G05780 lon protease 3 1 0 
AT3G06350 dehydroquinate dehydratase, putative / shikimate dehydrogenase, putative 1 0 
AT3G06650 ATP-citrate lyase B-1 1 0 
AT3G07630 arogenate dehydratase 2 1 0 
AT3G13300 Transducin/WD40 repeat-like superfamily protein 1 0 
AT3G15590 Tetratricopeptide repeat (TPR)-like superfamily protein 1 0 
AT3G17210 heat stable protein 1 1 0 
AT3G19170 presequence protease 1 1 0 
AT3G22980 Ribosomal protein S5/Elongation factor G/III/V family protein 1 0 
AT3G52230 unknown protein 1 0 
AT3G54540 general control non-repressible 4 1 0 
AT3G55610 delta 1-pyrroline-5-carboxylate synthase 2 1 0 
AT3G62010 unknown protein 1 0 
AT3G63250 homocysteine methyltransferase 2 1 0 
AT4G10320 tRNA synthetase class I (I, L, M and V) family protein 1 0 
AT4G24840 Protein coding 1 0 
AT4G26840 small ubiquitin-like modifier 1 1 0 
AT4G27070 tryptophan synthase beta-subunit 2 1 0 
AT4G27490 3'-5'-exoribonuclease family protein 1 0 
AT4G28400 Protein phosphatase 2C family protein 1 0 
AT4G32050 neurochondrin family protein 1 0 
AT4G34040 RING/U-box superfamily protein 1 0 
AT4G34110 poly(A) binding protein 2 1 0 
AT5G06770 KH domain-containing protein / zinc finger (CCCH type) family protein 1 0 
AT5G10470 kinesin like protein for actin based chloroplast movement 1 1 0 
AT5G12860 dicarboxylate transporter 1 1 0 
AT5G17060 ADP-ribosylation factor B1B 1 0 
AT5G22770 alpha-adaptin 1 0 
AT5G23060 calcium sensing receptor 1 0 
AT5G42970 Proteasome component (PCI) domain protein 1 0 
AT5G43940 GroES-like zinc-binding dehydrogenase family protein 1 0 
AT5G46280 Minichromosome maintenance (MCM2/3/5) family protein 1 0 
AT5G47880 eukaryotic release factor 1-1 1 0 
AT5G51430 conserved oligomeric Golgi complex component-related / COG complex 
component-related 
1 0 
AT5G53460 NADH-dependent glutamate synthase 1 1 0 
AT5G54900 RNA-binding protein 45A 1 0 
AT5G58040 homolog of yeast FIP1 [V] 1 0 
AT5G58220.3 transthyretin-like protein 1 0 
AT5G58410 HEAT/U-box domain-containing protein 1 0 
AT5G58490 NAD(P)-binding Rossmann-fold superfamily protein 1 0 
AT5G61220 LYR family of Fe/S cluster biogenesis protein 1 0 
AT5G65270 RAB GTPase homolog A4A 1 0 
ATMG00510 NADH dehydrogenase subunit 7 1 0 
AT1G09080 Heat shock protein 70 (Hsp 70) family protein 1 0 
AT1G11180 Secretory carrier membrane protein (SCAMP) family protein 1 0 
AT1G12310 Calcium-binding EF-hand family protein 1 0 
AT1G14510 alfin-like 7 1 0 
AT1G23190 Phosphoglucomutase/phosphomannomutase family protein 1 0 
AT1G35460 basic helix-loop-helix (bHLH) DNA-binding superfamily protein 1 0 
AT1G45000 AAA-type ATPase family protein 1 0 
AT1G53260 Protein coding 1 0 
AT1G53850 20S proteasome alpha subunit E1 1 0 
AT1G66080 unknown protein 1 0 
AT1G66240 homolog of anti-oxidant 1 1 0 
AT1G69830 alpha-amylase-like 3 1 0 
AT1G72550 tRNA synthetase beta subunit family protein 1 0 
AT1G80270 PENTATRICOPEPTIDE REPEAT 596 1 0 
AT1G80410 tetratricopeptide repeat (TPR)-containing protein 1 0 
AT1G80670 Transducin/WD40 repeat-like superfamily protein 1 0 
AT2G17630 Pyridoxal phosphate (PLP)-dependent transferases superfamily protein 1 0 
AT2G21150 XAP5 family protein 1 0 
AT2G22300 signal responsive 1 1 0 
AT2G45300 RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta 1 0 
AT3G02020 aspartate kinase 3 1 0 
AT3G03250 UDP-GLUCOSE PYROPHOSPHORYLASE 1 1 0 
AT3G10360 pumilio 4 1 0 
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AT3G12500 basic chitinase 1 0 
AT3G25530 glyoxylate reductase 1 1 0 
AT3G47340 glutamine-dependent asparagine synthase 1 1 0 
AT3G49680 branched-chain aminotransferase 3 1 0 
AT3G52140 tetratricopeptide repeat (TPR)-containing protein 1 0 
AT3G57610 adenylosuccinate synthase 1 0 
AT3G61960 Protein kinase superfamily protein 1 0 
AT4G00620 Amino acid dehydrogenase family protein 1 0 
AT4G02350 exocyst complex component sec15B 1 0 
AT4G02570 cullin 1 1 0 
AT4G04770 ATP binding cassette protein 1 1 0 
AT4G09000 general regulatory factor 1 1 0 
AT4G11150 vacuolar ATP synthase subunit E1 1 0 
AT4G17520 Hyaluronan / mRNA binding family 1 0 
AT5G21160 LA RNA-binding protein 1 0 
AT5G22480 ZPR1 zinc-finger domain protein 1 0 
AT5G43330 Lactate/malate dehydrogenase family protein 1 0 
AT5G43830 Aluminium induced protein with YGL and LRDR motifs 1 0 
AT5G63620 GroES-like zinc-binding alcohol dehydrogenase family protein 1 0 
AT5G64290 dicarboxylate transport 2 1 0 
AT5G66420 Uncharacterised conserved protein 1 0 
AT1G01620 plasma membrane intrinsic protein 1C 1 0 
AT1G07670 endomembrane-type CA-ATPase 4 1 0 
AT1G18450 actin-related protein 4 1 0 
AT1G64190 6-phosphogluconate dehydrogenase family protein 1 0 
AT1G79500 Aldolase-type TIM barrel family protein 1 0 
AT1G80480 plastid transcriptionally active 17 1 0 
AT2G01350.4 quinolinate phoshoribosyltransferase 1 0 
AT2G07640 NAD(P)-binding Rossmann-fold superfamily protein 1 0 
AT2G20630 PP2C induced by AVRRPM1 1 0 
AT2G36250 Tubulin/FtsZ family protein 1 0 
AT2G40290 Eukaryotic translation initiation factor 2 subunit 1 1 0 
AT2G40620 Basic-leucine zipper (bZIP) transcription factor family protein 1 0 
AT2G41100 Calcium-binding EF hand family protein 1 0 
AT3G05530 regulatory particle triple-A ATPase 5A 1 0 
AT3G13222 GBF-interacting protein 1 1 0 
AT4G01050 thylakoid rhodanese-like 1 0 
AT4G02060 Minichromosome maintenance (MCM2/3/5) family protein 1 0 
AT4G18480 P-loop containing nucleoside triphosphate hydrolases superfamily protein 1 0 
AT4G19540 IND1(iron-sulfur protein required for NADH dehydrogenase)-like 1 0 
AT4G31300 N-terminal nucleophile aminohydrolases (Ntn hydrolases) superfamily 
protein 
1 0 
AT4G38630 regulatory particle non-ATPase 10 1 0 
AT5G10940 transducin family protein / WD-40 repeat family protein 1 0 
AT5G16510 Alpha-1,4-glucan-protein synthase family protein 1 0 
AT5G24520 Transducin/WD40 repeat-like superfamily protein 1 0 
AT5G39570 Protein coding 1 0 
AT5G50920 CLPC homologue 1 1 0 
AT5G54430 Adenine nucleotide alpha hydrolases-like superfamily protein 1 0 
AT5G60980 Nuclear transport factor 2 (NTF2) family protein with RNA binding 
(RRM-RBD-RNP motifs) domain 
1 0 
AT5G62690 tubulin beta chain 2 1 0 
AT1G66410 calmodulin 4 1 0 
AT1G51710 ubiquitin-specific protease 6 6 1 
AT2G42520 P-loop containing nucleoside triphosphate hydrolases superfamily protein 6 1 
AT1G79920 Heat shock protein 70 (Hsp 70) family protein 6 1 
AT1G56410 heat shock protein 70 (Hsp 70) family protein 5 1 
AT1G49760 poly(A) binding protein 8 4 1 
AT1G09640 Translation elongation factor EF1B, gamma chain 4 1 
AT1G14980 chaperonin 10 4 1 
AT5G20890 TCP-1/cpn60 chaperonin family protein 4 1 
AT5G13110 glucose-6-phosphate dehydrogenase 2 4 1 
AT1G42970 glyceraldehyde-3-phosphate dehydrogenase B subunit 3 1 
AT2G31660 ARM repeat superfamily protein 3 1 
AT3G03910 glutamate dehydrogenase 3 3 1 
AT2G47510 fumarase 1 3 1 
AT3G43190 sucrose synthase 4 3 1 
AT5G50850 Transketolase family protein 3 1 
AT1G07370 proliferating cellular nuclear antigen 1 3 1 
AT1G52760 lysophospholipase 2 3 1 
AT2G32730 26S proteasome regulatory complex, non-ATPase subcomplex, 
Rpn2/Psmd1 subunit 
3 1 
AT2G45620 Nucleotidyltransferase family protein 3 1 
AT3G07770 HEAT SHOCK PROTEIN 89 3 1 
AT3G59820 LETM1-like protein 3 1 
AT4G15410 serine/threonine protein phosphatase 2A 55 kDa regulatory subunit B 
prime gamma 
3 1 
AT4G24190 Chaperone protein htpG family protein 3 1 
AT4G39260 cold, circadian rhythm, and RNA binding 1 3 1 
AT5G10860 Cystathionine beta-synthase (CBS) family protein 3 1 
AT5G26360 TCP-1/cpn60 chaperonin family protein 3 1 
AT5G65430 general regulatory factor 8 3 1 
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AT5G67630 P-loop containing nucleoside triphosphate hydrolases superfamily protein 3 1 
AT1G18500 methylthioalkylmalate synthase-like 4 3 1 
AT3G13920 eukaryotic translation initiation factor 4A1 3 1 
AT5G22060 DNAJ homologue 2 3 1 
AT5G15530 biotin carboxyl carrier protein 2 3 1 
AT3G50370 unknown protein 3 1 
AT4G33030 sulfoquinovosyldiacylglycerol 1 3 1 
AT1G17720 Protein phosphatase 2A, regulatory subunit PR55 2 1 
AT1G60690 NAD(P)-linked oxidoreductase superfamily protein 2 1 
AT1G65220 ARM repeat superfamily protein 2 1 
AT1G71220 UDP-glucose:glycoprotein glucosyltransferases 2 1 
AT2G01140 Aldolase superfamily protein 2 1 
AT2G36060 MMS ZWEI homologue 3 2 1 
AT2G44100 guanosine nucleotide diphosphate dissociation inhibitor 1 2 1 
AT3G02260 auxin transport protein (BIG) 2 1 
AT4G05530 indole-3-butyric acid response 1 2 1 
AT5G05990 Mitochondrial glycoprotein family protein 2 1 
AT5G17000 Zinc-binding dehydrogenase family protein 2 1 
AT5G17270 Protein prenylyltransferase superfamily protein 2 1 
AT5G35790 glucose-6-phosphate dehydrogenase 1 2 1 
AT5G44720 Molybdenum cofactor sulfurase family protein 2 1 
AT5G51110 Transcriptional coactivator/pterin dehydratase 2 1 
AT5G67560 ADP-ribosylation factor-like A1D 2 1 
AT1G52360 Coatomer, beta' subunit 2 1 
AT1G62020 Coatomer, alpha subunit 2 1 
AT1G78650 DNA-directed DNA polymerases 2 1 
AT2G01190 Octicosapeptide/Phox/Bem1p family protein 2 1 
AT2G18510 RNA-binding (RRM/RBD/RNP motifs) family protein 2 1 
AT2G25970 KH domain-containing protein 2 1 
AT2G41220 glutamate synthase 2 2 1 
AT3G05790 lon protease 4 2 1 
AT3G09840 cell division cycle 48 2 1 
AT3G52180 dual specificity protein phosphatase (DsPTP1) family protein 2 1 
AT3G54360 zinc ion binding 2 1 
AT3G55380 ubiquitin-conjugating enzyme 14 2 1 
AT3G60240.2 eukaryotic translation initiation factor 4G 2 1 
AT4G01100 adenine nucleotide transporter 1 2 1 
AT4G20850 tripeptidyl peptidase ii 2 1 
AT5G23140 nuclear-encoded CLP protease P7 2 1 
AT5G37510 NADH-ubiquinone dehydrogenase, mitochondrial, putative 2 1 
AT5G41210 glutathione S-transferase THETA 1 2 1 
AT5G42220 Ubiquitin-like superfamily protein 2 1 
AT1G04810 26S proteasome regulatory complex, non-ATPase subcomplex, 
Rpn2/Psmd1 subunit 
2 1 
AT1G07360 CCCH-type zinc fingerfamily protein with RNA-binding domain 2 1 
AT1G10200 GATA type zinc finger transcription factor family protein 2 1 
AT1G11840 glyoxalase I homolog 2 1 
AT1G13870 calmodulin binding*purine nucleotide binding 2 1 
AT1G15870 Mitochondrial glycoprotein family protein 2 1 
AT1G16300 glyceraldehyde-3-phosphate dehydrogenase of plastid 2 2 1 
AT1G20010 tubulin beta-5 chain 2 1 
AT1G24360 NAD(P)-binding Rossmann-fold superfamily protein 2 1 
AT1G28200 FH interacting protein 1 2 1 
AT1G34430 2-oxoacid dehydrogenases acyltransferase family protein 2 1 
AT1G35160 GF14 protein phi chain 2 1 
AT1G51690 protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform 2 1 
AT1G69230 SPIRAL1-like2 2 1 
AT1G71270 Vps52 / Sac2 family 2 1 
AT1G79550 phosphoglycerate kinase 2 1 
AT2G03680 spiral1 2 1 
AT2G07690 Minichromosome maintenance (MCM2/3/5) family protein 2 1 
AT2G07727 Di-haem cytochrome, transmembrane*Cytochrome b/b6, C-terminal 2 1 
AT2G17980 Sec1/munc18-like (SM) proteins superfamily 2 1 
AT2G31390 pfkB-like carbohydrate kinase family protein 2 1 
AT3G08590 Phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent 2 1 
AT3G13860 heat shock protein 60-3A 2 1 
AT3G19760 eukaryotic initiation factor 4A-III 2 1 
AT3G20250 pumilio 5 2 1 
AT3G48750 cell division control 2 2 1 
AT3G48870 Clp ATPase 2 1 
AT3G52300 ATP synthase D chain, mitochondrial 2 1 
AT4G09320 Nucleoside diphosphate kinase family protein 2 1 
AT4G27585 SPFH/Band 7/PHB domain-containing membrane-associated protein 
family 
2 1 
AT4G31790 Tetrapyrrole (Corrin/Porphyrin) Methylases 2 1 
AT5G06460 ubiquitin activating enzyme 2 2 1 
AT5G10240 asparagine synthetase 3 2 1 
AT5G11670 NADP-malic enzyme 2 2 1 
AT5G12850 CCCH-type zinc finger protein with ARM repeat domain 2 1 
AT5G13420 Aldolase-type TIM barrel family protein 2 1 
AT5G16050 general regulatory factor 5 2 1 
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AT5G16290 VALINE-TOLERANT 1 2 1 
AT5G17310.2 UDP-glucose pyrophosphorylase 2 2 1 
AT5G27600 long-chain acyl-CoA synthetase 7 2 1 
AT5G38480 general regulatory factor 3 2 1 
AT5G40190 RNA ligase/cyclic nucleotide phosphodiesterase family protein 2 1 
AT5G54770 thiazole biosynthetic enzyme, chloroplast (ARA6) (THI1) (THI4) 2 1 
AT1G72370 40s ribosomal protein SA 2 1 
AT3G29360 UDP-glucose 6-dehydrogenase family protein 2 1 
AT5G12110 Glutathione S-transferase, C-terminal-like*Translation elongation  factor 
EF1B/ribosomal protein S6 
2 1 
AT5G60170 RNA binding (RRM/RBD/RNP motifs) family protein 2 1 
AT2G22250 aspartate aminotransferase 2 1 
AT5G66760 succinate dehydrogenase 1-1 2 1 
AT3G03780 methionine synthase 2 6 2 
AT4G27440 protochlorophyllide oxidoreductase B 6 2 
AT3G09440 Heat shock protein 70 (Hsp 70) family protein 6 2 
AT2G25140 casein lytic proteinase B4 6 2 
AT1G52670 Single hybrid motif superfamily protein 5 2 
AT3G60750 Transketolase 5 2 
AT3G63460 transducin family protein / WD-40 repeat family protein 5 2 
AT1G27450.2 adenine phosphoribosyl transferase 1 5 2 
AT5G17920 Cobalamin-independent synthase family protein 5 2 
AT2G16600 rotamase CYP 3 4 2 
AT3G22330 putative mitochondrial RNA helicase 2 4 2 
AT3G18190 TCP-1/cpn60 chaperonin family protein 4 2 
AT3G22200 Pyridoxal phosphate (PLP)-dependent transferases superfamily protein 4 2 
AT3G16950 lipoamide dehydrogenase 1 4 2 
AT1G71380 cellulase 3 4 2 
AT1G12410 CLP protease proteolytic subunit 2 3 2 
AT1G22920 COP9 signalosome 5A 3 2 
AT1G26570 UDP-glucose dehydrogenase 1 3 2 
AT2G44310 Calcium-binding EF-hand family protein 3 2 
AT3G22430 Protein coding 3 2 
AT3G02520 general regulatory factor 7 3 2 
AT3G56150 eukaryotic translation initiation factor 3C 3 2 
AT4G19880 Glutathione S-transferase family protein 3 2 
AT1G15140 FAD/NAD(P)-binding oxidoreductase 3 2 
AT1G27970 nuclear transport factor 2B 3 2 
AT1G70770 Protein of unknown function DUF2359, transmembrane 3 2 
AT1G79340 metacaspase 4 3 2 
AT1G79530 glyceraldehyde-3-phosphate dehydrogenase of plastid 1 3 2 
AT2G45140 plant VAP homolog 12 3 2 
AT3G22890 ATP sulfurylase 1 3 2 
AT3G43300 HOPM interactor 7 3 2 
AT3G55440 triosephosphate isomerase 3 2 
AT5G11340 Acyl-CoA N-acyltransferases (NAT) superfamily protein 3 2 
AT5G15770 glucose-6-phosphate acetyltransferase 1 3 2 
AT5G20720 chaperonin 20 3 2 
AT5G42790 proteasome alpha subunit F1 3 2 
AT5G45130 RAB homolog 1 3 2 
AT5G65020 annexin 2 3 2 
AT1G53240 Lactate/malate dehydrogenase family protein 3 2 
AT1G73010 phosphate starvation-induced gene 2 3 2 
AT3G46060 RAB GTPase homolog 8A 3 2 
AT3G51160 NAD(P)-binding Rossmann-fold superfamily protein 3 2 
AT4G20020 unknown protein 3 2 
AT4G28440 Nucleic acid-binding, OB-fold-like protein 3 2 
AT4G34870 rotamase cyclophilin 5 3 2 
AT5G13260 unknown protein 3 2 
AT5G17380 Thiamine pyrophosphate dependent pyruvate decarboxylase family 
protein 
3 2 
AT5G56030 heat shock protein 81-2 3 2 
AT5G58290 regulatory particle triple-A ATPase 3 3 2 
AT5G59710 VIRE2 interacting protein 2 3 2 
AT1G36160 acetyl-CoA carboxylase 1 3 2 
AT2G16440 Minichromosome maintenance (MCM2/3/5) family protein 3 2 
AT2G38940 phosphate transporter 1*4 3 2 
AT2G43140 basic helix-loop-helix (bHLH) DNA-binding superfamily protein 3 2 
AT2G05990 NAD(P)-binding Rossmann-fold superfamily protein 3 2 
AT3G07810 RNA-binding (RRM/RBD/RNP motifs) family protein 3 2 
AT5G64260 EXORDIUM like 2 3 2 
AT1G49600 RNA-binding protein 47A 2 2 
AT3G42790 alfin-like 3 2 2 
AT5G16730 Plant protein of unknown function (DUF827) 2 2 
AT1G16890.2 ubiquitin-conjugating enzyme 36 2 2 
AT1G32580 plastid developmental protein DAG, putative 2 2 
AT2G03230 GCK domain-containing protein 2 2 
AT2G20140 AAA-type ATPase family protein 2 2 
AT3G02090 Insulinase (Peptidase family M16) protein 2 2 
AT4G17510 ubiquitin C-terminal hydrolase 3 2 2 
AT5G03290 isocitrate dehydrogenase V 2 2 
AT5G12370 exocyst complex component sec10 2 2 
AT5G25940 early nodulin-related 2 2 
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AT5G27770 Ribosomal L22e protein family 2 2 
AT1G09100 26S proteasome AAA-ATPase subunit RPT5B 2 2 
AT1G16520 unknown protein 2 2 
AT1G30890 Integral membrane HRF1 family protein 2 2 
AT1G43190 polypyrimidine tract-binding protein 3 2 2 
AT2G02470 alfin-like 6 2 2 
AT2G02740 ssDNA-binding transcriptional regulator 2 2 
AT2G41530 S-formylglutathione hydrolase 2 2 
AT2G46520 cellular apoptosis susceptibility protein, putative / importin-alpha re-
exporter, putative 
2 2 
AT3G03660 WUSCHEL related homeobox 11 2 2 
AT3G10380 subunit of exocyst complex 8 2 2 
AT3G45770 Polyketide synthase, enoylreductase family protein 2 2 
AT3G52560 ubiquitin E2 variant 1D-4 2 2 
AT3G55620 Translation initiation factor IF6 2 2 
AT3G60830 actin-related protein 7 2 2 
AT4G11380 Adaptin family protein 2 2 
AT4G23650 calcium-dependent protein kinase 6 2 2 
AT4G27270 Quinone reductase family protein 2 2 
AT4G34200 D-3-phosphoglycerate dehydrogenase 2 2 
AT4G37190 Protein coding 2 2 
AT4G38740 rotamase CYP 1 2 2 
AT5G02500 heat shock cognate protein 70-1 2 2 
AT5G08300 Succinyl-CoA ligase, alpha subunit 2 2 
AT5G12150 Rho GTPase activation protein (RhoGAP) with PH domain 2 2 
AT5G16300 Vps51/Vps67 family (components of vesicular transport) protein 2 2 
AT5G55280 homolog of bacterial cytokinesis Z-ring protein FTSZ 1-1 2 2 
AT5G56290 peroxin 5 2 2 
AT1G51980 Insulinase (Peptidase family M16) protein 2 2 
AT2G39770 Glucose-1-phosphate adenylyltransferase family protein 2 2 
AT4G33070 Thiamine pyrophosphate dependent pyruvate decarboxylase family 
protein 
2 2 
AT5G12250 beta-6 tubulin 2 2 
AT5G52920 plastidic pyruvate kinase beta subunit 1 2 2 
AT2G29550 tubulin beta-7 chain 2 2 
AT4G34030 3-methylcrotonyl-CoA carboxylase 2 2 
AT5G23540 Mov34/MPN/PAD-1 family protein 2 2 
AT5G52640 heat shock protein 90 6 3 
AT3G48560 chlorsulfuron/imidazolinone resistant 1 6 3 
AT2G02560 cullin-associated and neddylation dissociated 6 3 
AT3G02530 TCP-1/cpn60 chaperonin family protein 6 3 
AT2G39730 rubisco activase 5 3 
AT2G21330 fructose-bisphosphate aldolase 1 5 3 
AT1G16030 heat shock protein 70B 4 3 
AT1G12000 Phosphofructokinase family protein 4 3 
AT1G13440 glyceraldehyde-3-phosphate dehydrogenase C2 4 3 
AT3G04880 DNA-damage-repair/toleration protein (DRT102) 3 3 
AT1G30630 Coatomer epsilon subunit 3 3 
AT1G79230 mercaptopyruvate sulfurtransferase 1 3 3 
AT2G43090 Aconitase/3-isopropylmalate dehydratase protein 3 3 
AT3G22850 Aluminium induced protein with YGL and LRDR motifs 3 3 
AT3G44110 DNAJ homologue 3 3 3 
AT1G04410 Lactate/malate dehydrogenase family protein 3 3 
AT1G07705 NOT2 / NOT3 / NOT5 family 3 3 
AT1G32500 non-intrinsic ABC protein 6 3 3 
AT2G36530 Enolase 3 3 
AT3G15660 glutaredoxin 4 3 3 
AT3G20050 T-complex protein 1 alpha subunit 3 3 
AT3G56240 copper chaperone 3 3 
AT3G62120 Class II aaRS and biotin synthetases superfamily protein 3 3 
AT5G22650 histone deacetylase 2B 3 3 
AT1G50570 Calcium-dependent lipid-binding (CaLB domain) family protein 3 3 
AT2G05710 aconitase 3 3 3 
AT1G35720 annexin 1 3 3 
AT1G53500 NAD-dependent epimerase/dehydratase family protein 3 3 
AT1G69410 eukaryotic elongation factor 5A-3 3 3 
AT3G54470 uridine 5'-monophosphate synthase / UMP synthase (PYRE-F) (UMPS) 3 3 
AT4G29840 Pyridoxal-5'-phosphate-dependent enzyme family protein 2 3 
AT1G22840 CYTOCHROME C-1 2 3 
AT1G52730 Transducin/WD40 repeat-like superfamily protein 2 3 
AT3G53580 diaminopimelate epimerase family protein 2 3 
AT4G25130 peptide met sulfoxide reductase 4 2 3 
AT5G20060 alpha/beta-Hydrolases superfamily protein 2 3 
AT1G20110 RING/FYVE/PHD zinc finger superfamily protein 2 3 
AT3G08530 Clathrin, heavy chain 2 3 
AT5G15490 UDP-glucose 6-dehydrogenase family protein 2 3 
AT5G55530 Calcium-dependent lipid-binding (CaLB domain) family protein 2 3 
AT1G63000 nucleotide-rhamnose synthase/epimerase-reductase 2 3 
AT4G24280 chloroplast heat shock protein 70-1 7 4 
AT1G77120 alcohol dehydrogenase 1 6 4 
AT1G03090.2 methylcrotonyl-CoA carboxylase alpha chain, mitochondrial / 3-
methylcrotonyl-CoA carboxylase 1 (MCCA) 
6 4 
AT2G16570 GLN phosphoribosyl pyrophosphate amidotransferase 1 6 4 
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AT5G14040 phosphate transporter 3*1 5 4 
AT2G27730 copper ion binding 4 4 
AT2G21660 cold, circadian rhythm, and rna binding 2 4 4 
AT1G24510 TCP-1/cpn60 chaperonin family protein 4 4 
AT3G12050 Aha1 domain-containing protein 4 4 
AT5G28540 heat shock protein 70 (Hsp 70) family protein 4 4 
AT5G16710 dehydroascorbate reductase 1 4 4 
AT5G44340 tubulin beta chain 4 3 4 
AT5G20010 RAS-related nuclear protein-1 3 4 
AT5G02490 Heat shock protein 70 (Hsp 70) family protein 2 4 
AT5G09810 actin 7 2 4 
AT3G62530 ARM repeat superfamily protein 9 5 
AT2G37620 actin 1 8 5 
AT1G49240 actin 8 7 5 
AT5G56000 HEAT SHOCK PROTEIN 81.4 6 5 
AT2G44060 Late embryogenesis abundant protein, group 2 6 5 
AT3G25860 2-oxoacid dehydrogenases acyltransferase family protein 6 5 
AT2G04030 Chaperone protein htpG family protein 5 5 
AT2G36460 Aldolase superfamily protein 4 5 
AT3G08580 ADP/ATP carrier 1 4 5 
AT2G20580 26S proteasome regulatory subunit S2 1A 4 5 
AT3G56130 biotin/lipoyl attachment domain-containing protein 4 5 
AT5G13280 aspartate kinase 1 3 5 
AT1G55490 chaperonin 60 beta 9 6 
AT3G12580 heat shock protein 70 8 6 
AT1G54270 eif4a-2 8 6 
AT1G78900 vacuolar ATP synthase subunit A 8 6 
AT5G65720 nitrogen fixation S (NIFS)-like 1 7 6 
AT1G56070 Ribosomal protein S5/Elongation factor G/III/V family protein 7 6 
AT3G52930 Aldolase superfamily protein 7 6 
AT1G43800 Plant stearoyl-acyl-carrier-protein desaturase family protein 6 6 
AT5G35360 acetyl Co-enzyme a carboxylase biotin carboxylase subunit 6 6 
AT5G18230 transcription regulator NOT2/NOT3/NOT5 family protein 6 6 
AT2G45290 Transketolase 6 6 
AT1G24300 GYF domain-containing protein 5 6 
AT5G16390 chloroplastic acetylcoenzyme A carboxylase 1 5 6 
AT4G02930 GTP binding Elongation factor Tu family protein 9 7 
AT4G20360 RAB GTPase homolog E1B 9 7 
AT5G08670 ATP synthase alpha/beta family protein 9 7 
AT2G07698 ATPase, F1 complex, alpha subunit protein 9 7 
AT3G17390 S-adenosylmethionine synthetase family protein 9 7 
AT5G09590 mitochondrial HSO70 2 9 7 
AT1G26630 Eukaryotic translation initiation factor 5A-1 (eIF-5A 1) protein 6 7 
AT1G27430 GYF domain-containing protein 6 7 
AT2G28000 chaperonin-60alpha 6 7 
AT1G07920 GTP binding Elongation factor Tu family protein 9 8 
AT3G04120 glyceraldehyde-3-phosphate dehydrogenase C subunit 1 8 8 
AT5G19550 aspartate aminotransferase 2 8 8 
AT3G03960 TCP-1/cpn60 chaperonin family protein 7 8 
AT4G37910 mitochondrial heat shock protein 70-1 9 9 
AT1G04820 tubulin alpha-4 chain 8 9 
 
Supplemental table 2. List of identified proteins for the ES9-18 affinity purification 
Numbers indicate the times a protein is found out of 3 biological repeats. Proteins which were not 
found with the ES9-18 analog, yet were present with the ES9-13 analog, are removed. Similarly all 
proteins found only once with the ES9-18 analog, but present at least once with the ES9-13 analog 
were removed. 
ACCESSION DESCRIPTION ES9-18 ES9-13 
AT3G01540 DEAD box RNA helicase 1 3 0 
AT4G36210.3 Protein of unknown function (DUF726) 3 0 
AT1G09870 histidine acid phosphatase family protein 2 0 
AT1G22840 CYTOCHROME C-1 2 0 
AT1G31910 GHMP kinase family protein 2 0 
AT1G34430 2-oxoacid dehydrogenases acyltransferase family protein 2 0 
AT1G70660 MMS ZWEI homologue 2 2 0 
AT1G72150 PATELLIN 1 2 0 
AT1G73430 sec34-like family protein 2 0 
AT2G05990 NAD(P)-binding Rossmann-fold superfamily protein 2 0 
AT3G04120 glyceraldehyde-3-phosphate dehydrogenase C subunit 1 2 0 
AT4G18480 P-loop containing nucleoside triphosphate hydrolases superfamily 
protein 
2 0 
AT4G29840 Pyridoxal-5'-phosphate-dependent enzyme family protein 2 0 
AT5G05980 DHFS-FPGS homolog B 2 0 
AT5G19990 regulatory particle triple-A ATPase 6A 2 0 
AT5G48300 ADP glucose pyrophosphorylase  1 2 0 
AT1G01960 SEC7-like guanine nucleotide exchange family protein 1 0 
AT1G03630 protochlorophyllide oxidoreductase C 1 0 
AT1G04620 coenzyme F420 hydrogenase family / dehydrogenase, beta subunit 
family 
1 0 
AT1G06410 trehalose-phosphatase/synthase 7 1 0 
AT1G07360 CCCH-type zinc fingerfamily protein with RNA-binding domain 1 0 
AT1G07370 proliferating cellular nuclear antigen 1 1 0 
AT1G07790 Histone superfamily protein 1 0 
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AT1G08200 UDP-D-apiose/UDP-D-xylose synthase 2 1 0 
AT1G09430 ATP-citrate lyase A-3 1 0 
AT1G11840 glyoxalase I homolog 1 0 
AT1G12775 Pentatricopeptide repeat (PPR) superfamily protein 1 0 
AT1G13450 Homeodomain-like superfamily protein 1 0 
AT1G14360 UDP-galactose transporter 3 1 0 
AT1G15210 pleiotropic drug resistance 7 1 0 
AT1G15710 prephenate dehydrogenase family protein 1 0 
AT1G15910 XH/XS domain-containing protein 1 0 
AT1G16520 unknown protein 1 0 
AT1G18450 actin-related protein 4 1 0 
AT1G18500 methylthioalkylmalate synthase-like 4 1 0 
AT1G20260 ATPase, V1 complex, subunit B protein 1 0 
AT1G20950 Phosphofructokinase family protein 1 0 
AT1G23260 MMS ZWEI homologue 1 1 0 
AT1G30890 Integral membrane HRF1 family protein 1 0 
AT1G31230 aspartate kinase-homoserine dehydrogenase i 1 0 
AT1G31800 cytochrome P450, family 97, subfamily A, polypeptide 3 1 0 
AT1G32350 alternative oxidase 1D 1 0 
AT1G42550 plastid movement impaired1 1 0 
AT1G42970 glyceraldehyde-3-phosphate dehydrogenase B subunit 1 0 
AT1G74310 heat shock protein 101 1 0 
AT1G77730 Pleckstrin homology (PH) domain superfamily protein 1 0 
AT2G14120 dynamin related protein 1 0 
AT2G23370 unknown protein 1 0 
AT2G26660 SPX domain gene 2 1 0 
AT2G29470 glutathione S-transferase tau 3 1 0 
AT2G33040 gamma subunit of Mt ATP synthase 1 0 
AT2G42890 MEI2-like 2 1 0 
AT2G42910 Phosphoribosyltransferase family protein 1 0 
AT2G47730 glutathione S-transferase phi 8 1 0 
AT3G02080 Ribosomal protein S19e family protein 1 0 
AT3G03570 Protein of unknown function (DUF3550/UPF0682) 1 0 
AT3G05590 ribosomal protein L18 1 0 
AT3G08943 ARM repeat superfamily protein 1 0 
AT3G09200 Ribosomal protein L10 family protein 1 0 
AT3G10950 Zinc-binding ribosomal protein family protein 1 0 
AT3G11510 Ribosomal protein S11 family protein 1 0 
AT3G16950 lipoamide dehydrogenase 1 1 0 
AT3G22270 Topoisomerase II-associated protein PAT1 1 0 
AT3G29360 UDP-glucose 6-dehydrogenase family protein 1 0 
AT3G48850 phosphate transporter 3*2 1 0 
AT3G48860 unknown protein 1 0 
AT3G50370 unknown protein 1 0 
AT3G51550 Malectin/receptor-like protein kinase family protein 1 0 
AT3G62010 unknown protein 1 0 
AT4G02570 cullin 1 1 0 
AT4G04910 AAA-type ATPase family protein 1 0 
AT4G13890 Pyridoxal phosphate (PLP)-dependent transferases superfamily protein 1 0 
AT4G21710 DNA-directed RNA polymerase family protein 1 0 
AT4G22000 unknown protein 1 0 
AT4G22380 Ribosomal protein L7Ae/L30e/S12e/Gadd45 family protein 1 0 
AT4G34450 coatomer gamma-2 subunit, putative / gamma-2 coat protein, putative / 
gamma-2 COP, putative 
1 0 
AT5G01010 Protein coding 1 0 
AT5G02490 Heat shock protein 70 (Hsp 70) family protein 1 0 
AT5G06970 Protein of unknown function (DUF810) 1 0 
AT5G08300 Succinyl-CoA ligase, alpha subunit 1 0 
AT5G08740 NAD(P)H dehydrogenase C1 1 0 
AT5G09810 actin 7 1 0 
AT5G10860 Cystathionine beta-synthase (CBS) family protein 1 0 
AT5G16210 HEAT repeat-containing protein 1 0 
AT5G16730 Plant protein of unknown function (DUF827) 1 0 
AT5G20650 copper transporter 5 1 0 
AT5G25270 Ubiquitin-like superfamily protein 1 0 
AT5G26040 histone deacetylase 2 1 0 
AT5G43010 regulatory particle triple-A ATPase 4A 1 0 
AT5G49830 exocyst complex component 84B 1 0 
AT5G50210 quinolinate synthase 1 0 
AT5G50870 ubiquitin-conjugating enzyme 27 1 0 
AT5G53930 unknown protein 1 0 
AT5G62690 tubulin beta chain 2 1 0 
AT5G67630 P-loop containing nucleoside triphosphate hydrolases superfamily 
protein 
1 0 
AT1G29150 non-ATPase subunit 9 3 1 
AT1G53500 NAD-dependent epimerase/dehydratase family protein 3 1 
AT1G56500 haloacid dehalogenase-like hydrolase family protein 3 1 
AT1G70770 Protein of unknown function DUF2359, transmembrane 3 1 
AT3G14390 Pyridoxal-dependent decarboxylase family protein 3 1 
AT3G55620 Translation initiation factor IF6 3 1 
AT5G16300 Vps51/Vps67 family (components of vesicular transport) protein 3 1 
AT5G52520 Class II aaRS and biotin synthetases superfamily protein 3 1 
AT5G60980 Nuclear transport factor 2 (NTF2) family protein with RNA binding 
(RRM-RBD-RNP motifs) domain 
3 1 
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ATCG00470 ATP synthase epsilon chain 3 1 
AT1G02690 importin alpha isoform 6 2 1 
AT1G04750 vesicle-associated membrane protein 721 2 1 
AT1G07180 alternative  NAD(P)H dehydrogenase 1 2 1 
AT1G24510 TCP-1/cpn60 chaperonin family protein 2 1 
AT1G36160 acetyl-CoA carboxylase 1 2 1 
AT1G37130 nitrate reductase 2 2 1 
AT1G51980 Insulinase (Peptidase family M16) protein 2 1 
AT1G71820 SEC6 2 1 
AT1G76810 eukaryotic translation initiation factor 2 (eIF-2) family protein 2 1 
AT1G78650 DNA-directed DNA polymerases 2 1 
AT1G79920 Heat shock protein 70 (Hsp 70) family protein 2 1 
AT2G15620 nitrite reductase 1 2 1 
AT2G21790 ribonucleotide reductase 1 2 1 
AT2G43160 ENTH/VHS family protein 2 1 
AT3G02260 auxin transport protein (BIG) 2 1 
AT3G05560 Ribosomal L22e protein family 2 1 
AT3G05680 embryo defective 2016 2 1 
AT3G08530 Clathrin, heavy chain 2 1 
AT3G12760 Protein coding 2 1 
AT3G15450 Aluminium induced protein with YGL and LRDR motifs 2 1 
AT3G21110 purin 7 2 1 
AT3G22310 putative mitochondrial RNA helicase 1 2 1 
AT3G57350 Nucleoporin interacting component (Nup93/Nic96-like) family protein 2 1 
AT3G62460 Putative endonuclease or glycosyl hydrolase 2 1 
AT3G63460 transducin family protein / WD-40 repeat family protein 2 1 
AT4G02060 Minichromosome maintenance (MCM2/3/5) family protein 2 1 
AT5G04910 unknown protein 2 1 
AT5G09890 Protein kinase family protein 2 1 
AT5G11060 KNOTTED1-like homeobox gene 4 2 1 
AT5G13260 unknown protein 2 1 
AT5G13280 aspartate kinase 1 2 1 
AT5G15770 glucose-6-phosphate acetyltransferase 1 2 1 
AT5G16050 general regulatory factor 5 2 1 
AT5G44720 Molybdenum cofactor sulfurase family protein 2 1 
AT5G58290 regulatory particle triple-A ATPase 3 2 1 
AT5G64270 splicing factor, putative 2 1 
AT5G65020 annexin 2 2 1 
AT1G04290 Thioesterase superfamily protein 3 2 
AT1G22410 Class-II DAHP synthetase family protein 3 2 
AT1G33120 Ribosomal protein L6 family 3 2 
AT1G51710 ubiquitin-specific protease 6 3 2 
AT2G04030 Chaperone protein htpG family protein 3 2 
AT2G07727 Di-haem cytochrome, transmembrane*Cytochrome b/b6, C-terminal 3 2 
AT2G15860 unknown protein 3 2 
AT2G16440 Minichromosome maintenance (MCM2/3/5) family protein 3 2 
AT2G16570 GLN phosphoribosyl pyrophosphate amidotransferase 1 3 2 
AT2G20140 AAA-type ATPase family protein 3 2 
AT2G21600 endoplasmatic reticulum retrieval protein 1B 3 2 
AT2G22170 Lipase/lipooxygenase, PLAT/LH2 family protein 3 2 
AT2G31660 ARM repeat superfamily protein 3 2 
AT2G36530 Enolase 3 2 
AT2G39770 Glucose-1-phosphate adenylyltransferase family protein 3 2 
AT2G45140 plant VAP homolog 12 3 2 
AT3G02530 TCP-1/cpn60 chaperonin family protein 3 2 
AT3G04880 DNA-damage-repair/toleration protein (DRT102) 3 2 
AT3G05790 lon protease 4 3 2 
AT3G09840 cell division cycle 48 3 2 
AT3G12580 heat shock protein 70 3 2 
AT3G15410 Leucine-rich repeat (LRR) family protein 3 2 
AT3G20050 T-complex protein 1 alpha subunit 3 2 
AT3G22200 Pyridoxal phosphate (PLP)-dependent transferases superfamily protein 3 2 
AT3G23400 Plastid-lipid associated protein PAP / fibrillin family protein 3 2 
AT3G45190 SIT4 phosphatase-associated family protein 3 2 
AT3G51140 Protein of unknown function (DUF3353) 3 2 
AT3G62120 Class II aaRS and biotin synthetases superfamily protein 3 2 
AT4G24840 Protein coding 3 2 
AT4G28440 Nucleic acid-binding, OB-fold-like protein 3 2 
AT4G34490 cyclase associated protein 1 3 2 
AT5G03290 isocitrate dehydrogenase V 3 2 
AT5G17380 Thiamine pyrophosphate dependent pyruvate decarboxylase family 
protein 
3 2 
AT5G18230 transcription regulator NOT2/NOT3/NOT5 family protein 3 2 
AT5G27770 Ribosomal L22e protein family 3 2 
AT5G28540 heat shock protein 70 (Hsp 70) family protein 3 2 
AT5G35360 acetyl Co-enzyme a carboxylase biotin carboxylase subunit 3 2 
AT5G42150 Glutathione S-transferase family protein 3 2 
AT5G43970 translocase of outer membrane 22-V 3 2 
AT5G62810 peroxin 14 3 2 
AT5G66760 succinate dehydrogenase 1-1 3 2 
AT1G10270 glutamine-rich protein 23 2 2 
AT1G21770 Acyl-CoA N-acyltransferases (NAT) superfamily protein 2 2 
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AT1G28200 FH interacting protein 1 2 2 
AT1G31780 Protein coding 2 2 
AT1G32500 non-intrinsic ABC protein 6 2 2 
AT1G32580 plastid developmental protein DAG, putative 2 2 
AT1G43190 polypyrimidine tract-binding protein 3 2 2 
AT1G44900 minichromosome maintenance (MCM2/3/5) family protein 2 2 
AT1G48760 delta-adaptin 2 2 
AT1G50670 OTU-like cysteine protease family protein 2 2 
AT1G55840 Sec14p-like phosphatidylinositol transfer family protein 2 2 
AT1G62020 Coatomer, alpha subunit 2 2 
AT1G71270 Vps52 / Sac2 family 2 2 
AT1G71380 cellulase 3 2 2 
AT1G77120 alcohol dehydrogenase 1 2 2 
AT2G20580 26S proteasome regulatory subunit S2 1A 2 2 
AT2G20790 clathrin adaptor complexes medium subunit family protein 2 2 
AT2G21390 Coatomer, alpha subunit 2 2 
AT2G27600 AAA-type ATPase family protein 2 2 
AT2G32730 26S proteasome regulatory complex, non-ATPase subcomplex, 
Rpn2/Psmd1 subunit 
2 2 
AT2G41620 Nucleoporin interacting component (Nup93/Nic96-like) family protein 2 2 
AT2G42520 P-loop containing nucleoside triphosphate hydrolases superfamily 
protein 
2 2 
AT2G43140 basic helix-loop-helix (bHLH) DNA-binding superfamily protein 2 2 
AT3G01290 SPFH/Band 7/PHB domain-containing membrane-associated protein 
family 
2 2 
AT3G02360 6-phosphogluconate dehydrogenase family protein 2 2 
AT3G05040 ARM repeat superfamily protein 2 2 
AT3G12050 Aha1 domain-containing protein 2 2 
AT3G20250 pumilio 5 2 2 
AT3G26650 glyceraldehyde 3-phosphate dehydrogenase A subunit 2 2 
AT3G45450 Double Clp-N motif-containing P-loop nucleoside triphosphate 
hydrolases superfamily protein 
2 2 
AT3G45770 Polyketide synthase, enoylreductase family protein 2 2 
AT3G46060 RAB GTPase homolog 8A 2 2 
AT3G52180 dual specificity protein phosphatase (DsPTP1) family protein 2 2 
AT3G52300 ATP synthase D chain, mitochondrial 2 2 
AT3G59820 LETM1-like protein 2 2 
AT4G16130 arabinose kinase 2 2 
AT4G20260 plasma-membrane associated cation-binding protein 1 2 2 
AT4G21150 ribophorin II (RPN2) family protein 2 2 
AT4G24190 Chaperone protein htpG family protein 2 2 
AT4G27270 Quinone reductase family protein 2 2 
AT4G39220 Rer1 family protein 2 2 
AT5G02500 heat shock cognate protein 70-1 2 2 
AT5G06460 ubiquitin activating enzyme 2 2 2 
AT5G13110 glucose-6-phosphate dehydrogenase 2 2 2 
AT5G15450 casein lytic proteinase B3 2 2 
AT5G15490 UDP-glucose 6-dehydrogenase family protein 2 2 
AT5G23060 calcium sensing receptor 2 2 
AT5G27600 long-chain acyl-CoA synthetase 7 2 2 
AT5G41210 glutathione S-transferase THETA 1 2 2 
AT5G45130 RAB homolog 1 2 2 
AT5G46630 Clathrin adaptor complexes medium subunit family protein 2 2 
AT5G52920 plastidic pyruvate kinase beta subunit 1 2 2 
AT5G53480 ARM repeat superfamily protein 2 2 
AT5G58070 temperature-induced lipocalin 2 2 
AT5G59710 VIRE2 interacting protein 2 2 2 
AT5G65720 nitrogen fixation S (NIFS)-like 1 2 2 
ATCG00120 ATP synthase subunit alpha 2 2 
AT1G03090.2 methylcrotonyl-CoA carboxylase alpha chain, mitochondrial / 3-
methylcrotonyl-CoA carboxylase 1 (MCCA) 
3 3 
AT1G04820 tubulin alpha-4 chain 3 3 
AT1G07920 GTP binding Elongation factor Tu family protein 3 3 
AT1G12000 Phosphofructokinase family protein 3 3 
AT1G13440 glyceraldehyde-3-phosphate dehydrogenase C2 3 3 
AT1G22920 COP9 signalosome 5A 3 3 
AT1G24300 GYF domain-containing protein 3 3 
AT1G26630 Eukaryotic translation initiation factor 5A-1 (eIF-5A 1) protein 3 3 
AT1G27450.2 adenine phosphoribosyl transferase 1 3 3 
AT1G30630 Coatomer epsilon subunit 3 3 
AT1G55490 chaperonin 60 beta 3 3 
AT1G56070 Ribosomal protein S5/Elongation factor G/III/V family protein 3 3 
AT1G64190 6-phosphogluconate dehydrogenase family protein 3 3 
AT1G78900 vacuolar ATP synthase subunit A 3 3 
AT1G79230 mercaptopyruvate sulfurtransferase 1 3 3 
AT2G02560 cullin-associated and neddylation dissociated 3 3 
AT2G07698 ATPase, F1 complex, alpha subunit protein 3 3 
AT2G21470 SUMO-activating enzyme 2 3 3 
AT2G21640 Encodes a protein of unknown function that is a marker for oxidative 
stress response. 
3 3 
AT2G21660 cold, circadian rhythm, and rna binding 2 3 3 
AT2G27730 copper ion binding 3 3 
AT2G28000 chaperonin-60alpha 3 3 
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AT2G39730 rubisco activase 3 3 
AT2G44060 Late embryogenesis abundant protein, group 2 3 3 
AT2G45290 Transketolase 3 3 
AT3G02090 Insulinase (Peptidase family M16) protein 3 3 
AT3G03780 methionine synthase 2 3 3 
AT3G03960 TCP-1/cpn60 chaperonin family protein 3 3 
AT3G08580 ADP/ATP carrier 1 3 3 
AT3G11270 Mov34/MPN/PAD-1 family protein 3 3 
AT3G17390 S-adenosylmethionine synthetase family protein 3 3 
AT3G22330 putative mitochondrial RNA helicase 2 3 3 
AT3G43300 HOPM interactor 7 3 3 
AT3G52230 unknown protein 3 3 
AT3G56130 biotin/lipoyl attachment domain-containing protein 3 3 
AT3G58610 ketol-acid reductoisomerase 3 3 
AT3G60240.2 eukaryotic translation initiation factor 4G 3 3 
AT3G62530 ARM repeat superfamily protein 3 3 
AT4G02930 GTP binding Elongation factor Tu family protein 3 3 
AT4G11380 Adaptin family protein 3 3 
AT4G11420 eukaryotic translation initiation factor 3A 3 3 
AT4G20360 RAB GTPase homolog E1B 3 3 
AT4G24280 chloroplast heat shock protein 70-1 3 3 
AT4G37910 mitochondrial heat shock protein 70-1 3 3 
AT5G09590 mitochondrial HSO70 2 3 3 
AT5G15530 biotin carboxyl carrier protein 2 3 3 
AT5G16390 chloroplastic acetylcoenzyme A carboxylase 1 3 3 
AT5G17920 Cobalamin-independent synthase family protein 3 3 
AT5G28840 GDP-D-mannose 3',5'-epimerase 3 3 
AT5G41670 6-phosphogluconate dehydrogenase family protein 3 3 
AT5G52640 heat shock protein 90 3 3 
AT5G53620 unknown protein 3 3 
AT5G56000 HEAT SHOCK PROTEIN 81.4 3 3 
AT5G56030 heat shock protein 81-2 3 3 
AT5G59720 heat shock protein 18.2 3 3 
AT5G64260 EXORDIUM like 2 3 3 
AT1G27970 nuclear transport factor 2B 2 3 
AT1G49240 actin 8 2 3 
AT1G50200 Alanyl-tRNA synthetase 2 3 
AT1G69410 eukaryotic elongation factor 5A-3 2 3 
AT2G25140 casein lytic proteinase B4 2 3 
AT3G09440 Heat shock protein 70 (Hsp 70) family protein 2 3 
AT3G13920 eukaryotic translation initiation factor 4A1 2 3 
AT3G16400 nitrile specifier protein 1 2 3 
AT3G18190 TCP-1/cpn60 chaperonin family protein 2 3 
AT3G56150 eukaryotic translation initiation factor 3C 2 3 
AT3G60750 Transketolase 2 3 
AT4G13930 serine hydroxymethyltransferase 4 2 3 
AT4G27440 protochlorophyllide oxidoreductase B 2 3 
AT4G34030 3-methylcrotonyl-CoA carboxylase 2 3 
AT5G08670 ATP synthase alpha/beta family protein 2 3 
AT5G19550 aspartate aminotransferase 2 2 3 
AT5G22650 histone deacetylase 2B 2 3 
AT5G24810 ABC1 family protein 2 3 
AT5G27640 translation initiation factor 3B1 2 3 
AT5G55280 homolog of bacterial cytokinesis Z-ring protein FTSZ 1-1 2 3 
AT5G56010 heat shock protein 81-3 2 3 
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Abstract 
 
Computational prediction of small molecule target proteins is not well established in 
plant chemical biology, despite its success in mammalian drug discovery. In this study 
we attempt to identify target proteins in Arabidopsis of a small molecule effector of 
endomembrane traffic based on its chemical similarities with the know drug 
Rosiglitazone and protein structural data of Rosiglitazone in complex with its target 
in human systems. We identified a family of trans-membrane proteins with unknown 
function, and tried to validate the computational prediction by mutant growth on the 
small molecule hit. In addition, we initialize the characterization of the trans-
membrane protein family, and found indications of involvement in sterol metabolism 
or transport and possibly defense responses. 
  
Introduction 
 
The majority of target identification strategies in drug discovery and plant chemical biology employ 
affinity purification based approaches, biochemical or genetic tools and phenotype-based selection 
of target proteins1-3. A much less explored target identification strategy includes the use of 
computational strategies to predict target proteins. Though in recent years the mammalian drug 
discovery field witnessed a surge in novel prediction algorithms4, plant chemical biology has yet to 
see this field of target prediction to emerge fully. Examples exist3, including the design of a novel 
auxin antagonist auxinole5. Alternatively, molecular design of target proteins might repurpose small 
molecules, as exemplified by mandipropamid binding to the abscisic acid (ABA) receptor 
PYRABACTIN RESISTANCE 1 (PYR1)6, which itself was identified through a chemical genetics 
screen for Pyrabactin resistant mutants6. One of the main reasons for the backlog in computational 
approaches in the plant field is the absence of internationally recognized large data collections 
containing protein structural, chemical and biological data related to small molecules used in the plant 
field7. In drug discovery, large depositories of small molecule related data such as ChEMBL8 and 
PubChem9 are the backbone for computational target prediction strategies, which can be ligand or 
target based4,10,11. Often, computational prediction is aimed at finding new interactions for small 
molecules or proteins of interest, yet an increasing number of studies are geared towards the 
identification of additional target proteins for known small molecule drugs10,12. These efforts fit into 
the current increasingly accepted view that the old ‘lock and key’ model13 is outdated for most small 
molecules, while a polypharmacology model, or the ability of a small molecule to bind multiple target 
proteins, is more suited4,10,12. This is supported by the prediction that, on average, small molecules in 
drug discovery bind to six target proteins14,15. As small molecules, or certain substructures thereof, 
can bind different target proteins, which probably offer a similar binding environment in their tertiary 
and quaternary structure in one system, it becomes conceivable that this principle is applicable across 
different systems. 
The latter hypothesis is the starting point of this chapter as we report on attempts to identify target 
proteins in Arabidopsis for a small molecule hit. The idea of transferability is not new as several small 
molecules used in plant biology with known mode of action have their origin in mammalian systems. 
The best known example, and one of the few well characterized small molecule effectors of 
endomembrane traffic in plants, is Brefeldin A (BFA). BFA was identified as an inhibitor of ADP-
ribosylation factor (ARF) proteins in association with guanine exchange factors (GEFs), through 
binding the Sec7 domain, which determines BFA sensitivity16-20. The result is a heavily affected ER-
Golgi traffic through a failed recruitment of vesicle coat proteins21. BFA has been show to affect 
ARF-GEFS in plants through genetic means22, thereby successfully translating the mode of action in 
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mammalian and other systems to plant, despite a detailed biochemical characterization of BFA target 
proteins in plants. 
However, in our study it concerns the attempt to identify target proteins of a small molecule hit, based 
on data from the mammalian field, which does not necessarily have the same mode of action across 
different systems. It therefore potentially deals with the transferability of protein structural and 
chemical data, rather than biological data. The small molecule was identified through a screen for 
inhibitors of clathrin mediated endocytosis (CME) (Chapter 2, this thesis), and shared a chemical 
group with the known drug Rosiglitazone. Rosiglitazone is well known as drug against diabetes type 
223,24. Though on the market for a number of years, popularity and availability have decreased as a 
result of undesired side effects, including heart failure, weight gain through water retention and even 
the increased risk for bladder cancer23,24. In addition, a recent report suggests a dysfunction of 
mitochondria at higher concentrations25. As a consequence, Rosiglitazone has been withdrawn from 
European markets, while under strict regulations in the United States24. The protein target of 
Rosiglitazone is known as peroxisome proliferator-activated receptor γ (PPARγ)26, for which a crystal 
structure has been reported in complex with Rosiglitazone27. PPARγ belongs to the ligand-activated 
nuclear receptor transcription factor family. Its domain architecture includes, from N- to C-terminus, 
a trans activation domain, highly conserved DNA binding domain and ligand binding domain 
(LBD)28. 
Given that Rosiglitazone and our small molecule hit share a chemical group involved in target 
binding, and the reported crystal structure of Rosiglitazone in complex with its target protein27,28 , we 
adopt a strategy combining aspects of both the ligand and target orientated computational strategies 
to identify possible target proteins of our small molecule of interest in Arabidopsis. To this end, 
structural data of the PPARγ LBD in complex with Rosiglitazone was used to query the Arabidopsis 
genome with BackPhyre29 (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index_advanced), 
in search of proteins which possibly adopt a similar tertiary or quaternary structure such that it could 
accommodate our small molecule in a similar way as the PPARγ LBD Rosiglitazone. We identified 
a plant specific transmembrane protein family with unknown function as possible targets. The main 
goal is to assess possible binding between the small molecule hit and identified proteins in what is a 
proof of concept study. In addition, as the identified protein family has an unknown function, we 
initiate their characterization in terms of biological function, and speculate on their possible 
connection with brassinosteroid transport and signaling aside a possible role in endomembrane traffic. 
 
 
Results 
 
Structure-activity relation analysis reveals the core structure of small molecule 39 
Small molecule 39 (Figure 1a) was identified as a hit since it retained the ability to de-phosphorylate 
BRI1 EMS-SUPPRESSOR1 (BES1)30, while inhibiting FM4-64 uptake at relative low concentration 
(Figure 2a,b) (Chapter 2, this thesis). De-phosphorylation of BES1 was used as a measure of active 
brassinosteroid (BR) signaling30,31, while FM4-64 is frequently used as a dye to visualize CME in 
Arabidopsis32. Small molecule 39 therefore inhibited CME, yet activated BR signaling at a 
concentration of 25 μM. In addition, compound 39 caused depolymerization of the microtubules, seen 
as diffuse cytosolic signal of MAP4-GFP33 (Figure 2b). Structure-activity relation (SAR) analysis of 
several 39 analogs aimed at mapping the essential chemical moieties for activity. Analogs were tested 
for FM4-64 uptake and MAP4-GFP destabilization as readouts for activity. Small molecules 39-1 
and 39-2 (Figure 1a) were active in terms of FM4-64 uptake inhibition and partial depolymerization 
of MAP4-GFP (Figure 2b) at 25 µM, and therefore showed hardly any loss in activity compared to 
39. Analogues 39-3, 39-4 and 39-5 (Figure 1a) were not active in terms of FM4-64 uptake and 
MAP4-GFP at 50 µM (Figure 2b). Our SAR analysis revealed 39-2 as the core chemical structure. 
The reason lies in the relative instability in aqueous solution of the carbon bond between the tertiary 
amine of the thiazolidinedione (TZD) moiety and the secondary amine linked to the toluene moiety. 
This type of bond is present in 39, 39-1, 39-4 and 39-5. Hydrolysis results in the conversion of the 
formaldehyde-aminal derived imide of the TZD moiety into a free imide, which now can form 
hydrogen bonds, and might be required for protein binding. Small molecule 39-3 lacks such unstable 
carbon bond, therefore retains the tertiary amine of the TZD moiety, and remains inactive. Both 39 
and 39-1 are thus most likely converted into 39-2 in vivo, while 39-4 and 39-5 illustrate the necessity 
of the fluorobenzene moiety for activity, as both are probably converted into TZD, which as such 
appeared inactive. 
The TZD moiety of 39-2 appeared essential for activity and is shared with Rosiglitazone (Figure 1b). 
In fact, Rosiglitazone contains a substructure which largely resembles 39-2 (Figure 1b, box), lacking 
the fluorine and double bond between the TZD and fluorobenzene moieties of 39-2. Although both 
the double bond, dictating the orientation of the fluorobenzene moiety, and the fluorine might have 
important implications for 39-2 activity in Arabidopsis, the overall similarity with the Rosiglitazone 
substructure was the incentive to use the available structural data of Rosiglitazone in complex with 
its target protein to predict possible targets of 39, and by extension 39-2, in Arabidopsis. 
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Figure 1. Analogues of small molecule 39, and the similarity with Rosiglitazone.  
(a) Original structure of 39 and tested commercial analogues. (b) Structure of the thiazolidinedione 
moiety and Rosiglitazone. 
 
Small molecule 39 potentially binds a family of 4 membrane proteins in Arabidopsis 
Since PPARγ, the target of Rosiglitazone, would be used as a template to identify possible target 
proteins of 39 in Arabidopsis, both nucleotide and protein sequences of human PPARγ were used to 
query for paralogues genes in Arabidopsis. However, only alignments with very low scores were 
retrieved, even for the LBD as a template, indicating little conservation. We therefore relied solely 
on structural protein data for prediction. We used BackPhyre, part of the Protein Homology/analogY 
Recognition Engine V 2.0 (Phyre2)29 expert mode module, to perform this prediction. BackPhyre 
uses a Protein Data Bank (PDB) entry as template to query a genome of choice for protein sequences 
which might fold into similar tertiary or quaternary structure. As template we used the PDB entry 
2PRG27, which represents the LBD of PPARγ in complex with Rosiglitazone (Figure 3a). The figure 
depicts a render generated by PyMol34, and shows a selection of LBD secondary structure elements 
engaged in Rosiglitazone binding. A schematic representation of the binding pocket28 (Figure 3b) 
provides a better view on amino acids involved in Rosiglitazone binding. Only the LBD was 
considered to avoid added complexity of the DNA binding and transactivation domain, which could 
increase the risk of false positives. Interestingly, only 10 hits were retrieved (Supplemental Table 
1) of which the first 4 are of the same protein family with unknown function in Arabidopsis.  
A closer look revealed that all four are members of the same land plant specific gene family, according 
to the online comparative genomics platform PLAZA 335. In addition, the top two hits, AT5G40640 
and AT3G27390 were closest related, while AT4G37030 and AT4G12680 were more distant (Figure 
4a). As possible target proteins of 39, we named this gene family PTE (Putative Target of Endosidin), 
since 39 belongs to the collection of small molecules following the endosidin nomenclature36. The  
 Figure 2. BR signaling in presence of 39, and FM4-64 based structure activity relation analysis.  
(a) BES1 phosphorylation as measured in PSB-D cell cultures expressing BES1-TAP, incubated for 
1 hour with appropriate concentration of 39. (b) MAP4-GFP seedlings of 5 days old treated with 39 
and analogues for 15 min, followed by a 2μM FM4-64 pulse for 30 min. Scale bar: 5 μm 
 
numbering of the genes is according to the BackPhyre ranking, therefore PTE1 represents 
AT5G40640, PTE2 AT3G27390, PTE3 AT4G37030 and PTE4 AT4G12680. Further classification 
by PLAZA revealed that the PTE genes belong to the ligand binding nuclear hormone receptor gene 
family (HOM03D001281), while gene ontology terms based on experimental evidence indicated 
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plasma membrane localization (GO:0005886)37. Gene ontology for biological process or molecular 
function were unknown. In addition, PTE proteins were predicted to contain up to eight trans-
membrane regions, while possibly situated in the secretory pathway according to the plant membrane 
protein database ARAMEMNON38. 
 
Figure 3 Structural aspects of Peroxisome Proliferator-activated Receptor γ interaction with 
Rosiglitazone.  
(a) 3-dimensional representation of the Rosiglitazone binding site, as depicted by partial alpha helices 
of the Peroxisome Proliferator-activated Receptor γ (PPARγ) ligand binding domain (grey) 
contributing amino acids participating in Rosiglitazone binding (orange). Brown structure represents 
Rosiglitazone. Yellow indicates Sulfur, blue nitrogen and red oxygen. Dotted blue lines indicate 
hydrogen bonds between Rosiglitazone and PPARγ. Crystal structure 2PRG27, obtained through the 
protein data bank and visualized using PyMOL molecular viewer (http://www.pymol.org/). (b) 
Adopted27 schematic representation of the Rosiglitazone binding site, and amino acids involved in 
binding. 
 
Higher order mutants of the PTE gene family were sensitive to 39 
The strategy to assess the possibility of compound 39 binding to the PTE proteins included growth 
analysis of pte mutant lines on medium containing 39. Increased resistance or sensitivity could be a 
first indication of binding. Initial efforts were focused on PTE1 and PTE2 mutant lines, as the 
likelihood of 39 binding was the highest. Several insertion mutants were acquired per gene to test the 
hypothesis above. Two SALK lines for PTE1 were characterized in terms of insertion site and 
transcript levels: SALK_099018 and SALK_142384. While SALK_142384 contained an insertion 
approximately in the middle of the first intron, SALK 099018 appeared to have an insertion situated 
in the beginning of the second exon (Figure 5a). Amplification products for genotyping purposes 
were normal, without presence of surplus bands or other aberrant amplification products (Figure 5b-
c). The SALK_142384 mutant had reduced transcript levels of PTE1, to about 30% as compared to 
the wild type, whereas SALK_099018 transcript levels were decreased to about 10% as compared to 
the wild type (Figure 5d). A more detailed analysis of the SALK_099018 lines revealed that the 5’ 
and 3’ transcripts of PTE1 were down regulated to about 10%, while transcription over the insertion 
was absent (Figure 5e). Therefore, SALK_099018 (pte1-1) was considered as a null mutant and 
selected for further characterization. 
 
Figure 4. Evolutionary relationship of plant nuclear hormone receptor orthologues 
Multiple sequence alignment, including 64 complete protein sequences from 17 plant species. Based 
on their relative sequence relatedness, protein sequences clustered in three different groups. Four 
members are encoded by Arabidopsis whereas at least six members are encoded by its close relative 
Brassica rapa. At5g40640 and At3g27390 sequences were found to be relatively more conserved 
than the remaining Arabidopsis homologs. Bootstrap supports are indicated at each branch. 
 
Only one insertion mutant was found for the PTE2 gene: WiscDsLox320E02 (pte2). The insertion 
was in the second intron, just upstream of the third exon (Figure 6a). Probably because of the intronic 
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nature of the insertion, genotyping revealed a weak PCR product for homozygous mutants which was 
slightly smaller in size compared to PCR products obtained with the same primers in heterozygous 
or wild type plants (Figure 6b). Overall expression was substantially reduced (Figure 6c), yet more 
detailed analysis revealed still some 5’ transcripts, while the expression of 3’ transcripts were virtually 
absent (Figure 6d). In contrast to the pte1-1 allele, pte2 showed residual transcript levels over the 
insertion (Figure 6d), which could be due to aberrant splicing events. 
 
Figure 5. Characterization of PTE1 mutants.  
(a) Schematic representation of the PTE1 genomic region (black line), with light grey boxes 
representing exons and dark grey regions primer binding sites (e.g. p54). Remaining regions represent 
sequences upstream and downstream of the PTE1 gene, as well as introns. SALK insertions are 
indicated by triangular structures, with relevant sequence. Insertion site is situated between both 
nucleotides colored red. (b-c) Representative gels showing amplification products seen with 
combinations of the left primer (LP) flanking the SALK insertion, right primer (RP) and TDNA 
specific primer (LBA1). (d) Results of quantitative PCR (qPCR) for both SALK lines, and (e) more 
detailed qPCR results for selected SALK line. SALK 099018: pte1 
 
To assess the sensitivity of the pte mutants to compound 39, mutant seedlings grown on normal 
medium for 5 days were transferred to medium complemented with different concentrations of 
compound 39. Seedlings were gravistimulated in early experiments, as inhibition of endocytosis 
would be reflected in gravitropic resonses39. In addition, seedlings were grown in the dark to avoid 
possible interference of phototropism with gravitropic responses41. Root growth was measured after 
48 hours. Both pte1-1 and pte2 mutants were not significantly affected when compared to wild type 
Col-0 seedlings (Figure 7a). In fact, both seemed to be slightly resistant, with pte1-1 showing the 
strongest effect. As PTE1 and PTE2 genes might be redundant we generated a double mutant pte1-
1pte2, and three independent homozygous mutant lines were selected. Transcript levels for PTE1 and 
PTE2 remained residual for all three mutants (Figure 7b), while PTE3 and PTE4 expression was 
partially down regulated in the pte1-1pte2 double mutant with number 27 (Figure 7b). The two other 
pte1-1pte2 mutant lines, with numbers 11 and 33, appeared to have normal PTE3 and PTE4 
expression. Root growth of the three independent mutant lines was evaluated in the same conditions 
as for the single mutants. The initially observed resistance was not reproduced, instead all three pte1-
1pte2 mutant lines showed higher sensitivity to compound 39 (Figure 7c). The highest sensitivity 
was observed for the pte1-1pte2 line with number 27, which therefore was selected as the mutant line 
for further experimental work. The  obtained results were the first indication of a possible connection 
between the mode of action of compound 39 and the PTE protein family. Further triple and quadruple 
mutants were generated to strengthen these observations. 
 
Figure 6. Characterization of PTE2 mutant.  
(a) Schematic representation of the PTE2 genomic region (black line), with light grey boxes 
representing exons and dark grey regions primer binding sites (e.g. p58). Remaining regions represent 
sequences upstream and downstream of the PTE2 gene, as well as introns. WiscDsLox insertion is 
indicated by triangular structure, with relevant sequence. Insertion site is situated between both 
nucleotides colored red. (b) Representative gels showing amplification products seen with 
combinations of the left primer (LP) flanking the WiscDsLox insertion, right primer (RP) and TDNA 
specific primer (p745). (c) Results of quantitative PCR (qPCR) for two homozygous lines, and (d) 
more detailed qPCR results for selected mutant line. WiscDsLox320E02: pte2 mutant 
 
To this end two additional SALK lines were tested, representing the remaining two members from 
the PTE family: SALK_133576 (pte3) and SALK_025092 (pte4). The pte3 mutant contained a double 
insertion in the fourth exon (Figure 8a), which is probably an inverted repeat as both the left and 
right primer flanking the insertion yielded PCR product in combination with the SALK primer LBA1. 
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Only the combination with the right flanking primer is depicted (Figure 8b). The insertion for 
SALK_025092 was situated at the very end of the first exon (Figure 8a), and no aberrant 
amplification products were observed (Figure 8c). No gene specific qPCR primer pair could be 
designed spanning the insertion site for SALK_133576, therefore transcript analysis is only 
represented by primer pairs 5’ and 3’ from the insertion (Figure 8d). In contrast to SALK_099018 
(pte1-1) and WiscDsLox320E02 (pte2), 3’ transcript levels of At4g37030 (PTE3) increased in 
SALK_133576, likely as a result of transcription driven from the T-DNA insertion. A similar result 
was obtained for SALK_025092, where an even higher increase of transcript was observed at the 5’ 
and 3’ ends of the gene, while absent over the insertion (Figure 8e). 
 
Figure 7. Growth of single and double mutants on small molecule 39.  
(a) Relative root growth rate of 5 days old seedlings, transferred to new growth medium supplemented 
with small molecule 39, and left to grow for 48h hours in the dark. (b) Quantitative PCR analysis of 
PTE gene expression in different independent pte1pte2 double mutants. (c) Relative root growth rate 
for different independent pte1pte2 double mutants as described in (a). PTE: putative target of 
endosidin. Error bars: Standard error of the mean in (a) and (c), standard deviation in (b). n is at least 
20 in (a) and (c), 3 in (b) 
 
The pte3 and pte4 mutants were first grown on medium containing compound 39 as was done for the 
other mutant lines in order to evaluate possible resistance or sensitivity to the compound (Figure 9a). 
Both pte3 and pte4 single mutants behaved similar to Col-0 and pte1-1 and pte2 mutants. 
Subsequently each single pte3 and pte4 mutant was crossed with the pte1-1pte2 double mutant to 
generate triple mutants. The resulting pte1-1pte2pte3 and pte1-1pte2pte4 triple mutants were crossed 
in order to generate a quadruple mutant pte1-1pte2pte3pte4 (referred to in the rest of the manuscript 
as pte1to4). We identified only 2 potential quadruple mutants from the more than 100 F2 plants used 
for genotyping, of which only one was confirmed by genotyping and qPCR (Figure 9b). Though we 
used the same primers as for the pte1-1pte2 qPCR analysis, we noted an unexpected reduction in 
transcripts for PTE3 and PTE4. Upon evaluation of root growth in presence of 39, a similar trend 
emerged as seen for the pte1-1pte2 double mutant, though sensitivity appeared to be spread over a 
wider concentration range (Figure 9c). 
 
Figure 8. Characterization of PTE3 and PTE4 mutants.  
(a) Schematic representation of the PTE3 and PTE4 genomic region (black line), with light grey 
boxes representing exons and dark grey regions primer binding sites (e.g. p152). Remaining regions 
represent sequences upstream and downstream of the PTE3 and PTE4 genes, as well as introns. 
SALK insertions are indicated by triangular structure, with relevant sequence. Insertion site is situated 
between both nucleotides colored red. (b-c) Representative gels showing amplification products seen 
with combinations of the left primer (LP) flanking the SALK insertion, right primer (RP) and TDNA 
specific primer (LBA1). (d) Detailed quantitative PCR (qPCR) result for the pte3 mutant, and (e) 
detailed qPCR results for the pte4 mutant. SALK 133576: pte3 mutant. SALK02592: pte4 mutant 
 
Sensitivity of mutant lines appeared to be 39 specific. 
In order to evaluate if compound 39 affects energy metabolism, PSB-D wild type cell cultures were 
tested for ATP depletion in the presence of compound. Surprisingly, 39 was able to deplete ATP 
(Figure 10a), though the depletion signature was quite different compared to the protonophore 
compounds (Chapter 3, this thesis) While the initial ATP levels dropped with about 20%, they 
remained constant during the remainder measuring time. A similar trend emerged for 39-2 (Figure 
10a). The observation that 39 could deplete ATP to a certain extent, might indicate that compound 
39 is a protonophore. However, ATP production can be affected through a different mode of action, 
as the ATP depletion signature differed from the one described for protonophore compounds. We 
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next tested if  the increased sensitivity of the pte1to4 mutant to compound 39 is also retained in the 
presence of protonophore compounds, thus if the observed sensitivity on 39 was specific. For this, 
pte1-1pte2 and pte1to4 mutant lines were grown in dark on different concentrations of CCCP and 
compared to Col-0 (Figure 10b). We observed a similar sensitivity on 39 appeared for mutant lines 
compared to Col-0, and suggests a general increase of sensitivity of mutant lines towards small 
molecules with protonophore mode of action. However, to extend the root growth assays further, 
pte1-1pte2 and pte1to4 mutant lines were grown on 39 and CCCP in the light (Figure 10c). Here a 
different situation emerged. While pte1-1pte2 seemed to have lost its sensitivity on 39 in the light, 
pte1to4 appeared to have an even higher sensitivity on 39 (Figure 10c). Surprisingly, this behavior 
on 39 was not repeated for growth on CCCP, in contrast to the situation in the dark, as both pte1pte2 
and pte1to4 behaved much like Col-0 on CCCP in the light (Figure 10c). 
 
Figure 9. Growth of single and quadruple mutants on small molecule 39-2.  
(a) Relative root growth rate of 5 days old seedlings, transferred to new growth medium supplemented 
with small molecule 39-2, and left to grow for 48h hours in the dark. (b) Quantitative PCR analysis 
of PTE gene expression in the pte1to4 quadruple mutant. (c) Relative root growth rate of the pte1to4 
quadruple mutant on 39-2 as described in (a). PTE: putative target of endosidin. Error bars: Standard 
error of the mean. N is at least 20. 
 
In conclusion we showed that, although pte1-1pte2 and pte1to4 appear slightly sensitive on 39 and 
possibly protonophores in general, only pte1to4 retained its increased sensitivity towards compound 
39 in the light. The sensitivity of pte1pte2 on 39 and CCCP was largely gone. This is possibly a first 
indication that 39 can bind PTE proteins, as the sensitivity of pte1to4 on 39 appeared to be specific. 
 Figure 10. Compound 39 possibly acts as a weak protonophore. 
(a) Relative (to mock, DMSO) ATP levels in PSB-D wild type cell cultures for ES9 and ES9-2 
treatments at the indicated concentration and time-points compared to ES9 mediated ATP depletion. 
(b) Wild type Arabidopsis seedlings (Col-0, 5 days) grown in the dark for 48 hour on different 
concentrations of carbonyl cyanide m-chlorophenyl hydrazone (CCCP), relative to mock (DMSO). 
Note the higher sensitivity compared to Col-0 of pte1to4 on CCCP. (c) Wild type Arabidopsis 
seedlings (Col-0, 5 days) grown in the light for 48 hour on different concentrations of ES9-2 and 
CCCP, relative to mock (DMSO). Note the difference in sensitivity compared to Col-0 of pte1to4 on 
CCCP and ES9-2. Error bars: standard error of the mean. N is 8 in (a), and at least 20 in (b) and (c). 
 
PTE proteins localize mainly to the plasma membrane. 
In a first attempt to characterize the function of the PTE family in Arabidopsis we set out to evaluate 
the localization of the PTE proteins. The PTE proteins were predicted to be located in the PM, 
according to gene ontology terms. Based on the plant membrane database ARAMAMNON38, all four 
members of the PTE family are predicted to have a total of 5-6 transmembrane domains (Figure 11a). 
The putative transmembrane regions are assigned a score between 0 and 1, with 1 the highest 
probability, according to AramTmCon, a consensus transmembrane region prediction based on 18 
individual algorithms (Figure 11a). As PTE1 and PTE2 appear to be the two most important PTE 
family members, efforts were first focused on them, and several tagged versions of PTE1 and PTE2 
were made in to visualize the protein family. In an attempt to determine the topology we inserted 
GFP in predicted loop regions for PTE1 and PTE2 (Figure 11a). From tobacco infiltration 
experiments we found that only constructs with GFP inserted in the second loop resulted in 
fluorescence, while the other two GFP insertions were not fluorescent in all experiments (Figure 
11b). Although the possibility exists that GFP was inserted too close to, or in the actual 
transmembrane region, it is tempting to speculate that this situation reflects the topology of the PTE 
protein family. That would mean the N-terminus is oriented towards the cytosol, the first loop to the 
apoplast, while the second again towards the cytosol (Figure 11c). Further experiments are needed 
to conclude in favor of such situation. 
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Figure 11 Loop 2 of PTE1 and PTE2 is likely oriented into the cytosol. 
(a) Schematic representation of predicted trans-membrane regions for PTE proteins according to 
ARAMEMNON(ref). Dark grey boxes indicate trans-membrane regions with a score above 0.5, while 
white boxes are predicted trans-membrane regions with a score below 0,5 Triangles indicate the 
insertion positions of GFP in predicted loop regions between two trans-membrane domains. (b) 
Nicotiana benthamiana leaf infiltration with different constructs representing the GFP insertions in 
loops regions of PTE1 and PTE2. Control represents non-infiltrated leaf. Scale bar 50 μm. (c) 
Schematic representation of the possible PTE1 and PTE2 topology. Only transmembrane regions with 
a prediction score above 0.5 (black boxes) are depicted. 
 
Next, classical C-terminal GFP fusions were generated for all four members and visualized when 
stably expressed in Arabidopsis (Figure 12). As expected, both PTE1 and PTE2 localized mainly to 
the plasma membrane, while a weaker cytosolic signal was present. Though the cytosolic signal 
resembled ER localization, it is preliminary to conclude to such localization as no co-localization 
experiments with ER markers or dyes were performed. In addition, PTE1-GFP localized to distinct 
spots in the cytosol (Figure 12 inset), which are of unknown nature. The localization of the other two 
members, PTE3-GFP and PTE4-GFP is ongoing. 
 
Figure 12. PTE1 and PTE2 localized mainly at the plasma membrane 
C-terminal tagged PTE1-GFP (left) and PTE2-GFP (right) localized mainly at the plasma membrane, 
in addition to a weaker cytosolic signal. Note the spot-like structures observed for PTE1-GFP (inset), 
likely of endosomal nature. Scale bar: 15 µM 
 
PTE1 interacts with MSBP2 
In search for more information on the different PTE proteins, all members of the family were queried 
against the Membrane-based Interactome Network Database (MIND, http://cas-
biodb.cas.unt.edu/project/mind/index.php)41. Only PTE1 was found to interact with a number of 
proteins. Interactions were scored based on the number of positive split-ubiquitin interaction in the 2 
primary and 2 secondary screens. Amongst interactors of PTE1 with the highest score (i.e. scored in 
all 4 assays positive) were a considerable amount of proteins involved in sterol binding and 
metabolism. These include a member of the sterol methyl oxidase (SMO) family (AT4G22756), 
MEMBRANE-ASSOCIATED PROGESTERONE BINDING PROTEIN 2 (MAPR2; AT2G24940) 
and MEMBRANE STEROID BINDING PROTEIN 2 (MSBP2; AT3G48890). A related interactor 
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which was only confirmed in 3 out of 4 experiments was the MEMBRANE STEROID BINDING 
PROTEIN 1 (MSBP1; AT5G52240). It is worth mentioning that also BRASSINOSTEROID 
INSENSITIVE 1 (BRI1; AT4G39400) was found, yet only in one out of four experiments. As MSBP2 
was one of the best interactors in the initial release of the MIND database we decided to confirm the 
PTE1-MSBP2 interaction by bimolecular fluorescence complementation (BiFC). As expected, PTE1 
and MSBP2 fused to head GFP (hGFP) or tail GFP (tGFP) alone were not able to fluoresce (Figure 
13a). PTE1 fused to tGFP combined with hGFP induced fluorescence (Figure 13b), though PTE1-
hGFP with tGFP could not. The latter is probably be due to very weak tGFP expression, as evaluated 
by the weak RFP signal. Both hGFP and tGFP constructs contain RFP in the backbone, which serves 
as a control for efficient infiltration. For that reason, both hGFP and tGFP alone were not able to 
induce fluorescence (Figure 13b). When MSBP2 and PTE1 constructs were combined, both 
orientations induced fluorescence (Figure 13c), similar as the PTE1-hGFP and PTE1-tGFP 
combination. The former indicates binding, especially because both are transmembrane proteins, 
while the latter hints towards the ability of PTE1 proteins to homodimerize. The above results 
therefore indicate binding between MSBP2 and PTE1, though this interaction would need to be 
validated with independent experimental readouts. 
 Figure 13. PTE1 interacts with MSBP2 through BiFC in Nicotiana benthamiana 
(a) Infiltration of bimolecular fluorescence complementation (BiFC) constructs for PTE1 and MSBP2 
alone fail to induce fluorescence. (b) Combination of PTE1 BiFC constructs with either hGFP or 
tGFP constructs induced GFP signal, though the PTE1-hGFP and tGFP combination induced very 
weak signal. No GFP signal was observed for hGFP or tGFP alone, while infiltration was successful, 
judged from the RFP signal originating from the vector backbone. (c) Combination of MSBP2 and 
PTE1 constructs induced GFP signal, in addition to the PTE1-hGFP and PTE1-tGFP combination, 
indicating possible homodimerization. Head GFP (hGFP), tail gfp (tGFP). Scale bar: 5 µm  
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Discussion 
 
Protein function annotation based on structural homology searches and predictions is a field of 
computational biology which is increasingly used as proteins can lack orthologs in other systems 
based on primary sequence alone42, yet might share a similar tertiary or quaternary protein structure. 
Although several computational strategies exist to identify possible target proteins for selected 
ligands43, or explore possible ligands for a given target protein, we chose an approach within reach 
of our limited knowledge on computational prediction to find putative target proteins of 39 in 
Arabidopsis. To this end we used BackPhyre as part of the Phyre229. We identified four putative 
target proteins of 39, based on the LBD of PPARγ in complex with Rosiglitazone27. However, 
BackPhyre seems to be rarely used, as only one report was found which used BackPhyre44, and 
therefore might indicate a poor performance in terms of prediction. This could, in combination with 
the unconventional target fishing result in unreliable target prediction for 39. An independent search 
with the same parameters however, using a similar an frequently used search engine called HHpred45, 
resulted in the identification of the same set of proteins in Arabidopsis (data not shown), indicating 
the BackPhyre predictions are valid. Interestingly the HHpred structural alignment was located at the 
C-terminal part of the PTE protein family. 
As the entire PTE protein family has unknown function, little is found on either PTE protein in 
literature. The most information can be found on PTE1 and PTE2, which have been localized on the 
PM based on a study which evaluated phosphorylation events of PM proteins after 10 min of 
flagellin22 (flg22) or xylanase37. A phosphorylation on S223 was identified for PTE2, located in the 
C-terminal cytosolic domain for samples treated with flg22, but not with xylanase. While the 
identified phosphorylation on the PTE2 peptide was considered significant, the phosphorylated 
peptide for PTE1 was found only once, and thus not significant. Another study indicated that PTE2 
can be phosphorylated on S560, further towards the C-terminus compared to the flg22 induced 
phosphorylation, by Ca2+-dependent protein kinase 16 (CPK16)46. These results suggest a role for 
PTE2 in flg22-induced defense responses, which might be mediated through Ca2+ signaling. The only 
report where PTE1 is mentioned37 indicates it is probably not involved in defense responses, at least 
not through flg22 or xylanase induced signaling events. Therefore PTE1 might have a different 
function, which might be linked with sterol metabolism and transport, as PTE1 seems to interact with 
sterol binding proteins such as MSBP2. Although these observations have to be further strengthened 
and validated, it is probable that PTE proteins interact with different kinds of sterol binding proteins. 
One could therefore speculate that PTE proteins are the link between defense induced signaling and 
adaptation of the plasma membrane through altered sterol composition in order to properly respond 
to pathogen attack. 
Currently, substantial efforts go into the characterization of the PTE protein family in terms of mutant 
phenotype, interaction with proteins such as MSBP1 and MSBP2, and the implications for cell 
biology and endomembrane traffic. Importantly though, because pte mutants are still viable and show 
hardly any obvious phenotype, inhibition of CME by 39 application is likely not mediated by the PTE 
protein family. It might therefore be established through an non-specific mechanism, or through 
different protein targets of 39. Here the reduction in ATP content comes into view, together with the 
slight sensitivity of pte mutants on CCCP. Indeed, it is conceivable that 39 would possess 
protonophoric characteristics, though much less potent compared to ES9 (Chapter 3, this thesis), as 
judged from the ATP depletion in PSB-D wild type cell cultures. The observations concerning the 
pte1-1pte2 and pte1to4 sensitivity on CCCP and 39 are in support of the above hypothesis. In dark 
grown seedlings the only source of ATP is derived from the mitochondria, while chloroplast provide 
an important contribution in the light. Any interference with mitochondrial function which reflects 
on ATP production will be therefore more pronounced in the dark. As such the slight increase in 
sensitivity on 39 can be explained, given that the mutants display a similar sensitivity on the known 
protonophore CCCP. How the PTE protein family is linked to a higher sensitivity on protonophoric 
small molecules is unclear. Furthermore, the marked increase in sensitivity on 39 of the pte1to4 
quadruple mutant, which was not repeated on CCCP, indicates that this particular increase in 
sensitivity is likely linked to PTE proteins, either directly or indirectly, and possibly reflects 39 
binding. It would be interesting to see how all other possible mutant combination behave on 39, (i.e. 
the pte3pte4 double mutant), in order to fully dissect the individual contribution of PTE proteins in 
terms of 39 binding, in addition to a thorough analysis of CME in the quadruple mutant. 
Initial SAR analysis was based on the ability to inhibit FM4-64 uptake, but given the discussion 
above, might be an insufficient assessment of 39 and related analogs in terms of activity towards the 
PTE protein family. It would therefore be essential to re-assess analog activity by evaluating effects 
on pte1to4 root growth. 
As the PTE protein family is not essential for cell survival, sensitivity of the pte1to4 mutant to 
compound 39 indicated that growth inhibition is not established through possible 39 binding to the 
PTE protein family alone. It therefore confirms the existence of additional target proteins, and thus a 
polypharmacological binding nature. The opposite situation, in which the pte1to4 mutant is 
completely resistant to 39, would be indicative of the sole contribution of the PTE protein family to 
growth inhibition, and would indicate that 39 only targets PTE proteins which mediate the growth 
inhibition. Other protein targets which are not contributing to growth inhibition cannot be excluded 
in that situation however. 
Further dissection of chemical structure requirements for 39 activity towards PTE proteins would 
allow a better understanding on 39 association with PTE proteins, and would facilitate the 
development of a more specific inhibitor for the PTE protein family through abolishing non-specific 
241 
 
effects such as the presumed protonophore characteristics. To this end a continuation of 39 SAR has 
been initiated, for which the chemical synthesis is described in the methods section. 
In conclusion we identified a small molecule which has the potential to be confirmed as an inhibitor 
of the PTE protein family with unknown function in Arabidopsis. Identification was mediated through 
computational prediction of putative targets, based on a known small molecule with similar chemical 
characteristics as 39, in complex with its target in human systems. Although we don’t have a clear 
image yet on the contribution of the PTE protein family in plant biology, evidence suggests a role in 
defense responses and sterol metabolism or transport. 
  
Material and methods 
 
Plant material and growth conditions 
Arabidopsis thaliana (accession Columbia-0 [Col-0]) seedlings and other lines were stratified for 2 
days at 4°C, and grown vertically on agar plates containing ½ strength Murashige and Skoog (½MS) 
medium supplemented with 1% (w/v) sucrose for 5 days at 22°C in a light/dark cycle of 16 h/ 8 h 
respectively, prior to use. Following marker line was used: MAP4-GFP47. SALK_099018 (N599018), 
SALK_142384 (N642384), SALK_133576 (N679117), SALK_025092 (N525092) and 
WiscDsLox320E02 (N851129) were acquired through the European Arabidopsis Stock Centre 
NASC. 
Genotyping of insertion mutants and preparation of constructs. 
All primers used for genotyping of insertion mutants (single mutants and higher order mutants) can 
be found in Supplemental table 1. The LBA1 and p745 primers were used for SALK and WiscDsLox 
insertion mutant respectively.  
At5g40640 (attB1F_40640, attB2R_40640, attB2R_40640_nostop), At3g27390 (attB1F_27390, 
attB2R_27390, attB2R_27390_nostop), At4g37030 (attB1F_37030, attB2R_37030, 
attB2R_37030_nostop) and At4g12680 (attB1F_12680, attB2R_12680, attB2R_12680_nostop) were 
amplified from Arabidopsis Col-0 cDNA with indicated primers to yield coding sequence (CDS) with 
stop and without stop flanked by attB-sites (Invitrogen). Amplified fragments were cloned in the 
pDONR221 vector (Life Technologies). The resulting entry vectors were used in subsequent cloning. 
In order to insert GFP in the different loops of At5g40640 and At3g27390 we adopted a cloning 
strategy as previously described48. The general strategy consisted of the GFP CDS insertion in the 
middle of each loop region, as identified through the consensus prediction of trans-membrane regions 
(Figure 11a, ARAMEMNON38. Predictions with a score below 0.5 were not considered as potential 
trans-membrane region. On each side, between GFP and the protein sequence, a linker region was 
inserted (amino acid composition SGGGGS) to allow flexibility for GFP and the protein to fold 
properly. The nucleotide sequence of each linker used a different codon for serine 
(TCTGGAGGCGGCGGATCT and TCAGGCGGAGGAGGCTCA) to control directionality of the 
GFP insertion. Briefly, each CDS was amplified in two fragments: one from the start codon to 
insertion site (primers attB1F_40640/27390 and 40640/27390_L1rev), the second from the insertion 
site to the stop codon (primers attB2R_40640/27390 and 40640/27390_L1fw). The GFP CDS was 
amplified from any GFP (without stop) containing vector with primers eGFP_Lxfw and eGFP_Lxrev. 
DNA was purified from resulting gel-pieces and combined in a standard PCR reaction without added 
primers. As such the total CDS with inserted GFP sequence was generated through annealing of the 
linker sequence overhangs of each fragment. A final PCR reaction with attB containing primers 
(attB1F_40640/27390, attB2R_40640/27390) ensured amplification of enough product to insert in a 
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pDONR221 vector. Entry vectors were used for subsequent cloning into several destination 
constructs, including pH2GW7 (for constructs with GFP insertion) and pDONRRP4-1R_RPS5A, 
pDONRRP2R-P3_GFPstop and pK7m34GW for C-terminal GFP-tagged versions. 
Generation of clones for bimolecular fluorescence complementation was done as described before49. 
qPCR 
Seedlings (5 days) were flash frozen in liquid N2, grinded using a Retsch® MM400, and 1 ml Trizol 
reagent (Molecular Research Center) was applied per sample. Next, 0.2 ml chloroform was added 
prior to centrifugation for 15 min at 12000 g and 4°C. The top phase was transferred to a new recipient 
and supplemented with 0.5 ml isopropanol. From there on, samples were applied on RNeasy mini kit 
columns (Qiagen) and the protocol was finished according to manufacturer’s instructions. 
Concentration of purified RNA was determined with a NanoDrop spectrophotometer (Thermo 
Scientific), after which all samples were brought to a concentration of approximately 100 ng/μl. For 
each sample 1 μg of RNA was subsequently used for cDNA synthesis (iScript, Bio-Rad, according 
to manufacturer’s instructions), and cDNA was diluted 10 times. Samples and primers (Supplemental 
table 1) were distributed and mixed with SYBR green I master mix (Roche Diagnostics) and run on 
a Light Cycler 480 (Roche Diagnostics).  
Tobacco infiltration and bimolecular fluorescence complementation 
Nicotiana benthamiana infiltration with Agrobacterium tumefaciens culture was performed as 
described earlier49. Agrobacterium transformed with appropriate constructs was cultured in yeast 
extract broth (YEB) medium for 2 days with applicable antibiotics. Culture was washed and re-
suspended in infiltration medium (0.5 mM methyl esther sulfonate [MES], 1 mM MgCl2 and 100 μM 
acetosyringone) with a final optical density at 600 nm (OD600) of 1. Leaves of four weeks old N. 
bentamiana plants were infiltrated with a syringe, and imaged 3-4 days after. 
Chemical treatments and imaging 
Compound 39 and analogs were acquired through Chembridge (http://www.chembridge.com/) or 
synthesized as described below. Carbonyl cyanide 3-chlorophenylhydrazone was acquired through 
Sigma-Aldrich. All were dissolved in DMSO (Sigma-Aldrich). Visualization of endocytosis was 
achieved with 2μM N-(3-Triethylammoniumpropyl)-4-(6-(4-(Diethylamino) Phenyl) Hexatrienyl) 
Pyridinium Dibromide (FM4-64, Life technologies) application. Imaging of seedlings and N. 
benthamiana leaves was performed with an Olympus FV10 ASW confocal laser scanning microscope 
using a 60x water immersion lens (NA 1.2) and 3x digital zoom. Images were processed using the 
imageJ (Fiji) software packages. 
 
 
BES1 dephosphorylation assay 
PSB-D cell cultures expressing BES1-TAP were generated and maintained as described before50,51. 
Cell cultures were treated with different concentrations of 39 as indicated, brassinolide (BL, 1 µM) 
for 1 hour while shaking at 130 rpm and harvested and homogenized in liquid nitrogen. Protein 
extraction was performed with a 20mM Tris-HCl buffer containing 150 mM NaCl, 1% Sodium 
Dodecyl Sulfate (SDS), 100 mM Dithiothreitol (DTT) and 1 cOmplete ultra tablet per 10 ml of EDTA 
free protease inhibitor cocktail (Roche). Protein concentration was determined with the Quick start 
Bradford 1x Dye reagent (Bio-Rad). Samples (30 µg) were run on a 10% SDS-PAGE gel and 
transferred to polyvinyl difluoride (PVDF) membrane from iBlot Gel Transfer Stack (Novex, Life 
Technologies) using the iBlot device (Life technologies). Membranes were blocked for 1 hour in Tris 
buffered Saline with 0.1 % Tween 20 (TBS-T, Sigma-Aldrich) and 3% Difco Skim milk (Becton, 
Dickinson and Company). Detection of BES1-TAP occurred with a 1/5000 dilution in TBS-T 3% 
skim milk of Horseradish peroxidase (HRP) conjugated Peroxidase Anti-Peroxidase (PAP) Soluble 
Complex antibody produced in rabbit (P1291, Sigma) for 1 hour. Membrane was developed with 
application of Western Lightning® Plus–ECL, Enhanced Chemiluminescence Substrate (Perkin-
Helmer) and Amersham Hyperfilm ECL (GE Healthcare). 
ATP measurements 
Wild type PSB-D Arabidopsis cell cultures were used and maintained as described beforeVan Leene, 
2007. Cell culture of 3 days old was diluted 5 times and mixed thoroughly prior to distribution of 95 
μl in 96-well plates. Subsequently, 5 μl of a 1/50 dilution of small molecule stock solution (1000x) 
in MS medium with Minimal Organics (MSMO) medium was added to cells (final dilution of 1000x) 
using a Tecan Freedom EVO® robot. ATP levels were detected by addition of 80 μl of ATPlite 1step 
Luminescence Assay System (Perkin Elmer) after incubation of cells in presence of small molecule 
for indicated time. Fluorescence was detected using a Perkin Elmer EnVision 2104 multilabel reader 
with the Wallac Envision manager software package. ATP-lite luminescence was detected with the 
ultra-sensitive luminescence techonology.  
Phylogenetic tree generation 
Complete protein sequences (64) from algae (chlamydomonas reinhardtii), lower plants 
(Physcomitrella patens) and higher plants including both monocots and dicots, covering in total 17 
species, were down loaded from PLAZA v3.035. A ClustalX v2.0 multiple sequence alignment52 was 
generated, which was subsequently used for the Molecular Evolutionary Genetic Analysis (MEGA 
6) tool. A Neighbor-joining (NJ) algorithm with p-distance method and pair wise deletion of gaps, 
using default parameters was adopted to generate an un-rooted phylogenetic tree. A total number of 
1000 replicates were tested per analysis and bootstrap statistical analysis for these replicates was 
employed to test the phylogeny53. 
Chemical syntheses 
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Compounds a-d (Knoevenagel condensation) 
 
2,4-thiazolidinedione (1g, 8.5 mmol, 1.0 equiv.) together with the appropriate aldehyde (1.0 equiv.) 
is dissolved in ethanol (85 ml). Piperidine (672 μL, 0.8 equiv.) is added and the mixture is refluxed 
for 20h. After cooling, the mixture is poured into water (50 mL) and acetic acid is added until 
precipitation occurs. The solid is collected and dried at 50°C under vacuum. The resulting amorphous 
solid is recrystallized from methanol. 
 
Compound e 
 
5-(4-hydroxybenzyl)-2,4-thiazolidinedione (500 mg, 2.2 mmol, 1.0 equiv.) is dissolved in 
dimethylformamide (5 mL). Potassium carbonate (588 mg, 4.1 mmol, 1.9 equiv.) is added and the 
mixture is stirred for 5 min. Methyl iodide (164 μL, 2.6 mmol, 1.2 equiv.) is added and the reaction 
is heated to 70°C and stirred until judged complete by TLC. The mixture is concentrated in vacuo 
and the residue is taken up in an ethyl acetate-ammonium chloride mixture (60 mL, 1:1 v/v). The 
organic phase is washed with water (3×10 mL) and a saturated sodium chloride solution (10 mL). 
The organic phase is dried on sodium sulfate, filtered and concentrated in vacuo. The resulting solid 
is dried at 50°C under vacuum and subsequently purified by flash chromatography (silica, methanol: 
chloroform, 6:94 v/v) to yield e as a pale yellow solid (245.9 mg, 1.1 mmol, 47%). 
 a: Formula: C10H7NO2S; M: 205.23 g/mol; 
1H-NMR (300MHz, (CD3)2SO): δ 12.62 (s(br), 1H), 7.80 
(s, 1H), 7.60 (d(br), 2H, J = 7.4 Hz), 7.54 (d(br), 2H, J = 7.4 Hz), 7.48 (d(br), 2H, J = 7.4 Hz); 13C-
NMR (125 MHz, (CD3)2SO): δ 167.9, 167.3, 133.0, 131.8, 130.4, 130.0, 129.3, 123.5; HRMS (m/z): 
[M-H+]- calcd. for C10H6NO2S
-, 204.0125; found, 204.0131 
 
b: Formula: C10H6FNO2S; M: 223.22 g/mol; 
1H-NMR (300MHz, (CD3)2SO): δ 12.70 (s(br), 1H), 
7.97 (s, 1H) ), 7.59 – 7.51 (band, 2H), 7.42 – 7.35 (band, 2H); 13C-NMR (125 MHz, (CD3)2SO): δ 
167.6, 167.0, 160.5 (d, 1JCF = 250.0 Hz), 132.8 (d, 
3JCF = 8.8 Hz), 128.8, 126.3, 125.4, 122.7 (d, 
3JCF 
= 6.5 Hz), 121.0 (d, 3JCF = 11.9 Hz), 116.2 (d, 
2JCF = 21.7 Hz); HRMS (m/z): [M-H
+]- calcd. for 
C10H5FNO2S
-, 222.0031; found, 222.0038 
 
c: Formula: C11H9NO3S; M: 235.26 g/mol; 
1H-NMR (300MHz, (CD3)2SO): δ 11.01 (s(br), 1H), 7.75 
(s, 1H), 7.62 – 7.57 (m, 2H), 7.14 – 7.09 (m, 2H), 3.89 (s, 3H); 13C-NMR (125 MHz, (CD3)2SO): δ 
132.1, 132.0, 125.9, 114.8, 55.0; HRMS (m/z): [M-H+]- calcd. for C11H8NO3S
-, 234.0230; found, 
234.0228 
 
d: Formula: C11H9NO3S; M: 235.26 g/mol; 
1H-NMR (300MHz, (CD3)2SO): δ 12.55 (s, 1H), 7.97 (s, 
1H), 7.50 – 7.46 (m, 1H), 7.43 – 7.40 (m, 1H), 7.16 (d(br), 1H, J = 8.4 Hz), 7.10 (d(br), 1H, J = 8.4 
Hz), 3.89 (s, 3H); 13C-NMR (125 MHz, (CD3)2SO): δ 168.1, 167.4, 158.0, 132.4, 128.6, 126.5, 123.5, 
121.4, 121.0, 111.9, 55.8; HRMS (m/z): [M-H+]- calcd. for C11H8NO3S
-, 234.0230; found, 234.0231 
 
e: Formula: C11H11NO3S; M: 237.27 g/mol; TLC (methanol:chloroform, 1:9 v/v): Rf = 0.7; 
1H-NMR 
(300MHz, (CD3)2SO): δ 9.33 (s, 1H), 7.10 – 6.99 (m, 2H), 6.72 – 6.66 (m, 2H), 4.82 (dd, 1H, J = 9.4, 
4.3 Hz), 3.31 (dd, 1H, J = 14.1, 4.3 Hz), 2.98 (dd, 1H, J = 14.1, 9.4 Hz); 13C-NMR (125 MHz, 
(CD3)2SO): δ 174.0, 171.2, 156.4, 130.2, 126.6, 115.2, 51.4, 36.5, 27.5; HRMS (m/z): [M-H+]-
 calcd. 
for C11H10NO3S
-, 236.0387; found, 236.0379 
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Supplemental information 
 
Supplemental Table 1. Putative interactors of 39 as identified through BackPhyre 
Rank Description Organism Gene name Alignment Confidence 
% 
i.d. 
1 
gi|30693640|ref|NP_198880.2| 
unknown protein 
A. thaliana AT5G40640 105-225 86.6 19 
2 
gi|30688768|ref|NP_189375.2| 
unknown protein 
A. thaliana AT3G27390 105-225 80 17 
3 
gi|79497780|ref|NP_195420.2| 
unknown protein 
A. thaliana AT4G37030 105-225 77 15 
4 
gi|15235450|ref|NP_193004.1| 
unknown protein 
A. thaliana AT4G12680 105-223 74.6 13 
5 
gi|15220546|ref|NP_176947.1| 
unknown protein 
A. thaliana AT1G67810 78-222 65.3 11 
6 
gi|15220831|ref|NP_178196.1| 
unknown protein 
A. thaliana AT1G80810 169-256 57.1 9 
7 
gi|18409259|ref|NP_564964.1| 
unknown protein 
A. thaliana AT1G69390 174-206 49.1 26 
8 
gi|15223907|ref|NP_172353.1| 
unknown protein 
A. thaliana AT1G08760 110-207 29.6 9 
9 
gi|15234115|ref|NP_192035.1| 
transcription regulator 
A. thaliana AT4G01260 82-104 21.5 36 
10 
gi|42564175|ref|NP_188107.3| 
DNA binding / catalytic 
A. thaliana AT3G14890 86-103 20 33 
 
Supplemental Table 2. List of used primers. 
Primers used for genotyping 
SALK_099018_LP AATCACAGCACCTGGAATTTG 
SALK_099018_RP GCGATCTTCAATGCCATAAAG 
SALK_142384_LP ACCGATCACCAAGAAACACAC 
SALK_142384_RP GCCAGAGAATGACACCAAGAG 
SALK_133576_LP CATCTTTGCCTTTTGTTCTGC 
SALK_133576_RP CTCGATTAATCGCGTCTTGAG 
SALK_025092_LP GAACCATCAACAAAGCAATGG 
SALK_025092_RP ATTTGTATGTCCTCGGCAATG 
WiscDsLox320E02_LP ACTCGTATGCCTCGTTGTGAC 
WiscDsLox320E02_RP GGTACAGGACCAGAAAAAGGC 
LBA1 TGGTTCACGTAGTGGGCCATC 
P745 AACGTCCGCAATGTGTTATTAAGTTGTC 
Primers used for cloning 
attB1F_40640 GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGGAGCCTCCAACGGGA 
attB2R_40640 GGGGACCACTTTGTACAAGAAAGCTGGGTTTTACACAATATCAATGTCTCTT
AAC 
attB2R_40640_nostop GGGGACCACTTTGTACAAGAAAGCTGGGTTCACAATATCAATGTCTCTTAAC
C 
attB1F_27390 GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGGAGCCTCCAATAGGATT 
attB2R_27390 GGGGACCACTTTGTACAAGAAAGCTGGGTTTTAAACTATATCTACATTCCTTG
A 
attB2R_27390_nostop GGGGACCACTTTGTACAAGAAAGCTGGGTTAACTATATCTACATTCCTTGAG
A 
attB1F_37030 GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGGCTGTCGTCGTCACT 
attB2R_37030 GGGGACCACTTTGTACAAGAAAGCTGGGTTTTAACCCTCTTCAATGAAATCT 
attB2R_37030_nostop GGGGACCACTTTGTACAAGAAAGCTGGGTTACCCTCTTCAATGAAATCTC 
attB1F_12680 GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGGAAGTTCCCAAAGGATT 
attB2R_12680 GGGGACCACTTTGTACAAGAAAGCTGGGTTTTAGACAACATCCATGTCCG 
attB2R_12680_nostop GGGGACCACTTTGTACAAGAAAGCTGGGTTGACAACATCCATGTCCGG 
AttB1F_MSBP2 GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGGTTCAGCAAATATGGGA 
AttB2R_MSBP2 GGGGACCACTTTGTACAAGAAAGCTGGGTTTTACTCCTTTGCAGCATCAT 
AttB2R_MSBP2_nosto
p 
GGGGACCACTTTGTACAAGAAAGCTGGGTTCTCCTTTGCAGCATCATCAT 
40640_L1rev AGATCCGCCGCCTCCAGAACCTTTAATGACACCGAGAAGC 
40640_L1fw TCAGGCGGAGGAGGCTCAATCGTTTTATGCCCGCTTATATGC 
40640_L2rev AGATCCGCCGCCTCCAGAATATAGAGTCCAAATCGCGTGTAC 
40640_L2fw TCAGGCGGAGGAGGCTCATCGATAGCGAGTGCTAAACAGT 
40640_L4fw TCAGGCGGAGGAGGCTCAAAAGATGTTTGCTTTCACTCCTACT 
40640_L4rev AGATCCGCCGCCTCCAGAAAAATCACAAACAACGGTGAAACTG 
27390_L1rev AGATCCGCCGCCTCCAGATATAGTCACAACGAGGCATACG 
27390_L1fw TCAGGCGGAGGAGGCTCAGGCAACTCCGCGGTCATAC 
27390_L2rev AGATCCGCCGCCTCCAGACAAGATTGGTCCTACTTGTTTGG 
27390_L2fw TCAGGCGGAGGAGGCTCAAAGATCTTTCTATGCTTATGTCTTCC 
27390_L3rev AGATCCGCCGCCTCCAGAGGTGAAGCTGCGTTGCATG 
27390_L3fw TCAGGCGGAGGAGGCTCAGTTGTTCGGGATTTTAAAGATGTTT 
eGFP_Lxrev TGAGCCTCCTCCGCCTGACTTGTACAGCTCGTCCATGC 
eGFP_Lxfw TCTGGAGGCGGCGGATCTATGGTGAGCAAGGGCGAGG 
Primers used for qPCR 
33 GGCGGTTCGAGATCAGTTC 
34 CCCTCTGTTTGGTGAATCTTG 
35 AAGACAACAATTCGGCTAAGG 
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36 GATCAGATCCATTGACACTTCC 
51 GAGCCTCCAACGGGAATCTTG 
52 TGACACCGAGAAGCAGTAAACC 
53 TTTCACTGGTTTACTGCTTCTC 
54 CAGAGTTTCCAATAGCCACAG 
55 CTCGTATGCCTCGTTGTG 
56 AGATTGGTCCTACTTGTTTGG 
57 ACTTATGGATGAGCTGAAACAAAG 
58 TCCCGAGAACTGAAACTACTAAAG 
149 ATGGAAGTTCCCAAAGGATTCT 
150 GCCAAGGAGCAGCAAGAG 
151 TCTTCCTTACTTCTTCCT 
152 TTATAGCAGATGATATTGGA 
153 GTACATAGAAGCTCTTGAA 
154 ATCCAGATTTCCTGTTTG 
161 AATGTTGGAGTGATTCTT 
162 TTGCTAGACTTAGACCTA 
163 AAGGAATCAGCAGAAGGA 
164 TAACCACTTGTCTGAACCT 
Eef_Fw ACGGAGACATGGACCAGAAC 
Eef_rev GCTGAGTTGGGAGATCGAAG 
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Chapter VI: Discussion 
  
Conclusions and future challenges 
 
Small molecule effectors of endomembrane trafficking have the potential to become valuable tools 
in cell biology, signaling pathways and other biological processes dependent on the endomembrane 
continuum. With a well-defined interactome they can provide novel insights in what is by nature a 
highly dynamic and often essential process. In this thesis we identified, characterized, and explored 
target identification and validation strategies for small molecule hits derived from a library of 
potential effectors of endomembrane trafficking1. We take a step back and discuss some general 
principles which emerged with our obtained results, while reflecting on the future direction of plant 
chemical biology. 
 
Small molecules and cytotoxicity 
An important consideration when identifying and working with small molecule hits is their ability to 
affect general metabolism or any other process affecting general cellular functions, which will reflect 
on overall cell viability and behavior. In this thesis we provided evidence that one of the commonly 
used endocytic inhibitors in plants, Tyrphostin A23 (TyrA23), is a potent inhibitor of mitochondrial 
function and uncouples proton gradients throughout the cell, similar to the mode of action of Carbonyl 
cyanide m-chlorophenyl hydrazine (CCCP)2,3. This has come as a surprise, but fits with a currently 
increasing awareness in mammalian drug discovery concerning undesirable side effects of small 
molecules on mitochondrial function4,5. Mammalian drug discovery suffers from low success rates, 
mostly due to undesirable side effects of lead molecules. Often these are only found in later stages of 
hit optimization, or when the drug is already released, leading to market withdrawal6,7. One of the 
major responsible complications concerns the ability of the small molecule hit to affect mitochondrial 
functions4-7. This notion is fairly recent, which can be partially attributed to a process whereby ATP 
is generated through glycolysis rather than mitochondrial oxidative phosphorylation, also referred to 
as the Crabtree effect8. Since mammalian cell cultures tested for small molecule induced 
mitochondrial side effects are often tumor-derived, and culture conditions include much higher 
concentrations of glucose compared to physiological conditions, mitochondrial side-effects often go 
unnoticed5,8. Although PSB-D wild type cell cultures used for ATP measurements in this study were 
not evaluated for the presence of functional glycolysis, it is reasonable to assume that most ATP in 
the cell was produced by the mitochondria, as they are dark grown, and given the strong effect of 
CCCP, TyrA23 and ES9. In addition, another major difference with mammalian cell cultures is the 
pH of the medium. For plant cell cultures medium has a pH in the range of 5.5 to 6, while for 
mammalian cell cultures pH is much closer to cytosolic values. Since CCCP has been described to 
affect proton gradients over the plasma membrane5,9, it is reasonable to assume that protonophores 
will have a more pronounced effect in plant cell cultures opposed to mammalian cell cultures, as they 
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will induce a proton flux over the plasma membrane into the cytosol. The notion that a considerable 
amount of small molecule hits affect mitochondrial function was also reflected in preliminary 
experiments of our own. Aside ES9, a number of other small molecules inhibiting FM4-64 uptake 
were tested for ATP depletion, though were not further considered. From a total of 12, only 2 were 
found not to deplete ATP. In addition, small molecule 39 (Chapter 5, this thesis), which belonged to 
the same group of ES9 (Chapter 2, this thesis) also induced ATP depletion, though not as strong as 
ES9 (Chapter 5, this thesis). It is preliminary to conclude these small molecules would affect ATP 
depletion through a similar mechanism as ES9, though it illustrates the commonality of affecting 
mitochondrial functions. Taken together, above examples indicate that affecting mitochondrial 
functions is of frequent occurrence for small molecule hits, and this can be more pronounced 
depending on the biological material used. 
Generally speaking, in mammalian drug discovery two approaches can be distinguished: target-based 
and phenotype-based6. While target-based approaches start from a particular protein, which serves as 
a template for small molecule fitting and later phenotypic validation, phenotype-based approaches 
start from the induced phenotype and subsequently try to identify the target. It is the latter strategy 
which frequently employs screening readouts related to cytotoxicity. Often the incentive is to arrest 
growth and kill tumor cells, thus cytotoxic effects are a desired feature, yet need to be specific as non-
tumor cells should not be affected. Many assay types exist, among which ATP measurements6,7. In 
plants however, small molecule tools, not considering herbicides, are preferably perturbing the 
process of interest without affecting cell viability. They need to affect as specific as possible the 
process of interest, preferably in a direct manner. It would therefore be of use if new small molecules, 
and especially libraries designed and screened for the plant community, were evaluated for general 
cytotoxicity. One way could be through ATP measurements, which can be easily done in a high 
throughput fashion. Alternatively, cell cultures or other biologically relevant material could harbor a 
fluorescent marker induced upon cell death. Such readouts, when adopted for high throughput 
screening, could be used as one of the early screenings to eliminate small molecules which affect cell 
viability. Small molecules should be screened for such effects prior to any major commitments in the 
context of target identification or thorough description of target-linked effects. 
The primary mode of action of ES9, as described in Chapter 3 of this thesis (Figure1), which is shared 
with TyrA23 and CCCP, is an illustration of how non-specific metabolic effects might complicate 
interpretation of results, especially when small molecules are transferred to other systems without a 
thorough assessment of small molecule implications on general metabolism, cell survival, and of-
target effects. As different systems might present a different environment to the small molecule 
compared to the original system in which the small molecule was described, certain characteristics of 
the small molecule might be enhanced. 
  
Figure 1 Schematic representation of ES9 mode of action 
ES9 induced a dissipation of proton gradients throughout the cell, affecting processes such as ATP 
production, vacuolar morphology and clathrin mediated endocytosis. 
 
Small molecules and target deconvolution. 
Once established the small molecule of interest induces no undesirable side effects related to cell 
viability and overall function, the process of target identification can start. As outlined in the 
introduction, several small molecules identified through screening are known which affect 
endomembrane traffic in plants. Yet few have a well-defined target, and are considered as specific, 
thus are affecting only the target and process described. For a small molecule to become a useful tool 
in cell biology, the targets which have direct or indirect roles in endomembrane traffic should be 
known. As such the small molecule-induced perturbations of the endomembrane system can be 
interpreted correctly. In case targets remain obscure or not well defined, an element of uncertainty 
will remain in any conclusions drawn based on the small molecule induced perturbations. An example 
concerns the small molecule gravacin. Initially identified in a screen for small molecules able to 
inhibit vacuolar trafficking and gravitropic responses10, gravacin was later identified as an interactor 
of the ATP-binding cassette (ABC) transporter P-glycoprotein 19 (PGP19)11. Yet the induced 
phenotype could not be explained entirely by inhibition of PGP19 alone, as the perturbed vacuolar 
trafficking appeared unaffected, while pgp mutants were only partially resistant to gravitropic 
bending. 
A textbook example of a small molecule for which the target is known, and appears to be largely 
responsible for the observed phenotypes, is Brefeldin A (BFA). BFA was identified in the early 90ies 
as an inhibitor of the GTP conversion on ADP-ribosylation factor (ARF) proteins by guanine 
exchange factors (GEFs)12,13. Subsequent studies revealed that BFA acts as an uncompetitive 
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stabilizer of an otherwise transient ARF-GDP-GEF complex through binding the Sec7 domain of 
GEF proteins14-16, which dictates BFA sensitivity of GEFs in different systems. The consequence is 
a failed recruitment of coat proteins which results in a fusion of mostly cis-Golgi compartments with 
the endoplasmic reticulum (ER), while more trans Golgi cisternae fuse with endosomal compartments 
to form the BFA body17.  
In plants, BFA has been shown to target the ARF-GEF interface through genetic means18, while the 
current knowledge on BFA mode of action has allowed in recent years for a detailed dissection of 
endomembrane processes involving ARF-GEFs in plants19-21. BFA is therefore one of the few small 
molecules for which it is generally accepted that it targets mainly one protein family, while other 
probable targets have minor contributions to endomembrane disruptions mediated by BFA. 
Nonetheless, it would be interesting to gain insight on BFA target proteins proteome wide by 
biochemical means. As BFA related research has been going on for decades, while gravacin only 
emerged about 10 years ago, it could seem unfair to criticize specificity of gravacin. However, both 
examples are an illustration of the requirement for a thorough understanding of small molecule mode 
of action before it can become a useful tool in cell biology.  
Although knowledge on target proteins is in any case useful, some small molecules can be used 
without detailed specification of their interactome. For example, inhibitors of enzymatic steps in 
metabolism or biosynthesis, such as Brassinazole (Brz)22 are mostly evaluated for their effect on the 
pathway in question, for Brz the biosynthesis of brassinosteroids. They are often used to deplete the 
cell of a pathway intermediate or final product, which can be used as a discovery tool for signaling 
pathway components initiated by the final product23. Usually additional target proteins have little 
effect on the pathway in question, hence are not considered to interfere with the experimental 
outcome.  
Clearly a high degree of specificity is favorable, but off-target proteins seem to be a necessary evil 
for most small molecules. The question arises if this high degree of specificity is really required. As 
is known in the mammalian drug discovery field, small molecules appear to have on average six target 
proteins24,25, which all contribute to the overall observed phenotype, depending on the point of view. 
The crucial point here is the purpose and mode of action of the small molecule in question. As outlined 
above, enzyme inhibitors might be less prone to interference from off-target proteins as the 
phenotypic readout is usually very specific. In contrast, trafficking modulators are more sensitive as 
the endomembrane compartment is a complex and dynamic continuum, where additional targets 
affecting endomembrane traffic might complicate interpretation of results. It is therefore essential for 
endomembrane modulators, and preferable for other small molecules, to have knowledge on the entire 
interactome if possible, in order for the small molecule to become a valuable tool for biology. 
 
Target identification and validation: the importance of biochemical approaches 
Knowledge of the small molecule interactome is essential for modulators of trafficking, and as 
discussed in the introduction, classical genetics approaches are less suited, as they will fail to identify 
the entire interactome. Only few approaches allow interactome identification, including affinity 
purification and label free approaches. Yet all of them have pitfalls, most commonly related to 
modification of the small molecule and membrane proteins26. As we explored in this thesis, a 
combination of biochemical assays to identify and validate target binding holds the promise to reveal 
the most important contributors to the phenotype of interest. If the small molecule allows modification 
without losing activity, affinity purification can reveal candidate interactors based on the abundance 
and reproducibility in affinity purification. Subsequent selection of promising candidate target 
proteins for further validation can confirm the relevance of their presence in pull-down experiments. 
Depending on the resources available, several experimental approaches can be adopted, with some of 
the most accessible being cellular thermal shift assay (CETSA)27 and drug affinity responsive target 
stability (DARTS)28. If possible target proteins score positive with CETSA and DARTS for binding, 
chances are high the small molecule of interest is a true interactor. This can be confirmed by further 
in-depth analysis of the small molecule-target protein complex using crystallographic studies or 
techniques such as isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR). 
Finally, as the list of potential target proteins is reduced to few candidates, mutant analysis can 
provide further genetic proof of small molecule binding. Alternatively, depending on resources 
available, one could opt to start from a genetics perspective, screening mutant libraries for resistant 
individuals, which then serve to identify genomic mutations leading to the resistant phenotype. 
Subsequently targeted biochemical approaches are used to validate small molecule binding. Although 
successful examples exist11,29-31, the chances are relatively high the target protein will not be directly 
involved in the phenotype of interest32,33. In addition, genetic strategies have an inherent pitfall when 
targets are of essential nature, certainly when the mutation renders the protein inactive. Redundancy 
can pose a significant problem as well, as only higher order mutants might reveal a phenotype on 
small molecule. 
It is therefore more suited to approach target identification from a biochemical perspective rather than 
a genetic perspective, certainly when working with small molecule modulators of endomembrane 
traffic. Naturally not all small molecule hits are suited for affinity purification based approaches, as 
modification might interfere with small molecule activity, or when affinity for its target is not high 
enough for successful purification. To solve those issues, label free approaches have gained more 
attention over the recent years. Although most of them are relatively recent, technological advances 
in the coming years might propel label free target identification to the forefront of target 
identification. Especially proteome wide target identification holds big promises, as they allow an 
almost total view on the small molecule interactome. Examples are target identification by 
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chromatographic co-elution34, and the recently described proteome-wide CETSA approach35. 
Although currently a major investment in terms of time and effort, future technological advances will 
increase accessibility of such approaches, and might provide solutions to current pitfalls such as 
membrane proteins, low abundant targets, and low affinity. 
In conclusion, chemical biology approaches for cell biology hold great promises if certain criteria are 
met. First, the small molecule should not affect cell viability through interference with a variety of 
essential cellular processes, unless meant to. Second, small molecule interactomes are essential to 
fully explore and use the small molecule potential. This is best achieved through biochemical means, 
as genetic strategies fall short. Last, but certainly not least, is the role of chemists in projects as 
described in this thesis. It is one thing to work on a chemical biology project from a biologists point 
of view, yet completely different when viewed from a chemists point of view. Cross pollination of 
both disciplines can only propel a chemical biology project further, as both help each other in a better 
understanding of the biological problem in question, which alone they would not achieve.  
 
Small molecules and CME 
Small molecule inhibition of CME is currently a very active field of research, as few specific 
inhibitors have been identified, both in plant and mammalian systems. The best known examples are 
Pitstops36 and Dynasore37, but both have yet to find their way to the plant field. Specific inhibitors of 
clathrin have the potential to facilitate a better understanding of the different roles clathrin has in 
several aspects of plant biology in a conditional, reversible and dynamic fashion. They are therefore 
of great value, as genetic means cannot provide a similar versatile and quick inhibition of clathrin 
mediated processes. Though small molecule inhibitors of endocytosis are valuable tools in 
deciphering the molecular machinery driving CME, their use extends fundamental cell biology, and 
finds application in healthcare. As clathrin is essential for cell survival, major defects in CME are not 
expected in human disease38. However, subtle changes in functionality of CME machinery can have 
several implications for human health38. More importantly, engineering of CME machinery, which 
could involve clathrin, can be a tool to inhibit pathogen uptake into the cell38. 
Although the substantial investment in time and money will remain a major hurdle, it would be 
extremely interesting to inhibit CME at different points with small molecules. One group could 
comprise small molecule inhibitors of structural aspects, such as clathrin and vesicle formation, while 
another group could include inhibitors which interfere with cargo recognition and recruitment. The 
latter group might contain inhibitors which specifically inhibit cargo recognition at the level of cargo 
rather than adaptor complexes such as AP2, since highly specific inhibition of CME might be 
achieved for a particular group of receptors. As such implications for cell biology could be evaluated 
without the risk that CME inhibition of other cargo would complicate interpretation of results.  
On a final note this thought. Supposedly the ultimate goal for small molecule interference of 
endomembrane traffic can be illustrated by the following analogy: imagine a complex system like an 
ant colony, with its many supply routes, nurseries, soldiers and central command, all dependent on 
each other. One could imagine ants as individual proteins, while routes, nurseries or other chambers 
in the colony represent different endomembrane compartments and their complex connections. Our 
current efforts to understand its intricate behavior equals hitting the colony as hard as we can in a 
variety of ways, admittedly with a little thought, only to observe how it reassembles itself, if it 
survives the sudden disturbance. We ought to be able to disturb the colony in such a way, by subtly 
rerouting certain supply routes to the colony for example, that the system hardly notices the changes, 
and quietly readjusts to run as smooth as possible again. Only then we can start to appreciate the 
delicate hierarchical relations required to run a highly complex and dynamic system like an ant 
colony. 
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Administrative experiences 
August 27th - 30th, 2013 
Member of the organizing committee of the 16th European Network of Plant Endomembrane 
Research (ENPER) meeting. 
Several supporting responsibilities such as organization of transport, poster session, lunch sessions 
and reception.  
Ghent, Belgium 
 
July 23rd - 26th, 2013 
Chairman of the organizing committee of the 5th European Plant Science Retreat (EPSR) for PhD 
students 
Taking the initiative of organizing and end responsibility of the event, coordination with the 
University of Ghent for housing, venue, financial administration and with the doctoral schools unit 
of the university. Contact person for European doctoral schools and participants, attracting funding 
and several other aspects such as transport and catering. 
Ghent, Belgium 
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Conference participation and contributions 
Participation was aimed at getting feedback on our work and to increase on international visibility 
and collaborations. 
 
2014 
25th International Conference on Arabidopsis Research (ICAR), Poster Presentation 
Vancouver, Canada 
 
BASF Research Forum Europe, Poster presentation 
Antwerp, Belgium 
 
2013 
16th European Network of Plant Endomembrane Research (ENPER) meeting, Oral Presentation 
Gent, Belgium 
 
5th European Plant Science Retreat (EPSR) for PhD students 
Gent, Belgium 
 
2012 
15th ENPER meeting, Poster Presentation 
Madrid, Spain 
 
4th EPSR for PhD students, Poster presentation 
Norwich, UK 
 
1st International Brassinosteroid Conference, Poster presentation 
Barcelona, Spain 
 
2011 
14th ENPER meeting, Poster presentation 
Assisi, Italy 
 
Skills and attended courses 
Languages: 
Dutch: mother tongue. English: fluent. French: basic. 
 Selection of scientific techniques: 
Confocal laser scanning microscopy, spinning disc microscopy, affinity purification of (small 
molecule) target proteins, Drug Affinity Responsive Target Stability, protein thermal shift assays, 
standard molecular biology techniques, qPCR, western blotting. 
 
December 16th 2011 
Mass spectrometry data analysis 
Bioinformatics Training and Service Facility (BITS) of VIB 
VIB, Ghent, Belgium 
 
May 16th - 20th 2011 
Summer school on advanced light microscopy 
VIB research training course 
VIB, Ghent, Belgium 
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Dejonghe, W., Van Houtte, I., Russinova, E. Identification of a plant specific membrane-bound 
protein family involved in steroid homeostasis. In preparation 
 
Publications 
 
Dejonghe, W., Mishev, K. & Russinova, E. The brassinosteroid chemical toolbox. Curr Opin Plant 
Biol, 22, 48-55 (2014). 
 Writing of the manuscript and parts of figure design 
 
Dejonghe, W. & Russinova, E. Target identification strategies in plant chemical biology. Front Plant 
Sci 5, 352 (2014). 
 Writing the manuscript and figure design 
 
Kerchev, P. I., De Clercq, I., Denecker, J., Mühlenbock, P., Kumpf, R., Nguyen, L., Audenaert, D., 
Dejonghe, W. & Van Breusegem, F. Mitochondrial perturbation negatively affects auxin 
signaling. Mol Plant 7, 1138–1150 (2014). 
 Confocal laser scanning microscopy analysis of mitochondrial membrane potential. 
 
Di Rubbo, S., Irani, N. G., Kim, S. Y., Xu, Z. Y., Gadeyne, A., Dejonghe, W., Vanhoutte, I., Persiau, 
G., Eeckhout, D., Simon, S., Song, K., Kleine-Vehn, J., Friml, J., De Jaeger, G., Van Damme, 
D., Hwang, I. & Russinova, E. The clathrin adaptor complex AP-2 mediates endocytosis of 
brassinosteroid insensitive1 in Arabidopsis. Plant Cell 25, 2986–2997 (2013). 
 Parts of qPCR analysis 
 
Mishev, K., Dejonghe, W. & Russinova, E. Small molecules for dissecting endomembrane trafficking: 
a cross-systems view. Chem Biol 20, 475–486 (2013). 
 Figure design and parts of manuscript writing 
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